data_2mul_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mul _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.03 -31.55 83.86 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.307 2.005 . . . . 0.0 113.132 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 -16.57 61.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.118 0.567 . . . . 0.0 109.836 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.97 16.33 0.56 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 65.14 22.45 68.96 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2962 ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' 2970 ' ' PRO . 20.4 pt -68.7 141.87 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.605 0.762 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.0 m -83.71 83.29 7.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.469 0.707 . . . . 0.0 111.778 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.439 HD21 HD11 ' A' 2973 ' ' LEU . 11.1 mp -119.28 146.27 40.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.391 1.076 . . . . 0.0 109.674 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.74 162.38 37.64 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.258 2.639 . . . . 0.0 111.845 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.55 141.99 56.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.09 0.556 . . . . 0.0 110.679 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 92.33 -33.23 5.04 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.346 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 13.9 t -84.05 105.98 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.489 0.716 . . . . 0.0 109.515 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.26 135.93 20.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.323 0.649 . . . . 0.0 109.44 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.486 ' HG3' HD11 ' A' 2962 ' ' ILE . 86.7 Cg_endo -74.03 -3.22 13.43 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.137 2.558 . . . . 0.0 115.521 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 73.2 m -62.05 -53.49 54.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.753 0.706 . . . . 0.0 110.916 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 31.6 p90 -71.76 -22.4 61.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.45 HD23 ' HG2' ' A' 2981 ' ' ARG . 55.6 mt -73.57 -37.33 65.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.484 0.313 . . . . 0.0 111.746 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.52 -36.35 12.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.327 0.651 . . . . 0.0 111.391 -174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -76.28 -29.93 57.61 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.145 0.578 . . . . 0.0 111.228 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.487 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 68.8 mt -104.26 165.25 13.7 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2977 ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 32.2 Cg_endo -59.76 168.65 5.3 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.943 2.429 . . . . 0.0 114.519 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.13 -15.46 61.48 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.102 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.46 -53.82 31.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.467 0.707 . . . . 0.0 111.488 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.577 ' HA ' ' HB3' ' A' 2983 ' ' GLU . 0.1 OUTLIER -78.91 -17.7 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 120.653 0.263 . . . . 0.0 110.355 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.45 ' HG2' HD23 ' A' 2973 ' ' LEU . 7.8 tmm_? -63.7 -52.29 61.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.493 1.117 . . . . 0.0 110.645 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.27 -32.96 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.582 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.577 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 8.6 tp10 -51.99 -56.48 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 111.295 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.4 m -68.65 -34.51 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.602 0.361 . . . . 0.0 111.464 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2985 ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' 2989 ' ' LEU . 25.3 tp -67.3 -54.75 17.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.343 0.592 . . . . 0.0 111.397 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.26 -43.28 74.25 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.442 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.79 -43.01 38.49 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.469 ' HB2' HD21 ' A' 2989 ' ' LEU . 25.0 mt-30 -76.81 -50.94 12.28 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.713 0.292 . . . . 0.0 111.704 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.7 mm? -93.4 -30.76 14.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.819 0.447 . . . . 0.0 111.086 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 77.52 4.76 85.18 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.23 0.332 . . . . 0.0 113.763 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.54 134.94 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.733 0.813 . . . . 0.0 109.708 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 CA--C 1.548 0.87 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.719 178.426 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 -29.2 80.96 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.902 2.401 . . . . 0.0 112.522 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -19.49 62.71 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.285 0.634 . . . . 0.0 110.254 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.62 -23.14 65.83 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.464 0.706 . . . . 0.0 112.058 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 120.33 -9.97 10.87 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.767 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.9 pp -78.97 165.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 117.054 0.427 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 26.5 p -115.71 96.27 5.53 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.11 0.481 . . . . 0.0 111.915 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 64.6 mt -76.44 139.47 67.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.95 0.5 . . . . 0.0 109.973 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 20.8 Cg_exo -63.17 167.88 11.84 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.94 2.427 . . . . 0.0 112.785 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.22 132.66 54.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.803 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 85.57 5.19 84.85 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.49 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 37.9 t -111.36 101.04 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.559 0.68 . . . . 0.0 110.387 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.72 151.69 37.74 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.686 0.794 . . . . 0.0 109.352 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.5 -0.22 8.46 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.559 2.173 . . . . 0.0 112.547 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 16.5 m -65.54 -60.1 3.28 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.903 0.881 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.6 p90 -72.17 -30.04 64.6 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.137 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 10.8 tp -68.23 -30.89 70.06 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.547 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -95.04 -53.37 3.84 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.483 0.713 . . . . 0.0 111.789 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.71 89.0 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.746 0.818 . . . . 0.0 112.113 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.778 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.1 mt -80.68 140.5 51.21 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.01 167.01 13.0 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.706 2.271 . . . . 0.0 112.387 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.22 -29.29 63.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.46 -59.2 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.536 0.522 . . . . 0.0 111.715 -171.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.22 -29.71 9.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.732 -175.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -39.35 89.91 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.989 0.423 . . . . 0.0 110.209 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -77.1 -36.81 55.34 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.738 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -36.83 70.23 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.191 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2984 ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' 2980 ' ' ILE . 26.8 m -65.9 -33.67 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.1 0.409 . . . . 0.0 110.851 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 58.5 tp -59.44 -56.35 23.08 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.177 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -73.8 -25.98 60.39 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.06 -55.05 5.96 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 117.835 0.289 . . . . 0.0 111.032 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -64.54 -42.29 95.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 0.0 112.149 -172.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.1 mm? -101.05 -27.98 12.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.32 0.248 . . . . 0.0 111.498 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 70.2 37.37 71.86 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.25 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.17 122.99 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 . . . . . 0 CA--C 1.551 1.015 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.089 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 2958 ' ' PRO . . . . . 0.485 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 13.4 Cg_endo -55.22 -22.35 32.17 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.154 2.569 . . . . 0.0 114.341 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.48 10.32 9.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 111.721 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -83.63 0.65 45.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.629 0.772 . . . . 0.0 110.273 164.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 97.78 -1.6 59.86 Favored Glycine 0 C--N 1.351 1.388 0 C-N-CA 123.309 0.481 . . . . 0.0 112.708 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 30.9 pt -89.21 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.005 0.522 . . . . 0.0 111.081 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -117.09 102.91 9.72 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.733 0.813 . . . . 0.0 109.66 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.77 120.43 70.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.85 175.32 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.904 3.069 . . . . 0.0 114.064 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -70.29 131.81 44.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.702 0.401 . . . . 0.0 110.457 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.66 -19.93 44.97 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.543 0.527 . . . . 0.0 112.715 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 24.5 t -87.46 90.04 3.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.399 0.68 . . . . 0.0 109.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 56.3 t0 -85.34 118.27 70.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.485 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 56.6 Cg_endo -64.9 -3.6 7.27 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.737 2.291 . . . . 0.0 114.074 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.9 m -60.07 -50.15 74.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.989 0.516 . . . . 0.0 110.932 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 10.7 p90 -75.36 -25.76 57.97 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.513 HD11 HH21 ' A' 2981 ' ' ARG . 87.5 mt -67.17 -37.55 83.93 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.968 0.413 . . . . 0.0 110.599 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -90.02 -38.78 13.37 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.02 0.928 . . . . 0.0 112.223 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.88 63.32 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.09 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.5 158.59 36.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 123.802 0.841 . . . . 0.0 109.007 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.83 -171.8 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.777 2.318 . . . . 0.0 113.796 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2978 ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' 2981 ' ' ARG . 29.8 t70 -72.29 -34.89 68.49 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.17 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.34 -54.01 51.88 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.366 1.067 . . . . 0.0 111.285 -165.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.622 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.36 -26.31 14.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.371 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.513 HH21 HD11 ' A' 2973 ' ' LEU . 0.0 OUTLIER -68.12 -38.17 81.94 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.449 0.568 . . . . 0.0 110.535 -175.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -41.32 57.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.037 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 9.9 pt-20 -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 118.031 0.378 . . . . 0.0 111.341 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 31.6 m -69.69 -38.94 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 117.929 0.331 . . . . 0.0 110.774 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -49.38 78.07 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.113 0.482 . . . . 0.0 111.57 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.5 -35.81 65.69 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.918 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.39 -31.35 57.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.516 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.9 mm-40 -82.38 -48.23 11.39 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 111.51 -177.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' 2988 ' ' GLN . 0.8 OUTLIER -109.08 -34.88 6.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.346 0.258 . . . . 0.0 111.348 -171.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 86.05 2.04 86.25 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.347 0.404 . . . . 0.0 113.066 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.53 129.45 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 123.399 0.68 . . . . 0.0 109.552 175.929 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.94 -31.47 93.71 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.942 2.428 . . . . 0.0 112.716 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.78 -24.59 44.56 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.491 0.717 . . . . 0.0 110.382 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.2 -21.38 61.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.548 0.739 . . . . 0.0 112.74 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.91 -0.54 64.66 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.271 0.357 . . . . 0.0 113.363 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.62 167.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.079 0.952 . . . . 0.0 111.164 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -80.25 87.04 5.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.063 0.545 . . . . 0.0 110.904 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 11.1 tp -118.76 124.46 28.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.445 ' HG3' HG23 ' A' 2991 ' ' ILE . 96.3 Cg_endo -74.04 -162.04 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.954 2.436 . . . . 0.0 113.735 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -82.44 157.77 23.53 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.765 0.826 . . . . 0.0 110.61 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 62.76 18.22 59.06 Favored Glycine 0 N--CA 1.479 1.511 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.72 146.48 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.138 0.975 . . . . 0.0 108.884 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -132.79 124.32 18.72 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.279 0.632 . . . . 0.0 110.13 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.546 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 85.4 Cg_endo -76.21 2.72 6.91 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.675 2.25 . . . . 0.0 114.774 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 8.4 m -72.84 -56.96 4.45 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.881 0.764 . . . . 0.0 109.936 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 27.3 p90 -73.09 -22.33 60.6 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.17 0.188 . . . . 0.0 110.938 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' 2981 ' ' ARG . 6.9 mp -63.96 -51.5 64.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.49 0.716 . . . . 0.0 110.703 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -80.12 -26.78 39.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.289 0.636 . . . . 0.0 112.325 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -79.96 -49.3 12.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.676 0.39 . . . . 0.0 110.888 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 40.1 mt -97.73 150.38 36.72 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.113 0.965 . . . . 0.0 109.989 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.76 151.91 60.6 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.148 3.232 . . . . 0.0 113.482 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.21 -21.69 3.63 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 125.199 1.4 . . . . 0.0 113.796 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -51.57 -50.06 60.86 Favored 'General case' 0 C--O 1.248 1.017 0 C-N-CA 124.188 0.995 . . . . 0.0 111.353 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -72.56 -31.62 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.565 -177.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.547 ' HB2' ' HG ' ' A' 2973 ' ' LEU . 0.1 OUTLIER -70.06 -43.08 71.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.725 0.81 . . . . 0.0 109.888 -174.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -76.06 -31.34 58.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.219 0.324 . . . . 0.0 110.852 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -76.21 -40.43 52.25 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.99 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2984 ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' 2980 ' ' ILE . 27.0 m -66.24 -30.96 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-N 118.34 0.518 . . . . 0.0 110.171 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.15 -51.08 70.58 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 123.774 0.83 . . . . 0.0 110.672 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -75.02 -40.88 60.3 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.631 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -70.1 -53.63 16.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.329 . . . . 0.0 111.0 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.506 ' HB2' HD21 ' A' 2989 ' ' LEU . 28.9 mm-40 -64.07 -54.63 31.11 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.276 0.36 . . . . 0.0 111.891 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -103.99 -35.57 8.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.103 0.252 . . . . 0.0 111.628 -169.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 10.35 85.39 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.354 0.409 . . . . 0.0 113.436 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.445 HG23 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.48 121.96 24.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 . . . . . 0 CA--C 1.547 0.859 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.841 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.36 -24.33 22.92 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.242 2.628 . . . . 0.0 113.175 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 37.1 tp -83.36 -14.0 53.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.008 0.523 . . . . 0.0 110.767 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.34 41.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.402 0.681 . . . . 0.0 112.104 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 92.86 6.78 63.31 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 113.268 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.09 157.81 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.873 0.469 . . . . 0.0 110.97 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.0 p -88.68 100.4 13.09 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.152 0.581 . . . . 0.0 111.6 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 68.2 mt -100.08 133.73 21.37 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 167.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.79 173.84 13.82 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.205 1.936 . . . . 0.0 111.803 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.11 143.12 50.73 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.386 0.674 . . . . 0.0 111.676 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 81.66 7.02 88.63 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.778 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 62.0 t -105.48 108.66 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.707 0.803 . . . . 0.0 109.609 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.1 141.07 27.57 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.602 0.761 . . . . 0.0 110.647 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.48 ' HA ' HD11 ' A' 2973 ' ' LEU . 59.3 Cg_endo -67.23 -10.89 30.2 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.903 2.402 . . . . 0.0 112.687 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.1 m -56.6 -59.22 5.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2972 ' ' PHE . . . . . 0.517 ' HB2' HD12 ' A' 2976 ' ' LEU . 54.6 p90 -75.57 -24.22 56.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.383 0.273 . . . . 0.0 111.434 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.559 HD22 ' HB2' ' A' 2981 ' ' ARG . 81.5 mt -68.5 -35.44 77.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.512 0.325 . . . . 0.0 110.921 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.79 -31.18 14.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.714 0.806 . . . . 0.0 112.134 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.1 24.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.879 0.471 . . . . 0.0 111.732 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' 2972 ' ' PHE . 58.3 mt -108.06 161.23 24.06 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.895 0.878 . . . . 0.0 110.087 -172.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.7 -177.74 1.04 Allowed 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.928 2.418 . . . . 0.0 113.956 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.43 -27.52 62.38 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.012 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2979 ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' 2982 ' ' ARG . 29.6 t70 -59.19 -54.15 50.19 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.548 0.739 . . . . 0.0 112.524 -170.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.52 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.91 -28.9 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.65 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.559 ' HB2' HD22 ' A' 2973 ' ' LEU . 0.0 OUTLIER -69.29 -36.81 77.42 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -175.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2982 ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' 2979 ' ' ASP . 27.7 ptt180 -74.66 -40.39 61.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.931 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.7 pt-20 -69.65 -43.24 72.99 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.659 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 24.1 m -65.81 -32.81 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.113 0.415 . . . . 0.0 110.466 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 36.0 tp -63.8 -49.56 72.43 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.345 0.658 . . . . 0.0 111.046 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.79 -36.24 50.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.743 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.57 -53.63 11.42 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.718 0.407 . . . . 0.0 110.413 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.403 ' HB2' HD21 ' A' 2989 ' ' LEU . 24.8 mt-30 -66.67 -54.82 19.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.343 0.657 . . . . 0.0 111.401 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' 2988 ' ' GLN . 2.5 mm? -88.23 -48.89 7.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.922 0.489 . . . . 0.0 110.982 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.1 61.95 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.418 -0.657 . . . . 0.0 113.846 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.56 127.01 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.378 0.671 . . . . 0.0 110.473 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.029 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.52 -29.61 88.97 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.897 2.398 . . . . 0.0 113.758 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 32.2 tp -72.89 -16.81 61.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.336 0.655 . . . . 0.0 111.533 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.69 64.5 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.267 0.627 . . . . 0.0 111.525 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 103.84 13.25 28.01 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.442 0.464 . . . . 0.0 112.869 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 23.2 pt -110.18 154.92 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.321 0.648 . . . . 0.0 110.753 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.3 m -105.42 102.05 11.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.55 143.02 96.7 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.194 0.598 . . . . 0.0 109.664 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.569 ' HG2' HG22 ' A' 2968 ' ' VAL . 29.1 Cg_endo -67.48 166.27 24.34 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.443 2.095 . . . . 0.0 112.049 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.17 132.26 53.03 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.48 0.712 . . . . 0.0 111.275 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 76.18 26.17 64.65 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.705 0.628 . . . . 0.0 113.921 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' 2965 ' ' PRO . 52.2 t -119.01 132.13 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.0 0.52 . . . . 0.0 109.783 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -120.86 134.58 24.34 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.007 0.923 . . . . 0.0 109.176 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.54 -7.6 20.81 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.897 2.398 . . . . 0.0 114.816 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 55.9 m -65.36 -54.97 21.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.334 0.515 . . . . 0.0 110.943 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.9 p90 -71.58 -30.28 65.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.578 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.66 -21.67 61.05 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.986 -174.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -96.94 -47.51 5.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.454 0.702 . . . . 0.0 111.773 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.29 70.43 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.676 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.8 mt -71.73 139.91 83.61 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.784 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 158.16 43.54 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.624 2.216 . . . . 0.0 111.161 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.29 -16.83 61.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.39 -58.17 4.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.306 0.503 . . . . 0.0 112.283 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.43 -23.08 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.746 -0.596 . . . . 0.0 109.78 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -65.28 -44.89 86.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.613 0.765 . . . . 0.0 110.157 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -70.99 -39.5 72.4 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.377 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.9 pt-20 -70.21 -37.41 75.04 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.855 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.5 m -67.42 -32.11 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 118.255 0.479 . . . . 0.0 110.558 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.67 -45.23 83.67 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 121.48 0.657 . . . . 0.0 109.952 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -73.95 -44.73 53.94 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.386 0.674 . . . . 0.0 112.357 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.3 -39.21 59.81 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.932 0.493 . . . . 0.0 112.008 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -74.51 -48.47 26.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.485 0.314 . . . . 0.0 111.512 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.82 -43.52 7.47 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.298 0.239 . . . . 0.0 111.271 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 11.15 84.46 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.819 0.699 . . . . 0.0 113.58 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.54 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -74.45 123.93 30.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 . . . . . 0 CA--C 1.547 0.841 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.759 -176.447 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 2958 ' ' PRO . . . . . 0.406 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 22.7 Cg_endo -57.11 -34.68 98.18 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.068 2.512 . . . . 0.0 113.536 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -16.33 58.66 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.912 0.485 . . . . 0.0 111.309 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.01 -16.49 61.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.604 0.762 . . . . 0.0 112.503 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 96.58 3.06 59.81 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.797 -0.446 . . . . 0.0 113.606 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2962 ' ' ILE . . . . . 0.401 HD12 ' HG ' ' A' 2964 ' ' LEU . 2.6 pp -74.12 156.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 122.913 0.485 . . . . 0.0 110.786 175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 54.5 m -94.19 97.46 10.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.99 0.516 . . . . 0.0 111.153 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' 2962 ' ' ILE . 81.3 mt -103.14 134.54 19.72 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.397 0.679 . . . . 0.0 109.328 167.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.466 ' HG3' HG22 ' A' 2991 ' ' ILE . 42.2 Cg_endo -64.4 156.72 58.56 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.107 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.15 138.14 43.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.04 0.536 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 110.57 -27.77 10.93 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.962 -0.355 . . . . 0.0 113.461 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.583 ' HB ' HD22 ' A' 2989 ' ' LEU . 7.3 p -91.14 137.78 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 122.894 0.477 . . . . 0.0 110.714 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.4 124.98 59.61 Favored Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.406 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 54.4 Cg_endo -65.68 -9.26 22.07 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.828 2.352 . . . . 0.0 113.079 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 40.0 m -54.09 -60.03 3.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.296 1.039 . . . . 0.0 111.456 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 40.6 p90 -79.62 -21.96 44.23 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.325 0.391 . . . . 0.0 111.21 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.432 HD21 ' HD2' ' A' 2981 ' ' ARG . 72.8 mt -63.99 -36.02 82.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.22 -35.99 12.84 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.558 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -73.15 -24.44 60.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.581 0.752 . . . . 0.0 112.118 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.741 ' HB3' HD12 ' A' 2980 ' ' ILE . 58.6 mt -111.26 144.65 30.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.722 0.809 . . . . 0.0 109.603 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.79 172.08 10.06 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.332 2.688 . . . . 0.0 113.553 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2978 ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 6.3 p-10 -63.12 -17.25 62.13 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -168.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.44 -58.99 4.09 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 121.456 0.646 . . . . 0.0 110.297 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.783 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -82.37 -27.18 8.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.099 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 26.1 tpt85 -51.58 -49.85 61.3 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.664 0.785 . . . . 0.0 111.245 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -72.95 -43.99 61.67 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.036 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.783 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.6 pt-20 -66.28 -40.43 90.07 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 117.993 0.361 . . . . 0.0 111.182 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.3 m -68.28 -35.84 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 117.891 0.314 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2985 ' ' LEU . . . . . 0.406 HD22 ' NH1' ' A' 2981 ' ' ARG . 17.5 tp -65.72 -45.19 83.65 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.409 0.624 . . . . 0.0 110.844 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -73.38 -40.22 64.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.345 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -75.63 -38.62 58.77 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.018 -175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.508 ' HB2' HD21 ' A' 2989 ' ' LEU . 26.5 mm-40 -75.7 -55.83 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.462 0.305 . . . . 0.0 111.392 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.583 HD22 ' HB ' ' A' 2968 ' ' VAL . 1.2 mm? -96.73 -23.47 16.41 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.387 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.21 19.58 71.74 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.585 0.553 . . . . 0.0 113.624 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.466 HG22 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -84.42 141.38 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 123.687 0.795 . . . . 0.0 109.44 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 . . . . . 0 CA--C 1.559 1.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.242 -179.251 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 2957 ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 22.3 t70 . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2958 ' ' PRO . . . . . 0.546 ' HA ' HD12 ' A' 2964 ' ' LEU . 56.6 Cg_endo -65.15 -21.41 62.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.103 2.535 . . . . 0.0 113.982 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.05 9.08 30.62 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.234 0.614 . . . . 0.0 110.959 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2960 ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -67.18 -14.95 63.39 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.16 12.53 76.21 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2962 ' ' ILE . . . . . 0.488 HG12 ' HB1' ' A' 2960 ' ' ALA . 26.5 pt -91.12 162.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.837 0.855 . . . . 0.0 110.577 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 31.9 p -81.04 81.87 7.16 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.21 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' 2958 ' ' PRO . 78.2 mt -106.43 116.26 59.44 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.532 0.733 . . . . 0.0 109.342 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.586 ' HG3' HG21 ' A' 2991 ' ' ILE . 72.6 Cg_endo -70.1 168.32 22.33 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.595 2.196 . . . . 0.0 112.461 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2966 ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' 2989 ' ' LEU . 42.4 tt0 -78.99 129.15 34.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.03 0.532 . . . . 0.0 110.68 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 111.85 0.72 27.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 120.063 -0.298 . . . . 0.0 113.661 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 11.9 p -110.31 112.71 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 121.677 0.751 . . . . 0.0 109.82 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.97 130.45 36.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 110.187 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.26 28.18 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.304 2.669 . . . . 0.0 115.038 -174.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.6 m -72.05 -47.24 53.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.549 0.613 . . . . 0.0 110.832 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2972 ' ' PHE . . . . . 0.416 ' HB2' HD12 ' A' 2976 ' ' LEU . 17.4 p90 -73.2 -30.22 63.37 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.319 0.58 . . . . 0.0 110.302 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' 2981 ' ' ARG . 9.8 tp -69.49 -27.05 64.87 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.582 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.65 -54.75 3.38 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.273 1.029 . . . . 0.0 111.443 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.71 80.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.526 0.73 . . . . 0.0 112.168 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.88 ' HB3' HD11 ' A' 2980 ' ' ILE . 86.4 mt -79.58 143.99 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.76 174.54 6.47 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.937 2.425 . . . . 0.0 112.067 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -27.59 68.68 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.93 -57.5 10.55 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 123.974 0.909 . . . . 0.0 112.142 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.66 -28.46 8.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.604 -176.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.408 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.3 OUTLIER -68.74 -34.24 75.28 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -176.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -75.33 -40.09 58.71 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 122.542 0.337 . . . . 0.0 110.473 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.7 pt-20 -70.24 -38.42 75.18 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-O 118.952 -0.546 . . . . 0.0 110.987 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 30.8 m -68.99 -34.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.574 0.35 . . . . 0.0 110.638 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.93 -47.6 80.24 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.714 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.89 -32.46 51.87 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.693 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.12 -28.2 54.28 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.801 0.44 . . . . 0.0 111.823 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' 2989 ' ' LEU . 26.9 mt-30 -78.81 -51.93 9.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.603 0.361 . . . . 0.0 110.871 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' 2988 ' ' GLN . 2.4 mm? -98.43 -49.61 4.6 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.651 0.38 . . . . 0.0 111.914 -171.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 96.36 9.59 56.63 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.431 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.586 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -70.97 125.06 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.843 0.857 . . . . 0.0 109.457 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.549 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 19.1 t0 . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.37 -27.17 71.15 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.066 2.511 . . . . 0.0 112.534 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.38 -19.5 60.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.22 0.608 . . . . 0.0 110.935 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -67.79 -10.98 57.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.094 0.557 . . . . 0.0 111.869 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 74.12 19.88 79.74 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.078 0.37 . . . . 0.0 113.073 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2962 ' ' ILE . . . . . 0.483 HG13 ' HG ' ' A' 2964 ' ' LEU . 37.6 pt -85.65 167.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.893 0.877 . . . . 0.0 111.114 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.0 p -81.86 79.13 8.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.349 0.66 . . . . 0.0 111.083 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' 2962 ' ' ILE . 76.0 mt -100.02 148.16 34.46 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 123.362 0.665 . . . . 0.0 109.577 173.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 173.4 9.66 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.88 139.65 39.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 69.29 12.77 66.58 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 124.158 0.911 . . . . 0.0 114.965 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 14.4 p -79.43 121.68 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 117.218 0.509 . . . . 0.0 109.865 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.97 120.18 75.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.07 -12.47 19.46 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.03 2.487 . . . . 0.0 113.416 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -69.43 -55.28 10.75 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 122.778 0.431 . . . . 0.0 110.759 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -75.74 -33.19 60.25 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.23 -46.59 88.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.246 1.019 . . . . 0.0 110.88 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -89.45 -35.03 16.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.927 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -72.65 -41.04 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' 2980 ' ' ILE . 87.3 mt -75.0 150.34 85.77 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.486 0.714 . . . . 0.0 109.854 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.39 166.07 6.59 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.982 2.454 . . . . 0.0 113.598 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.14 -23.97 67.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.308 1.043 . . . . 0.0 112.713 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.75 -57.52 10.67 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 124.205 1.002 . . . . 0.0 111.675 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.76 -22.65 8.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 O-C-N 122.256 -0.277 . . . . 0.0 110.409 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 13.5 tpt85 -54.26 -52.6 60.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.093 0.957 . . . . 0.0 110.898 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -71.78 -37.51 70.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 0.0 OUTLIER -69.7 -39.56 76.85 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.129 -175.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.1 m -69.45 -33.58 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.377 0.271 . . . . 0.0 110.383 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.34 -46.88 87.41 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.26 -43.4 57.11 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.868 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.68 -43.24 48.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.011 0.524 . . . . 0.0 111.382 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.494 ' HB2' HD23 ' A' 2989 ' ' LEU . 27.6 mm-40 -72.13 -57.28 4.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.923 0.489 . . . . 0.0 111.305 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.494 HD23 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -95.25 -26.74 15.83 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -168.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 73.11 15.17 78.67 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.592 0.558 . . . . 0.0 114.032 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.84 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.571 0.748 . . . . 0.0 109.133 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.174 0.59 . . . . 0.0 109.708 -179.578 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t0 . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 119.475 -0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.11 -26.26 30.82 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.62 -5.37 52.73 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.365 0.666 . . . . 0.0 111.09 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.65 36.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.446 0.699 . . . . 0.0 111.892 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.2 69.22 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 113.425 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.8 144.56 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.207 0.603 . . . . 0.0 110.648 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 27.8 m -79.5 85.54 5.26 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.785 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.471 ' HB3' HG13 ' A' 2968 ' ' VAL . 27.3 mt -93.77 149.73 37.54 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.505 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.566 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 67.0 Cg_endo -66.85 -178.39 1.27 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 123.296 2.664 . . . . 0.0 114.693 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -70.48 125.76 27.71 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.572 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 64.33 27.29 71.42 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.207 0.942 . . . . 0.0 114.383 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' 2964 ' ' LEU . 6.9 p -89.76 149.84 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.56 132.13 18.59 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.249 1.019 . . . . 0.0 109.296 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.14 -17.2 10.93 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.495 2.797 . . . . 0.0 113.491 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.6 m -53.27 -60.61 3.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 111.671 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2972 ' ' PHE . . . . . 0.469 ' HB2' HD12 ' A' 2976 ' ' LEU . 55.3 p90 -80.69 -24.96 38.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.307 0.243 . . . . 0.0 111.586 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.68 -35.74 81.65 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.5 -51.25 5.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.681 0.793 . . . . 0.0 111.517 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.18 87.96 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.213 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.469 HD12 ' HB2' ' A' 2972 ' ' PHE . 70.7 mt -93.95 160.71 31.83 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.456 0.702 . . . . 0.0 109.452 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.52 178.23 4.0 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.796 2.331 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2978 ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 31.0 m-20 -73.84 -15.49 61.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 112.368 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2979 ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' 2982 ' ' ARG . 7.3 m-20 -62.22 -55.52 27.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.188 0.595 . . . . 0.0 112.106 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.635 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -79.52 -24.1 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 122.129 -0.357 . . . . 0.0 110.499 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -59.36 -49.02 79.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.947 0.899 . . . . 0.0 109.64 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2982 ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' 2979 ' ' ASP . 17.9 ptt180 -72.85 -34.91 67.08 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.914 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.9 pt-20 -74.7 -42.43 58.39 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.189 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2984 ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' 2988 ' ' GLN . 33.0 m -63.88 -34.52 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 119.108 0.867 . . . . 0.0 110.508 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.75 -62.86 1.56 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.69 0.796 . . . . 0.0 111.005 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -80.2 -47.43 14.67 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.149 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.95 -37.51 81.67 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.357 0.663 . . . . 0.0 112.05 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' 2984 ' ' VAL . 27.4 mt-30 -82.13 -56.56 3.86 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.229 0.468 . . . . 0.0 111.585 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.2 mm? -88.96 -34.36 16.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.104 0.162 . . . . 0.0 111.314 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 93.57 1.09 66.4 Favored Glycine 0 C--N 1.34 0.764 0 O-C-N 123.445 0.466 . . . . 0.0 113.42 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.53 121.38 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.303 0.641 . . . . 0.0 109.475 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 CA--C 1.549 0.928 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.722 178.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 2958 ' ' PRO . . . . . 0.423 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 42.3 Cg_endo -64.28 -31.41 63.27 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.941 2.427 . . . . 0.0 113.483 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 43.4 tp -78.77 -9.7 59.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.222 0.609 . . . . 0.0 111.339 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.69 -15.41 28.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 88.27 28.91 21.34 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 35.1 pt -87.06 160.46 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 110.973 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 50.9 p -99.13 83.88 2.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.504 0.722 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 83.5 mt -77.64 119.57 77.97 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.404 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 45.1 Cg_endo -67.1 164.92 28.25 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.113 1.876 . . . . 0.0 112.282 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.19 132.62 53.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.445 0.698 . . . . 0.0 111.449 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 71.75 14.52 75.47 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.898 0.749 . . . . 0.0 113.847 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.52 HG23 HD22 ' A' 2989 ' ' LEU . 95.3 t -119.97 111.96 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.099 0.96 . . . . 0.0 109.603 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.04 157.48 33.79 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.813 0.845 . . . . 0.0 109.44 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.423 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 45.4 Cg_endo -82.11 8.02 4.74 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.502 2.135 . . . . 0.0 113.036 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 29.9 p -63.11 -59.37 4.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.339 1.056 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2972 ' ' PHE . . . . . 0.43 ' HE2' HG22 ' A' 2984 ' ' VAL . 26.6 p90 -75.01 -26.8 59.8 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.3 0.64 . . . . 0.0 110.987 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' 2980 ' ' ILE . 73.4 mt -67.72 -29.65 68.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.754 0.422 . . . . 0.0 110.825 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -92.1 -43.26 9.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.978 0.911 . . . . 0.0 111.638 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.6 -48.36 55.53 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.391 0.676 . . . . 0.0 111.119 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 51.4 mt -92.31 160.99 33.98 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.239 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2977 ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.9 Cg_endo -61.23 153.05 67.85 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.213 2.609 . . . . 0.0 113.076 -174.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -55.31 -15.52 2.57 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.926 0.89 . . . . 0.0 112.616 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.95 -49.76 65.41 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.717 1.607 . . . . 0.0 111.436 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.1 OUTLIER -69.95 -32.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -178.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.449 ' N ' HD11 ' A' 2980 ' ' ILE . 23.3 tpt180 -57.6 -52.17 66.52 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.641 1.177 . . . . 0.0 111.119 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -72.08 -42.14 66.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.505 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.517 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -71.52 -40.22 70.25 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2984 ' ' VAL . . . . . 0.43 HG22 ' HE2' ' A' 2972 ' ' PHE . 18.3 m -73.26 -33.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.25 0.477 . . . . 0.0 110.215 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.2 tp -57.22 -48.31 79.12 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.168 0.508 . . . . 0.0 110.701 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.8 -48.38 14.91 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.046 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.07 -27.72 57.34 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.05 0.54 . . . . 0.0 112.303 -170.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.521 ' HB2' HD21 ' A' 2989 ' ' LEU . 26.1 mm-40 -91.24 -47.81 7.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.557 0.343 . . . . 0.0 110.856 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -105.26 -45.16 4.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.086 0.154 . . . . 0.0 111.049 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.99 6.07 89.29 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.43 0.456 . . . . 0.0 113.642 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.04 114.97 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 . . . . . 0 CA--C 1.55 0.965 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 -173.548 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 2957 ' ' ASP . . . . . 0.495 ' HB3' ' HB1' ' A' 2960 ' ' ALA . 17.6 t70 . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2958 ' ' PRO . . . . . 0.535 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 98.0 Cg_endo -75.05 -23.74 13.43 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.983 2.456 . . . . 0.0 113.49 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.45 28.9 7.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.608 0.763 . . . . 0.0 110.011 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2960 ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' 2957 ' ' ASP . . . -72.66 -13.62 61.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.55 0.74 . . . . 0.0 112.419 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.18 39.29 9.31 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 38.9 pt -124.83 170.83 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.449 1.1 . . . . 0.0 109.974 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.2 m -90.62 100.58 13.4 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.112 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.497 ' HB3' HG13 ' A' 2968 ' ' VAL . 98.2 mt -72.33 139.9 81.98 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.61 169.96 20.02 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.116 1.877 . . . . 0.0 111.7 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -72.41 139.72 47.96 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 68.33 27.8 73.58 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.774 -0.25 . . . . 0.0 113.128 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' 2964 ' ' LEU . 8.0 p -69.52 132.53 33.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.295 0.569 . . . . 0.0 109.933 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2969 ' ' ASP . . . . . 0.483 ' HB3' ' HE1' ' A' 2972 ' ' PHE . 13.4 t70 -144.37 110.37 4.98 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.535 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 72.6 Cg_endo -68.09 -10.11 27.86 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.045 2.497 . . . . 0.0 113.894 -175.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.8 m -62.95 -56.28 18.54 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 122.841 0.456 . . . . 0.0 110.5 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2972 ' ' PHE . . . . . 0.483 ' HE1' ' HB3' ' A' 2969 ' ' ASP . 50.3 p90 -75.74 -26.61 57.6 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 117.765 0.257 . . . . 0.0 110.972 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.415 HD22 ' HD3' ' A' 2981 ' ' ARG . 95.5 mt -68.79 -26.56 65.27 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.388 0.275 . . . . 0.0 111.312 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.88 -37.53 11.15 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 0.0 111.708 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.24 52.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.36 0.664 . . . . 0.0 111.877 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.828 ' HB3' HD12 ' A' 2980 ' ' ILE . 89.8 mt -103.32 152.11 38.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.622 0.769 . . . . 0.0 110.151 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.59 173.58 5.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.978 2.452 . . . . 0.0 113.084 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.0 -19.69 61.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.83 -54.84 13.47 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.61 0.764 . . . . 0.0 112.043 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.416 ' HA ' HG23 ' A' 2984 ' ' VAL . 0.0 OUTLIER -75.21 -32.02 61.07 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.08 -31.55 56.09 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.247 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -39.64 82.16 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 117.836 0.289 . . . . 0.0 110.252 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2984 ' ' VAL . . . . . 0.482 HG21 ' HE2' ' A' 2972 ' ' PHE . 33.4 m -72.13 -31.83 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.71 -50.81 72.38 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.036 0.535 . . . . 0.0 111.517 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.52 -39.98 51.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.887 0.475 . . . . 0.0 111.798 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -75.76 -27.16 57.95 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.627 0.371 . . . . 0.0 111.672 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.482 ' HB2' HD21 ' A' 2989 ' ' LEU . 29.3 mm-40 -83.98 -56.39 3.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.726 0.239 . . . . 0.0 111.038 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.2 mm? -105.53 -35.61 7.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.79 17.04 72.85 Favored Glycine 0 C--N 1.343 0.957 0 O-C-N 123.176 0.298 . . . . 0.0 113.299 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 130.1 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 CA--C 1.554 1.112 0 O-C-N 123.406 0.441 . . . . 0.0 110.885 -176.187 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 2957 ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 26.8 t70 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -59.57 -33.45 96.91 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.551 2.167 . . . . 0.0 112.159 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.61 21.91 11.63 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.345 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2960 ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -74.73 -10.63 59.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.267 0.627 . . . . 0.0 111.978 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 105.5 29.5 5.03 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 31.9 pt -114.58 163.11 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.154 0.981 . . . . 0.0 111.541 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.0 p -101.48 79.7 1.99 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 111.669 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.86 125.55 58.67 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.91 172.95 4.22 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.169 2.579 . . . . 0.0 113.117 171.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.04 139.28 54.9 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.419 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.73 67.88 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.373 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 26.5 t -89.37 100.0 10.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 117.384 0.592 . . . . 0.0 109.999 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.39 138.37 86.53 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.459 0.703 . . . . 0.0 109.532 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.95 -4.82 15.33 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.488 2.126 . . . . 0.0 111.581 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -60.94 -60.43 3.81 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.934 0.894 . . . . 0.0 110.595 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -73.81 -31.31 63.18 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.074 0.464 . . . . 0.0 110.23 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.668 ' HG ' HH11 ' A' 2981 ' ' ARG . 11.8 tp -69.84 -33.59 72.49 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.818 0.847 . . . . 0.0 111.758 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.77 -35.37 12.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 111.55 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.4 80.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.81 0.444 . . . . 0.0 111.794 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.771 ' HB3' HD13 ' A' 2980 ' ' ILE . 69.7 mt -89.25 145.51 34.28 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.95 167.06 5.95 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.039 2.493 . . . . 0.0 113.707 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.38 -27.82 69.35 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.03 -55.41 25.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 112.101 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.771 HD13 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.62 -24.49 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.629 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.668 HH11 ' HG ' ' A' 2973 ' ' LEU . 0.0 OUTLIER -70.22 -31.98 69.65 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.102 0.41 . . . . 0.0 110.242 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -74.95 -38.86 61.62 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 119.542 -0.266 . . . . 0.0 110.477 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 6.7 pt-20 -67.2 -37.97 84.54 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.955 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2984 ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' 2980 ' ' ILE . 25.0 m -69.51 -33.85 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.114 0.416 . . . . 0.0 110.159 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2985 ' ' LEU . . . . . 0.446 HD11 HD22 ' A' 2989 ' ' LEU . 39.9 tp -61.91 -40.25 94.82 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.355 0.598 . . . . 0.0 110.802 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -79.02 -37.7 38.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.422 0.689 . . . . 0.0 111.584 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -74.78 -38.83 62.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.491 0.717 . . . . 0.0 111.147 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.434 ' HB2' HD23 ' A' 2989 ' ' LEU . 28.6 mt-30 -83.48 -50.82 7.91 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.072 0.549 . . . . 0.0 111.09 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.446 HD22 HD11 ' A' 2985 ' ' LEU . 2.3 mm? -95.7 -48.17 5.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.561 0.344 . . . . 0.0 110.96 -173.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.91 40.71 74.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 113.745 0.258 . . . . 0.0 113.745 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.82 130.63 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.55 0.74 . . . . 0.0 109.201 -177.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.306 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -46.99 -44.53 22.78 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 124.133 3.222 . . . . 0.0 114.063 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.25 -10.27 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.248 0.619 . . . . 0.0 111.018 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.55 1.8 15.68 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.33 0.652 . . . . 0.0 111.912 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 77.6 18.99 76.79 Favored Glycine 0 C--N 1.355 1.615 0 C-N-CA 123.313 0.482 . . . . 0.0 113.287 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2962 ' ' ILE . . . . . 0.433 HD12 HD12 ' A' 2964 ' ' LEU . 2.5 pp -76.08 164.21 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.646 0.778 . . . . 0.0 111.876 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 25.0 t -115.97 81.15 1.55 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' 2968 ' ' VAL . 10.4 mp -112.34 143.24 28.47 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.61 164.63 34.68 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.321 2.681 . . . . 0.0 113.228 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.6 129.05 38.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2967 ' ' GLY . . . . . 0.431 ' HA3' HD12 ' A' 2989 ' ' LEU . . . 115.12 25.9 3.69 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' 2964 ' ' LEU . 9.0 p -139.21 153.86 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.74 0.816 . . . . 0.0 109.174 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2969 ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' 2972 ' ' PHE . 3.4 t70 -146.03 124.38 6.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.12 0.968 . . . . 0.0 109.1 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 79.0 Cg_endo -73.58 -0.64 9.59 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.979 2.452 . . . . 0.0 113.971 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.3 m -68.33 -57.09 6.47 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2972 ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' 2969 ' ' ASP . 22.7 p90 -72.53 -32.23 65.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' 2981 ' ' ARG . 8.6 tp -67.61 -30.88 70.58 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.786 0.834 . . . . 0.0 111.273 -173.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.82 -43.94 7.99 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.727 0.811 . . . . 0.0 111.616 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.73 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.509 0.724 . . . . 0.0 111.878 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' 2980 ' ' ILE . 79.5 mt -92.78 150.02 38.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.511 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -58.18 165.69 6.78 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.985 2.457 . . . . 0.0 113.612 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.99 -20.29 66.14 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.5 -52.54 13.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.634 0.774 . . . . 0.0 112.251 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.0 -24.58 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.133 -0.354 . . . . 0.0 110.553 -178.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.577 ' HD3' ' HG ' ' A' 2973 ' ' LEU . 0.8 OUTLIER -71.52 -35.67 70.79 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -69.83 -42.76 73.2 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -38.67 84.64 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.944 -174.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 35.3 m -68.32 -40.27 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.482 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2985 ' ' LEU . . . . . 0.445 HD13 HD22 ' A' 2989 ' ' LEU . 57.4 tp -59.67 -45.88 90.73 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.871 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2986 ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' 2991 ' ' ILE . 24.0 mt-30 -74.26 -34.85 63.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.885 0.874 . . . . 0.0 111.999 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.82 -36.76 56.68 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.973 0.509 . . . . 0.0 112.136 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.47 ' HB2' HD23 ' A' 2989 ' ' LEU . 20.0 mt-30 -71.59 -56.98 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.346 0.258 . . . . 0.0 111.233 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' 2988 ' ' GLN . 1.4 mm? -97.45 -22.43 16.58 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.67 -170.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 74.74 40.97 35.83 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' 2986 ' ' GLN . 0.0 OUTLIER -110.62 128.64 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 0.0 108.654 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.882 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.68 -33.19 96.34 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.377 2.718 . . . . 0.0 113.688 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.0 -14.89 61.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.119 0.567 . . . . 0.0 110.455 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.99 -21.48 64.88 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.979 0.512 . . . . 0.0 111.68 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 114.3 5.67 20.99 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 123.605 0.621 . . . . 0.0 113.047 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 14.5 pt -92.69 147.68 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.285 0.634 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.8 t -101.58 95.51 6.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.13 0.972 . . . . 0.0 109.99 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.15 136.84 40.41 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.542 ' HG3' HG23 ' A' 2991 ' ' ILE . 52.1 Cg_endo -66.61 141.82 62.02 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.712 2.274 . . . . 0.0 112.02 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.97 122.51 16.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.225 0.61 . . . . 0.0 111.573 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 117.07 -19.87 11.73 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.722 0.639 . . . . 0.0 112.961 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.641 ' HB ' HD22 ' A' 2989 ' ' LEU . 4.7 p -96.57 155.34 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 118.106 0.953 . . . . 0.0 109.071 171.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.82 129.91 22.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.66 -16.26 50.0 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.123 2.548 . . . . 0.0 114.627 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 23.9 m -62.92 -55.39 26.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.737 0.415 . . . . 0.0 111.082 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 20.0 p90 -74.9 -30.71 61.37 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.856 0.36 . . . . 0.0 110.126 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.36 -42.05 96.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.713 0.805 . . . . 0.0 110.737 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.82 -28.67 15.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.736 0.814 . . . . 0.0 112.535 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -78.38 -43.81 26.59 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.64 0.376 . . . . 0.0 111.425 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.704 ' HB3' HD11 ' A' 2980 ' ' ILE . 97.2 mt -80.48 157.96 71.95 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.28 1.032 . . . . 0.0 110.749 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.59 -179.47 0.5 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.941 2.427 . . . . 0.0 114.378 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2978 ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 6.7 p-10 -72.03 -28.64 63.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.751 0.42 . . . . 0.0 111.996 -172.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.19 -55.38 18.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.329 0.652 . . . . 0.0 112.344 -170.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.26 -18.69 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.516 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -74.56 -38.45 62.69 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2982 ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' 2978 ' ' ASP . 12.2 ptm180 -75.88 -34.44 60.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 6.8 tp10 -53.06 -52.08 59.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.767 1.227 . . . . 0.0 110.599 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 34.7 m -77.59 -31.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.502 0.321 . . . . 0.0 111.328 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.98 -53.28 18.41 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.421 0.629 . . . . 0.0 111.062 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -44.31 68.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.099 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -77.01 -39.59 49.69 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.25 -55.36 6.13 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.836 0.289 . . . . 0.0 111.418 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.641 HD22 ' HB ' ' A' 2968 ' ' VAL . 1.9 mm? -84.98 -29.91 24.66 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.171 0.294 . . . . 0.0 110.645 -172.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 84.19 5.47 87.35 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.726 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.32 127.74 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.67 0.788 . . . . 0.0 109.086 -177.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 CA--C 1.553 1.083 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 -178.086 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 2957 ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' 2960 ' ' ALA . 13.0 t70 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2958 ' ' PRO . . . . . 0.484 ' HD3' HD22 ' A' 2964 ' ' LEU . 42.1 Cg_endo -63.27 -30.92 74.12 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.282 1.988 . . . . 0.0 112.287 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.13 -7.17 58.77 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.331 0.652 . . . . 0.0 110.064 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2960 ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' 2957 ' ' ASP . . . -65.86 -19.83 66.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.993 -0.442 . . . . 0.0 111.071 170.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.79 -3.39 28.95 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.523 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.8 pp -88.66 176.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.084 0.554 . . . . 0.0 111.246 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.1 p -120.91 113.48 20.18 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.484 HD22 ' HD3' ' A' 2958 ' ' PRO . 2.3 pp -103.42 152.43 38.76 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.689 0.795 . . . . 0.0 109.751 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.24 177.58 8.69 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.807 2.338 . . . . 0.0 113.504 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.68 150.97 42.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.288 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 67.3 21.76 72.38 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.7 0.625 . . . . 0.0 112.915 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 90.6 t -129.38 95.66 2.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.741 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.58 133.95 36.96 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.154 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.37 -14.44 45.02 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.349 2.699 . . . . 0.0 115.015 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 59.0 m -62.45 -56.07 21.69 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.46 0.573 . . . . 0.0 111.404 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 39.2 p90 -72.47 -30.78 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.409 0.623 . . . . 0.0 110.522 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' 2981 ' ' ARG . 17.0 tp -69.81 -33.08 71.86 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.471 -171.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.98 -49.59 5.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.838 . . . . 0.0 111.339 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.45 74.49 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.52 158.78 62.62 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.799 0.84 . . . . 0.0 109.657 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.35 178.06 1.0 Allowed 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 123.238 2.625 . . . . 0.0 114.003 -173.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.85 -26.94 65.4 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.48 -54.7 28.39 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.139 0.576 . . . . 0.0 112.072 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.542 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -76.48 -32.25 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.637 -178.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.527 ' HB2' HD13 ' A' 2973 ' ' LEU . 0.1 OUTLIER -66.53 -39.88 88.84 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.756 0.312 . . . . 0.0 110.265 -175.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -74.62 -38.38 62.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.159 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.3 pt-20 -73.49 -38.61 65.32 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.259 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 32.6 m -66.41 -34.32 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.326 0.512 . . . . 0.0 110.261 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.23 -52.99 63.29 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.405 0.682 . . . . 0.0 110.136 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.78 -40.01 79.89 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.832 -1.077 . . . . 0.0 112.263 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.14 -41.4 50.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.151 0.581 . . . . 0.0 111.223 -172.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -70.49 -57.06 5.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.8 0.44 . . . . 0.0 111.259 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.15 -34.74 20.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.829 0.452 . . . . 0.0 111.298 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.93 20.82 67.07 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.66 -165.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.68 129.37 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 123.244 0.617 . . . . 0.0 109.672 -176.41 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 118.914 -0.565 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.34 -43.79 36.62 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.71 2.94 . . . . 0.0 113.837 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.77 -4.82 55.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.093 0.957 . . . . 0.0 112.017 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.81 -10.82 59.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.902 0.481 . . . . 0.0 111.094 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.15 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 113.593 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -75.81 175.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.339 0.656 . . . . 0.0 111.089 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.9 p -122.46 93.06 3.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.114 0.566 . . . . 0.0 109.913 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 152.89 48.64 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.499 ' HG2' HG23 ' A' 2968 ' ' VAL . 33.8 Cg_endo -62.92 152.47 78.93 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.535 2.156 . . . . 0.0 112.35 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.42 145.64 50.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.285 0.634 . . . . 0.0 111.66 -176.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 77.57 18.28 77.85 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.228 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.499 HG23 ' HG2' ' A' 2965 ' ' PRO . 38.7 t -120.26 114.75 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.132 0.973 . . . . 0.0 109.44 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -85.64 126.74 65.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 123.556 0.535 . . . . 0.0 109.694 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.441 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 58.6 Cg_endo -68.65 -9.36 25.92 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.502 2.801 . . . . 0.0 113.811 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.0 m -58.4 -57.44 12.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.311 0.644 . . . . 0.0 111.251 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -77.14 -31.86 55.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.441 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 15.6 tp -67.08 -31.16 71.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.056 0.942 . . . . 0.0 111.172 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.37 -52.24 4.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.911 0.884 . . . . 0.0 111.373 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.12 76.83 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.818 ' HB3' HD11 ' A' 2980 ' ' ILE . 90.2 mt -81.32 150.57 67.82 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 0.0 110.462 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.3 170.16 8.35 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.44 2.76 . . . . 0.0 113.592 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2978 ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 4.5 p-10 -66.84 -18.73 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -169.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.51 -55.64 8.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.029 0.531 . . . . 0.0 111.84 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.818 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -75.14 -29.75 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 119.289 -0.386 . . . . 0.0 110.193 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' 2973 ' ' LEU . 23.0 tpt85 -50.97 -49.19 60.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.234 1.013 . . . . 0.0 111.37 173.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.69 -39.4 61.99 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.4 pt-20 -72.25 -42.68 65.36 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.706 -175.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.0 m -65.65 -30.06 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 118.326 0.512 . . . . 0.0 110.197 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.04 -48.8 77.18 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.46 -28.41 41.58 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -77.66 -49.84 13.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.887 0.475 . . . . 0.0 111.089 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.52 ' HB2' HD23 ' A' 2989 ' ' LEU . 26.3 mm-40 -62.85 -56.63 15.67 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.512 0.507 . . . . 0.0 110.791 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -97.32 -37.25 10.12 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 76.87 23.1 70.24 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 123.335 0.397 . . . . 0.0 112.209 -169.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.74 127.42 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 123.339 0.656 . . . . 0.0 109.926 -177.407 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -78.4 22.61 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.063 2.509 . . . . 0.0 113.483 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.8 4.0 3.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.959 0.904 . . . . 0.0 109.137 171.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.2 60.99 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.519 0.728 . . . . 0.0 112.605 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 118.56 -20.58 10.16 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 123.013 0.34 . . . . 0.0 112.442 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2962 ' ' ILE . . . . . 0.583 HD12 HD21 ' A' 2964 ' ' LEU . 2.3 pp -72.83 176.65 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.46 1.104 . . . . 0.0 112.332 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 19.2 m -91.12 76.64 6.1 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 121.135 0.493 . . . . 0.0 111.544 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2964 ' ' LEU . . . . . 0.583 HD21 HD12 ' A' 2962 ' ' ILE . 2.8 mm? -121.88 114.45 31.06 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.74 -171.32 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.636 2.891 . . . . 0.0 113.089 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.87 144.14 30.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.088 0.955 . . . . 0.0 109.795 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.07 20.21 39.93 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.074 0.234 . . . . 0.0 113.128 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 3.3 p -141.44 106.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 124.074 0.949 . . . . 0.0 109.6 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.12 140.92 77.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.053 0.541 . . . . 0.0 110.997 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.35 -10.35 23.93 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.061 2.507 . . . . 0.0 112.434 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 18.4 m -58.64 -59.0 6.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.39 1.076 . . . . 0.0 110.595 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2972 ' ' PHE . . . . . 0.448 ' HB2' HD11 ' A' 2976 ' ' LEU . 34.0 p90 -79.64 -28.33 40.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' 2981 ' ' ARG . 0.5 OUTLIER -65.17 -38.54 90.86 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.842 0.857 . . . . 0.0 110.472 -174.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.83 11.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.927 0.491 . . . . 0.0 111.468 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.41 -48.96 59.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.588 ' HB3' HD11 ' A' 2980 ' ' ILE . 93.9 mt -79.42 156.54 75.9 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.929 0.892 . . . . 0.0 110.088 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.09 -178.56 1.77 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.187 2.591 . . . . 0.0 113.593 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2978 ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' 2982 ' ' ARG . 3.6 p30 -72.71 -27.3 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -171.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.81 -52.74 58.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 112.963 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -76.78 -23.08 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.529 ' HB2' HD23 ' A' 2973 ' ' LEU . 0.1 OUTLIER -74.56 -36.23 63.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.243 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2982 ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' 2978 ' ' ASP . 5.8 ptm180 -69.81 -40.64 75.8 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 8.5 pt-20 -69.97 -38.36 76.04 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.223 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2984 ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' 2980 ' ' ILE . 33.1 m -69.36 -31.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.87 0.759 . . . . 0.0 110.708 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.13 -50.32 68.69 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.58 0.705 . . . . 0.0 110.967 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -80.27 -45.69 17.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.954 -173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.5 -43.08 81.76 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.06 -56.35 4.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.141 0.276 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.66 -52.63 5.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.251 0.221 . . . . 0.0 111.164 -172.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 106.24 -12.54 44.21 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.786 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.42 125.89 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.368 0.667 . . . . 0.0 109.536 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.051 0.54 . . . . 0.0 110.058 -178.336 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 2957 ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' 2960 ' ' ALA . 13.6 t70 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2958 ' ' PRO . . . . . 0.51 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 29.5 Cg_endo -60.57 -35.15 91.26 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.234 . . . . 0.0 112.846 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.6 tp -91.05 7.31 41.04 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.663 0.785 . . . . 0.0 111.333 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2960 ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' 2957 ' ' ASP . . . -69.77 -9.98 56.64 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 107.98 4.69 33.59 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 47.0 pt -79.04 168.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.969 0.508 . . . . 0.0 110.453 173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.3 p -127.62 88.03 2.72 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.012 0.525 . . . . 0.0 110.477 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.3 pp -107.66 149.67 39.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.42 156.34 32.59 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.593 2.196 . . . . 0.0 111.911 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.67 121.93 16.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 116.71 -21.93 11.09 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.7 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 93.4 t -88.63 104.11 14.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.402 0.681 . . . . 0.0 109.541 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.34 126.44 92.7 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.009 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2970 ' ' PRO . . . . . 0.51 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 53.7 Cg_endo -65.8 -8.01 18.34 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.879 2.386 . . . . 0.0 112.444 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -59.11 5.37 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.497 1.119 . . . . 0.0 110.737 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 28.8 p90 -80.23 -32.42 38.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.9 0.381 . . . . 0.0 110.387 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' 2981 ' ' ARG . 26.6 tp -63.98 -45.08 90.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.465 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.3 -49.75 5.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.969 0.508 . . . . 0.0 111.733 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.9 63.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 82.7 mt -95.65 160.79 29.58 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.481 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2977 ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 57.8 Cg_endo -66.3 176.73 3.73 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.416 2.077 . . . . 0.0 112.854 -174.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2978 ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 27.2 t70 -70.25 -21.39 62.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.205 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.44 -55.28 16.46 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 123.415 0.686 . . . . 0.0 111.741 -168.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.51 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.04 -31.89 16.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 -177.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.519 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.4 OUTLIER -67.39 -35.84 80.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.741 0.417 . . . . 0.0 110.597 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2982 ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' 2978 ' ' ASP . 8.7 ptm180 -73.76 -46.2 47.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 14.1 pt-20 -69.0 -34.9 76.02 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.455 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 25.0 m -73.08 -34.85 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.04 -43.35 99.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.677 0.751 . . . . 0.0 110.673 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.05 -44.86 45.31 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.776 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.68 -33.21 58.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.688 0.395 . . . . 0.0 112.0 -173.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.472 ' HB2' HD21 ' A' 2989 ' ' LEU . 20.8 mt-30 -82.47 -52.25 7.05 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.547 0.339 . . . . 0.0 111.235 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.527 ' HB2' HG22 ' A' 2991 ' ' ILE . 2.0 mm? -97.43 -39.98 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.635 0.374 . . . . 0.0 110.979 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 90.81 17.88 49.96 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.534 -0.303 . . . . 0.0 112.775 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -108.02 130.23 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.108 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 118.996 -0.525 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.92 -30.57 67.44 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.624 2.216 . . . . 0.0 112.889 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -77.83 -21.23 51.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.432 0.693 . . . . 0.0 110.136 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -58.94 -21.02 57.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.612 0.765 . . . . 0.0 112.679 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.87 -2.63 28.76 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 123.191 0.424 . . . . 0.0 112.767 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.0 172.73 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.354 0.662 . . . . 0.0 110.903 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 28.3 t -112.87 109.77 19.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.481 0.713 . . . . 0.0 109.862 -177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.44 155.6 56.85 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.48 0.712 . . . . 0.0 109.208 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2965 ' ' PRO . . . . . 0.536 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 59.3 Cg_endo -70.29 157.65 58.68 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.314 2.009 . . . . 0.0 112.067 170.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -70.77 141.62 51.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.645 0.778 . . . . 0.0 111.431 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.39 70.24 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.807 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2968 ' ' VAL . . . . . 0.544 HG21 HD22 ' A' 2989 ' ' LEU . 82.6 t -128.54 96.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.62 156.4 41.17 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 124.004 0.922 . . . . 0.0 109.215 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.22 9.31 2.15 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.555 2.17 . . . . 0.0 112.84 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 19.2 m -63.11 -61.41 2.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.214 1.005 . . . . 0.0 111.21 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 23.9 p90 -78.26 -24.27 46.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.679 0.792 . . . . 0.0 111.28 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2973 ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' 2981 ' ' ARG . 68.3 mt -69.43 -37.45 77.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.28 0.632 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.83 -24.89 19.22 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.788 0.835 . . . . 0.0 112.208 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.4 70.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.209 0.604 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2976 ' ' LEU . . . . . 0.467 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 55.9 mt -107.52 164.25 15.19 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.339 1.056 . . . . 0.0 109.346 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2977 ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.1 Cg_endo -60.35 155.29 47.34 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 123.685 2.924 . . . . 0.0 113.078 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.76 -17.33 5.83 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.924 1.29 . . . . 0.0 113.54 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.91 -39.39 90.53 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.143 0.977 . . . . 0.0 111.614 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2980 ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.94 -32.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2981 ' ' ARG . . . . . 0.492 ' N ' HD12 ' A' 2980 ' ' ILE . 10.5 tpt180 -60.04 -55.34 35.12 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.315 1.046 . . . . 0.0 110.422 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -64.38 -43.62 93.91 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.005 0.816 . . . . 0.0 110.961 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2983 ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' 2987 ' ' ASN . 13.5 pt-20 -68.96 -50.34 50.02 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.973 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 19.3 m -67.43 -30.42 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.177 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2985 ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' 2991 ' ' ILE . 18.4 tp -61.61 -55.68 28.05 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.888 0.852 . . . . 0.0 109.868 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2986 ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' 2992 ' ' ARG . 46.7 mt-30 -75.2 -34.7 61.53 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.618 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2987 ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' 2983 ' ' GLU . 2.5 t-20 -75.15 -46.85 31.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.19 0.596 . . . . 0.0 110.24 -172.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2988 ' ' GLN . . . . . 0.417 ' HB2' HD21 ' A' 2989 ' ' LEU . 23.5 mt-30 -72.29 -51.7 19.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.737 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2989 ' ' LEU . . . . . 0.544 HD22 HG21 ' A' 2968 ' ' VAL . 1.0 OUTLIER -102.17 -40.04 6.98 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -171.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 102.19 0.03 50.92 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.559 0.537 . . . . 0.0 112.799 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2991 ' ' ILE . . . . . 0.58 HG22 ' HG ' ' A' 2985 ' ' LEU . 0.0 OUTLIER -78.64 121.37 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2992 ' ' ARG . . . . . 0.497 ' HA ' ' HG2' ' A' 2986 ' ' GLN . 10.2 ptp180 . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 123.669 0.788 . . . . 0.0 109.705 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.707 0.289 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 38.6 t -134.01 160.61 37.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.368 0.667 . . . . 0.0 109.897 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 15.4 m -74.73 -19.88 60.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.656 0.782 . . . . 0.0 110.29 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.7 82.28 0.86 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.213 1.005 . . . . 0.0 109.738 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.21 137.41 34.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.557 0.743 . . . . 0.0 109.998 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2956 ' ' GLU . . . . . 0.407 ' HB2' HG21 ' A' 2962 ' ' ILE . 9.5 pt-20 -86.51 123.52 31.81 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -89.03 138.3 29.2 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.115 0.566 . . . . 0.0 110.22 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.03 -31.55 83.86 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.307 2.005 . . . . 0.0 113.132 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 -16.57 61.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.118 0.567 . . . . 0.0 109.836 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.97 16.33 0.56 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 65.14 22.45 68.96 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2962 ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' 2970 ' ' PRO . 20.4 pt -68.7 141.87 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.605 0.762 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.0 m -83.71 83.29 7.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.469 0.707 . . . . 0.0 111.778 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.439 HD21 HD11 ' A' 2973 ' ' LEU . 11.1 mp -119.28 146.27 40.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.391 1.076 . . . . 0.0 109.674 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.74 162.38 37.64 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.258 2.639 . . . . 0.0 111.845 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.55 141.99 56.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.09 0.556 . . . . 0.0 110.679 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 92.33 -33.23 5.04 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.346 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 13.9 t -84.05 105.98 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.489 0.716 . . . . 0.0 109.515 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.26 135.93 20.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.323 0.649 . . . . 0.0 109.44 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.486 ' HG3' HD11 ' A' 2962 ' ' ILE . 86.7 Cg_endo -74.03 -3.22 13.43 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.137 2.558 . . . . 0.0 115.521 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 73.2 m -62.05 -53.49 54.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.753 0.706 . . . . 0.0 110.916 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 31.6 p90 -71.76 -22.4 61.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.45 HD23 ' HG2' ' A' 2981 ' ' ARG . 55.6 mt -73.57 -37.33 65.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.484 0.313 . . . . 0.0 111.746 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.52 -36.35 12.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.327 0.651 . . . . 0.0 111.391 -174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -76.28 -29.93 57.61 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.145 0.578 . . . . 0.0 111.228 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.487 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 68.8 mt -104.26 165.25 13.7 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2977 ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 32.2 Cg_endo -59.76 168.65 5.3 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.943 2.429 . . . . 0.0 114.519 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.13 -15.46 61.48 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.102 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.46 -53.82 31.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.467 0.707 . . . . 0.0 111.488 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.577 ' HA ' ' HB3' ' A' 2983 ' ' GLU . 0.1 OUTLIER -78.91 -17.7 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 120.653 0.263 . . . . 0.0 110.355 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.45 ' HG2' HD23 ' A' 2973 ' ' LEU . 7.8 tmm_? -63.7 -52.29 61.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.493 1.117 . . . . 0.0 110.645 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.27 -32.96 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.582 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.577 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 8.6 tp10 -51.99 -56.48 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 111.295 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.4 m -68.65 -34.51 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.602 0.361 . . . . 0.0 111.464 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2985 ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' 2989 ' ' LEU . 25.3 tp -67.3 -54.75 17.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.343 0.592 . . . . 0.0 111.397 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.26 -43.28 74.25 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.442 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.79 -43.01 38.49 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.469 ' HB2' HD21 ' A' 2989 ' ' LEU . 25.0 mt-30 -76.81 -50.94 12.28 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.713 0.292 . . . . 0.0 111.704 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.7 mm? -93.4 -30.76 14.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.819 0.447 . . . . 0.0 111.086 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 77.52 4.76 85.18 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.23 0.332 . . . . 0.0 113.763 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.54 134.94 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.733 0.813 . . . . 0.0 109.708 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -111.3 115.91 51.68 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.719 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.88 -37.4 92.88 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 122.931 2.421 . . . . 0.0 114.296 167.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.79 165.84 19.87 Favored 'Trans proline' 0 C--N 1.403 3.444 0 C-N-CA 122.123 1.882 . . . . 0.0 112.634 168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 40.0 p -62.74 121.99 14.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.731 0.812 . . . . 0.0 112.069 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.87 116.93 11.74 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.409 0.623 . . . . 0.0 111.277 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 43.9 p -123.65 1.4 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.057 0.943 . . . . 0.0 110.462 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -146.82 114.51 4.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.723 0.809 . . . . 0.0 109.522 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.86 -30.81 39.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.841 2.36 . . . . 0.0 111.863 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 34.7 p -80.39 75.6 7.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.944 0.878 . . . . 0.0 109.629 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.6 t -95.8 171.08 8.87 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.985 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.7 t30 -64.17 103.44 0.62 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.252 0.621 . . . . 0.0 109.359 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.844 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.641 0.258 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.8 p -78.41 75.05 4.94 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.645 0.736 . . . . 0.0 109.813 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 25.4 t -134.7 -16.42 2.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 110.389 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -101.53 68.74 1.2 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.09 152.1 36.25 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.817 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2956 ' ' GLU . . . . . 0.4 ' O ' HD12 ' A' 2964 ' ' LEU . 3.6 mp0 -82.99 89.13 6.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.82 119.87 79.1 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.915 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 -29.2 80.96 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.902 2.401 . . . . 0.0 112.522 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -19.49 62.71 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.285 0.634 . . . . 0.0 110.254 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.62 -23.14 65.83 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.464 0.706 . . . . 0.0 112.058 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 120.33 -9.97 10.87 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.767 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.9 pp -78.97 165.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 117.054 0.427 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 26.5 p -115.71 96.27 5.53 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.11 0.481 . . . . 0.0 111.915 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' 2956 ' ' GLU . 64.6 mt -76.44 139.47 67.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.95 0.5 . . . . 0.0 109.973 170.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 20.8 Cg_exo -63.17 167.88 11.84 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.94 2.427 . . . . 0.0 112.785 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.22 132.66 54.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.803 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 85.57 5.19 84.85 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.49 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 37.9 t -111.36 101.04 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.559 0.68 . . . . 0.0 110.387 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.72 151.69 37.74 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.686 0.794 . . . . 0.0 109.352 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.5 -0.22 8.46 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.559 2.173 . . . . 0.0 112.547 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 16.5 m -65.54 -60.1 3.28 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.903 0.881 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.6 p90 -72.17 -30.04 64.6 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.137 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 10.8 tp -68.23 -30.89 70.06 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.547 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -95.04 -53.37 3.84 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.483 0.713 . . . . 0.0 111.789 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.71 89.0 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.746 0.818 . . . . 0.0 112.113 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.778 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.1 mt -80.68 140.5 51.21 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.01 167.01 13.0 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.706 2.271 . . . . 0.0 112.387 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.22 -29.29 63.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.46 -59.2 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.536 0.522 . . . . 0.0 111.715 -171.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.22 -29.71 9.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.732 -175.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -39.35 89.91 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.989 0.423 . . . . 0.0 110.209 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -77.1 -36.81 55.34 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.738 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -36.83 70.23 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.191 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2984 ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' 2980 ' ' ILE . 26.8 m -65.9 -33.67 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.1 0.409 . . . . 0.0 110.851 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 58.5 tp -59.44 -56.35 23.08 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.177 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -73.8 -25.98 60.39 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.06 -55.05 5.96 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 117.835 0.289 . . . . 0.0 111.032 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -64.54 -42.29 95.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 0.0 112.149 -172.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.1 mm? -101.05 -27.98 12.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.32 0.248 . . . . 0.0 111.498 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 70.2 37.37 71.86 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.25 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.17 122.99 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -94.44 129.9 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.24 -45.45 31.18 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 121.931 1.754 . . . . 0.0 114.534 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.64 143.44 12.04 Favored 'Trans proline' 0 C--N 1.395 3.021 0 CA-C-N 121.738 1.657 . . . . 0.0 113.801 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 6.6 t -123.64 138.6 54.51 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -71.81 94.83 1.44 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.246 0.546 . . . . 0.0 109.852 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 32.8 p -118.45 114.47 22.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.99 0.916 . . . . 0.0 108.576 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 62.09 83.82 0.2 Allowed Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 124.566 1.147 . . . . 0.0 110.399 -173.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.03 178.4 6.93 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.829 2.353 . . . . 0.0 113.365 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 34.9 t -139.93 146.24 38.94 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.016 0.926 . . . . 0.0 108.895 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.8 t -66.39 145.89 55.19 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.58 0.352 . . . . 0.0 110.369 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -78.61 125.8 29.86 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.535 0.734 . . . . 0.0 109.699 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 CA--C 1.55 0.966 0 C-N-CA 123.442 0.697 . . . . 0.0 109.547 -175.278 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 36.5 m -139.75 -178.36 5.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.483 0.713 . . . . 0.0 109.701 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 23.0 t -127.15 11.04 6.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.296 0.638 . . . . 0.0 109.789 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.54 -1.4 6.18 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.494 0.718 . . . . 0.0 111.682 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.24 143.67 50.34 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.534 0.333 . . . . 0.0 111.24 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -123.55 85.68 2.46 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.837 0.855 . . . . 0.0 109.53 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.63 145.46 78.78 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.214 0.606 . . . . 0.0 110.161 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2958 ' ' PRO . . . . . 0.485 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 13.4 Cg_endo -55.22 -22.35 32.17 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.154 2.569 . . . . 0.0 114.341 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.48 10.32 9.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 111.721 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -83.63 0.65 45.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.629 0.772 . . . . 0.0 110.273 164.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 97.78 -1.6 59.86 Favored Glycine 0 C--N 1.351 1.388 0 C-N-CA 123.309 0.481 . . . . 0.0 112.708 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 30.9 pt -89.21 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.005 0.522 . . . . 0.0 111.081 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -117.09 102.91 9.72 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.733 0.813 . . . . 0.0 109.66 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.77 120.43 70.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.85 175.32 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.904 3.069 . . . . 0.0 114.064 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -70.29 131.81 44.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.702 0.401 . . . . 0.0 110.457 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.66 -19.93 44.97 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.543 0.527 . . . . 0.0 112.715 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 24.5 t -87.46 90.04 3.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.399 0.68 . . . . 0.0 109.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 56.3 t0 -85.34 118.27 70.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.485 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 56.6 Cg_endo -64.9 -3.6 7.27 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.737 2.291 . . . . 0.0 114.074 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.9 m -60.07 -50.15 74.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.989 0.516 . . . . 0.0 110.932 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 10.7 p90 -75.36 -25.76 57.97 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.513 HD11 HH21 ' A' 2981 ' ' ARG . 87.5 mt -67.17 -37.55 83.93 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.968 0.413 . . . . 0.0 110.599 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -90.02 -38.78 13.37 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.02 0.928 . . . . 0.0 112.223 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.88 63.32 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.09 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.5 158.59 36.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 123.802 0.841 . . . . 0.0 109.007 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.83 -171.8 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.777 2.318 . . . . 0.0 113.796 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2978 ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' 2981 ' ' ARG . 29.8 t70 -72.29 -34.89 68.49 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.17 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.34 -54.01 51.88 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.366 1.067 . . . . 0.0 111.285 -165.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.622 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.36 -26.31 14.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.371 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.513 HH21 HD11 ' A' 2973 ' ' LEU . 0.0 OUTLIER -68.12 -38.17 81.94 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.449 0.568 . . . . 0.0 110.535 -175.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -41.32 57.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.037 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 9.9 pt-20 -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 118.031 0.378 . . . . 0.0 111.341 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 31.6 m -69.69 -38.94 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 117.929 0.331 . . . . 0.0 110.774 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -49.38 78.07 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.113 0.482 . . . . 0.0 111.57 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.5 -35.81 65.69 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.918 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.39 -31.35 57.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.516 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.9 mm-40 -82.38 -48.23 11.39 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 111.51 -177.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' 2988 ' ' GLN . 0.8 OUTLIER -109.08 -34.88 6.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.346 0.258 . . . . 0.0 111.348 -171.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 86.05 2.04 86.25 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.347 0.404 . . . . 0.0 113.066 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.53 129.45 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2992 ' ' ARG . . . . . 0.532 HH11 ' HG3' ' A' 2996 ' ' ARG . 10.6 ptp85 -116.99 131.6 23.88 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.399 0.68 . . . . 0.0 109.552 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.77 -42.64 51.17 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 122.757 2.305 . . . . 0.0 115.146 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -177.87 3.7 Favored 'Trans proline' 0 C--N 1.399 3.199 0 CA-C-N 122.111 1.79 . . . . 0.0 113.135 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 17.8 p -61.01 137.21 58.24 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.882 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2996 ' ' ARG . . . . . 0.532 ' HG3' HH11 ' A' 2992 ' ' ARG . 0.1 OUTLIER -84.39 94.05 8.41 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 71.5 p -97.08 18.43 14.87 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.361 1.064 . . . . 0.0 110.693 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 56.96 74.79 0.63 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.757 1.223 . . . . 0.0 111.042 -171.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -84.45 10.76 3.59 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.946 2.43 . . . . 0.0 112.885 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 24.8 m -73.58 84.29 1.55 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.719 0.808 . . . . 0.0 110.817 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.9 t -88.41 152.07 22.15 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.748 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 13.5 m120 -75.04 111.8 10.63 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.009 0.524 . . . . 0.0 109.818 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.35 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 32.5 t -108.7 148.24 30.75 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.471 0.708 . . . . 0.0 110.245 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 17.2 m -115.8 -23.55 8.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.047 0.939 . . . . 0.0 110.051 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2954 ' ' GLU . . . . . 0.644 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 12.8 pt-20 -83.3 -36.84 24.14 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.021 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2955 ' ' GLU . . . . . 0.644 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 43.7 mt-10 -92.99 14.95 16.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.321 0.648 . . . . 0.0 111.785 -174.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -57.52 97.45 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 110.975 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -91.06 129.68 42.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.563 1.145 . . . . 0.0 109.201 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.94 -31.47 93.71 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.942 2.428 . . . . 0.0 112.716 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.78 -24.59 44.56 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.491 0.717 . . . . 0.0 110.382 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.2 -21.38 61.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.548 0.739 . . . . 0.0 112.74 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.91 -0.54 64.66 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.271 0.357 . . . . 0.0 113.363 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.62 167.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.079 0.952 . . . . 0.0 111.164 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -80.25 87.04 5.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.063 0.545 . . . . 0.0 110.904 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 11.1 tp -118.76 124.46 28.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.445 ' HG3' HG23 ' A' 2991 ' ' ILE . 96.3 Cg_endo -74.04 -162.04 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.954 2.436 . . . . 0.0 113.735 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -82.44 157.77 23.53 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.765 0.826 . . . . 0.0 110.61 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 62.76 18.22 59.06 Favored Glycine 0 N--CA 1.479 1.511 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.72 146.48 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.138 0.975 . . . . 0.0 108.884 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -132.79 124.32 18.72 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.279 0.632 . . . . 0.0 110.13 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.546 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 85.4 Cg_endo -76.21 2.72 6.91 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.675 2.25 . . . . 0.0 114.774 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 8.4 m -72.84 -56.96 4.45 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.881 0.764 . . . . 0.0 109.936 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 27.3 p90 -73.09 -22.33 60.6 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.17 0.188 . . . . 0.0 110.938 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' 2981 ' ' ARG . 6.9 mp -63.96 -51.5 64.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.49 0.716 . . . . 0.0 110.703 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2974 ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' 2954 ' ' GLU . . . -80.12 -26.78 39.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.289 0.636 . . . . 0.0 112.325 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -79.96 -49.3 12.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.676 0.39 . . . . 0.0 110.888 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 40.1 mt -97.73 150.38 36.72 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.113 0.965 . . . . 0.0 109.989 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.76 151.91 60.6 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.148 3.232 . . . . 0.0 113.482 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.21 -21.69 3.63 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 125.199 1.4 . . . . 0.0 113.796 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -51.57 -50.06 60.86 Favored 'General case' 0 C--O 1.248 1.017 0 C-N-CA 124.188 0.995 . . . . 0.0 111.353 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -72.56 -31.62 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.565 -177.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.547 ' HB2' ' HG ' ' A' 2973 ' ' LEU . 0.1 OUTLIER -70.06 -43.08 71.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.725 0.81 . . . . 0.0 109.888 -174.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -76.06 -31.34 58.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.219 0.324 . . . . 0.0 110.852 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -76.21 -40.43 52.25 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.99 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2984 ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' 2980 ' ' ILE . 27.0 m -66.24 -30.96 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-N 118.34 0.518 . . . . 0.0 110.171 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.15 -51.08 70.58 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 123.774 0.83 . . . . 0.0 110.672 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -75.02 -40.88 60.3 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.631 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -70.1 -53.63 16.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.329 . . . . 0.0 111.0 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.506 ' HB2' HD21 ' A' 2989 ' ' LEU . 28.9 mm-40 -64.07 -54.63 31.11 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.276 0.36 . . . . 0.0 111.891 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -103.99 -35.57 8.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.103 0.252 . . . . 0.0 111.628 -169.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 10.35 85.39 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.354 0.409 . . . . 0.0 113.436 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.445 HG23 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.48 121.96 24.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -106.42 127.97 27.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.87 -43.92 34.09 Favored 'Trans proline' 0 CA--C 1.581 2.825 0 C-N-CA 122.083 1.855 . . . . 0.0 113.554 164.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.64 82.05 2.2 Favored 'Trans proline' 0 C--N 1.409 3.758 0 C-N-CA 121.922 1.748 . . . . 0.0 113.196 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 46.7 p -77.01 122.16 24.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -73.88 95.64 2.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.546 0.738 . . . . 0.0 109.964 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.9 p -88.14 73.1 9.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.117 0.967 . . . . 0.0 110.777 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 55.7 63.29 6.41 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.892 1.277 . . . . 0.0 112.8 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -96.22 -1.36 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.658 2.239 . . . . 0.0 113.115 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 32.3 p -145.26 135.12 23.62 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.626 0.77 . . . . 0.0 110.143 -171.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 90.4 m -72.36 95.02 1.68 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.672 0.608 . . . . 0.0 110.117 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.02 147.73 27.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.241 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 123.302 0.641 . . . . 0.0 109.639 -178.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.5 m -79.04 92.17 4.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.742 0.817 . . . . 0.0 111.253 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 58.9 m -75.97 -4.28 40.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.984 0.914 . . . . 0.0 111.291 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.75 -15.27 62.68 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.458 1.103 . . . . 0.0 112.263 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.7 130.91 19.54 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.249 1.02 . . . . 0.0 108.68 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -133.27 102.58 5.61 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.85 126.97 32.23 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 123.886 0.874 . . . . 0.0 110.612 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.36 -24.33 22.92 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.242 2.628 . . . . 0.0 113.175 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 37.1 tp -83.36 -14.0 53.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.008 0.523 . . . . 0.0 110.767 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.34 41.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.402 0.681 . . . . 0.0 112.104 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 92.86 6.78 63.31 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 113.268 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.09 157.81 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.873 0.469 . . . . 0.0 110.97 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.0 p -88.68 100.4 13.09 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.152 0.581 . . . . 0.0 111.6 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 68.2 mt -100.08 133.73 21.37 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 167.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.79 173.84 13.82 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.205 1.936 . . . . 0.0 111.803 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.11 143.12 50.73 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.386 0.674 . . . . 0.0 111.676 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 81.66 7.02 88.63 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.778 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 62.0 t -105.48 108.66 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.707 0.803 . . . . 0.0 109.609 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.1 141.07 27.57 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.602 0.761 . . . . 0.0 110.647 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.48 ' HA ' HD11 ' A' 2973 ' ' LEU . 59.3 Cg_endo -67.23 -10.89 30.2 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.903 2.402 . . . . 0.0 112.687 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.1 m -56.6 -59.22 5.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2972 ' ' PHE . . . . . 0.517 ' HB2' HD12 ' A' 2976 ' ' LEU . 54.6 p90 -75.57 -24.22 56.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.383 0.273 . . . . 0.0 111.434 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.559 HD22 ' HB2' ' A' 2981 ' ' ARG . 81.5 mt -68.5 -35.44 77.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.512 0.325 . . . . 0.0 110.921 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.79 -31.18 14.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.714 0.806 . . . . 0.0 112.134 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.1 24.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.879 0.471 . . . . 0.0 111.732 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' 2972 ' ' PHE . 58.3 mt -108.06 161.23 24.06 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.895 0.878 . . . . 0.0 110.087 -172.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.7 -177.74 1.04 Allowed 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.928 2.418 . . . . 0.0 113.956 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.43 -27.52 62.38 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.012 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2979 ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' 2982 ' ' ARG . 29.6 t70 -59.19 -54.15 50.19 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.548 0.739 . . . . 0.0 112.524 -170.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.52 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.91 -28.9 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.65 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.559 ' HB2' HD22 ' A' 2973 ' ' LEU . 0.0 OUTLIER -69.29 -36.81 77.42 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -175.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2982 ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' 2979 ' ' ASP . 27.7 ptt180 -74.66 -40.39 61.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.931 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.7 pt-20 -69.65 -43.24 72.99 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.659 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 24.1 m -65.81 -32.81 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.113 0.415 . . . . 0.0 110.466 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 36.0 tp -63.8 -49.56 72.43 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.345 0.658 . . . . 0.0 111.046 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.79 -36.24 50.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.743 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.57 -53.63 11.42 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.718 0.407 . . . . 0.0 110.413 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.403 ' HB2' HD21 ' A' 2989 ' ' LEU . 24.8 mt-30 -66.67 -54.82 19.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.343 0.657 . . . . 0.0 111.401 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' 2988 ' ' GLN . 2.5 mm? -88.23 -48.89 7.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.922 0.489 . . . . 0.0 110.982 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.1 61.95 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.418 -0.657 . . . . 0.0 113.846 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.56 127.01 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.378 0.671 . . . . 0.0 110.473 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -107.06 132.34 20.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -59.99 -45.25 25.0 Favored 'Trans proline' 0 CA--C 1.575 2.547 0 C-N-CA 122.22 1.946 . . . . 0.0 113.941 169.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.11 90.11 1.27 Allowed 'Trans proline' 0 C--N 1.405 3.512 0 C-N-CA 121.877 1.718 . . . . 0.0 112.205 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 38.6 p -61.73 122.46 15.4 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -67.7 97.17 0.6 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.625 0.77 . . . . 0.0 110.304 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 44.0 p -90.47 38.77 0.95 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.64 1.176 . . . . 0.0 110.355 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -96.18 109.14 45.63 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.248 1.019 . . . . 0.0 110.675 -175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.96 175.01 11.93 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.754 2.302 . . . . 0.0 111.79 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 22.1 p -81.46 73.96 8.47 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.47 0.652 . . . . 0.0 110.321 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 4.3 t -130.61 102.48 6.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 0.0 109.627 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -97.12 118.51 33.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.075 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 42.9 p . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.888 0.375 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 40.4 m -95.52 150.76 19.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.973 0.909 . . . . 0.0 109.857 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.8 m -135.89 30.95 3.05 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.421 0.688 . . . . 0.0 109.641 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.38 -36.4 83.86 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.614 0.766 . . . . 0.0 111.294 -169.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 128.64 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.577 1.151 . . . . 0.0 109.084 174.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -112.66 97.96 6.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -128.32 138.25 32.61 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.193 -164.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.52 -29.61 88.97 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.897 2.398 . . . . 0.0 113.758 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 32.2 tp -72.89 -16.81 61.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.336 0.655 . . . . 0.0 111.533 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.69 64.5 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.267 0.627 . . . . 0.0 111.525 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 103.84 13.25 28.01 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.442 0.464 . . . . 0.0 112.869 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 23.2 pt -110.18 154.92 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.321 0.648 . . . . 0.0 110.753 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.3 m -105.42 102.05 11.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.55 143.02 96.7 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.194 0.598 . . . . 0.0 109.664 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.569 ' HG2' HG22 ' A' 2968 ' ' VAL . 29.1 Cg_endo -67.48 166.27 24.34 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.443 2.095 . . . . 0.0 112.049 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.17 132.26 53.03 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.48 0.712 . . . . 0.0 111.275 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 76.18 26.17 64.65 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.705 0.628 . . . . 0.0 113.921 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' 2965 ' ' PRO . 52.2 t -119.01 132.13 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.0 0.52 . . . . 0.0 109.783 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -120.86 134.58 24.34 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.007 0.923 . . . . 0.0 109.176 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.54 -7.6 20.81 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.897 2.398 . . . . 0.0 114.816 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 55.9 m -65.36 -54.97 21.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.334 0.515 . . . . 0.0 110.943 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.9 p90 -71.58 -30.28 65.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.578 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.66 -21.67 61.05 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.986 -174.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -96.94 -47.51 5.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.454 0.702 . . . . 0.0 111.773 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.29 70.43 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.676 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.8 mt -71.73 139.91 83.61 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.784 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 158.16 43.54 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.624 2.216 . . . . 0.0 111.161 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.29 -16.83 61.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.39 -58.17 4.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.306 0.503 . . . . 0.0 112.283 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.43 -23.08 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.746 -0.596 . . . . 0.0 109.78 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -65.28 -44.89 86.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.613 0.765 . . . . 0.0 110.157 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -70.99 -39.5 72.4 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.377 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.9 pt-20 -70.21 -37.41 75.04 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.855 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.5 m -67.42 -32.11 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 118.255 0.479 . . . . 0.0 110.558 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.67 -45.23 83.67 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 121.48 0.657 . . . . 0.0 109.952 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -73.95 -44.73 53.94 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.386 0.674 . . . . 0.0 112.357 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.3 -39.21 59.81 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.932 0.493 . . . . 0.0 112.008 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -74.51 -48.47 26.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.485 0.314 . . . . 0.0 111.512 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.82 -43.52 7.47 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.298 0.239 . . . . 0.0 111.271 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 11.15 84.46 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.819 0.699 . . . . 0.0 113.58 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.54 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -74.45 123.93 30.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -106.4 142.88 25.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.759 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.57 -32.7 30.59 Favored 'Trans proline' 0 CA--C 1.581 2.875 0 C-N-CA 122.607 2.205 . . . . 0.0 116.714 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 89.72 0.61 Allowed 'Trans proline' 0 C--N 1.403 3.397 0 CA-C-N 123.362 2.236 . . . . 0.0 113.261 -173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 47.3 p -92.27 94.41 9.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.146 0.978 . . . . 0.0 108.555 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -80.94 96.58 7.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.4 p -121.76 76.01 1.24 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.982 0.913 . . . . 0.0 109.767 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -159.26 139.61 8.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.31 1.044 . . . . 0.0 109.498 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.18 -12.99 30.82 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 112.305 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 28.9 m -64.76 91.45 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.248 1.019 . . . . 0.0 110.286 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 4.0 t -86.14 91.58 8.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.474 0.71 . . . . 0.0 110.178 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.64 103.22 0.83 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.135 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 123.795 0.838 . . . . 0.0 109.223 -175.823 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.615 0.245 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 31.9 t -106.75 124.66 49.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.633 0.773 . . . . 0.0 109.329 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 25.8 m -86.64 -0.86 57.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.39 0.676 . . . . 0.0 111.613 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -90.6 2.67 55.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.251 0.62 . . . . 0.0 111.565 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.02 132.4 19.63 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.233 0.54 . . . . 0.0 111.761 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -104.01 100.9 10.68 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.502 1.121 . . . . 0.0 108.287 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.82 124.81 66.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 123.72 0.808 . . . . 0.0 109.749 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2958 ' ' PRO . . . . . 0.406 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 22.7 Cg_endo -57.11 -34.68 98.18 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.068 2.512 . . . . 0.0 113.536 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -16.33 58.66 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.912 0.485 . . . . 0.0 111.309 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.01 -16.49 61.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.604 0.762 . . . . 0.0 112.503 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 96.58 3.06 59.81 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.797 -0.446 . . . . 0.0 113.606 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2962 ' ' ILE . . . . . 0.401 HD12 ' HG ' ' A' 2964 ' ' LEU . 2.6 pp -74.12 156.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 122.913 0.485 . . . . 0.0 110.786 175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 54.5 m -94.19 97.46 10.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.99 0.516 . . . . 0.0 111.153 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' 2962 ' ' ILE . 81.3 mt -103.14 134.54 19.72 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.397 0.679 . . . . 0.0 109.328 167.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.466 ' HG3' HG22 ' A' 2991 ' ' ILE . 42.2 Cg_endo -64.4 156.72 58.56 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.107 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.15 138.14 43.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.04 0.536 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 110.57 -27.77 10.93 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.962 -0.355 . . . . 0.0 113.461 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.583 ' HB ' HD22 ' A' 2989 ' ' LEU . 7.3 p -91.14 137.78 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 122.894 0.477 . . . . 0.0 110.714 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.4 124.98 59.61 Favored Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.406 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 54.4 Cg_endo -65.68 -9.26 22.07 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.828 2.352 . . . . 0.0 113.079 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 40.0 m -54.09 -60.03 3.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.296 1.039 . . . . 0.0 111.456 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 40.6 p90 -79.62 -21.96 44.23 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.325 0.391 . . . . 0.0 111.21 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.432 HD21 ' HD2' ' A' 2981 ' ' ARG . 72.8 mt -63.99 -36.02 82.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.22 -35.99 12.84 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.558 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -73.15 -24.44 60.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.581 0.752 . . . . 0.0 112.118 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.741 ' HB3' HD12 ' A' 2980 ' ' ILE . 58.6 mt -111.26 144.65 30.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.722 0.809 . . . . 0.0 109.603 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.79 172.08 10.06 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.332 2.688 . . . . 0.0 113.553 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2978 ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 6.3 p-10 -63.12 -17.25 62.13 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -168.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.44 -58.99 4.09 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 121.456 0.646 . . . . 0.0 110.297 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.783 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -82.37 -27.18 8.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.099 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 26.1 tpt85 -51.58 -49.85 61.3 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.664 0.785 . . . . 0.0 111.245 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -72.95 -43.99 61.67 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.036 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.783 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.6 pt-20 -66.28 -40.43 90.07 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 117.993 0.361 . . . . 0.0 111.182 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.3 m -68.28 -35.84 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 117.891 0.314 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2985 ' ' LEU . . . . . 0.406 HD22 ' NH1' ' A' 2981 ' ' ARG . 17.5 tp -65.72 -45.19 83.65 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.409 0.624 . . . . 0.0 110.844 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -73.38 -40.22 64.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.345 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -75.63 -38.62 58.77 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.018 -175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.508 ' HB2' HD21 ' A' 2989 ' ' LEU . 26.5 mm-40 -75.7 -55.83 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.462 0.305 . . . . 0.0 111.392 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.583 HD22 ' HB ' ' A' 2968 ' ' VAL . 1.2 mm? -96.73 -23.47 16.41 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.387 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.21 19.58 71.74 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.585 0.553 . . . . 0.0 113.624 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.466 HG22 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -84.42 141.38 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 123.687 0.795 . . . . 0.0 109.44 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2992 ' ' ARG . . . . . 0.645 ' HD2' ' HA ' ' A' 2996 ' ' ARG . 20.3 ptp180 -112.67 125.91 29.17 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.242 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -57.96 -36.65 97.97 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.523 2.815 . . . . 0.0 115.122 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -75.59 -169.29 0.64 Allowed 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 122.172 1.811 . . . . 0.0 112.753 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 38.9 p -60.15 136.23 57.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.307 0.643 . . . . 0.0 111.437 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2996 ' ' ARG . . . . . 0.645 ' HA ' ' HD2' ' A' 2992 ' ' ARG . 15.9 ptp180 -72.17 93.47 1.45 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.572 1.177 . . . . 0.0 110.195 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 39.7 p -81.02 -42.1 21.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.288 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -111.85 98.25 40.92 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 -30.48 92.06 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.298 2.666 . . . . 0.0 113.247 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 18.9 m 61.2 25.97 15.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.644 1.178 . . . . 0.0 112.025 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 50.8 m -89.8 126.91 35.86 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.49 0.716 . . . . 0.0 109.466 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 29.1 p30 -62.85 140.17 58.78 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.536 0.523 . . . . 0.0 110.983 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 124.392 1.077 . . . . 0.0 109.043 -179.319 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -43.21 98.16 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.9 m -123.93 34.88 4.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.102 0.561 . . . . 0.0 110.865 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 62.72 34.61 14.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.021 0.928 . . . . 0.0 110.645 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.93 157.3 26.25 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.498 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.15 116.08 31.33 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2957 ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 22.3 t70 -83.21 126.94 70.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2958 ' ' PRO . . . . . 0.546 ' HA ' HD12 ' A' 2964 ' ' LEU . 56.6 Cg_endo -65.15 -21.41 62.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.103 2.535 . . . . 0.0 113.982 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.05 9.08 30.62 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.234 0.614 . . . . 0.0 110.959 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2960 ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -67.18 -14.95 63.39 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.16 12.53 76.21 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2962 ' ' ILE . . . . . 0.488 HG12 ' HB1' ' A' 2960 ' ' ALA . 26.5 pt -91.12 162.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.837 0.855 . . . . 0.0 110.577 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 31.9 p -81.04 81.87 7.16 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.21 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' 2958 ' ' PRO . 78.2 mt -106.43 116.26 59.44 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.532 0.733 . . . . 0.0 109.342 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.586 ' HG3' HG21 ' A' 2991 ' ' ILE . 72.6 Cg_endo -70.1 168.32 22.33 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.595 2.196 . . . . 0.0 112.461 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2966 ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' 2989 ' ' LEU . 42.4 tt0 -78.99 129.15 34.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.03 0.532 . . . . 0.0 110.68 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 111.85 0.72 27.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 120.063 -0.298 . . . . 0.0 113.661 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 11.9 p -110.31 112.71 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 121.677 0.751 . . . . 0.0 109.82 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.97 130.45 36.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 110.187 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.26 28.18 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.304 2.669 . . . . 0.0 115.038 -174.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.6 m -72.05 -47.24 53.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.549 0.613 . . . . 0.0 110.832 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2972 ' ' PHE . . . . . 0.416 ' HB2' HD12 ' A' 2976 ' ' LEU . 17.4 p90 -73.2 -30.22 63.37 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.319 0.58 . . . . 0.0 110.302 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' 2981 ' ' ARG . 9.8 tp -69.49 -27.05 64.87 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.582 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.65 -54.75 3.38 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.273 1.029 . . . . 0.0 111.443 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.71 80.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.526 0.73 . . . . 0.0 112.168 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.88 ' HB3' HD11 ' A' 2980 ' ' ILE . 86.4 mt -79.58 143.99 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.76 174.54 6.47 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.937 2.425 . . . . 0.0 112.067 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -27.59 68.68 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.93 -57.5 10.55 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 123.974 0.909 . . . . 0.0 112.142 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.66 -28.46 8.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.604 -176.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.408 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.3 OUTLIER -68.74 -34.24 75.28 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -176.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -75.33 -40.09 58.71 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 122.542 0.337 . . . . 0.0 110.473 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.7 pt-20 -70.24 -38.42 75.18 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-O 118.952 -0.546 . . . . 0.0 110.987 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 30.8 m -68.99 -34.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.574 0.35 . . . . 0.0 110.638 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.93 -47.6 80.24 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.714 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.89 -32.46 51.87 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.693 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.12 -28.2 54.28 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.801 0.44 . . . . 0.0 111.823 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' 2989 ' ' LEU . 26.9 mt-30 -78.81 -51.93 9.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.603 0.361 . . . . 0.0 110.871 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' 2988 ' ' GLN . 2.4 mm? -98.43 -49.61 4.6 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.651 0.38 . . . . 0.0 111.914 -171.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 96.36 9.59 56.63 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.431 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.586 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -70.97 125.06 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.843 0.857 . . . . 0.0 109.457 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -85.28 118.6 71.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.76 -39.47 81.69 Favored 'Trans proline' 0 CA--C 1.582 2.88 0 C-N-CA 122.588 2.192 . . . . 0.0 114.528 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.55 106.75 1.68 Allowed 'Trans proline' 0 C--N 1.412 3.89 0 CA-C-N 121.736 1.656 . . . . 0.0 112.249 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 63.8 p -99.31 139.8 34.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.254 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -120.05 102.94 8.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.537 0.735 . . . . 0.0 109.148 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 50.4 p -88.97 -8.48 54.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.436 0.694 . . . . 0.0 111.187 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -79.74 153.58 75.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.004 0.921 . . . . 0.0 110.022 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.63 15.57 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.083 2.522 . . . . 0.0 113.638 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 15.7 m -77.92 117.8 19.61 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.581 0.752 . . . . 0.0 110.213 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 27.5 m -128.03 137.57 52.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.068 0.947 . . . . 0.0 110.145 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -74.03 87.91 1.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.555 1.137 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.006 176.8 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 93.9 p -85.13 -146.37 0.1 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 123.878 0.871 . . . . 0.0 109.905 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 45.7 m -127.91 13.34 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.014 0.925 . . . . 0.0 110.648 174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -83.86 -42.13 16.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.596 0.759 . . . . 0.0 111.811 -171.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.03 95.79 0.5 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.841 0.829 . . . . 0.0 110.661 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.79 85.27 5.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 19.1 t0 -96.37 123.05 55.99 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.754 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.37 -27.17 71.15 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.066 2.511 . . . . 0.0 112.534 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.38 -19.5 60.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.22 0.608 . . . . 0.0 110.935 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -67.79 -10.98 57.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.094 0.557 . . . . 0.0 111.869 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 74.12 19.88 79.74 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.078 0.37 . . . . 0.0 113.073 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2962 ' ' ILE . . . . . 0.483 HG13 ' HG ' ' A' 2964 ' ' LEU . 37.6 pt -85.65 167.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.893 0.877 . . . . 0.0 111.114 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.0 p -81.86 79.13 8.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.349 0.66 . . . . 0.0 111.083 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' 2962 ' ' ILE . 76.0 mt -100.02 148.16 34.46 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 123.362 0.665 . . . . 0.0 109.577 173.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 173.4 9.66 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.88 139.65 39.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 69.29 12.77 66.58 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 124.158 0.911 . . . . 0.0 114.965 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 14.4 p -79.43 121.68 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 117.218 0.509 . . . . 0.0 109.865 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.97 120.18 75.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.07 -12.47 19.46 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.03 2.487 . . . . 0.0 113.416 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -69.43 -55.28 10.75 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 122.778 0.431 . . . . 0.0 110.759 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -75.74 -33.19 60.25 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.23 -46.59 88.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.246 1.019 . . . . 0.0 110.88 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -89.45 -35.03 16.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.927 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -72.65 -41.04 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' 2980 ' ' ILE . 87.3 mt -75.0 150.34 85.77 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.486 0.714 . . . . 0.0 109.854 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.39 166.07 6.59 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.982 2.454 . . . . 0.0 113.598 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.14 -23.97 67.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.308 1.043 . . . . 0.0 112.713 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.75 -57.52 10.67 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 124.205 1.002 . . . . 0.0 111.675 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.76 -22.65 8.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 O-C-N 122.256 -0.277 . . . . 0.0 110.409 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 13.5 tpt85 -54.26 -52.6 60.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.093 0.957 . . . . 0.0 110.898 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -71.78 -37.51 70.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 0.0 OUTLIER -69.7 -39.56 76.85 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.129 -175.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.1 m -69.45 -33.58 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.377 0.271 . . . . 0.0 110.383 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.34 -46.88 87.41 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.26 -43.4 57.11 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.868 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.68 -43.24 48.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.011 0.524 . . . . 0.0 111.382 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.494 ' HB2' HD23 ' A' 2989 ' ' LEU . 27.6 mm-40 -72.13 -57.28 4.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.923 0.489 . . . . 0.0 111.305 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.494 HD23 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -95.25 -26.74 15.83 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -168.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 73.11 15.17 78.67 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.592 0.558 . . . . 0.0 114.032 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.84 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.571 0.748 . . . . 0.0 109.133 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -93.2 117.35 67.43 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.174 0.59 . . . . 0.0 109.708 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.28 -37.74 59.55 Favored 'Trans proline' 0 CA--C 1.582 2.899 0 C-N-CA 122.379 2.052 . . . . 0.0 114.037 165.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.09 119.32 6.33 Favored 'Trans proline' 0 C--N 1.411 3.866 0 CA-C-N 122.02 1.757 . . . . 0.0 112.447 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 3.6 p -128.31 115.57 18.49 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.321 1.049 . . . . 0.0 109.706 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2996 ' ' ARG . . . . . 0.716 ' HG3' ' HB3' ' A' 3002 ' ' ASN . 20.8 mmt180 -68.41 102.69 1.47 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.909 0.884 . . . . 0.0 110.598 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 71.7 p -80.33 -16.91 53.5 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.804 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -65.59 153.38 90.67 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.144 0.978 . . . . 0.0 111.215 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.02 -31.13 33.59 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.612 2.875 . . . . 0.0 113.28 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 30.0 t -66.27 101.3 0.71 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 110.196 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.1 m -82.58 79.37 9.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.935 0.894 . . . . 0.0 109.058 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 3002 ' ' ASN . . . . . 0.716 ' HB3' ' HG3' ' A' 2996 ' ' ARG . 5.8 t30 -87.95 109.35 19.74 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.262 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 17.6 p . . . . . 0 CA--C 1.551 1.012 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 173.469 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 10.1 t 62.96 17.66 10.25 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.382 1.073 . . . . 0.0 112.185 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 36.6 t -74.02 -4.3 34.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.927 0.891 . . . . 0.0 111.387 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.72 -35.49 70.75 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.979 0.912 . . . . 0.0 111.087 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -114.0 146.41 40.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2956 ' ' GLU . . . . . 0.529 ' HG2' HD12 ' A' 2964 ' ' LEU . 38.8 tt0 -134.21 85.45 2.19 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.6 125.43 78.39 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.524 1.13 . . . . 0.0 110.897 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.11 -26.26 30.82 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.62 -5.37 52.73 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.365 0.666 . . . . 0.0 111.09 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.65 36.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.446 0.699 . . . . 0.0 111.892 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.2 69.22 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 113.425 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.8 144.56 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.207 0.603 . . . . 0.0 110.648 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 27.8 m -79.5 85.54 5.26 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.785 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.529 HD12 ' HG2' ' A' 2956 ' ' GLU . 27.3 mt -93.77 149.73 37.54 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.505 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.566 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 67.0 Cg_endo -66.85 -178.39 1.27 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 123.296 2.664 . . . . 0.0 114.693 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -70.48 125.76 27.71 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.572 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 64.33 27.29 71.42 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.207 0.942 . . . . 0.0 114.383 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' 2964 ' ' LEU . 6.9 p -89.76 149.84 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.56 132.13 18.59 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.249 1.019 . . . . 0.0 109.296 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.14 -17.2 10.93 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.495 2.797 . . . . 0.0 113.491 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.6 m -53.27 -60.61 3.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 111.671 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2972 ' ' PHE . . . . . 0.469 ' HB2' HD12 ' A' 2976 ' ' LEU . 55.3 p90 -80.69 -24.96 38.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.307 0.243 . . . . 0.0 111.586 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.68 -35.74 81.65 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.5 -51.25 5.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.681 0.793 . . . . 0.0 111.517 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.18 87.96 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.213 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.469 HD12 ' HB2' ' A' 2972 ' ' PHE . 70.7 mt -93.95 160.71 31.83 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.456 0.702 . . . . 0.0 109.452 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.52 178.23 4.0 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.796 2.331 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2978 ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 31.0 m-20 -73.84 -15.49 61.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 112.368 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2979 ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' 2982 ' ' ARG . 7.3 m-20 -62.22 -55.52 27.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.188 0.595 . . . . 0.0 112.106 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.635 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -79.52 -24.1 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 122.129 -0.357 . . . . 0.0 110.499 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -59.36 -49.02 79.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.947 0.899 . . . . 0.0 109.64 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2982 ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' 2979 ' ' ASP . 17.9 ptt180 -72.85 -34.91 67.08 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.914 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.9 pt-20 -74.7 -42.43 58.39 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.189 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2984 ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' 2988 ' ' GLN . 33.0 m -63.88 -34.52 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 119.108 0.867 . . . . 0.0 110.508 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.75 -62.86 1.56 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.69 0.796 . . . . 0.0 111.005 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -80.2 -47.43 14.67 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.149 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.95 -37.51 81.67 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.357 0.663 . . . . 0.0 112.05 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' 2984 ' ' VAL . 27.4 mt-30 -82.13 -56.56 3.86 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.229 0.468 . . . . 0.0 111.585 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.2 mm? -88.96 -34.36 16.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.104 0.162 . . . . 0.0 111.314 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 93.57 1.09 66.4 Favored Glycine 0 C--N 1.34 0.764 0 O-C-N 123.445 0.466 . . . . 0.0 113.42 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.53 121.38 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.303 0.641 . . . . 0.0 109.475 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2992 ' ' ARG . . . . . 0.422 ' HE ' ' HG2' ' A' 2994 ' ' PRO . 13.7 ptm180 -99.54 129.42 29.01 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.722 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.39 -40.42 58.07 Favored 'Trans proline' 0 CA--C 1.572 2.404 0 C-N-CA 122.35 2.033 . . . . 0.0 114.287 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2994 ' ' PRO . . . . . 0.422 ' HG2' ' HE ' ' A' 2992 ' ' ARG . 86.2 Cg_endo -74.27 81.31 2.04 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 121.805 1.67 . . . . 0.0 111.772 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 37.1 p -67.99 93.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.502 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -71.79 94.71 1.42 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.608 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 21.0 p -95.07 101.48 13.23 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -147.8 161.57 34.63 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.133 0.973 . . . . 0.0 109.472 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.76 -35.31 17.37 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.36 2.707 . . . . 0.0 113.088 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 35.8 p -85.74 134.84 33.93 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.058 0.943 . . . . 0.0 110.005 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.0 t -76.68 139.36 40.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.759 0.424 . . . . 0.0 110.147 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.6 t30 -72.92 94.89 1.89 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 123.907 0.883 . . . . 0.0 108.756 -178.463 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 66.3 p -153.42 179.2 9.0 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.251 1.02 . . . . 0.0 109.083 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 66.7 p -103.11 27.41 7.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.443 0.697 . . . . 0.0 110.034 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.24 -35.89 76.48 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 123.986 0.915 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2955 ' ' GLU . . . . . 0.453 ' HA ' ' HB1' ' A' 2974 ' ' ALA . 4.9 pt-20 -124.36 107.0 10.68 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.847 0.832 . . . . 0.0 108.772 162.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.76 131.16 40.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 22.5 t70 -110.96 118.3 48.46 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.226 0.611 . . . . 0.0 110.065 -168.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2958 ' ' PRO . . . . . 0.423 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 42.3 Cg_endo -64.28 -31.41 63.27 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.941 2.427 . . . . 0.0 113.483 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 43.4 tp -78.77 -9.7 59.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.222 0.609 . . . . 0.0 111.339 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.69 -15.41 28.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 88.27 28.91 21.34 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 35.1 pt -87.06 160.46 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 110.973 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 50.9 p -99.13 83.88 2.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.504 0.722 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 83.5 mt -77.64 119.57 77.97 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.404 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 45.1 Cg_endo -67.1 164.92 28.25 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.113 1.876 . . . . 0.0 112.282 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.19 132.62 53.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.445 0.698 . . . . 0.0 111.449 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 71.75 14.52 75.47 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.898 0.749 . . . . 0.0 113.847 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.52 HG23 HD22 ' A' 2989 ' ' LEU . 95.3 t -119.97 111.96 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.099 0.96 . . . . 0.0 109.603 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.04 157.48 33.79 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.813 0.845 . . . . 0.0 109.44 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.423 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 45.4 Cg_endo -82.11 8.02 4.74 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.502 2.135 . . . . 0.0 113.036 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 29.9 p -63.11 -59.37 4.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.339 1.056 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2972 ' ' PHE . . . . . 0.43 ' HE2' HG22 ' A' 2984 ' ' VAL . 26.6 p90 -75.01 -26.8 59.8 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.3 0.64 . . . . 0.0 110.987 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' 2980 ' ' ILE . 73.4 mt -67.72 -29.65 68.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.754 0.422 . . . . 0.0 110.825 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2974 ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' 2955 ' ' GLU . . . -92.1 -43.26 9.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.978 0.911 . . . . 0.0 111.638 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.6 -48.36 55.53 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.391 0.676 . . . . 0.0 111.119 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 51.4 mt -92.31 160.99 33.98 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.239 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2977 ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.9 Cg_endo -61.23 153.05 67.85 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.213 2.609 . . . . 0.0 113.076 -174.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -55.31 -15.52 2.57 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.926 0.89 . . . . 0.0 112.616 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.95 -49.76 65.41 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.717 1.607 . . . . 0.0 111.436 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.1 OUTLIER -69.95 -32.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -178.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.449 ' N ' HD11 ' A' 2980 ' ' ILE . 23.3 tpt180 -57.6 -52.17 66.52 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.641 1.177 . . . . 0.0 111.119 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -72.08 -42.14 66.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.505 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.517 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -71.52 -40.22 70.25 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2984 ' ' VAL . . . . . 0.43 HG22 ' HE2' ' A' 2972 ' ' PHE . 18.3 m -73.26 -33.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.25 0.477 . . . . 0.0 110.215 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.2 tp -57.22 -48.31 79.12 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.168 0.508 . . . . 0.0 110.701 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.8 -48.38 14.91 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.046 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.07 -27.72 57.34 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.05 0.54 . . . . 0.0 112.303 -170.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.521 ' HB2' HD21 ' A' 2989 ' ' LEU . 26.1 mm-40 -91.24 -47.81 7.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.557 0.343 . . . . 0.0 110.856 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -105.26 -45.16 4.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.086 0.154 . . . . 0.0 111.049 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.99 6.07 89.29 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.43 0.456 . . . . 0.0 113.642 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.04 114.97 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -86.43 127.77 59.67 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.97 -23.66 18.28 Favored 'Trans proline' 0 CA--C 1.588 3.18 0 C-N-CA 122.463 2.109 . . . . 0.0 116.275 170.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.74 97.04 0.17 Allowed 'Trans proline' 1 C--N 1.418 4.19 0 CA-C-N 123.729 2.368 . . . . 0.0 113.293 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 47.1 p -90.89 116.71 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 167.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -65.32 96.58 0.24 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 110.789 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 63.1 p -74.9 -48.38 25.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.27 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -81.69 140.67 47.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.847 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -80.73 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.952 2.435 . . . . 0.0 113.751 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 68.0 p 48.98 79.35 0.08 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.714 1.606 . . . . 0.0 111.95 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.5 t -105.67 154.17 20.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.123 0.969 . . . . 0.0 110.906 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.7 t30 -89.89 135.51 33.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.748 0.819 . . . . 0.0 110.008 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 CA--C 1.556 1.21 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.536 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 48.6 p -67.33 100.17 0.79 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 23.3 m -69.58 -17.28 63.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.495 0.718 . . . . 0.0 111.289 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -82.46 78.98 9.03 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -99.54 106.59 18.61 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.076 176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.29 150.2 49.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.306 0.642 . . . . 0.0 109.529 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2957 ' ' ASP . . . . . 0.495 ' HB3' ' HB1' ' A' 2960 ' ' ALA . 17.6 t70 -143.21 135.84 13.56 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 122.645 0.378 . . . . 0.0 110.822 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2958 ' ' PRO . . . . . 0.535 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 98.0 Cg_endo -75.05 -23.74 13.43 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.983 2.456 . . . . 0.0 113.49 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.45 28.9 7.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.608 0.763 . . . . 0.0 110.011 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2960 ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' 2957 ' ' ASP . . . -72.66 -13.62 61.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.55 0.74 . . . . 0.0 112.419 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.18 39.29 9.31 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 38.9 pt -124.83 170.83 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.449 1.1 . . . . 0.0 109.974 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.2 m -90.62 100.58 13.4 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.112 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.497 ' HB3' HG13 ' A' 2968 ' ' VAL . 98.2 mt -72.33 139.9 81.98 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.61 169.96 20.02 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.116 1.877 . . . . 0.0 111.7 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -72.41 139.72 47.96 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 68.33 27.8 73.58 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.774 -0.25 . . . . 0.0 113.128 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' 2964 ' ' LEU . 8.0 p -69.52 132.53 33.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.295 0.569 . . . . 0.0 109.933 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2969 ' ' ASP . . . . . 0.483 ' HB3' ' HE1' ' A' 2972 ' ' PHE . 13.4 t70 -144.37 110.37 4.98 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.535 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 72.6 Cg_endo -68.09 -10.11 27.86 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.045 2.497 . . . . 0.0 113.894 -175.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.8 m -62.95 -56.28 18.54 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 122.841 0.456 . . . . 0.0 110.5 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2972 ' ' PHE . . . . . 0.483 ' HE1' ' HB3' ' A' 2969 ' ' ASP . 50.3 p90 -75.74 -26.61 57.6 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 117.765 0.257 . . . . 0.0 110.972 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.415 HD22 ' HD3' ' A' 2981 ' ' ARG . 95.5 mt -68.79 -26.56 65.27 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.388 0.275 . . . . 0.0 111.312 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.88 -37.53 11.15 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 0.0 111.708 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.24 52.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.36 0.664 . . . . 0.0 111.877 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.828 ' HB3' HD12 ' A' 2980 ' ' ILE . 89.8 mt -103.32 152.11 38.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.622 0.769 . . . . 0.0 110.151 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.59 173.58 5.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.978 2.452 . . . . 0.0 113.084 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.0 -19.69 61.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.83 -54.84 13.47 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.61 0.764 . . . . 0.0 112.043 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.416 ' HA ' HG23 ' A' 2984 ' ' VAL . 0.0 OUTLIER -75.21 -32.02 61.07 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.08 -31.55 56.09 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.247 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -39.64 82.16 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 117.836 0.289 . . . . 0.0 110.252 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2984 ' ' VAL . . . . . 0.482 HG21 ' HE2' ' A' 2972 ' ' PHE . 33.4 m -72.13 -31.83 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.71 -50.81 72.38 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.036 0.535 . . . . 0.0 111.517 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.52 -39.98 51.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.887 0.475 . . . . 0.0 111.798 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -75.76 -27.16 57.95 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.627 0.371 . . . . 0.0 111.672 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.482 ' HB2' HD21 ' A' 2989 ' ' LEU . 29.3 mm-40 -83.98 -56.39 3.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.726 0.239 . . . . 0.0 111.038 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' 2988 ' ' GLN . 1.2 mm? -105.53 -35.61 7.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.79 17.04 72.85 Favored Glycine 0 C--N 1.343 0.957 0 O-C-N 123.176 0.298 . . . . 0.0 113.299 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 130.1 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2992 ' ' ARG . . . . . 0.576 ' HD2' ' HA ' ' A' 2996 ' ' ARG . 15.0 ptp180 -81.25 121.18 80.08 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 123.406 0.441 . . . . 0.0 110.885 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.73 -34.53 91.72 Favored 'Trans proline' 0 CA--C 1.574 2.481 0 C-N-CA 122.674 2.249 . . . . 0.0 114.375 168.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.17 -162.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.404 3.477 0 C-N-CA 122.482 2.122 . . . . 0.0 114.267 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 33.9 m -59.89 109.16 0.88 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.678 0.791 . . . . 0.0 111.044 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2996 ' ' ARG . . . . . 0.576 ' HA ' ' HD2' ' A' 2992 ' ' ARG . 86.9 mtm180 -71.84 95.78 1.57 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.155 0.982 . . . . 0.0 110.47 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 33.3 p -110.18 -6.3 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.204 1.002 . . . . 0.0 111.441 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -106.6 97.13 15.82 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.483 0.713 . . . . 0.0 109.516 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.23 12.17 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.287 2.658 . . . . 0.0 114.885 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 20.5 m 66.35 23.34 10.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.156 1.382 . . . . 0.0 111.518 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 41.4 m -78.21 86.31 4.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.335 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.26 142.54 37.77 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.883 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 CA--C 1.546 0.796 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.23 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 2952 ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' 2954 ' ' GLU . 37.9 t -77.41 170.33 16.75 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.172 0.589 . . . . 0.0 111.272 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 28.7 m -71.61 -4.12 25.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.63 0.772 . . . . 0.0 112.577 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2954 ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 11.2 pt-20 -56.51 -44.41 80.72 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.625 1.17 . . . . 0.0 111.441 173.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2955 ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 50.6 mt-10 -113.09 158.36 20.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.79 0.836 . . . . 0.0 110.019 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.77 130.41 48.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2957 ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 26.8 t70 -103.43 134.11 19.93 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.18 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -59.57 -33.45 96.91 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.551 2.167 . . . . 0.0 112.159 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.61 21.91 11.63 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.345 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2960 ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -74.73 -10.63 59.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.267 0.627 . . . . 0.0 111.978 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 105.5 29.5 5.03 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 31.9 pt -114.58 163.11 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.154 0.981 . . . . 0.0 111.541 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.0 p -101.48 79.7 1.99 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 111.669 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.86 125.55 58.67 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.91 172.95 4.22 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.169 2.579 . . . . 0.0 113.117 171.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.04 139.28 54.9 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.419 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.73 67.88 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.373 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 26.5 t -89.37 100.0 10.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 117.384 0.592 . . . . 0.0 109.999 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.39 138.37 86.53 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.459 0.703 . . . . 0.0 109.532 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.95 -4.82 15.33 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.488 2.126 . . . . 0.0 111.581 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -60.94 -60.43 3.81 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.934 0.894 . . . . 0.0 110.595 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -73.81 -31.31 63.18 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.074 0.464 . . . . 0.0 110.23 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.668 ' HG ' HH11 ' A' 2981 ' ' ARG . 11.8 tp -69.84 -33.59 72.49 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.818 0.847 . . . . 0.0 111.758 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.77 -35.37 12.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 111.55 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.4 80.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.81 0.444 . . . . 0.0 111.794 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.771 ' HB3' HD13 ' A' 2980 ' ' ILE . 69.7 mt -89.25 145.51 34.28 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.95 167.06 5.95 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.039 2.493 . . . . 0.0 113.707 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.38 -27.82 69.35 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.03 -55.41 25.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 112.101 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.771 HD13 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.62 -24.49 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.629 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.668 HH11 ' HG ' ' A' 2973 ' ' LEU . 0.0 OUTLIER -70.22 -31.98 69.65 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.102 0.41 . . . . 0.0 110.242 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -74.95 -38.86 61.62 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 119.542 -0.266 . . . . 0.0 110.477 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 6.7 pt-20 -67.2 -37.97 84.54 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.955 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2984 ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' 2980 ' ' ILE . 25.0 m -69.51 -33.85 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.114 0.416 . . . . 0.0 110.159 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2985 ' ' LEU . . . . . 0.446 HD11 HD22 ' A' 2989 ' ' LEU . 39.9 tp -61.91 -40.25 94.82 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.355 0.598 . . . . 0.0 110.802 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -79.02 -37.7 38.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.422 0.689 . . . . 0.0 111.584 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -74.78 -38.83 62.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.491 0.717 . . . . 0.0 111.147 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.434 ' HB2' HD23 ' A' 2989 ' ' LEU . 28.6 mt-30 -83.48 -50.82 7.91 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.072 0.549 . . . . 0.0 111.09 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.446 HD22 HD11 ' A' 2985 ' ' LEU . 2.3 mm? -95.7 -48.17 5.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.561 0.344 . . . . 0.0 110.96 -173.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.91 40.71 74.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 113.745 0.258 . . . . 0.0 113.745 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.82 130.63 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.55 0.74 . . . . 0.0 109.201 -177.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2992 ' ' ARG . . . . . 0.424 ' HE ' ' HG2' ' A' 2994 ' ' PRO . 10.5 ptm85 -96.44 129.06 34.3 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -62.32 -33.54 80.1 Favored 'Trans proline' 0 CA--C 1.579 2.773 0 C-N-CA 121.886 1.724 . . . . 0.0 114.811 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2994 ' ' PRO . . . . . 0.424 ' HG2' ' HE ' ' A' 2992 ' ' ARG . 92.9 Cg_endo -73.16 178.44 6.55 Favored 'Trans proline' 0 C--N 1.398 3.156 0 CA-C-N 122.538 1.942 . . . . 0.0 112.657 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 51.5 p -71.85 152.45 42.62 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.436 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 66.5 mtm-85 -80.88 94.73 6.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 62.8 p -80.86 87.58 5.91 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.613 0.765 . . . . 0.0 109.808 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2998 ' ' ALA . . . . . 0.53 ' HB2' ' HD3' ' A' 2999 ' ' PRO . . . -85.91 -63.55 0.23 Allowed Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.023 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2999 ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' 2998 ' ' ALA . 34.3 Cg_endo -93.19 -7.48 2.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.842 1.694 . . . . 0.0 112.163 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 76.3 p -101.58 47.82 0.9 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.697 0.799 . . . . 0.0 110.252 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 11.0 t -139.46 142.95 37.36 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.972 0.509 . . . . 0.0 110.126 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -75.67 123.9 26.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.645 0.778 . . . . 0.0 110.128 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 123.751 0.821 . . . . 0.0 110.725 -177.658 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.5 t 66.84 8.39 5.99 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.416 1.486 . . . . 0.0 112.672 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 43.7 p -89.45 16.65 7.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.976 0.91 . . . . 0.0 111.441 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.91 -41.15 99.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.072 0.949 . . . . 0.0 110.796 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -100.6 170.59 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.248 1.019 . . . . 0.0 111.224 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2956 ' ' GLU . . . . . 0.449 ' HB2' HD22 ' A' 2973 ' ' LEU . 24.8 mt-10 -92.52 85.39 5.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.454 0.702 . . . . 0.0 109.152 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.2 138.31 19.65 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.14 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -46.99 -44.53 22.78 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 124.133 3.222 . . . . 0.0 114.063 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.25 -10.27 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.248 0.619 . . . . 0.0 111.018 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.55 1.8 15.68 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.33 0.652 . . . . 0.0 111.912 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 77.6 18.99 76.79 Favored Glycine 0 C--N 1.355 1.615 0 C-N-CA 123.313 0.482 . . . . 0.0 113.287 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2962 ' ' ILE . . . . . 0.433 HD12 HD12 ' A' 2964 ' ' LEU . 2.5 pp -76.08 164.21 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.646 0.778 . . . . 0.0 111.876 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 25.0 t -115.97 81.15 1.55 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' 2968 ' ' VAL . 10.4 mp -112.34 143.24 28.47 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.61 164.63 34.68 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.321 2.681 . . . . 0.0 113.228 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.6 129.05 38.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2967 ' ' GLY . . . . . 0.431 ' HA3' HD12 ' A' 2989 ' ' LEU . . . 115.12 25.9 3.69 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' 2964 ' ' LEU . 9.0 p -139.21 153.86 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.74 0.816 . . . . 0.0 109.174 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2969 ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' 2972 ' ' PHE . 3.4 t70 -146.03 124.38 6.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.12 0.968 . . . . 0.0 109.1 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 79.0 Cg_endo -73.58 -0.64 9.59 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.979 2.452 . . . . 0.0 113.971 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.3 m -68.33 -57.09 6.47 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2972 ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' 2969 ' ' ASP . 22.7 p90 -72.53 -32.23 65.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' 2981 ' ' ARG . 8.6 tp -67.61 -30.88 70.58 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.786 0.834 . . . . 0.0 111.273 -173.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.82 -43.94 7.99 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.727 0.811 . . . . 0.0 111.616 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.73 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.509 0.724 . . . . 0.0 111.878 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' 2980 ' ' ILE . 79.5 mt -92.78 150.02 38.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.511 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -58.18 165.69 6.78 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.985 2.457 . . . . 0.0 113.612 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.99 -20.29 66.14 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.5 -52.54 13.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.634 0.774 . . . . 0.0 112.251 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.0 -24.58 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.133 -0.354 . . . . 0.0 110.553 -178.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.577 ' HD3' ' HG ' ' A' 2973 ' ' LEU . 0.8 OUTLIER -71.52 -35.67 70.79 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -69.83 -42.76 73.2 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -38.67 84.64 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.944 -174.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 35.3 m -68.32 -40.27 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.482 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2985 ' ' LEU . . . . . 0.445 HD13 HD22 ' A' 2989 ' ' LEU . 57.4 tp -59.67 -45.88 90.73 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.871 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2986 ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' 2991 ' ' ILE . 24.0 mt-30 -74.26 -34.85 63.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.885 0.874 . . . . 0.0 111.999 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.82 -36.76 56.68 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.973 0.509 . . . . 0.0 112.136 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.47 ' HB2' HD23 ' A' 2989 ' ' LEU . 20.0 mt-30 -71.59 -56.98 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.346 0.258 . . . . 0.0 111.233 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' 2988 ' ' GLN . 1.4 mm? -97.45 -22.43 16.58 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.67 -170.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 74.74 40.97 35.83 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' 2986 ' ' GLN . 0.0 OUTLIER -110.62 128.64 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 0.0 108.654 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -116.07 131.1 23.93 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.1 -38.98 63.24 Favored 'Trans proline' 0 CA--C 1.573 2.434 0 C-N-CA 123.281 2.654 . . . . 0.0 115.92 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.31 -179.51 3.66 Favored 'Trans proline' 0 C--N 1.401 3.322 0 CA-C-N 122.255 1.841 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 92.6 m -58.9 103.9 0.2 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.469 0.652 . . . . 0.0 111.602 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.42 96.49 0.89 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.879 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 58.4 p -90.55 2.47 55.76 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.11 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 55.38 70.95 1.38 Allowed Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.833 1.253 . . . . 0.0 110.814 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.89 93.09 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.378 2.718 . . . . 0.0 112.94 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 8.4 t 60.89 29.37 18.97 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.149 1.38 . . . . 0.0 111.644 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.9 t -146.46 158.74 43.94 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.126 0.971 . . . . 0.0 109.602 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -109.89 132.3 54.28 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 123.961 0.904 . . . . 0.0 109.398 179.134 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.555 1.143 0 CA-C-O 121.691 0.758 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 37.7 m -124.13 -165.96 1.43 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.714 1.206 . . . . 0.0 109.911 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 19.2 m -81.97 -2.75 52.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.583 0.753 . . . . 0.0 111.582 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.15 -40.2 95.18 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.996 0.919 . . . . 0.0 111.05 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2955 ' ' GLU . . . . . 0.584 ' HA ' ' HB1' ' A' 2974 ' ' ALA . 1.8 pm0 -82.41 141.12 33.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.643 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2956 ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' 2974 ' ' ALA . 12.6 pt-20 -107.62 154.2 21.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.884 0.873 . . . . 0.0 109.497 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -146.35 139.98 14.93 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.452 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.68 -33.19 96.34 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.377 2.718 . . . . 0.0 113.688 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.0 -14.89 61.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.119 0.567 . . . . 0.0 110.455 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.99 -21.48 64.88 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.979 0.512 . . . . 0.0 111.68 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 114.3 5.67 20.99 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 123.605 0.621 . . . . 0.0 113.047 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 14.5 pt -92.69 147.68 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.285 0.634 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.8 t -101.58 95.51 6.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.13 0.972 . . . . 0.0 109.99 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.15 136.84 40.41 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.542 ' HG3' HG23 ' A' 2991 ' ' ILE . 52.1 Cg_endo -66.61 141.82 62.02 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.712 2.274 . . . . 0.0 112.02 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.97 122.51 16.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.225 0.61 . . . . 0.0 111.573 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 117.07 -19.87 11.73 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.722 0.639 . . . . 0.0 112.961 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.641 ' HB ' HD22 ' A' 2989 ' ' LEU . 4.7 p -96.57 155.34 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 118.106 0.953 . . . . 0.0 109.071 171.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.82 129.91 22.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.66 -16.26 50.0 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.123 2.548 . . . . 0.0 114.627 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 23.9 m -62.92 -55.39 26.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.737 0.415 . . . . 0.0 111.082 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 20.0 p90 -74.9 -30.71 61.37 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.856 0.36 . . . . 0.0 110.126 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.36 -42.05 96.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.713 0.805 . . . . 0.0 110.737 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2974 ' ' ALA . . . . . 0.593 ' HB3' ' HG2' ' A' 2956 ' ' GLU . . . -93.82 -28.67 15.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.736 0.814 . . . . 0.0 112.535 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -78.38 -43.81 26.59 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.64 0.376 . . . . 0.0 111.425 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.704 ' HB3' HD11 ' A' 2980 ' ' ILE . 97.2 mt -80.48 157.96 71.95 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.28 1.032 . . . . 0.0 110.749 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.59 -179.47 0.5 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.941 2.427 . . . . 0.0 114.378 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2978 ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 6.7 p-10 -72.03 -28.64 63.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.751 0.42 . . . . 0.0 111.996 -172.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.19 -55.38 18.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.329 0.652 . . . . 0.0 112.344 -170.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.26 -18.69 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.516 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -74.56 -38.45 62.69 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2982 ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' 2978 ' ' ASP . 12.2 ptm180 -75.88 -34.44 60.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 6.8 tp10 -53.06 -52.08 59.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.767 1.227 . . . . 0.0 110.599 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 34.7 m -77.59 -31.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.502 0.321 . . . . 0.0 111.328 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.98 -53.28 18.41 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.421 0.629 . . . . 0.0 111.062 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -44.31 68.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.099 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -77.01 -39.59 49.69 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.25 -55.36 6.13 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.836 0.289 . . . . 0.0 111.418 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.641 HD22 ' HB ' ' A' 2968 ' ' VAL . 1.9 mm? -84.98 -29.91 24.66 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.171 0.294 . . . . 0.0 110.645 -172.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 84.19 5.47 87.35 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.726 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.32 127.74 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.67 0.788 . . . . 0.0 109.086 -177.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -97.04 119.43 63.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.04 -43.23 37.64 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 C-N-CA 122.537 2.158 . . . . 0.0 113.592 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.87 113.82 3.78 Favored 'Trans proline' 0 C--N 1.409 3.712 0 CA-C-N 121.776 1.67 . . . . 0.0 112.152 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 9.8 t -84.37 144.27 28.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.462 0.705 . . . . 0.0 109.68 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -80.14 95.65 6.3 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.724 0.774 . . . . 0.0 110.528 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 39.1 p -116.31 -10.57 11.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.159 0.984 . . . . 0.0 110.625 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -71.66 142.25 85.89 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.565 0.746 . . . . 0.0 109.682 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.83 25.53 0.68 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.919 2.413 . . . . 0.0 112.569 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 13.1 m -79.93 145.32 32.69 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.626 1.17 . . . . 0.0 109.794 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 22.3 m -79.3 82.25 5.47 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 39.2 t30 -105.11 116.09 31.37 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.224 1.009 . . . . 0.0 108.433 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 35.4 p . . . . . 0 CA--C 1.556 1.204 0 C-N-CA 123.183 0.593 . . . . 0.0 110.613 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 50.0 m -68.14 88.4 0.29 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.569 0.747 . . . . 0.0 109.546 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 19.9 m -126.54 -0.35 6.86 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 0.0 110.462 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.32 -22.91 59.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.612 0.765 . . . . 0.0 110.846 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -74.24 94.87 2.54 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.621 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2956 ' ' GLU . . . . . 0.518 ' HB3' HD23 ' A' 2973 ' ' LEU . 33.5 tt0 -109.32 86.74 2.34 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2957 ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' 2960 ' ' ALA . 13.0 t70 -103.94 128.6 26.89 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.27 -170.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2958 ' ' PRO . . . . . 0.484 ' HD3' HD22 ' A' 2964 ' ' LEU . 42.1 Cg_endo -63.27 -30.92 74.12 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.282 1.988 . . . . 0.0 112.287 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.13 -7.17 58.77 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.331 0.652 . . . . 0.0 110.064 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2960 ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' 2957 ' ' ASP . . . -65.86 -19.83 66.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.993 -0.442 . . . . 0.0 111.071 170.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.79 -3.39 28.95 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.523 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.8 pp -88.66 176.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.084 0.554 . . . . 0.0 111.246 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.1 p -120.91 113.48 20.18 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.484 HD22 ' HD3' ' A' 2958 ' ' PRO . 2.3 pp -103.42 152.43 38.76 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.689 0.795 . . . . 0.0 109.751 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.24 177.58 8.69 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.807 2.338 . . . . 0.0 113.504 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.68 150.97 42.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.288 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 67.3 21.76 72.38 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.7 0.625 . . . . 0.0 112.915 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 90.6 t -129.38 95.66 2.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.741 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.58 133.95 36.96 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.154 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.37 -14.44 45.02 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.349 2.699 . . . . 0.0 115.015 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 59.0 m -62.45 -56.07 21.69 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.46 0.573 . . . . 0.0 111.404 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 39.2 p90 -72.47 -30.78 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.409 0.623 . . . . 0.0 110.522 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' 2981 ' ' ARG . 17.0 tp -69.81 -33.08 71.86 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.471 -171.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.98 -49.59 5.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.838 . . . . 0.0 111.339 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.45 74.49 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.52 158.78 62.62 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.799 0.84 . . . . 0.0 109.657 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.35 178.06 1.0 Allowed 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 123.238 2.625 . . . . 0.0 114.003 -173.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.85 -26.94 65.4 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.48 -54.7 28.39 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.139 0.576 . . . . 0.0 112.072 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.542 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -76.48 -32.25 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.637 -178.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.527 ' HB2' HD13 ' A' 2973 ' ' LEU . 0.1 OUTLIER -66.53 -39.88 88.84 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.756 0.312 . . . . 0.0 110.265 -175.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -74.62 -38.38 62.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.159 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.3 pt-20 -73.49 -38.61 65.32 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.259 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 32.6 m -66.41 -34.32 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.326 0.512 . . . . 0.0 110.261 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.23 -52.99 63.29 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.405 0.682 . . . . 0.0 110.136 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.78 -40.01 79.89 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.832 -1.077 . . . . 0.0 112.263 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.14 -41.4 50.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.151 0.581 . . . . 0.0 111.223 -172.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -70.49 -57.06 5.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.8 0.44 . . . . 0.0 111.259 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.15 -34.74 20.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.829 0.452 . . . . 0.0 111.298 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.93 20.82 67.07 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.66 -165.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.68 129.37 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -92.38 126.94 50.7 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.244 0.617 . . . . 0.0 109.672 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.09 -43.67 45.99 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.304 2.003 . . . . 0.0 113.593 168.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.2 95.69 0.44 Allowed 'Trans proline' 0 C--N 1.407 3.655 0 C-N-CA 121.967 1.778 . . . . 0.0 111.773 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 24.7 p -68.55 119.21 12.64 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.91 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -74.28 94.68 2.53 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.889 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 82.3 p -84.92 -43.46 14.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.099 0.959 . . . . 0.0 108.976 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -78.02 155.32 80.1 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.098 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.12 8.33 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.133 2.555 . . . . 0.0 113.721 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 14.8 m -62.81 84.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.471 1.109 . . . . 0.0 110.088 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 23.5 m -90.33 129.15 36.58 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.31 147.21 27.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.233 0.613 . . . . 0.0 109.559 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.117 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.382 0.134 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 66.0 m -66.25 111.85 3.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 0.0 111.106 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 33.5 t -122.75 -15.48 7.44 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.652 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2954 ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 12.2 pt-20 -87.79 -31.79 19.42 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.02 0.528 . . . . 0.0 110.728 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2955 ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 0.6 OUTLIER -142.13 130.03 21.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.846 0.858 . . . . 0.0 109.447 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2956 ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' 2970 ' ' PRO . 11.0 mp0 -108.88 105.49 15.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -105.31 127.36 28.77 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 123.553 0.741 . . . . 0.0 109.608 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.34 -43.79 36.62 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.71 2.94 . . . . 0.0 113.837 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.77 -4.82 55.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.093 0.957 . . . . 0.0 112.017 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.81 -10.82 59.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.902 0.481 . . . . 0.0 111.094 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.15 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 113.593 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -75.81 175.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.339 0.656 . . . . 0.0 111.089 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.9 p -122.46 93.06 3.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.114 0.566 . . . . 0.0 109.913 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 152.89 48.64 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.499 ' HG2' HG23 ' A' 2968 ' ' VAL . 33.8 Cg_endo -62.92 152.47 78.93 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.535 2.156 . . . . 0.0 112.35 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.42 145.64 50.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.285 0.634 . . . . 0.0 111.66 -176.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 77.57 18.28 77.85 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.228 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.499 HG23 ' HG2' ' A' 2965 ' ' PRO . 38.7 t -120.26 114.75 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.132 0.973 . . . . 0.0 109.44 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -85.64 126.74 65.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 123.556 0.535 . . . . 0.0 109.694 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.441 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 58.6 Cg_endo -68.65 -9.36 25.92 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.502 2.801 . . . . 0.0 113.811 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.0 m -58.4 -57.44 12.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.311 0.644 . . . . 0.0 111.251 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -77.14 -31.86 55.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.441 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 15.6 tp -67.08 -31.16 71.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.056 0.942 . . . . 0.0 111.172 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.37 -52.24 4.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.911 0.884 . . . . 0.0 111.373 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.12 76.83 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.818 ' HB3' HD11 ' A' 2980 ' ' ILE . 90.2 mt -81.32 150.57 67.82 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 0.0 110.462 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.3 170.16 8.35 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.44 2.76 . . . . 0.0 113.592 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2978 ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 4.5 p-10 -66.84 -18.73 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -169.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.51 -55.64 8.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.029 0.531 . . . . 0.0 111.84 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.818 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -75.14 -29.75 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 119.289 -0.386 . . . . 0.0 110.193 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' 2973 ' ' LEU . 23.0 tpt85 -50.97 -49.19 60.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.234 1.013 . . . . 0.0 111.37 173.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.69 -39.4 61.99 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.4 pt-20 -72.25 -42.68 65.36 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.706 -175.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.0 m -65.65 -30.06 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 118.326 0.512 . . . . 0.0 110.197 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.04 -48.8 77.18 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.46 -28.41 41.58 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -77.66 -49.84 13.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.887 0.475 . . . . 0.0 111.089 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.52 ' HB2' HD23 ' A' 2989 ' ' LEU . 26.3 mm-40 -62.85 -56.63 15.67 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.512 0.507 . . . . 0.0 110.791 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -97.32 -37.25 10.12 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 76.87 23.1 70.24 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 123.335 0.397 . . . . 0.0 112.209 -169.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.74 127.42 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.4 121.21 62.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.339 0.656 . . . . 0.0 109.926 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.23 -42.09 37.84 Favored 'Trans proline' 0 CA--C 1.575 2.557 0 C-N-CA 122.298 1.998 . . . . 0.0 113.652 164.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.33 127.2 13.82 Favored 'Trans proline' 0 C--N 1.408 3.709 0 C-N-CA 122.011 1.808 . . . . 0.0 112.3 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 70.8 p -86.72 105.83 17.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.722 0.809 . . . . 0.0 109.276 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -66.16 97.22 0.37 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.109 0.564 . . . . 0.0 109.845 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.2 p -116.0 44.13 2.0 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.486 1.114 . . . . 0.0 108.616 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 60.62 69.7 1.09 Allowed Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 125.039 1.336 . . . . 0.0 110.317 -168.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -63.29 121.31 9.08 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.973 2.448 . . . . 0.0 112.697 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 33.0 p -71.97 -32.6 67.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.942 0.897 . . . . 0.0 110.229 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 12.6 t -71.98 142.99 49.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.646 0.778 . . . . 0.0 110.232 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 19.9 m120 -91.63 102.89 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 123.791 0.837 . . . . 0.0 108.877 -178.353 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 21.5 m -85.1 71.76 10.87 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.194 0.597 . . . . 0.0 109.783 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 22.7 t -117.22 23.36 11.89 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.553 0.741 . . . . 0.0 109.836 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.32 -39.22 82.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.085 0.954 . . . . 0.0 110.33 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.97 100.36 7.17 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.54 86.48 7.09 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 122.096 0.951 . . . . 0.0 109.951 -175.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -71.99 143.38 86.38 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.946 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -78.4 22.61 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.063 2.509 . . . . 0.0 113.483 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.8 4.0 3.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.959 0.904 . . . . 0.0 109.137 171.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.2 60.99 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.519 0.728 . . . . 0.0 112.605 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 118.56 -20.58 10.16 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 123.013 0.34 . . . . 0.0 112.442 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2962 ' ' ILE . . . . . 0.583 HD12 HD21 ' A' 2964 ' ' LEU . 2.3 pp -72.83 176.65 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.46 1.104 . . . . 0.0 112.332 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 19.2 m -91.12 76.64 6.1 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 121.135 0.493 . . . . 0.0 111.544 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2964 ' ' LEU . . . . . 0.583 HD21 HD12 ' A' 2962 ' ' ILE . 2.8 mm? -121.88 114.45 31.06 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.74 -171.32 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.636 2.891 . . . . 0.0 113.089 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.87 144.14 30.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.088 0.955 . . . . 0.0 109.795 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.07 20.21 39.93 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.074 0.234 . . . . 0.0 113.128 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 3.3 p -141.44 106.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 124.074 0.949 . . . . 0.0 109.6 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.12 140.92 77.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.053 0.541 . . . . 0.0 110.997 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.35 -10.35 23.93 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.061 2.507 . . . . 0.0 112.434 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 18.4 m -58.64 -59.0 6.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.39 1.076 . . . . 0.0 110.595 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2972 ' ' PHE . . . . . 0.448 ' HB2' HD11 ' A' 2976 ' ' LEU . 34.0 p90 -79.64 -28.33 40.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' 2981 ' ' ARG . 0.5 OUTLIER -65.17 -38.54 90.86 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.842 0.857 . . . . 0.0 110.472 -174.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.83 11.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.927 0.491 . . . . 0.0 111.468 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.41 -48.96 59.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.588 ' HB3' HD11 ' A' 2980 ' ' ILE . 93.9 mt -79.42 156.54 75.9 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.929 0.892 . . . . 0.0 110.088 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.09 -178.56 1.77 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.187 2.591 . . . . 0.0 113.593 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2978 ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' 2982 ' ' ARG . 3.6 p30 -72.71 -27.3 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -171.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.81 -52.74 58.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 112.963 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -76.78 -23.08 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.529 ' HB2' HD23 ' A' 2973 ' ' LEU . 0.1 OUTLIER -74.56 -36.23 63.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.243 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2982 ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' 2978 ' ' ASP . 5.8 ptm180 -69.81 -40.64 75.8 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 8.5 pt-20 -69.97 -38.36 76.04 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.223 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2984 ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' 2980 ' ' ILE . 33.1 m -69.36 -31.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.87 0.759 . . . . 0.0 110.708 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.13 -50.32 68.69 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.58 0.705 . . . . 0.0 110.967 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -80.27 -45.69 17.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.954 -173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.5 -43.08 81.76 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.06 -56.35 4.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.141 0.276 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.66 -52.63 5.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.251 0.221 . . . . 0.0 111.164 -172.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 106.24 -12.54 44.21 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.786 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.42 125.89 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.368 0.667 . . . . 0.0 109.536 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -93.71 123.1 60.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.051 0.54 . . . . 0.0 110.058 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 -38.89 62.58 Favored 'Trans proline' 0 CA--C 1.582 2.914 0 C-N-CA 122.875 2.383 . . . . 0.0 114.771 170.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 93.39 0.43 Allowed 'Trans proline' 0 C--N 1.409 3.725 0 CA-C-N 122.431 1.904 . . . . 0.0 111.717 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 18.1 p -139.48 132.39 29.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -65.19 92.73 0.12 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.282 1.039 . . . . 0.0 109.888 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 17.2 p -113.93 100.6 8.55 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.623 -1.172 . . . . 0.0 109.325 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 63.57 101.44 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 111.716 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.4 110.04 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.063 1.842 . . . . 0.0 109.587 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 29.9 t -80.41 66.69 6.0 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.125 0.964 . . . . 0.0 111.078 -171.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 61.6 m -145.8 98.45 3.12 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -87.64 97.05 10.66 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.705 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.56 1.356 0 C-N-CA 124.778 1.231 . . . . 0.0 110.959 -179.093 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.342 0.115 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.9 m -96.77 62.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.863 0.84 . . . . 0.0 110.513 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.6 m -85.06 16.33 3.55 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.095 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.11 -42.13 66.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -158.84 108.21 1.95 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.236 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.28 114.79 29.09 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2957 ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' 2960 ' ' ALA . 13.6 t70 -62.17 138.54 96.03 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.283 1.033 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2958 ' ' PRO . . . . . 0.51 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 29.5 Cg_endo -60.57 -35.15 91.26 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.234 . . . . 0.0 112.846 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.6 tp -91.05 7.31 41.04 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.663 0.785 . . . . 0.0 111.333 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2960 ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' 2957 ' ' ASP . . . -69.77 -9.98 56.64 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 107.98 4.69 33.59 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 47.0 pt -79.04 168.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.969 0.508 . . . . 0.0 110.453 173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.3 p -127.62 88.03 2.72 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.012 0.525 . . . . 0.0 110.477 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.3 pp -107.66 149.67 39.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.42 156.34 32.59 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.593 2.196 . . . . 0.0 111.911 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.67 121.93 16.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 116.71 -21.93 11.09 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.7 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 93.4 t -88.63 104.11 14.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.402 0.681 . . . . 0.0 109.541 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.34 126.44 92.7 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.009 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2970 ' ' PRO . . . . . 0.51 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 53.7 Cg_endo -65.8 -8.01 18.34 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.879 2.386 . . . . 0.0 112.444 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -59.11 5.37 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.497 1.119 . . . . 0.0 110.737 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 28.8 p90 -80.23 -32.42 38.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.9 0.381 . . . . 0.0 110.387 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' 2981 ' ' ARG . 26.6 tp -63.98 -45.08 90.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.465 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.3 -49.75 5.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.969 0.508 . . . . 0.0 111.733 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.9 63.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 82.7 mt -95.65 160.79 29.58 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.481 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2977 ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 57.8 Cg_endo -66.3 176.73 3.73 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.416 2.077 . . . . 0.0 112.854 -174.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2978 ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 27.2 t70 -70.25 -21.39 62.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.205 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.44 -55.28 16.46 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 123.415 0.686 . . . . 0.0 111.741 -168.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.51 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.04 -31.89 16.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 -177.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.519 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.4 OUTLIER -67.39 -35.84 80.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.741 0.417 . . . . 0.0 110.597 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2982 ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' 2978 ' ' ASP . 8.7 ptm180 -73.76 -46.2 47.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 14.1 pt-20 -69.0 -34.9 76.02 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.455 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 25.0 m -73.08 -34.85 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.04 -43.35 99.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.677 0.751 . . . . 0.0 110.673 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.05 -44.86 45.31 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.776 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.68 -33.21 58.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.688 0.395 . . . . 0.0 112.0 -173.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.472 ' HB2' HD21 ' A' 2989 ' ' LEU . 20.8 mt-30 -82.47 -52.25 7.05 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.547 0.339 . . . . 0.0 111.235 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.527 ' HB2' HG22 ' A' 2991 ' ' ILE . 2.0 mm? -97.43 -39.98 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.635 0.374 . . . . 0.0 110.979 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 90.81 17.88 49.96 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.534 -0.303 . . . . 0.0 112.775 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -108.02 130.23 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -105.59 140.5 21.23 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.48 -42.31 62.67 Favored 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.338 2.025 . . . . 0.0 114.773 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.42 137.56 25.77 Favored 'Trans proline' 0 C--N 1.399 3.222 0 CA-C-N 121.919 1.721 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 36.7 p -69.31 99.47 1.19 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.014 0.926 . . . . 0.0 111.056 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -70.08 124.4 24.0 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.039 0.447 . . . . 0.0 109.854 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 2.8 t -145.18 99.36 3.3 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.62 0.768 . . . . 0.0 109.697 -172.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -72.58 122.77 88.39 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.7 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.25 -24.76 27.77 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.563 2.842 . . . . 0.0 114.802 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 22.9 t -72.75 -31.94 65.3 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.193 0.597 . . . . 0.0 111.61 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 88.8 m -116.94 127.73 54.51 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.246 0.618 . . . . 0.0 110.3 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -64.46 101.37 0.44 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.432 0.634 . . . . 0.0 111.087 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.549 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 109.721 -174.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 50.8 m -120.12 82.18 1.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.756 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 14.7 m -116.86 18.19 14.85 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.666 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 70.47 9.61 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.709 1.242 . . . . 0.0 110.463 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.67 105.85 2.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.573 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.63 126.44 42.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.1 126.07 64.09 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.075 0.95 . . . . 0.0 109.763 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.92 -30.57 67.44 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.624 2.216 . . . . 0.0 112.889 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -77.83 -21.23 51.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.432 0.693 . . . . 0.0 110.136 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -58.94 -21.02 57.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.612 0.765 . . . . 0.0 112.679 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.87 -2.63 28.76 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 123.191 0.424 . . . . 0.0 112.767 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.0 172.73 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.354 0.662 . . . . 0.0 110.903 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 28.3 t -112.87 109.77 19.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.481 0.713 . . . . 0.0 109.862 -177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.44 155.6 56.85 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.48 0.712 . . . . 0.0 109.208 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2965 ' ' PRO . . . . . 0.536 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 59.3 Cg_endo -70.29 157.65 58.68 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.314 2.009 . . . . 0.0 112.067 170.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -70.77 141.62 51.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.645 0.778 . . . . 0.0 111.431 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.39 70.24 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.807 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2968 ' ' VAL . . . . . 0.544 HG21 HD22 ' A' 2989 ' ' LEU . 82.6 t -128.54 96.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.62 156.4 41.17 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 124.004 0.922 . . . . 0.0 109.215 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.22 9.31 2.15 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.555 2.17 . . . . 0.0 112.84 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 19.2 m -63.11 -61.41 2.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.214 1.005 . . . . 0.0 111.21 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 23.9 p90 -78.26 -24.27 46.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.679 0.792 . . . . 0.0 111.28 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2973 ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' 2981 ' ' ARG . 68.3 mt -69.43 -37.45 77.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.28 0.632 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.83 -24.89 19.22 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.788 0.835 . . . . 0.0 112.208 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.4 70.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.209 0.604 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2976 ' ' LEU . . . . . 0.467 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 55.9 mt -107.52 164.25 15.19 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.339 1.056 . . . . 0.0 109.346 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2977 ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.1 Cg_endo -60.35 155.29 47.34 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 123.685 2.924 . . . . 0.0 113.078 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.76 -17.33 5.83 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.924 1.29 . . . . 0.0 113.54 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.91 -39.39 90.53 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.143 0.977 . . . . 0.0 111.614 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2980 ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.94 -32.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2981 ' ' ARG . . . . . 0.492 ' N ' HD12 ' A' 2980 ' ' ILE . 10.5 tpt180 -60.04 -55.34 35.12 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.315 1.046 . . . . 0.0 110.422 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -64.38 -43.62 93.91 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.005 0.816 . . . . 0.0 110.961 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2983 ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' 2987 ' ' ASN . 13.5 pt-20 -68.96 -50.34 50.02 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.973 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 19.3 m -67.43 -30.42 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.177 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2985 ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' 2991 ' ' ILE . 18.4 tp -61.61 -55.68 28.05 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.888 0.852 . . . . 0.0 109.868 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2986 ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' 2992 ' ' ARG . 46.7 mt-30 -75.2 -34.7 61.53 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.618 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2987 ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' 2983 ' ' GLU . 2.5 t-20 -75.15 -46.85 31.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.19 0.596 . . . . 0.0 110.24 -172.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2988 ' ' GLN . . . . . 0.417 ' HB2' HD21 ' A' 2989 ' ' LEU . 23.5 mt-30 -72.29 -51.7 19.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.737 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2989 ' ' LEU . . . . . 0.544 HD22 HG21 ' A' 2968 ' ' VAL . 1.0 OUTLIER -102.17 -40.04 6.98 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -171.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 102.19 0.03 50.92 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.559 0.537 . . . . 0.0 112.799 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2991 ' ' ILE . . . . . 0.58 HG22 ' HG ' ' A' 2985 ' ' LEU . 0.0 OUTLIER -78.64 121.37 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2992 ' ' ARG . . . . . 0.497 ' HA ' ' HG2' ' A' 2986 ' ' GLN . 10.2 ptp180 -105.81 145.97 31.94 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.669 0.788 . . . . 0.0 109.705 -176.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 -44.04 30.36 Favored 'Trans proline' 0 CA--C 1.574 2.496 0 C-N-CA 122.683 2.256 . . . . 0.0 114.377 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.06 171.74 15.28 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.296 1.856 . . . . 0.0 112.844 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 60.8 p -79.15 173.72 12.29 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -67.13 97.13 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.184 0.992 . . . . 0.0 110.354 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 19.5 p -118.62 6.75 11.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.546 1.138 . . . . 0.0 111.549 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 53.92 64.1 6.96 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 125.042 1.337 . . . . 0.0 112.565 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.13 152.09 30.91 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 45.4 p -72.75 129.22 37.72 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.095 0.558 . . . . 0.0 109.694 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.8 t -63.51 131.75 49.12 Favored 'General case' 0 CA--C 1.554 1.119 0 O-C-N 123.744 0.652 . . . . 0.0 111.147 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.0 t30 -84.61 134.25 34.39 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.262 0.625 . . . . 0.0 110.662 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 CA--C 1.551 1.004 0 C-N-CA 124.104 0.961 . . . . 0.0 108.932 176.773 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.03 -31.55 83.86 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.307 2.005 . . . . 0.0 113.132 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 -16.57 61.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.118 0.567 . . . . 0.0 109.836 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.97 16.33 0.56 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 65.14 22.45 68.96 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2962 ' ' ILE . . . . . 0.494 HD11 ' HG3' ' A' 2970 ' ' PRO . 20.4 pt -68.7 141.87 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.605 0.762 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.0 m -83.71 83.29 7.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.469 0.707 . . . . 0.0 111.778 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.448 HD21 HD12 ' A' 2973 ' ' LEU . 11.1 mp -119.28 146.27 40.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.391 1.076 . . . . 0.0 109.674 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.74 162.38 37.64 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.258 2.639 . . . . 0.0 111.845 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.55 141.99 56.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.09 0.556 . . . . 0.0 110.679 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 92.33 -33.23 5.04 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.346 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 13.9 t -84.05 105.98 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.489 0.716 . . . . 0.0 109.515 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.26 135.93 20.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.323 0.649 . . . . 0.0 109.44 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.494 ' HG3' HD11 ' A' 2962 ' ' ILE . 86.7 Cg_endo -74.03 -3.22 13.43 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.137 2.558 . . . . 0.0 115.521 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 73.2 m -62.05 -53.49 54.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.753 0.706 . . . . 0.0 110.916 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 31.6 p90 -71.76 -22.4 61.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.469 HD22 ' HG2' ' A' 2981 ' ' ARG . 55.6 mt -73.57 -37.33 65.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.484 0.313 . . . . 0.0 111.746 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.52 -36.35 12.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.327 0.651 . . . . 0.0 111.391 -174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -76.28 -29.93 57.61 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.145 0.578 . . . . 0.0 111.228 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 68.8 mt -104.26 165.25 13.7 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2977 ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 32.2 Cg_endo -59.76 168.65 5.3 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.943 2.429 . . . . 0.0 114.519 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.13 -15.46 61.48 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.102 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.46 -53.82 31.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.467 0.707 . . . . 0.0 111.488 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.552 ' HA ' ' HB3' ' A' 2983 ' ' GLU . 0.1 OUTLIER -78.91 -17.7 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 120.653 0.263 . . . . 0.0 110.355 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.469 ' HG2' HD22 ' A' 2973 ' ' LEU . 7.8 tmm_? -63.7 -52.29 61.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.493 1.117 . . . . 0.0 110.645 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.27 -32.96 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.582 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.552 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 8.6 tp10 -51.99 -56.48 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 111.295 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.4 m -68.65 -34.51 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.602 0.361 . . . . 0.0 111.464 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2985 ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' 2989 ' ' LEU . 25.3 tp -67.3 -54.75 17.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.343 0.592 . . . . 0.0 111.397 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.26 -43.28 74.25 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.442 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.79 -43.01 38.49 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.1 mt-30 -76.81 -50.94 12.28 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.713 0.292 . . . . 0.0 111.704 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.7 mm? -93.4 -30.76 14.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.819 0.447 . . . . 0.0 111.086 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 77.52 4.76 85.18 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.23 0.332 . . . . 0.0 113.763 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.54 134.94 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.733 0.813 . . . . 0.0 109.708 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 CA--C 1.548 0.87 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.719 178.426 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 -29.2 80.96 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.902 2.401 . . . . 0.0 112.522 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -19.49 62.71 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.285 0.634 . . . . 0.0 110.254 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.62 -23.14 65.83 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.464 0.706 . . . . 0.0 112.058 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 120.33 -9.97 10.87 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.767 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.9 pp -78.97 165.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 117.054 0.427 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 26.5 p -115.71 96.27 5.53 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.11 0.481 . . . . 0.0 111.915 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 64.6 mt -76.44 139.47 67.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.95 0.5 . . . . 0.0 109.973 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.434 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 20.8 Cg_exo -63.17 167.88 11.84 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.94 2.427 . . . . 0.0 112.785 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.22 132.66 54.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.803 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 85.57 5.19 84.85 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.49 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 37.9 t -111.36 101.04 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.559 0.68 . . . . 0.0 110.387 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.72 151.69 37.74 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.686 0.794 . . . . 0.0 109.352 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 87.0 Cg_endo -72.5 -0.22 8.46 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.559 2.173 . . . . 0.0 112.547 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 16.5 m -65.54 -60.1 3.28 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.903 0.881 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.6 p90 -72.17 -30.04 64.6 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.137 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 10.8 tp -68.23 -30.89 70.06 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.547 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -95.04 -53.37 3.84 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.483 0.713 . . . . 0.0 111.789 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.71 89.0 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.746 0.818 . . . . 0.0 112.113 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.1 mt -80.68 140.5 51.21 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.01 167.01 13.0 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.706 2.271 . . . . 0.0 112.387 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.22 -29.29 63.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.46 -59.2 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.536 0.522 . . . . 0.0 111.715 -171.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.22 -29.71 9.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.732 -175.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -39.35 89.91 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.989 0.423 . . . . 0.0 110.209 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -77.1 -36.81 55.34 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.738 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -36.83 70.23 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.191 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2984 ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' 2980 ' ' ILE . 26.8 m -65.9 -33.67 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.1 0.409 . . . . 0.0 110.851 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 58.5 tp -59.44 -56.35 23.08 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.177 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -73.8 -25.98 60.39 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.06 -55.05 5.96 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 117.835 0.289 . . . . 0.0 111.032 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -64.54 -42.29 95.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 0.0 112.149 -172.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.1 mm? -101.05 -27.98 12.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.32 0.248 . . . . 0.0 111.498 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 70.2 37.37 71.86 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.25 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.17 122.99 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 . . . . . 0 CA--C 1.551 1.015 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.089 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 2958 ' ' PRO . . . . . 0.513 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 13.4 Cg_endo -55.22 -22.35 32.17 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.154 2.569 . . . . 0.0 114.341 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.48 10.32 9.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 111.721 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -83.63 0.65 45.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.629 0.772 . . . . 0.0 110.273 164.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 97.78 -1.6 59.86 Favored Glycine 0 C--N 1.351 1.388 0 C-N-CA 123.309 0.481 . . . . 0.0 112.708 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 30.9 pt -89.21 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.005 0.522 . . . . 0.0 111.081 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -117.09 102.91 9.72 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.733 0.813 . . . . 0.0 109.66 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.77 120.43 70.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.85 175.32 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.904 3.069 . . . . 0.0 114.064 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -70.29 131.81 44.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.702 0.401 . . . . 0.0 110.457 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.66 -19.93 44.97 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.543 0.527 . . . . 0.0 112.715 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 24.5 t -87.46 90.04 3.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.399 0.68 . . . . 0.0 109.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 56.3 t0 -85.34 118.27 70.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.513 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 56.6 Cg_endo -64.9 -3.6 7.27 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.737 2.291 . . . . 0.0 114.074 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.9 m -60.07 -50.15 74.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.989 0.516 . . . . 0.0 110.932 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 10.7 p90 -75.36 -25.76 57.97 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.526 HD13 HH21 ' A' 2981 ' ' ARG . 87.5 mt -67.17 -37.55 83.93 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.968 0.413 . . . . 0.0 110.599 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -90.02 -38.78 13.37 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.02 0.928 . . . . 0.0 112.223 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.88 63.32 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.09 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' 2980 ' ' ILE . 54.5 mt -93.5 158.59 36.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 123.802 0.841 . . . . 0.0 109.007 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.83 -171.8 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.777 2.318 . . . . 0.0 113.796 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2978 ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' 2981 ' ' ARG . 29.8 t70 -72.29 -34.89 68.49 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.17 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.34 -54.01 51.88 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.366 1.067 . . . . 0.0 111.285 -165.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.36 -26.31 14.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.371 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.526 HH21 HD13 ' A' 2973 ' ' LEU . 0.0 OUTLIER -68.12 -38.17 81.94 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.449 0.568 . . . . 0.0 110.535 -175.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -41.32 57.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.037 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 9.9 pt-20 -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 118.031 0.378 . . . . 0.0 111.341 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 31.6 m -69.69 -38.94 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 117.929 0.331 . . . . 0.0 110.774 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -49.38 78.07 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.113 0.482 . . . . 0.0 111.57 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.5 -35.81 65.69 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.918 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.39 -31.35 57.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.557 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.9 mm-40 -82.38 -48.23 11.39 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 111.51 -177.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' 2988 ' ' GLN . 0.8 OUTLIER -109.08 -34.88 6.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.346 0.258 . . . . 0.0 111.348 -171.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 86.05 2.04 86.25 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.347 0.404 . . . . 0.0 113.066 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 129.45 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 -176.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 123.399 0.68 . . . . 0.0 109.552 175.929 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.94 -31.47 93.71 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.942 2.428 . . . . 0.0 112.716 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.78 -24.59 44.56 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.491 0.717 . . . . 0.0 110.382 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.2 -21.38 61.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.548 0.739 . . . . 0.0 112.74 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.91 -0.54 64.66 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.271 0.357 . . . . 0.0 113.363 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2962 ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' 2962 ' ' ILE . 2.5 pp -66.62 167.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.079 0.952 . . . . 0.0 111.164 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -80.25 87.04 5.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.063 0.545 . . . . 0.0 110.904 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 11.1 tp -118.76 124.46 28.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' 2991 ' ' ILE . 96.3 Cg_endo -74.04 -162.04 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.954 2.436 . . . . 0.0 113.735 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -82.44 157.77 23.53 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.765 0.826 . . . . 0.0 110.61 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 62.76 18.22 59.06 Favored Glycine 0 N--CA 1.479 1.511 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.72 146.48 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.138 0.975 . . . . 0.0 108.884 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2969 ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' 2973 ' ' LEU . 22.0 t70 -132.79 124.32 18.72 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.279 0.632 . . . . 0.0 110.13 -172.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 85.4 Cg_endo -76.21 2.72 6.91 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.675 2.25 . . . . 0.0 114.774 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 8.4 m -72.84 -56.96 4.45 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.881 0.764 . . . . 0.0 109.936 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 27.3 p90 -73.09 -22.33 60.6 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.17 0.188 . . . . 0.0 110.938 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' A' 2970 ' ' PRO . 6.9 mp -63.96 -51.5 64.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.49 0.716 . . . . 0.0 110.703 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -80.12 -26.78 39.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.289 0.636 . . . . 0.0 112.325 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -79.96 -49.3 12.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.676 0.39 . . . . 0.0 110.888 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 40.1 mt -97.73 150.38 36.72 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.113 0.965 . . . . 0.0 109.989 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.76 151.91 60.6 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.148 3.232 . . . . 0.0 113.482 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.21 -21.69 3.63 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 125.199 1.4 . . . . 0.0 113.796 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -51.57 -50.06 60.86 Favored 'General case' 0 C--O 1.248 1.017 0 C-N-CA 124.188 0.995 . . . . 0.0 111.353 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -72.56 -31.62 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.565 -177.035 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.569 ' HB2' ' HG ' ' A' 2973 ' ' LEU . 0.1 OUTLIER -70.06 -43.08 71.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.725 0.81 . . . . 0.0 109.888 -174.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -76.06 -31.34 58.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.219 0.324 . . . . 0.0 110.852 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.21 -40.43 52.25 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.99 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2984 ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' 2980 ' ' ILE . 27.0 m -66.24 -30.96 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-N 118.34 0.518 . . . . 0.0 110.171 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.15 -51.08 70.58 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 123.774 0.83 . . . . 0.0 110.672 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -75.02 -40.88 60.3 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.631 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -70.1 -53.63 16.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.329 . . . . 0.0 111.0 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.531 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.9 mm-40 -64.07 -54.63 31.11 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.276 0.36 . . . . 0.0 111.891 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -103.99 -35.57 8.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.103 0.252 . . . . 0.0 111.628 -169.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 10.35 85.39 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.354 0.409 . . . . 0.0 113.436 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -72.48 121.96 24.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 . . . . . 0 CA--C 1.547 0.859 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.841 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.36 -24.33 22.92 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.242 2.628 . . . . 0.0 113.175 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 37.1 tp -83.36 -14.0 53.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.008 0.523 . . . . 0.0 110.767 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.34 41.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.402 0.681 . . . . 0.0 112.104 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 92.86 6.78 63.31 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 113.268 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2962 ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' 2962 ' ' ILE . 2.7 pp -83.09 157.81 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.873 0.469 . . . . 0.0 110.97 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.0 p -88.68 100.4 13.09 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.152 0.581 . . . . 0.0 111.6 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 68.2 mt -100.08 133.73 21.37 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 167.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.79 173.84 13.82 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.205 1.936 . . . . 0.0 111.803 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.11 143.12 50.73 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.386 0.674 . . . . 0.0 111.676 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 81.66 7.02 88.63 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.778 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 62.0 t -105.48 108.66 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.707 0.803 . . . . 0.0 109.609 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.1 141.07 27.57 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.602 0.761 . . . . 0.0 110.647 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' 2973 ' ' LEU . 59.3 Cg_endo -67.23 -10.89 30.2 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.903 2.402 . . . . 0.0 112.687 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.1 m -56.6 -59.22 5.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.565 ' HB2' HD12 ' A' 2976 ' ' LEU . 54.6 p90 -75.57 -24.22 56.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.383 0.273 . . . . 0.0 111.434 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' 2981 ' ' ARG . 81.5 mt -68.5 -35.44 77.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.512 0.325 . . . . 0.0 110.921 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.79 -31.18 14.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.714 0.806 . . . . 0.0 112.134 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.1 24.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.879 0.471 . . . . 0.0 111.732 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' 2972 ' ' PHE . 58.3 mt -108.06 161.23 24.06 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.895 0.878 . . . . 0.0 110.087 -172.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.7 -177.74 1.04 Allowed 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.928 2.418 . . . . 0.0 113.956 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.43 -27.52 62.38 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.012 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2979 ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' 2982 ' ' ARG . 29.6 t70 -59.19 -54.15 50.19 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.548 0.739 . . . . 0.0 112.524 -170.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -78.91 -28.9 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.65 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.573 ' HB2' HD23 ' A' 2973 ' ' LEU . 0.0 OUTLIER -69.29 -36.81 77.42 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -175.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2979 ' ' ASP . 27.7 ptt180 -74.66 -40.39 61.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.931 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.7 pt-20 -69.65 -43.24 72.99 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.659 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 24.1 m -65.81 -32.81 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.113 0.415 . . . . 0.0 110.466 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 36.0 tp -63.8 -49.56 72.43 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.345 0.658 . . . . 0.0 111.046 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -77.79 -36.24 50.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.743 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.57 -53.63 11.42 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.718 0.407 . . . . 0.0 110.413 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.424 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.4 mt-30 -66.67 -54.82 19.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.343 0.657 . . . . 0.0 111.401 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.5 mm? -88.23 -48.89 7.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.922 0.489 . . . . 0.0 110.982 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.1 61.95 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.418 -0.657 . . . . 0.0 113.846 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.56 127.01 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.378 0.671 . . . . 0.0 110.473 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.029 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.52 -29.61 88.97 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.897 2.398 . . . . 0.0 113.758 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 32.2 tp -72.89 -16.81 61.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.336 0.655 . . . . 0.0 111.533 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.69 64.5 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.267 0.627 . . . . 0.0 111.525 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 103.84 13.25 28.01 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.442 0.464 . . . . 0.0 112.869 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 23.2 pt -110.18 154.92 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.321 0.648 . . . . 0.0 110.753 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.3 m -105.42 102.05 11.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.55 143.02 96.7 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.194 0.598 . . . . 0.0 109.664 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.601 ' HG2' HG21 ' A' 2968 ' ' VAL . 29.1 Cg_endo -67.48 166.27 24.34 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.443 2.095 . . . . 0.0 112.049 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.17 132.26 53.03 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.48 0.712 . . . . 0.0 111.275 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 76.18 26.17 64.65 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.705 0.628 . . . . 0.0 113.921 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.601 HG21 ' HG2' ' A' 2965 ' ' PRO . 52.2 t -119.01 132.13 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.0 0.52 . . . . 0.0 109.783 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -120.86 134.58 24.34 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.007 0.923 . . . . 0.0 109.176 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.54 -7.6 20.81 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.897 2.398 . . . . 0.0 114.816 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 55.9 m -65.36 -54.97 21.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.334 0.515 . . . . 0.0 110.943 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.9 p90 -71.58 -30.28 65.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.578 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.66 -21.67 61.05 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.986 -174.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -96.94 -47.51 5.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.454 0.702 . . . . 0.0 111.773 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.29 70.43 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.682 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.8 mt -71.73 139.91 83.61 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.784 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 158.16 43.54 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.624 2.216 . . . . 0.0 111.161 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.29 -16.83 61.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.39 -58.17 4.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.306 0.503 . . . . 0.0 112.283 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.682 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.43 -23.08 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.746 -0.596 . . . . 0.0 109.78 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -65.28 -44.89 86.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.613 0.765 . . . . 0.0 110.157 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -70.99 -39.5 72.4 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.377 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.9 pt-20 -70.21 -37.41 75.04 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.855 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.5 m -67.42 -32.11 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 118.255 0.479 . . . . 0.0 110.558 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.67 -45.23 83.67 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 121.48 0.657 . . . . 0.0 109.952 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -73.95 -44.73 53.94 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.386 0.674 . . . . 0.0 112.357 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.3 -39.21 59.81 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.932 0.493 . . . . 0.0 112.008 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.418 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.1 mt-30 -74.51 -48.47 26.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.485 0.314 . . . . 0.0 111.512 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.9 mm? -96.82 -43.52 7.47 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.298 0.239 . . . . 0.0 111.271 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 11.15 84.46 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.819 0.699 . . . . 0.0 113.58 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -74.45 123.93 30.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 . . . . . 0 CA--C 1.547 0.841 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.759 -176.447 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 2958 ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 22.7 Cg_endo -57.11 -34.68 98.18 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.068 2.512 . . . . 0.0 113.536 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -16.33 58.66 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.912 0.485 . . . . 0.0 111.309 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.01 -16.49 61.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.604 0.762 . . . . 0.0 112.503 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 96.58 3.06 59.81 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.797 -0.446 . . . . 0.0 113.606 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.12 156.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 122.913 0.485 . . . . 0.0 110.786 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 54.5 m -94.19 97.46 10.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.99 0.516 . . . . 0.0 111.153 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 81.3 mt -103.14 134.54 19.72 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.397 0.679 . . . . 0.0 109.328 167.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.464 ' HG3' HG21 ' A' 2991 ' ' ILE . 42.2 Cg_endo -64.4 156.72 58.56 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.107 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.15 138.14 43.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.04 0.536 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 110.57 -27.77 10.93 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.962 -0.355 . . . . 0.0 113.461 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.596 ' HB ' HD21 ' A' 2989 ' ' LEU . 7.3 p -91.14 137.78 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 122.894 0.477 . . . . 0.0 110.714 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.4 124.98 59.61 Favored Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 54.4 Cg_endo -65.68 -9.26 22.07 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.828 2.352 . . . . 0.0 113.079 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 40.0 m -54.09 -60.03 3.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.296 1.039 . . . . 0.0 111.456 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 40.6 p90 -79.62 -21.96 44.23 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.325 0.391 . . . . 0.0 111.21 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' 2981 ' ' ARG . 72.8 mt -63.99 -36.02 82.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.22 -35.99 12.84 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.558 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -73.15 -24.44 60.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.581 0.752 . . . . 0.0 112.118 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 58.6 mt -111.26 144.65 30.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.722 0.809 . . . . 0.0 109.603 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.79 172.08 10.06 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.332 2.688 . . . . 0.0 113.553 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2978 ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 6.3 p-10 -63.12 -17.25 62.13 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -168.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.44 -58.99 4.09 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 121.456 0.646 . . . . 0.0 110.297 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.37 -27.18 8.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.099 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 26.1 tpt85 -51.58 -49.85 61.3 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.664 0.785 . . . . 0.0 111.245 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -72.95 -43.99 61.67 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.036 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.6 pt-20 -66.28 -40.43 90.07 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 117.993 0.361 . . . . 0.0 111.182 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.3 m -68.28 -35.84 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 117.891 0.314 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2985 ' ' LEU . . . . . 0.426 HD22 ' NH1' ' A' 2981 ' ' ARG . 17.5 tp -65.72 -45.19 83.65 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.409 0.624 . . . . 0.0 110.844 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -73.38 -40.22 64.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.345 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -75.63 -38.62 58.77 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.018 -175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.541 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.5 mm-40 -75.7 -55.83 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.462 0.305 . . . . 0.0 111.392 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.2 mm? -96.73 -23.47 16.41 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.387 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.21 19.58 71.74 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.585 0.553 . . . . 0.0 113.624 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -84.42 141.38 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 123.687 0.795 . . . . 0.0 109.44 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 . . . . . 0 CA--C 1.559 1.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.242 -179.251 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 2957 ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 22.3 t70 . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2958 ' ' PRO . . . . . 0.527 ' HA ' HD12 ' A' 2964 ' ' LEU . 56.6 Cg_endo -65.15 -21.41 62.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.103 2.535 . . . . 0.0 113.982 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.05 9.08 30.62 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.234 0.614 . . . . 0.0 110.959 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2960 ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -67.18 -14.95 63.39 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.16 12.53 76.21 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2962 ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' 2960 ' ' ALA . 26.5 pt -91.12 162.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.837 0.855 . . . . 0.0 110.577 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 31.9 p -81.04 81.87 7.16 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.21 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' 2958 ' ' PRO . 78.2 mt -106.43 116.26 59.44 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.532 0.733 . . . . 0.0 109.342 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' 2991 ' ' ILE . 72.6 Cg_endo -70.1 168.32 22.33 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.595 2.196 . . . . 0.0 112.461 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2966 ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' 2989 ' ' LEU . 42.4 tt0 -78.99 129.15 34.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.03 0.532 . . . . 0.0 110.68 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 111.85 0.72 27.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 120.063 -0.298 . . . . 0.0 113.661 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' 2965 ' ' PRO . 11.9 p -110.31 112.71 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 121.677 0.751 . . . . 0.0 109.82 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.97 130.45 36.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 110.187 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.26 28.18 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.304 2.669 . . . . 0.0 115.038 -174.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.6 m -72.05 -47.24 53.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.549 0.613 . . . . 0.0 110.832 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.439 ' HB2' HD12 ' A' 2976 ' ' LEU . 17.4 p90 -73.2 -30.22 63.37 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.319 0.58 . . . . 0.0 110.302 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' 2981 ' ' ARG . 9.8 tp -69.49 -27.05 64.87 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.582 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.65 -54.75 3.38 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.273 1.029 . . . . 0.0 111.443 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.71 80.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.526 0.73 . . . . 0.0 112.168 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.897 ' HB3' HD11 ' A' 2980 ' ' ILE . 86.4 mt -79.58 143.99 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.76 174.54 6.47 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.937 2.425 . . . . 0.0 112.067 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -27.59 68.68 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.93 -57.5 10.55 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 123.974 0.909 . . . . 0.0 112.142 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.66 -28.46 8.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.604 -176.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.3 OUTLIER -68.74 -34.24 75.28 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -176.651 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -75.33 -40.09 58.71 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 122.542 0.337 . . . . 0.0 110.473 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.7 pt-20 -70.24 -38.42 75.18 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-O 118.952 -0.546 . . . . 0.0 110.987 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 30.8 m -68.99 -34.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.574 0.35 . . . . 0.0 110.638 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.93 -47.6 80.24 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.714 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.89 -32.46 51.87 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.693 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.12 -28.2 54.28 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.801 0.44 . . . . 0.0 111.823 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.453 ' HB2' HD22 ' A' 2989 ' ' LEU . 98.5 mt-30 -78.81 -51.93 9.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.603 0.361 . . . . 0.0 110.871 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.4 mm? -98.43 -49.61 4.6 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.651 0.38 . . . . 0.0 111.914 -171.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 96.36 9.59 56.63 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.431 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.599 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -70.97 125.06 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.843 0.857 . . . . 0.0 109.457 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.549 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 19.1 t0 . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.37 -27.17 71.15 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.066 2.511 . . . . 0.0 112.534 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.38 -19.5 60.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.22 0.608 . . . . 0.0 110.935 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -67.79 -10.98 57.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.094 0.557 . . . . 0.0 111.869 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 74.12 19.88 79.74 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.078 0.37 . . . . 0.0 113.073 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2962 ' ' ILE . . . . . 0.474 HG13 ' HG ' ' A' 2964 ' ' LEU . 37.6 pt -85.65 167.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.893 0.877 . . . . 0.0 111.114 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.0 p -81.86 79.13 8.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.349 0.66 . . . . 0.0 111.083 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' 2962 ' ' ILE . 76.0 mt -100.02 148.16 34.46 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 123.362 0.665 . . . . 0.0 109.577 173.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 173.4 9.66 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.88 139.65 39.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 69.29 12.77 66.58 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 124.158 0.911 . . . . 0.0 114.965 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 14.4 p -79.43 121.68 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 117.218 0.509 . . . . 0.0 109.865 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.97 120.18 75.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.07 -12.47 19.46 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.03 2.487 . . . . 0.0 113.416 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -69.43 -55.28 10.75 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 122.778 0.431 . . . . 0.0 110.759 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -75.74 -33.19 60.25 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.23 -46.59 88.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.246 1.019 . . . . 0.0 110.88 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -89.45 -35.03 16.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.927 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -72.65 -41.04 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' 2980 ' ' ILE . 87.3 mt -75.0 150.34 85.77 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.486 0.714 . . . . 0.0 109.854 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.39 166.07 6.59 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.982 2.454 . . . . 0.0 113.598 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.14 -23.97 67.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.308 1.043 . . . . 0.0 112.713 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.75 -57.52 10.67 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 124.205 1.002 . . . . 0.0 111.675 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.76 -22.65 8.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 O-C-N 122.256 -0.277 . . . . 0.0 110.409 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 13.5 tpt85 -54.26 -52.6 60.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.093 0.957 . . . . 0.0 110.898 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -71.78 -37.51 70.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 0.0 OUTLIER -69.7 -39.56 76.85 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.129 -175.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.1 m -69.45 -33.58 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.377 0.271 . . . . 0.0 110.383 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.34 -46.88 87.41 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.26 -43.4 57.11 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.868 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.68 -43.24 48.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.011 0.524 . . . . 0.0 111.382 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.535 ' HB2' HD22 ' A' 2989 ' ' LEU . 27.6 mm-40 -72.13 -57.28 4.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.923 0.489 . . . . 0.0 111.305 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -95.25 -26.74 15.83 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -168.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 73.11 15.17 78.67 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.592 0.558 . . . . 0.0 114.032 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.84 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.571 0.748 . . . . 0.0 109.133 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.174 0.59 . . . . 0.0 109.708 -179.578 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t0 . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 119.475 -0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.11 -26.26 30.82 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.62 -5.37 52.73 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.365 0.666 . . . . 0.0 111.09 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.65 36.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.446 0.699 . . . . 0.0 111.892 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.2 69.22 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 113.425 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.8 144.56 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.207 0.603 . . . . 0.0 110.648 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 27.8 m -79.5 85.54 5.26 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.785 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.472 ' HB3' HG11 ' A' 2968 ' ' VAL . 27.3 mt -93.77 149.73 37.54 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.505 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.569 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 67.0 Cg_endo -66.85 -178.39 1.27 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 123.296 2.664 . . . . 0.0 114.693 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -70.48 125.76 27.71 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.572 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 64.33 27.29 71.42 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.207 0.942 . . . . 0.0 114.383 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' 2964 ' ' LEU . 6.9 p -89.76 149.84 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.56 132.13 18.59 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.249 1.019 . . . . 0.0 109.296 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.14 -17.2 10.93 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.495 2.797 . . . . 0.0 113.491 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.6 m -53.27 -60.61 3.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 111.671 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.513 ' HB2' HD12 ' A' 2976 ' ' LEU . 55.3 p90 -80.69 -24.96 38.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.307 0.243 . . . . 0.0 111.586 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.68 -35.74 81.65 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.5 -51.25 5.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.681 0.793 . . . . 0.0 111.517 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.18 87.96 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.213 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' 2972 ' ' PHE . 70.7 mt -93.95 160.71 31.83 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.456 0.702 . . . . 0.0 109.452 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.52 178.23 4.0 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.796 2.331 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2978 ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 31.0 m-20 -73.84 -15.49 61.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 112.368 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2979 ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' 2982 ' ' ARG . 7.3 m-20 -62.22 -55.52 27.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.188 0.595 . . . . 0.0 112.106 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.595 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -79.52 -24.1 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 122.129 -0.357 . . . . 0.0 110.499 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.43 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -59.36 -49.02 79.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.947 0.899 . . . . 0.0 109.64 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2982 ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' 2979 ' ' ASP . 17.9 ptt180 -72.85 -34.91 67.08 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.914 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.9 pt-20 -74.7 -42.43 58.39 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.189 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2984 ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' 2988 ' ' GLN . 33.0 m -63.88 -34.52 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 119.108 0.867 . . . . 0.0 110.508 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.75 -62.86 1.56 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.69 0.796 . . . . 0.0 111.005 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -80.2 -47.43 14.67 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.149 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.95 -37.51 81.67 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.357 0.663 . . . . 0.0 112.05 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' 2984 ' ' VAL . 96.3 mt-30 -82.13 -56.56 3.86 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.229 0.468 . . . . 0.0 111.585 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.2 mm? -88.96 -34.36 16.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.104 0.162 . . . . 0.0 111.314 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 93.57 1.09 66.4 Favored Glycine 0 C--N 1.34 0.764 0 O-C-N 123.445 0.466 . . . . 0.0 113.42 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.404 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 121.38 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.303 0.641 . . . . 0.0 109.475 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 CA--C 1.549 0.928 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.722 178.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 2958 ' ' PRO . . . . . 0.424 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 42.3 Cg_endo -64.28 -31.41 63.27 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.941 2.427 . . . . 0.0 113.483 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 43.4 tp -78.77 -9.7 59.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.222 0.609 . . . . 0.0 111.339 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.69 -15.41 28.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 88.27 28.91 21.34 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 35.1 pt -87.06 160.46 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 110.973 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 50.9 p -99.13 83.88 2.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.504 0.722 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 83.5 mt -77.64 119.57 77.97 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.426 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 45.1 Cg_endo -67.1 164.92 28.25 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.113 1.876 . . . . 0.0 112.282 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.19 132.62 53.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.445 0.698 . . . . 0.0 111.449 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 71.75 14.52 75.47 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.898 0.749 . . . . 0.0 113.847 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.549 HG21 HD21 ' A' 2989 ' ' LEU . 95.3 t -119.97 111.96 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.099 0.96 . . . . 0.0 109.603 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.04 157.48 33.79 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.813 0.845 . . . . 0.0 109.44 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.424 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 45.4 Cg_endo -82.11 8.02 4.74 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.502 2.135 . . . . 0.0 113.036 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 29.9 p -63.11 -59.37 4.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.339 1.056 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.434 ' HE2' HG21 ' A' 2984 ' ' VAL . 26.6 p90 -75.01 -26.8 59.8 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.3 0.64 . . . . 0.0 110.987 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.72 -29.65 68.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.754 0.422 . . . . 0.0 110.825 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -92.1 -43.26 9.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.978 0.911 . . . . 0.0 111.638 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.6 -48.36 55.53 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.391 0.676 . . . . 0.0 111.119 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 51.4 mt -92.31 160.99 33.98 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.239 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2977 ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.9 Cg_endo -61.23 153.05 67.85 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.213 2.609 . . . . 0.0 113.076 -174.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -55.31 -15.52 2.57 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.926 0.89 . . . . 0.0 112.616 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.95 -49.76 65.41 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.717 1.607 . . . . 0.0 111.436 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.95 -32.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -178.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.482 ' N ' HD13 ' A' 2980 ' ' ILE . 23.3 tpt180 -57.6 -52.17 66.52 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.641 1.177 . . . . 0.0 111.119 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -72.08 -42.14 66.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.505 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -71.52 -40.22 70.25 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2984 ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' 2972 ' ' PHE . 18.3 m -73.26 -33.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.25 0.477 . . . . 0.0 110.215 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2985 ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' 2989 ' ' LEU . 34.2 tp -57.22 -48.31 79.12 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.168 0.508 . . . . 0.0 110.701 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -78.8 -48.38 14.91 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.046 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.07 -27.72 57.34 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.05 0.54 . . . . 0.0 112.303 -170.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.55 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.1 mm-40 -91.24 -47.81 7.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.557 0.343 . . . . 0.0 110.856 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -105.26 -45.16 4.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.086 0.154 . . . . 0.0 111.049 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.99 6.07 89.29 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.43 0.456 . . . . 0.0 113.642 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.04 114.97 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 . . . . . 0 CA--C 1.55 0.965 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 -173.548 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 2957 ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 17.6 t70 . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2958 ' ' PRO . . . . . 0.538 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 98.0 Cg_endo -75.05 -23.74 13.43 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.983 2.456 . . . . 0.0 113.49 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.45 28.9 7.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.608 0.763 . . . . 0.0 110.011 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2960 ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -72.66 -13.62 61.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.55 0.74 . . . . 0.0 112.419 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.18 39.29 9.31 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 38.9 pt -124.83 170.83 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.449 1.1 . . . . 0.0 109.974 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.2 m -90.62 100.58 13.4 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.112 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.505 HD22 HG21 ' A' 2968 ' ' VAL . 98.2 mt -72.33 139.9 81.98 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.61 169.96 20.02 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.116 1.877 . . . . 0.0 111.7 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -72.41 139.72 47.96 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 68.33 27.8 73.58 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.774 -0.25 . . . . 0.0 113.128 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.505 HG21 HD22 ' A' 2964 ' ' LEU . 8.0 p -69.52 132.53 33.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.295 0.569 . . . . 0.0 109.933 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2969 ' ' ASP . . . . . 0.493 ' HB3' ' HE1' ' A' 2972 ' ' PHE . 13.4 t70 -144.37 110.37 4.98 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.538 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 72.6 Cg_endo -68.09 -10.11 27.86 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.045 2.497 . . . . 0.0 113.894 -175.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.8 m -62.95 -56.28 18.54 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 122.841 0.456 . . . . 0.0 110.5 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.493 ' HE1' ' HB3' ' A' 2969 ' ' ASP . 50.3 p90 -75.74 -26.61 57.6 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 117.765 0.257 . . . . 0.0 110.972 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.456 HD22 ' HD3' ' A' 2981 ' ' ARG . 95.5 mt -68.79 -26.56 65.27 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.388 0.275 . . . . 0.0 111.312 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.88 -37.53 11.15 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 0.0 111.708 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.24 52.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.36 0.664 . . . . 0.0 111.877 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' 2980 ' ' ILE . 89.8 mt -103.32 152.11 38.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.622 0.769 . . . . 0.0 110.151 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.59 173.58 5.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.978 2.452 . . . . 0.0 113.084 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.0 -19.69 61.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.83 -54.84 13.47 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.61 0.764 . . . . 0.0 112.043 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.456 ' HD3' HD22 ' A' 2973 ' ' LEU . 0.0 OUTLIER -75.21 -32.02 61.07 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.08 -31.55 56.09 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.247 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -39.64 82.16 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 117.836 0.289 . . . . 0.0 110.252 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2984 ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' 2972 ' ' PHE . 33.4 m -72.13 -31.83 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.71 -50.81 72.38 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.036 0.535 . . . . 0.0 111.517 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.52 -39.98 51.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.887 0.475 . . . . 0.0 111.798 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -75.76 -27.16 57.95 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.627 0.371 . . . . 0.0 111.672 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' 2989 ' ' LEU . 29.3 mm-40 -83.98 -56.39 3.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.726 0.239 . . . . 0.0 111.038 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.2 mm? -105.53 -35.61 7.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.79 17.04 72.85 Favored Glycine 0 C--N 1.343 0.957 0 O-C-N 123.176 0.298 . . . . 0.0 113.299 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 130.1 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 CA--C 1.554 1.112 0 O-C-N 123.406 0.441 . . . . 0.0 110.885 -176.187 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 2957 ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 26.8 t70 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -59.57 -33.45 96.91 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.551 2.167 . . . . 0.0 112.159 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.61 21.91 11.63 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.345 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2960 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -74.73 -10.63 59.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.267 0.627 . . . . 0.0 111.978 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 105.5 29.5 5.03 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 31.9 pt -114.58 163.11 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.154 0.981 . . . . 0.0 111.541 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.0 p -101.48 79.7 1.99 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 111.669 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.86 125.55 58.67 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.91 172.95 4.22 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.169 2.579 . . . . 0.0 113.117 171.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.04 139.28 54.9 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.419 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.73 67.88 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.373 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 26.5 t -89.37 100.0 10.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 117.384 0.592 . . . . 0.0 109.999 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.39 138.37 86.53 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.459 0.703 . . . . 0.0 109.532 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.95 -4.82 15.33 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.488 2.126 . . . . 0.0 111.581 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -60.94 -60.43 3.81 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.934 0.894 . . . . 0.0 110.595 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -73.81 -31.31 63.18 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.074 0.464 . . . . 0.0 110.23 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.696 ' HG ' HH11 ' A' 2981 ' ' ARG . 11.8 tp -69.84 -33.59 72.49 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.818 0.847 . . . . 0.0 111.758 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.77 -35.37 12.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 111.55 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.4 80.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.81 0.444 . . . . 0.0 111.794 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.7 mt -89.25 145.51 34.28 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.95 167.06 5.95 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.039 2.493 . . . . 0.0 113.707 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.38 -27.82 69.35 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.03 -55.41 25.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 112.101 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.62 -24.49 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.629 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.696 HH11 ' HG ' ' A' 2973 ' ' LEU . 0.0 OUTLIER -70.22 -31.98 69.65 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.102 0.41 . . . . 0.0 110.242 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -74.95 -38.86 61.62 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 119.542 -0.266 . . . . 0.0 110.477 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.2 -37.97 84.54 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.955 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2984 ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' 2980 ' ' ILE . 25.0 m -69.51 -33.85 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.114 0.416 . . . . 0.0 110.159 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2985 ' ' LEU . . . . . 0.444 HD12 HD23 ' A' 2989 ' ' LEU . 39.9 tp -61.91 -40.25 94.82 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.355 0.598 . . . . 0.0 110.802 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -79.02 -37.7 38.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.422 0.689 . . . . 0.0 111.584 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -74.78 -38.83 62.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.491 0.717 . . . . 0.0 111.147 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.454 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.6 mt-30 -83.48 -50.82 7.91 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.072 0.549 . . . . 0.0 111.09 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.3 mm? -95.7 -48.17 5.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.561 0.344 . . . . 0.0 110.96 -173.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.91 40.71 74.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 113.745 0.258 . . . . 0.0 113.745 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.82 130.63 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.55 0.74 . . . . 0.0 109.201 -177.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.306 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -46.99 -44.53 22.78 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 124.133 3.222 . . . . 0.0 114.063 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.25 -10.27 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.248 0.619 . . . . 0.0 111.018 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.55 1.8 15.68 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.33 0.652 . . . . 0.0 111.912 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 77.6 18.99 76.79 Favored Glycine 0 C--N 1.355 1.615 0 C-N-CA 123.313 0.482 . . . . 0.0 113.287 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2962 ' ' ILE . . . . . 0.443 HD13 HD13 ' A' 2964 ' ' LEU . 2.5 pp -76.08 164.21 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.646 0.778 . . . . 0.0 111.876 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 25.0 t -115.97 81.15 1.55 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.478 ' HB3' HG11 ' A' 2968 ' ' VAL . 10.4 mp -112.34 143.24 28.47 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.61 164.63 34.68 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.321 2.681 . . . . 0.0 113.228 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.6 129.05 38.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2967 ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' 2989 ' ' LEU . . . 115.12 25.9 3.69 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' 2964 ' ' LEU . 9.0 p -139.21 153.86 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.74 0.816 . . . . 0.0 109.174 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2969 ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' 2972 ' ' PHE . 3.4 t70 -146.03 124.38 6.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.12 0.968 . . . . 0.0 109.1 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 79.0 Cg_endo -73.58 -0.64 9.59 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.979 2.452 . . . . 0.0 113.971 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.3 m -68.33 -57.09 6.47 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' 2969 ' ' ASP . 22.7 p90 -72.53 -32.23 65.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.587 ' HG ' ' HD3' ' A' 2981 ' ' ARG . 8.6 tp -67.61 -30.88 70.58 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.786 0.834 . . . . 0.0 111.273 -173.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.82 -43.94 7.99 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.727 0.811 . . . . 0.0 111.616 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.73 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.509 0.724 . . . . 0.0 111.878 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 79.5 mt -92.78 150.02 38.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.511 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -58.18 165.69 6.78 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.985 2.457 . . . . 0.0 113.612 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.99 -20.29 66.14 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2979 ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' 2982 ' ' ARG . 16.5 t70 -73.5 -52.54 13.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.634 0.774 . . . . 0.0 112.251 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.0 -24.58 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.133 -0.354 . . . . 0.0 110.553 -178.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.587 ' HD3' ' HG ' ' A' 2973 ' ' LEU . 0.8 OUTLIER -71.52 -35.67 70.79 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2982 ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' 2979 ' ' ASP . 19.3 ptt180 -69.83 -42.76 73.2 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -38.67 84.64 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.944 -174.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 35.3 m -68.32 -40.27 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.482 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2985 ' ' LEU . . . . . 0.458 HD12 HD23 ' A' 2989 ' ' LEU . 57.4 tp -59.67 -45.88 90.73 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.871 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2986 ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' 2991 ' ' ILE . 24.0 mt-30 -74.26 -34.85 63.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.885 0.874 . . . . 0.0 111.999 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.82 -36.76 56.68 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.973 0.509 . . . . 0.0 112.136 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.488 ' HB2' HD22 ' A' 2989 ' ' LEU . 95.2 mt-30 -71.59 -56.98 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.346 0.258 . . . . 0.0 111.233 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.4 mm? -97.45 -22.43 16.58 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.67 -170.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 74.74 40.97 35.83 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' 2986 ' ' GLN . 0.0 OUTLIER -110.62 128.64 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 0.0 108.654 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.882 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.68 -33.19 96.34 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.377 2.718 . . . . 0.0 113.688 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.0 -14.89 61.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.119 0.567 . . . . 0.0 110.455 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.99 -21.48 64.88 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.979 0.512 . . . . 0.0 111.68 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 114.3 5.67 20.99 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 123.605 0.621 . . . . 0.0 113.047 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 14.5 pt -92.69 147.68 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.285 0.634 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.8 t -101.58 95.51 6.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.13 0.972 . . . . 0.0 109.99 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.15 136.84 40.41 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.549 ' HG3' HG21 ' A' 2991 ' ' ILE . 52.1 Cg_endo -66.61 141.82 62.02 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.712 2.274 . . . . 0.0 112.02 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.97 122.51 16.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.225 0.61 . . . . 0.0 111.573 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 117.07 -19.87 11.73 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.722 0.639 . . . . 0.0 112.961 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.667 ' HB ' HD21 ' A' 2989 ' ' LEU . 4.7 p -96.57 155.34 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 118.106 0.953 . . . . 0.0 109.071 171.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.82 129.91 22.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.66 -16.26 50.0 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.123 2.548 . . . . 0.0 114.627 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 23.9 m -62.92 -55.39 26.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.737 0.415 . . . . 0.0 111.082 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 20.0 p90 -74.9 -30.71 61.37 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.856 0.36 . . . . 0.0 110.126 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.36 -42.05 96.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.713 0.805 . . . . 0.0 110.737 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.82 -28.67 15.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.736 0.814 . . . . 0.0 112.535 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -78.38 -43.81 26.59 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.64 0.376 . . . . 0.0 111.425 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 97.2 mt -80.48 157.96 71.95 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.28 1.032 . . . . 0.0 110.749 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.59 -179.47 0.5 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.941 2.427 . . . . 0.0 114.378 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2978 ' ' ASP . . . . . 0.592 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 6.7 p-10 -72.03 -28.64 63.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.751 0.42 . . . . 0.0 111.996 -172.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.19 -55.38 18.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.329 0.652 . . . . 0.0 112.344 -170.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.26 -18.69 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.516 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -74.56 -38.45 62.69 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.242 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2978 ' ' ASP . 12.2 ptm180 -75.88 -34.44 60.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 6.8 tp10 -53.06 -52.08 59.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.767 1.227 . . . . 0.0 110.599 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 34.7 m -77.59 -31.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.502 0.321 . . . . 0.0 111.328 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.98 -53.28 18.41 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.421 0.629 . . . . 0.0 111.062 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.34 -44.31 68.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.099 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -77.01 -39.59 49.69 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.25 -55.36 6.13 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.836 0.289 . . . . 0.0 111.418 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.9 mm? -84.98 -29.91 24.66 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.171 0.294 . . . . 0.0 110.645 -172.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 84.19 5.47 87.35 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.726 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.549 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.32 127.74 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.67 0.788 . . . . 0.0 109.086 -177.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 CA--C 1.553 1.083 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 -178.086 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 2958 ' ' PRO . . . . . 0.465 ' HD3' HD21 ' A' 2964 ' ' LEU . 42.1 Cg_endo -63.27 -30.92 74.12 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.282 1.988 . . . . 0.0 112.287 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2959 ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' 2959 ' ' LEU . 1.0 OUTLIER -86.13 -7.17 58.77 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.331 0.652 . . . . 0.0 110.064 -177.803 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -65.86 -19.83 66.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.993 -0.442 . . . . 0.0 111.071 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.79 -3.39 28.95 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.523 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.8 pp -88.66 176.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.084 0.554 . . . . 0.0 111.246 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.1 p -120.91 113.48 20.18 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' 2958 ' ' PRO . 2.3 pp -103.42 152.43 38.76 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.689 0.795 . . . . 0.0 109.751 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.24 177.58 8.69 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.807 2.338 . . . . 0.0 113.504 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.68 150.97 42.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.288 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 67.3 21.76 72.38 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.7 0.625 . . . . 0.0 112.915 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 90.6 t -129.38 95.66 2.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.741 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.58 133.95 36.96 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.154 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.37 -14.44 45.02 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.349 2.699 . . . . 0.0 115.015 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 59.0 m -62.45 -56.07 21.69 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.46 0.573 . . . . 0.0 111.404 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 39.2 p90 -72.47 -30.78 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.409 0.623 . . . . 0.0 110.522 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' 2981 ' ' ARG . 17.0 tp -69.81 -33.08 71.86 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.471 -171.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.98 -49.59 5.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.838 . . . . 0.0 111.339 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.45 74.49 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' HD11 ' A' 2980 ' ' ILE . 71.7 mt -83.52 158.78 62.62 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.799 0.84 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.35 178.06 1.0 Allowed 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 123.238 2.625 . . . . 0.0 114.003 -173.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.85 -26.94 65.4 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.48 -54.7 28.39 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.139 0.576 . . . . 0.0 112.072 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -76.48 -32.25 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.637 -178.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.553 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.1 OUTLIER -66.53 -39.88 88.84 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.756 0.312 . . . . 0.0 110.265 -175.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -74.62 -38.38 62.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.159 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.3 pt-20 -73.49 -38.61 65.32 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.259 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 32.6 m -66.41 -34.32 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.326 0.512 . . . . 0.0 110.261 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.23 -52.99 63.29 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.405 0.682 . . . . 0.0 110.136 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.78 -40.01 79.89 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.832 -1.077 . . . . 0.0 112.263 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.14 -41.4 50.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.151 0.581 . . . . 0.0 111.223 -172.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -70.49 -57.06 5.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.8 0.44 . . . . 0.0 111.259 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.15 -34.74 20.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.829 0.452 . . . . 0.0 111.298 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.93 20.82 67.07 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.66 -165.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.68 129.37 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 123.244 0.617 . . . . 0.0 109.672 -176.41 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 118.914 -0.565 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.34 -43.79 36.62 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.71 2.94 . . . . 0.0 113.837 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.77 -4.82 55.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.093 0.957 . . . . 0.0 112.017 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.81 -10.82 59.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.902 0.481 . . . . 0.0 111.094 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.15 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 113.593 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -75.81 175.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.339 0.656 . . . . 0.0 111.089 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.9 p -122.46 93.06 3.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.114 0.566 . . . . 0.0 109.913 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 152.89 48.64 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' 2968 ' ' VAL . 33.8 Cg_endo -62.92 152.47 78.93 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.535 2.156 . . . . 0.0 112.35 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.42 145.64 50.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.285 0.634 . . . . 0.0 111.66 -176.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 77.57 18.28 77.85 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.228 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' 2965 ' ' PRO . 38.7 t -120.26 114.75 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.132 0.973 . . . . 0.0 109.44 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -85.64 126.74 65.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 123.556 0.535 . . . . 0.0 109.694 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 58.6 Cg_endo -68.65 -9.36 25.92 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.502 2.801 . . . . 0.0 113.811 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.0 m -58.4 -57.44 12.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.311 0.644 . . . . 0.0 111.251 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -77.14 -31.86 55.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.494 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 15.6 tp -67.08 -31.16 71.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.056 0.942 . . . . 0.0 111.172 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.37 -52.24 4.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.911 0.884 . . . . 0.0 111.373 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.12 76.83 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.837 ' HB3' HD11 ' A' 2980 ' ' ILE . 90.2 mt -81.32 150.57 67.82 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 0.0 110.462 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.3 170.16 8.35 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.44 2.76 . . . . 0.0 113.592 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2978 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 4.5 p-10 -66.84 -18.73 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -169.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.51 -55.64 8.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.029 0.531 . . . . 0.0 111.84 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.837 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -75.14 -29.75 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 119.289 -0.386 . . . . 0.0 110.193 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 23.0 tpt85 -50.97 -49.19 60.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.234 1.013 . . . . 0.0 111.37 173.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.69 -39.4 61.99 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.4 pt-20 -72.25 -42.68 65.36 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.706 -175.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.0 m -65.65 -30.06 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 118.326 0.512 . . . . 0.0 110.197 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.04 -48.8 77.18 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.46 -28.41 41.58 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -77.66 -49.84 13.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.887 0.475 . . . . 0.0 111.089 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.553 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.3 mm-40 -62.85 -56.63 15.67 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.512 0.507 . . . . 0.0 110.791 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -97.32 -37.25 10.12 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 76.87 23.1 70.24 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 123.335 0.397 . . . . 0.0 112.209 -169.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.423 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -80.74 127.42 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 123.339 0.656 . . . . 0.0 109.926 -177.407 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 2957 ' ' ASP . . . . . 0.412 ' O ' HD11 ' A' 2962 ' ' ILE . 30.5 m-20 . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -78.4 22.61 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.063 2.509 . . . . 0.0 113.483 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2959 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 2959 ' ' LEU . 0.2 OUTLIER -134.8 4.0 3.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.959 0.904 . . . . 0.0 109.137 171.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.2 60.99 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.519 0.728 . . . . 0.0 112.605 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 118.56 -20.58 10.16 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 123.013 0.34 . . . . 0.0 112.442 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2962 ' ' ILE . . . . . 0.665 HD13 HD23 ' A' 2964 ' ' LEU . 2.3 pp -72.83 176.65 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.46 1.104 . . . . 0.0 112.332 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 19.2 m -91.12 76.64 6.1 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 121.135 0.493 . . . . 0.0 111.544 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2964 ' ' LEU . . . . . 0.665 HD23 HD13 ' A' 2962 ' ' ILE . 2.8 mm? -121.88 114.45 31.06 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.74 -171.32 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.636 2.891 . . . . 0.0 113.089 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.87 144.14 30.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.088 0.955 . . . . 0.0 109.795 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.07 20.21 39.93 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.074 0.234 . . . . 0.0 113.128 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 3.3 p -141.44 106.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 124.074 0.949 . . . . 0.0 109.6 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.12 140.92 77.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.053 0.541 . . . . 0.0 110.997 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.35 -10.35 23.93 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.061 2.507 . . . . 0.0 112.434 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 18.4 m -58.64 -59.0 6.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.39 1.076 . . . . 0.0 110.595 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' 2976 ' ' LEU . 34.0 p90 -79.64 -28.33 40.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' 2981 ' ' ARG . 0.5 OUTLIER -65.17 -38.54 90.86 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.842 0.857 . . . . 0.0 110.472 -174.172 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.83 11.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.927 0.491 . . . . 0.0 111.468 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.41 -48.96 59.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.691 ' HB3' HD11 ' A' 2980 ' ' ILE . 93.9 mt -79.42 156.54 75.9 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.929 0.892 . . . . 0.0 110.088 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.09 -178.56 1.77 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.187 2.591 . . . . 0.0 113.593 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2978 ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' 2982 ' ' ARG . 3.6 p30 -72.71 -27.3 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -171.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.81 -52.74 58.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 112.963 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -76.78 -23.08 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' 2973 ' ' LEU . 0.1 OUTLIER -74.56 -36.23 63.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.243 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2982 ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' 2978 ' ' ASP . 5.8 ptm180 -69.81 -40.64 75.8 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 8.5 pt-20 -69.97 -38.36 76.04 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.223 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2984 ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' 2980 ' ' ILE . 33.1 m -69.36 -31.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.87 0.759 . . . . 0.0 110.708 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.13 -50.32 68.69 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.58 0.705 . . . . 0.0 110.967 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -80.27 -45.69 17.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.954 -173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.5 -43.08 81.76 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.06 -56.35 4.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.141 0.276 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.66 -52.63 5.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.251 0.221 . . . . 0.0 111.164 -172.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 106.24 -12.54 44.21 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.786 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.42 125.89 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.368 0.667 . . . . 0.0 109.536 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.051 0.54 . . . . 0.0 110.058 -178.336 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 2957 ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 13.6 t70 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2958 ' ' PRO . . . . . 0.516 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 29.5 Cg_endo -60.57 -35.15 91.26 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.234 . . . . 0.0 112.846 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.6 tp -91.05 7.31 41.04 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.663 0.785 . . . . 0.0 111.333 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2960 ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -69.77 -9.98 56.64 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 107.98 4.69 33.59 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 47.0 pt -79.04 168.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.969 0.508 . . . . 0.0 110.453 173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.3 p -127.62 88.03 2.72 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.012 0.525 . . . . 0.0 110.477 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.3 pp -107.66 149.67 39.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.42 156.34 32.59 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.593 2.196 . . . . 0.0 111.911 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.67 121.93 16.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 116.71 -21.93 11.09 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.7 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 93.4 t -88.63 104.11 14.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.402 0.681 . . . . 0.0 109.541 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.34 126.44 92.7 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.009 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2970 ' ' PRO . . . . . 0.516 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 53.7 Cg_endo -65.8 -8.01 18.34 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.879 2.386 . . . . 0.0 112.444 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -59.11 5.37 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.497 1.119 . . . . 0.0 110.737 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2972 ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' 2976 ' ' LEU . 28.8 p90 -80.23 -32.42 38.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.9 0.381 . . . . 0.0 110.387 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 2981 ' ' ARG . 26.6 tp -63.98 -45.08 90.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.465 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.3 -49.75 5.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.969 0.508 . . . . 0.0 111.733 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.9 63.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.7 mt -95.65 160.79 29.58 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.481 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2977 ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 57.8 Cg_endo -66.3 176.73 3.73 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.416 2.077 . . . . 0.0 112.854 -174.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2978 ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 27.2 t70 -70.25 -21.39 62.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.205 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.44 -55.28 16.46 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 123.415 0.686 . . . . 0.0 111.741 -168.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.486 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.04 -31.89 16.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 -177.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.54 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.4 OUTLIER -67.39 -35.84 80.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.741 0.417 . . . . 0.0 110.597 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2982 ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' 2978 ' ' ASP . 8.7 ptm180 -73.76 -46.2 47.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 14.1 pt-20 -69.0 -34.9 76.02 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.455 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 25.0 m -73.08 -34.85 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.04 -43.35 99.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.677 0.751 . . . . 0.0 110.673 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.05 -44.86 45.31 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.776 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -76.68 -33.21 58.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.688 0.395 . . . . 0.0 112.0 -173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.493 ' HB2' HD22 ' A' 2989 ' ' LEU . 96.1 mt-30 -82.47 -52.25 7.05 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.547 0.339 . . . . 0.0 111.235 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' 2991 ' ' ILE . 2.0 mm? -97.43 -39.98 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.635 0.374 . . . . 0.0 110.979 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 90.81 17.88 49.96 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.534 -0.303 . . . . 0.0 112.775 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -108.02 130.23 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.108 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 118.996 -0.525 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.92 -30.57 67.44 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.624 2.216 . . . . 0.0 112.889 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -77.83 -21.23 51.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.432 0.693 . . . . 0.0 110.136 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -58.94 -21.02 57.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.612 0.765 . . . . 0.0 112.679 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.87 -2.63 28.76 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 123.191 0.424 . . . . 0.0 112.767 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.0 172.73 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.354 0.662 . . . . 0.0 110.903 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 28.3 t -112.87 109.77 19.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.481 0.713 . . . . 0.0 109.862 -177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.44 155.6 56.85 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.48 0.712 . . . . 0.0 109.208 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2965 ' ' PRO . . . . . 0.543 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 59.3 Cg_endo -70.29 157.65 58.68 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.314 2.009 . . . . 0.0 112.067 170.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -70.77 141.62 51.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.645 0.778 . . . . 0.0 111.431 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.39 70.24 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.807 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2968 ' ' VAL . . . . . 0.534 HG21 HD21 ' A' 2989 ' ' LEU . 82.6 t -128.54 96.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.62 156.4 41.17 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 124.004 0.922 . . . . 0.0 109.215 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.22 9.31 2.15 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.555 2.17 . . . . 0.0 112.84 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 19.2 m -63.11 -61.41 2.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.214 1.005 . . . . 0.0 111.21 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 23.9 p90 -78.26 -24.27 46.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.679 0.792 . . . . 0.0 111.28 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2973 ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' 2981 ' ' ARG . 68.3 mt -69.43 -37.45 77.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.28 0.632 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.83 -24.89 19.22 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.788 0.835 . . . . 0.0 112.208 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.4 70.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.209 0.604 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2976 ' ' LEU . . . . . 0.462 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 55.9 mt -107.52 164.25 15.19 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.339 1.056 . . . . 0.0 109.346 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2977 ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.1 Cg_endo -60.35 155.29 47.34 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 123.685 2.924 . . . . 0.0 113.078 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.76 -17.33 5.83 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.924 1.29 . . . . 0.0 113.54 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.91 -39.39 90.53 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.143 0.977 . . . . 0.0 111.614 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2980 ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.94 -32.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2981 ' ' ARG . . . . . 0.509 ' N ' HD13 ' A' 2980 ' ' ILE . 10.5 tpt180 -60.04 -55.34 35.12 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.315 1.046 . . . . 0.0 110.422 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -64.38 -43.62 93.91 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.005 0.816 . . . . 0.0 110.961 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2983 ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' 2987 ' ' ASN . 13.5 pt-20 -68.96 -50.34 50.02 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.973 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 19.3 m -67.43 -30.42 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.177 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2985 ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' 2991 ' ' ILE . 18.4 tp -61.61 -55.68 28.05 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.888 0.852 . . . . 0.0 109.868 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2986 ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' 2992 ' ' ARG . 46.7 mt-30 -75.2 -34.7 61.53 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.618 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2987 ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' 2983 ' ' GLU . 2.5 t-20 -75.15 -46.85 31.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.19 0.596 . . . . 0.0 110.24 -172.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2988 ' ' GLN . . . . . 0.435 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.3 mt-30 -72.29 -51.7 19.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.737 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2989 ' ' LEU . . . . . 0.548 ' HB2' HG22 ' A' 2991 ' ' ILE . 1.0 OUTLIER -102.17 -40.04 6.98 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -171.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 102.19 0.03 50.92 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.559 0.537 . . . . 0.0 112.799 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2991 ' ' ILE . . . . . 0.584 HG23 ' HG ' ' A' 2985 ' ' LEU . 0.0 OUTLIER -78.64 121.37 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.206 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2992 ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' 2986 ' ' GLN . 10.2 ptp180 . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 123.669 0.788 . . . . 0.0 109.705 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.707 0.289 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 38.6 t -134.01 160.61 37.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.368 0.667 . . . . 0.0 109.897 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 15.4 m -74.73 -19.88 60.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.656 0.782 . . . . 0.0 110.29 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.7 82.28 0.86 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.213 1.005 . . . . 0.0 109.738 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.21 137.41 34.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.557 0.743 . . . . 0.0 109.998 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.42 ' HB2' HG21 ' A' 2962 ' ' ILE . 9.5 pt-20 -86.51 123.52 31.81 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -89.03 138.3 29.2 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.115 0.566 . . . . 0.0 110.22 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.03 -31.55 83.86 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.307 2.005 . . . . 0.0 113.132 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 -16.57 61.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.118 0.567 . . . . 0.0 109.836 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.97 16.33 0.56 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 65.14 22.45 68.96 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2962 ' ' ILE . . . . . 0.494 HD11 ' HG3' ' A' 2970 ' ' PRO . 20.4 pt -68.7 141.87 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.605 0.762 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.0 m -83.71 83.29 7.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.469 0.707 . . . . 0.0 111.778 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.448 HD21 HD12 ' A' 2973 ' ' LEU . 11.1 mp -119.28 146.27 40.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.391 1.076 . . . . 0.0 109.674 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.74 162.38 37.64 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.258 2.639 . . . . 0.0 111.845 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.55 141.99 56.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.09 0.556 . . . . 0.0 110.679 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 92.33 -33.23 5.04 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.346 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 13.9 t -84.05 105.98 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.489 0.716 . . . . 0.0 109.515 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.26 135.93 20.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.323 0.649 . . . . 0.0 109.44 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.494 ' HG3' HD11 ' A' 2962 ' ' ILE . 86.7 Cg_endo -74.03 -3.22 13.43 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.137 2.558 . . . . 0.0 115.521 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 73.2 m -62.05 -53.49 54.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.753 0.706 . . . . 0.0 110.916 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 31.6 p90 -71.76 -22.4 61.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.469 HD22 ' HG2' ' A' 2981 ' ' ARG . 55.6 mt -73.57 -37.33 65.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.484 0.313 . . . . 0.0 111.746 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.52 -36.35 12.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.327 0.651 . . . . 0.0 111.391 -174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -76.28 -29.93 57.61 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.145 0.578 . . . . 0.0 111.228 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 68.8 mt -104.26 165.25 13.7 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2977 ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 32.2 Cg_endo -59.76 168.65 5.3 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.943 2.429 . . . . 0.0 114.519 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.13 -15.46 61.48 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.102 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.46 -53.82 31.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.467 0.707 . . . . 0.0 111.488 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.552 ' HA ' ' HB3' ' A' 2983 ' ' GLU . 0.1 OUTLIER -78.91 -17.7 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 120.653 0.263 . . . . 0.0 110.355 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.469 ' HG2' HD22 ' A' 2973 ' ' LEU . 7.8 tmm_? -63.7 -52.29 61.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.493 1.117 . . . . 0.0 110.645 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.27 -32.96 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.582 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.552 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 8.6 tp10 -51.99 -56.48 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 111.295 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.4 m -68.65 -34.51 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.602 0.361 . . . . 0.0 111.464 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2985 ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' 2989 ' ' LEU . 25.3 tp -67.3 -54.75 17.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.343 0.592 . . . . 0.0 111.397 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.26 -43.28 74.25 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.442 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.79 -43.01 38.49 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.1 mt-30 -76.81 -50.94 12.28 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.713 0.292 . . . . 0.0 111.704 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.7 mm? -93.4 -30.76 14.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.819 0.447 . . . . 0.0 111.086 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 77.52 4.76 85.18 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.23 0.332 . . . . 0.0 113.763 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.54 134.94 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.733 0.813 . . . . 0.0 109.708 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -111.3 115.91 51.68 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.719 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.88 -37.4 92.88 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 122.931 2.421 . . . . 0.0 114.296 167.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.79 165.84 19.87 Favored 'Trans proline' 0 C--N 1.403 3.444 0 C-N-CA 122.123 1.882 . . . . 0.0 112.634 168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 40.0 p -62.74 121.99 14.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.731 0.812 . . . . 0.0 112.069 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.87 116.93 11.74 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.409 0.623 . . . . 0.0 111.277 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 43.9 p -123.65 1.4 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.057 0.943 . . . . 0.0 110.462 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -146.82 114.51 4.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.723 0.809 . . . . 0.0 109.522 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.86 -30.81 39.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.841 2.36 . . . . 0.0 111.863 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 34.7 p -80.39 75.6 7.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.944 0.878 . . . . 0.0 109.629 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.6 t -95.8 171.08 8.87 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.985 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.7 t30 -64.17 103.44 0.62 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.252 0.621 . . . . 0.0 109.359 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.844 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.641 0.258 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.8 p -78.41 75.05 4.94 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.645 0.736 . . . . 0.0 109.813 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 25.4 t -134.7 -16.42 2.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 110.389 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -101.53 68.74 1.2 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.09 152.1 36.25 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.817 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' 2964 ' ' LEU . 3.6 mp0 -82.99 89.13 6.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.82 119.87 79.1 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.915 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 -29.2 80.96 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.902 2.401 . . . . 0.0 112.522 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -19.49 62.71 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.285 0.634 . . . . 0.0 110.254 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.62 -23.14 65.83 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.464 0.706 . . . . 0.0 112.058 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 120.33 -9.97 10.87 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.767 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.9 pp -78.97 165.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 117.054 0.427 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 26.5 p -115.71 96.27 5.53 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.11 0.481 . . . . 0.0 111.915 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' 2956 ' ' GLU . 64.6 mt -76.44 139.47 67.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.95 0.5 . . . . 0.0 109.973 170.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.434 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 20.8 Cg_exo -63.17 167.88 11.84 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.94 2.427 . . . . 0.0 112.785 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.22 132.66 54.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.803 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 85.57 5.19 84.85 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.49 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 37.9 t -111.36 101.04 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.559 0.68 . . . . 0.0 110.387 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.72 151.69 37.74 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.686 0.794 . . . . 0.0 109.352 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 87.0 Cg_endo -72.5 -0.22 8.46 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.559 2.173 . . . . 0.0 112.547 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 16.5 m -65.54 -60.1 3.28 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.903 0.881 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.6 p90 -72.17 -30.04 64.6 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.137 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 10.8 tp -68.23 -30.89 70.06 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.547 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -95.04 -53.37 3.84 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.483 0.713 . . . . 0.0 111.789 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.71 89.0 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.746 0.818 . . . . 0.0 112.113 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.1 mt -80.68 140.5 51.21 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.01 167.01 13.0 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.706 2.271 . . . . 0.0 112.387 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.22 -29.29 63.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.46 -59.2 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.536 0.522 . . . . 0.0 111.715 -171.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.22 -29.71 9.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.732 -175.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -39.35 89.91 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.989 0.423 . . . . 0.0 110.209 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -77.1 -36.81 55.34 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.738 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -36.83 70.23 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.191 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2984 ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' 2980 ' ' ILE . 26.8 m -65.9 -33.67 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.1 0.409 . . . . 0.0 110.851 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 58.5 tp -59.44 -56.35 23.08 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.177 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -73.8 -25.98 60.39 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.06 -55.05 5.96 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 117.835 0.289 . . . . 0.0 111.032 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -64.54 -42.29 95.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 0.0 112.149 -172.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.1 mm? -101.05 -27.98 12.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.32 0.248 . . . . 0.0 111.498 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 70.2 37.37 71.86 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.25 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.17 122.99 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -94.44 129.9 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.24 -45.45 31.18 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 121.931 1.754 . . . . 0.0 114.534 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.64 143.44 12.04 Favored 'Trans proline' 0 C--N 1.395 3.021 0 CA-C-N 121.738 1.657 . . . . 0.0 113.801 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 6.6 t -123.64 138.6 54.51 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -71.81 94.83 1.44 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.246 0.546 . . . . 0.0 109.852 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 32.8 p -118.45 114.47 22.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.99 0.916 . . . . 0.0 108.576 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 62.09 83.82 0.2 Allowed Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 124.566 1.147 . . . . 0.0 110.399 -173.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.03 178.4 6.93 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.829 2.353 . . . . 0.0 113.365 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 34.9 t -139.93 146.24 38.94 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.016 0.926 . . . . 0.0 108.895 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.8 t -66.39 145.89 55.19 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.58 0.352 . . . . 0.0 110.369 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -78.61 125.8 29.86 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.535 0.734 . . . . 0.0 109.699 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 CA--C 1.55 0.966 0 C-N-CA 123.442 0.697 . . . . 0.0 109.547 -175.278 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 36.5 m -139.75 -178.36 5.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.483 0.713 . . . . 0.0 109.701 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 23.0 t -127.15 11.04 6.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.296 0.638 . . . . 0.0 109.789 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.54 -1.4 6.18 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.494 0.718 . . . . 0.0 111.682 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.24 143.67 50.34 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.534 0.333 . . . . 0.0 111.24 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -123.55 85.68 2.46 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.837 0.855 . . . . 0.0 109.53 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.63 145.46 78.78 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.214 0.606 . . . . 0.0 110.161 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2958 ' ' PRO . . . . . 0.513 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 13.4 Cg_endo -55.22 -22.35 32.17 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.154 2.569 . . . . 0.0 114.341 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.48 10.32 9.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 111.721 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -83.63 0.65 45.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.629 0.772 . . . . 0.0 110.273 164.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 97.78 -1.6 59.86 Favored Glycine 0 C--N 1.351 1.388 0 C-N-CA 123.309 0.481 . . . . 0.0 112.708 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 30.9 pt -89.21 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.005 0.522 . . . . 0.0 111.081 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -117.09 102.91 9.72 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.733 0.813 . . . . 0.0 109.66 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.77 120.43 70.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.85 175.32 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.904 3.069 . . . . 0.0 114.064 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -70.29 131.81 44.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.702 0.401 . . . . 0.0 110.457 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.66 -19.93 44.97 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.543 0.527 . . . . 0.0 112.715 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 24.5 t -87.46 90.04 3.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.399 0.68 . . . . 0.0 109.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 56.3 t0 -85.34 118.27 70.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.513 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 56.6 Cg_endo -64.9 -3.6 7.27 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.737 2.291 . . . . 0.0 114.074 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.9 m -60.07 -50.15 74.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.989 0.516 . . . . 0.0 110.932 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 10.7 p90 -75.36 -25.76 57.97 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.526 HD13 HH21 ' A' 2981 ' ' ARG . 87.5 mt -67.17 -37.55 83.93 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.968 0.413 . . . . 0.0 110.599 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -90.02 -38.78 13.37 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.02 0.928 . . . . 0.0 112.223 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.88 63.32 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.09 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' 2980 ' ' ILE . 54.5 mt -93.5 158.59 36.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 123.802 0.841 . . . . 0.0 109.007 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.83 -171.8 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.777 2.318 . . . . 0.0 113.796 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2978 ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' 2981 ' ' ARG . 29.8 t70 -72.29 -34.89 68.49 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.17 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.34 -54.01 51.88 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.366 1.067 . . . . 0.0 111.285 -165.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.36 -26.31 14.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.371 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.526 HH21 HD13 ' A' 2973 ' ' LEU . 0.0 OUTLIER -68.12 -38.17 81.94 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.449 0.568 . . . . 0.0 110.535 -175.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -41.32 57.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.037 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 9.9 pt-20 -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 118.031 0.378 . . . . 0.0 111.341 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 31.6 m -69.69 -38.94 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 117.929 0.331 . . . . 0.0 110.774 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -49.38 78.07 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.113 0.482 . . . . 0.0 111.57 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.5 -35.81 65.69 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.918 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.39 -31.35 57.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.557 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.9 mm-40 -82.38 -48.23 11.39 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 111.51 -177.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' 2988 ' ' GLN . 0.8 OUTLIER -109.08 -34.88 6.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.346 0.258 . . . . 0.0 111.348 -171.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 86.05 2.04 86.25 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.347 0.404 . . . . 0.0 113.066 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 129.45 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 -176.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2992 ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' 2996 ' ' ARG . 10.6 ptp85 -116.99 131.6 23.88 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.399 0.68 . . . . 0.0 109.552 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.77 -42.64 51.17 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 122.757 2.305 . . . . 0.0 115.146 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -177.87 3.7 Favored 'Trans proline' 0 C--N 1.399 3.199 0 CA-C-N 122.111 1.79 . . . . 0.0 113.135 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 17.8 p -61.01 137.21 58.24 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.882 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2996 ' ' ARG . . . . . 0.551 ' HG3' HH11 ' A' 2992 ' ' ARG . 0.1 OUTLIER -84.39 94.05 8.41 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 71.5 p -97.08 18.43 14.87 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.361 1.064 . . . . 0.0 110.693 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 56.96 74.79 0.63 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.757 1.223 . . . . 0.0 111.042 -171.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -84.45 10.76 3.59 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.946 2.43 . . . . 0.0 112.885 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 24.8 m -73.58 84.29 1.55 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.719 0.808 . . . . 0.0 110.817 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.9 t -88.41 152.07 22.15 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.748 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 13.5 m120 -75.04 111.8 10.63 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.009 0.524 . . . . 0.0 109.818 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.35 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 32.5 t -108.7 148.24 30.75 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.471 0.708 . . . . 0.0 110.245 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 17.2 m -115.8 -23.55 8.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.047 0.939 . . . . 0.0 110.051 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2954 ' ' GLU . . . . . 0.662 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 12.8 pt-20 -83.3 -36.84 24.14 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.021 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2955 ' ' GLU . . . . . 0.662 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 43.7 mt-10 -92.99 14.95 16.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.321 0.648 . . . . 0.0 111.785 -174.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -57.52 97.45 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 110.975 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -91.06 129.68 42.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.563 1.145 . . . . 0.0 109.201 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.94 -31.47 93.71 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.942 2.428 . . . . 0.0 112.716 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.78 -24.59 44.56 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.491 0.717 . . . . 0.0 110.382 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.2 -21.38 61.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.548 0.739 . . . . 0.0 112.74 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.91 -0.54 64.66 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.271 0.357 . . . . 0.0 113.363 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2962 ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' 2962 ' ' ILE . 2.5 pp -66.62 167.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.079 0.952 . . . . 0.0 111.164 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -80.25 87.04 5.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.063 0.545 . . . . 0.0 110.904 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 11.1 tp -118.76 124.46 28.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' 2991 ' ' ILE . 96.3 Cg_endo -74.04 -162.04 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.954 2.436 . . . . 0.0 113.735 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -82.44 157.77 23.53 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.765 0.826 . . . . 0.0 110.61 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 62.76 18.22 59.06 Favored Glycine 0 N--CA 1.479 1.511 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.72 146.48 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.138 0.975 . . . . 0.0 108.884 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2969 ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' 2973 ' ' LEU . 22.0 t70 -132.79 124.32 18.72 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.279 0.632 . . . . 0.0 110.13 -172.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 85.4 Cg_endo -76.21 2.72 6.91 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.675 2.25 . . . . 0.0 114.774 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 8.4 m -72.84 -56.96 4.45 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.881 0.764 . . . . 0.0 109.936 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 27.3 p90 -73.09 -22.33 60.6 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.17 0.188 . . . . 0.0 110.938 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' A' 2970 ' ' PRO . 6.9 mp -63.96 -51.5 64.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.49 0.716 . . . . 0.0 110.703 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2974 ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' 2954 ' ' GLU . . . -80.12 -26.78 39.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.289 0.636 . . . . 0.0 112.325 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -79.96 -49.3 12.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.676 0.39 . . . . 0.0 110.888 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 40.1 mt -97.73 150.38 36.72 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.113 0.965 . . . . 0.0 109.989 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.76 151.91 60.6 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.148 3.232 . . . . 0.0 113.482 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.21 -21.69 3.63 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 125.199 1.4 . . . . 0.0 113.796 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -51.57 -50.06 60.86 Favored 'General case' 0 C--O 1.248 1.017 0 C-N-CA 124.188 0.995 . . . . 0.0 111.353 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -72.56 -31.62 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.565 -177.035 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.569 ' HB2' ' HG ' ' A' 2973 ' ' LEU . 0.1 OUTLIER -70.06 -43.08 71.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.725 0.81 . . . . 0.0 109.888 -174.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -76.06 -31.34 58.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.219 0.324 . . . . 0.0 110.852 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.21 -40.43 52.25 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.99 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2984 ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' 2980 ' ' ILE . 27.0 m -66.24 -30.96 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-N 118.34 0.518 . . . . 0.0 110.171 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.15 -51.08 70.58 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 123.774 0.83 . . . . 0.0 110.672 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -75.02 -40.88 60.3 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.631 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -70.1 -53.63 16.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.329 . . . . 0.0 111.0 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.531 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.9 mm-40 -64.07 -54.63 31.11 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.276 0.36 . . . . 0.0 111.891 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -103.99 -35.57 8.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.103 0.252 . . . . 0.0 111.628 -169.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 10.35 85.39 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.354 0.409 . . . . 0.0 113.436 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -72.48 121.96 24.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -106.42 127.97 27.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.87 -43.92 34.09 Favored 'Trans proline' 0 CA--C 1.581 2.825 0 C-N-CA 122.083 1.855 . . . . 0.0 113.554 164.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.64 82.05 2.2 Favored 'Trans proline' 0 C--N 1.409 3.758 0 C-N-CA 121.922 1.748 . . . . 0.0 113.196 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 46.7 p -77.01 122.16 24.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -73.88 95.64 2.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.546 0.738 . . . . 0.0 109.964 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.9 p -88.14 73.1 9.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.117 0.967 . . . . 0.0 110.777 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 55.7 63.29 6.41 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.892 1.277 . . . . 0.0 112.8 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -96.22 -1.36 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.658 2.239 . . . . 0.0 113.115 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 32.3 p -145.26 135.12 23.62 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.626 0.77 . . . . 0.0 110.143 -171.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 90.4 m -72.36 95.02 1.68 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.672 0.608 . . . . 0.0 110.117 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.02 147.73 27.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.241 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 123.302 0.641 . . . . 0.0 109.639 -178.868 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.5 m -79.04 92.17 4.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.742 0.817 . . . . 0.0 111.253 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 58.9 m -75.97 -4.28 40.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.984 0.914 . . . . 0.0 111.291 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.75 -15.27 62.68 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.458 1.103 . . . . 0.0 112.263 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.7 130.91 19.54 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.249 1.02 . . . . 0.0 108.68 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.404 ' HB3' HD13 ' A' 2973 ' ' LEU . 6.7 tp10 -133.27 102.58 5.61 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.85 126.97 32.23 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 123.886 0.874 . . . . 0.0 110.612 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.36 -24.33 22.92 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.242 2.628 . . . . 0.0 113.175 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 37.1 tp -83.36 -14.0 53.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.008 0.523 . . . . 0.0 110.767 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.34 41.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.402 0.681 . . . . 0.0 112.104 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 92.86 6.78 63.31 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 113.268 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2962 ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' 2962 ' ' ILE . 2.7 pp -83.09 157.81 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.873 0.469 . . . . 0.0 110.97 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.0 p -88.68 100.4 13.09 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.152 0.581 . . . . 0.0 111.6 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 68.2 mt -100.08 133.73 21.37 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 167.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.79 173.84 13.82 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.205 1.936 . . . . 0.0 111.803 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.11 143.12 50.73 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.386 0.674 . . . . 0.0 111.676 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 81.66 7.02 88.63 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.778 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 62.0 t -105.48 108.66 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.707 0.803 . . . . 0.0 109.609 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.1 141.07 27.57 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.602 0.761 . . . . 0.0 110.647 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' 2973 ' ' LEU . 59.3 Cg_endo -67.23 -10.89 30.2 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.903 2.402 . . . . 0.0 112.687 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.1 m -56.6 -59.22 5.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.565 ' HB2' HD12 ' A' 2976 ' ' LEU . 54.6 p90 -75.57 -24.22 56.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.383 0.273 . . . . 0.0 111.434 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' 2981 ' ' ARG . 81.5 mt -68.5 -35.44 77.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.512 0.325 . . . . 0.0 110.921 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.79 -31.18 14.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.714 0.806 . . . . 0.0 112.134 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.1 24.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.879 0.471 . . . . 0.0 111.732 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' 2972 ' ' PHE . 58.3 mt -108.06 161.23 24.06 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.895 0.878 . . . . 0.0 110.087 -172.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.7 -177.74 1.04 Allowed 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.928 2.418 . . . . 0.0 113.956 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.43 -27.52 62.38 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.012 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2979 ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' 2982 ' ' ARG . 29.6 t70 -59.19 -54.15 50.19 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.548 0.739 . . . . 0.0 112.524 -170.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -78.91 -28.9 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.65 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.573 ' HB2' HD23 ' A' 2973 ' ' LEU . 0.0 OUTLIER -69.29 -36.81 77.42 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -175.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2979 ' ' ASP . 27.7 ptt180 -74.66 -40.39 61.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.931 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.7 pt-20 -69.65 -43.24 72.99 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.659 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 24.1 m -65.81 -32.81 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.113 0.415 . . . . 0.0 110.466 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 36.0 tp -63.8 -49.56 72.43 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.345 0.658 . . . . 0.0 111.046 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -77.79 -36.24 50.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.743 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.57 -53.63 11.42 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.718 0.407 . . . . 0.0 110.413 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.424 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.4 mt-30 -66.67 -54.82 19.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.343 0.657 . . . . 0.0 111.401 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.5 mm? -88.23 -48.89 7.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.922 0.489 . . . . 0.0 110.982 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.1 61.95 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.418 -0.657 . . . . 0.0 113.846 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.56 127.01 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.378 0.671 . . . . 0.0 110.473 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -107.06 132.34 20.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -59.99 -45.25 25.0 Favored 'Trans proline' 0 CA--C 1.575 2.547 0 C-N-CA 122.22 1.946 . . . . 0.0 113.941 169.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.11 90.11 1.27 Allowed 'Trans proline' 0 C--N 1.405 3.512 0 C-N-CA 121.877 1.718 . . . . 0.0 112.205 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 38.6 p -61.73 122.46 15.4 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -67.7 97.17 0.6 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.625 0.77 . . . . 0.0 110.304 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 44.0 p -90.47 38.77 0.95 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.64 1.176 . . . . 0.0 110.355 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -96.18 109.14 45.63 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.248 1.019 . . . . 0.0 110.675 -175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.96 175.01 11.93 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.754 2.302 . . . . 0.0 111.79 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 22.1 p -81.46 73.96 8.47 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.47 0.652 . . . . 0.0 110.321 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 4.3 t -130.61 102.48 6.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 0.0 109.627 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -97.12 118.51 33.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.075 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 42.9 p . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.888 0.375 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 40.4 m -95.52 150.76 19.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.973 0.909 . . . . 0.0 109.857 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.8 m -135.89 30.95 3.05 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.421 0.688 . . . . 0.0 109.641 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.38 -36.4 83.86 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.614 0.766 . . . . 0.0 111.294 -169.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 128.64 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.577 1.151 . . . . 0.0 109.084 174.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -112.66 97.96 6.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -128.32 138.25 32.61 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.193 -164.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.52 -29.61 88.97 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.897 2.398 . . . . 0.0 113.758 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 32.2 tp -72.89 -16.81 61.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.336 0.655 . . . . 0.0 111.533 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.69 64.5 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.267 0.627 . . . . 0.0 111.525 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 103.84 13.25 28.01 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.442 0.464 . . . . 0.0 112.869 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 23.2 pt -110.18 154.92 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.321 0.648 . . . . 0.0 110.753 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.3 m -105.42 102.05 11.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.55 143.02 96.7 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.194 0.598 . . . . 0.0 109.664 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.601 ' HG2' HG21 ' A' 2968 ' ' VAL . 29.1 Cg_endo -67.48 166.27 24.34 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.443 2.095 . . . . 0.0 112.049 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.17 132.26 53.03 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.48 0.712 . . . . 0.0 111.275 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 76.18 26.17 64.65 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.705 0.628 . . . . 0.0 113.921 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.601 HG21 ' HG2' ' A' 2965 ' ' PRO . 52.2 t -119.01 132.13 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.0 0.52 . . . . 0.0 109.783 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -120.86 134.58 24.34 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.007 0.923 . . . . 0.0 109.176 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.54 -7.6 20.81 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.897 2.398 . . . . 0.0 114.816 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 55.9 m -65.36 -54.97 21.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.334 0.515 . . . . 0.0 110.943 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.9 p90 -71.58 -30.28 65.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.578 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.66 -21.67 61.05 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.986 -174.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -96.94 -47.51 5.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.454 0.702 . . . . 0.0 111.773 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.29 70.43 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.682 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.8 mt -71.73 139.91 83.61 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.784 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 158.16 43.54 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.624 2.216 . . . . 0.0 111.161 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.29 -16.83 61.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.39 -58.17 4.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.306 0.503 . . . . 0.0 112.283 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.682 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.43 -23.08 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.746 -0.596 . . . . 0.0 109.78 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -65.28 -44.89 86.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.613 0.765 . . . . 0.0 110.157 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -70.99 -39.5 72.4 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.377 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.9 pt-20 -70.21 -37.41 75.04 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.855 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.5 m -67.42 -32.11 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 118.255 0.479 . . . . 0.0 110.558 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.67 -45.23 83.67 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 121.48 0.657 . . . . 0.0 109.952 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -73.95 -44.73 53.94 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.386 0.674 . . . . 0.0 112.357 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.3 -39.21 59.81 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.932 0.493 . . . . 0.0 112.008 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.418 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.1 mt-30 -74.51 -48.47 26.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.485 0.314 . . . . 0.0 111.512 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.9 mm? -96.82 -43.52 7.47 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.298 0.239 . . . . 0.0 111.271 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 11.15 84.46 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.819 0.699 . . . . 0.0 113.58 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -74.45 123.93 30.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -106.4 142.88 25.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.759 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.57 -32.7 30.59 Favored 'Trans proline' 0 CA--C 1.581 2.875 0 C-N-CA 122.607 2.205 . . . . 0.0 116.714 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 89.72 0.61 Allowed 'Trans proline' 0 C--N 1.403 3.397 0 CA-C-N 123.362 2.236 . . . . 0.0 113.261 -173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 47.3 p -92.27 94.41 9.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.146 0.978 . . . . 0.0 108.555 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -80.94 96.58 7.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -172.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.4 p -121.76 76.01 1.24 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.982 0.913 . . . . 0.0 109.767 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -159.26 139.61 8.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.31 1.044 . . . . 0.0 109.498 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.18 -12.99 30.82 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 112.305 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 28.9 m -64.76 91.45 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.248 1.019 . . . . 0.0 110.286 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 4.0 t -86.14 91.58 8.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.474 0.71 . . . . 0.0 110.178 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.64 103.22 0.83 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.135 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 123.795 0.838 . . . . 0.0 109.223 -175.823 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.615 0.245 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 31.9 t -106.75 124.66 49.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.633 0.773 . . . . 0.0 109.329 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 25.8 m -86.64 -0.86 57.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.39 0.676 . . . . 0.0 111.613 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -90.6 2.67 55.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.251 0.62 . . . . 0.0 111.565 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.02 132.4 19.63 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.233 0.54 . . . . 0.0 111.761 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -104.01 100.9 10.68 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.502 1.121 . . . . 0.0 108.287 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.82 124.81 66.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 123.72 0.808 . . . . 0.0 109.749 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2958 ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 22.7 Cg_endo -57.11 -34.68 98.18 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.068 2.512 . . . . 0.0 113.536 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -16.33 58.66 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.912 0.485 . . . . 0.0 111.309 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.01 -16.49 61.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.604 0.762 . . . . 0.0 112.503 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 96.58 3.06 59.81 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.797 -0.446 . . . . 0.0 113.606 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.12 156.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 122.913 0.485 . . . . 0.0 110.786 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 54.5 m -94.19 97.46 10.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.99 0.516 . . . . 0.0 111.153 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 81.3 mt -103.14 134.54 19.72 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.397 0.679 . . . . 0.0 109.328 167.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.464 ' HG3' HG21 ' A' 2991 ' ' ILE . 42.2 Cg_endo -64.4 156.72 58.56 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.107 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.15 138.14 43.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.04 0.536 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 110.57 -27.77 10.93 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.962 -0.355 . . . . 0.0 113.461 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.596 ' HB ' HD21 ' A' 2989 ' ' LEU . 7.3 p -91.14 137.78 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 122.894 0.477 . . . . 0.0 110.714 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.4 124.98 59.61 Favored Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 54.4 Cg_endo -65.68 -9.26 22.07 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.828 2.352 . . . . 0.0 113.079 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 40.0 m -54.09 -60.03 3.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.296 1.039 . . . . 0.0 111.456 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 40.6 p90 -79.62 -21.96 44.23 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.325 0.391 . . . . 0.0 111.21 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' 2981 ' ' ARG . 72.8 mt -63.99 -36.02 82.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.22 -35.99 12.84 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.558 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -73.15 -24.44 60.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.581 0.752 . . . . 0.0 112.118 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 58.6 mt -111.26 144.65 30.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.722 0.809 . . . . 0.0 109.603 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.79 172.08 10.06 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.332 2.688 . . . . 0.0 113.553 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2978 ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 6.3 p-10 -63.12 -17.25 62.13 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -168.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.44 -58.99 4.09 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 121.456 0.646 . . . . 0.0 110.297 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.37 -27.18 8.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.099 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 26.1 tpt85 -51.58 -49.85 61.3 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.664 0.785 . . . . 0.0 111.245 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -72.95 -43.99 61.67 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.036 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.6 pt-20 -66.28 -40.43 90.07 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 117.993 0.361 . . . . 0.0 111.182 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.3 m -68.28 -35.84 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 117.891 0.314 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2985 ' ' LEU . . . . . 0.426 HD22 ' NH1' ' A' 2981 ' ' ARG . 17.5 tp -65.72 -45.19 83.65 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.409 0.624 . . . . 0.0 110.844 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -73.38 -40.22 64.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.345 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -75.63 -38.62 58.77 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.018 -175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.541 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.5 mm-40 -75.7 -55.83 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.462 0.305 . . . . 0.0 111.392 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.2 mm? -96.73 -23.47 16.41 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.387 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.21 19.58 71.74 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.585 0.553 . . . . 0.0 113.624 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -84.42 141.38 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 123.687 0.795 . . . . 0.0 109.44 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2992 ' ' ARG . . . . . 0.648 ' HD2' ' HA ' ' A' 2996 ' ' ARG . 20.3 ptp180 -112.67 125.91 29.17 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.242 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -57.96 -36.65 97.97 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.523 2.815 . . . . 0.0 115.122 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -75.59 -169.29 0.64 Allowed 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 122.172 1.811 . . . . 0.0 112.753 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 38.9 p -60.15 136.23 57.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.307 0.643 . . . . 0.0 111.437 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2996 ' ' ARG . . . . . 0.648 ' HA ' ' HD2' ' A' 2992 ' ' ARG . 15.9 ptp180 -72.17 93.47 1.45 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.572 1.177 . . . . 0.0 110.195 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 39.7 p -81.02 -42.1 21.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.288 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -111.85 98.25 40.92 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 -30.48 92.06 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.298 2.666 . . . . 0.0 113.247 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 18.9 m 61.2 25.97 15.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.644 1.178 . . . . 0.0 112.025 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 50.8 m -89.8 126.91 35.86 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.49 0.716 . . . . 0.0 109.466 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 29.1 p30 -62.85 140.17 58.78 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.536 0.523 . . . . 0.0 110.983 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 124.392 1.077 . . . . 0.0 109.043 -179.319 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -43.21 98.16 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.9 m -123.93 34.88 4.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.102 0.561 . . . . 0.0 110.865 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 62.72 34.61 14.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.021 0.928 . . . . 0.0 110.645 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.93 157.3 26.25 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.498 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.15 116.08 31.33 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2957 ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 22.3 t70 -83.21 126.94 70.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2958 ' ' PRO . . . . . 0.527 ' HA ' HD12 ' A' 2964 ' ' LEU . 56.6 Cg_endo -65.15 -21.41 62.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.103 2.535 . . . . 0.0 113.982 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.05 9.08 30.62 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.234 0.614 . . . . 0.0 110.959 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2960 ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -67.18 -14.95 63.39 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.16 12.53 76.21 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2962 ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' 2960 ' ' ALA . 26.5 pt -91.12 162.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.837 0.855 . . . . 0.0 110.577 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 31.9 p -81.04 81.87 7.16 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.21 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' 2958 ' ' PRO . 78.2 mt -106.43 116.26 59.44 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.532 0.733 . . . . 0.0 109.342 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' 2991 ' ' ILE . 72.6 Cg_endo -70.1 168.32 22.33 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.595 2.196 . . . . 0.0 112.461 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2966 ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' 2989 ' ' LEU . 42.4 tt0 -78.99 129.15 34.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.03 0.532 . . . . 0.0 110.68 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 111.85 0.72 27.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 120.063 -0.298 . . . . 0.0 113.661 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' 2965 ' ' PRO . 11.9 p -110.31 112.71 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 121.677 0.751 . . . . 0.0 109.82 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.97 130.45 36.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 110.187 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.26 28.18 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.304 2.669 . . . . 0.0 115.038 -174.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.6 m -72.05 -47.24 53.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.549 0.613 . . . . 0.0 110.832 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.439 ' HB2' HD12 ' A' 2976 ' ' LEU . 17.4 p90 -73.2 -30.22 63.37 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.319 0.58 . . . . 0.0 110.302 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' 2981 ' ' ARG . 9.8 tp -69.49 -27.05 64.87 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.582 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.65 -54.75 3.38 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.273 1.029 . . . . 0.0 111.443 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.71 80.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.526 0.73 . . . . 0.0 112.168 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.897 ' HB3' HD11 ' A' 2980 ' ' ILE . 86.4 mt -79.58 143.99 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.76 174.54 6.47 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.937 2.425 . . . . 0.0 112.067 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -27.59 68.68 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.93 -57.5 10.55 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 123.974 0.909 . . . . 0.0 112.142 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.66 -28.46 8.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.604 -176.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.3 OUTLIER -68.74 -34.24 75.28 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -176.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -75.33 -40.09 58.71 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 122.542 0.337 . . . . 0.0 110.473 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.7 pt-20 -70.24 -38.42 75.18 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-O 118.952 -0.546 . . . . 0.0 110.987 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 30.8 m -68.99 -34.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.574 0.35 . . . . 0.0 110.638 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.93 -47.6 80.24 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.714 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.89 -32.46 51.87 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.693 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.12 -28.2 54.28 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.801 0.44 . . . . 0.0 111.823 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.453 ' HB2' HD22 ' A' 2989 ' ' LEU . 98.5 mt-30 -78.81 -51.93 9.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.603 0.361 . . . . 0.0 110.871 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.4 mm? -98.43 -49.61 4.6 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.651 0.38 . . . . 0.0 111.914 -171.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 96.36 9.59 56.63 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.431 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.599 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -70.97 125.06 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.843 0.857 . . . . 0.0 109.457 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -85.28 118.6 71.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.76 -39.47 81.69 Favored 'Trans proline' 0 CA--C 1.582 2.88 0 C-N-CA 122.588 2.192 . . . . 0.0 114.528 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.55 106.75 1.68 Allowed 'Trans proline' 0 C--N 1.412 3.89 0 CA-C-N 121.736 1.656 . . . . 0.0 112.249 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 63.8 p -99.31 139.8 34.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.254 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -120.05 102.94 8.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.537 0.735 . . . . 0.0 109.148 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 50.4 p -88.97 -8.48 54.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.436 0.694 . . . . 0.0 111.187 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -79.74 153.58 75.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.004 0.921 . . . . 0.0 110.022 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.63 15.57 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.083 2.522 . . . . 0.0 113.638 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 15.7 m -77.92 117.8 19.61 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.581 0.752 . . . . 0.0 110.213 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 27.5 m -128.03 137.57 52.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.068 0.947 . . . . 0.0 110.145 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -74.03 87.91 1.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.555 1.137 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.006 176.8 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 93.9 p -85.13 -146.37 0.1 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 123.878 0.871 . . . . 0.0 109.905 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 45.7 m -127.91 13.34 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.014 0.925 . . . . 0.0 110.648 174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -83.86 -42.13 16.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.596 0.759 . . . . 0.0 111.811 -171.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.03 95.79 0.5 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.841 0.829 . . . . 0.0 110.661 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.79 85.27 5.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 19.1 t0 -96.37 123.05 55.99 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.754 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.37 -27.17 71.15 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.066 2.511 . . . . 0.0 112.534 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.38 -19.5 60.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.22 0.608 . . . . 0.0 110.935 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -67.79 -10.98 57.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.094 0.557 . . . . 0.0 111.869 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 74.12 19.88 79.74 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.078 0.37 . . . . 0.0 113.073 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2962 ' ' ILE . . . . . 0.474 HG13 ' HG ' ' A' 2964 ' ' LEU . 37.6 pt -85.65 167.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.893 0.877 . . . . 0.0 111.114 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.0 p -81.86 79.13 8.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.349 0.66 . . . . 0.0 111.083 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' 2962 ' ' ILE . 76.0 mt -100.02 148.16 34.46 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 123.362 0.665 . . . . 0.0 109.577 173.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 173.4 9.66 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.88 139.65 39.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 69.29 12.77 66.58 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 124.158 0.911 . . . . 0.0 114.965 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 14.4 p -79.43 121.68 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 117.218 0.509 . . . . 0.0 109.865 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.97 120.18 75.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.07 -12.47 19.46 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.03 2.487 . . . . 0.0 113.416 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -69.43 -55.28 10.75 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 122.778 0.431 . . . . 0.0 110.759 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -75.74 -33.19 60.25 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.23 -46.59 88.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.246 1.019 . . . . 0.0 110.88 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -89.45 -35.03 16.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.927 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -72.65 -41.04 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' 2980 ' ' ILE . 87.3 mt -75.0 150.34 85.77 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.486 0.714 . . . . 0.0 109.854 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.39 166.07 6.59 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.982 2.454 . . . . 0.0 113.598 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.14 -23.97 67.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.308 1.043 . . . . 0.0 112.713 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.75 -57.52 10.67 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 124.205 1.002 . . . . 0.0 111.675 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.76 -22.65 8.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 O-C-N 122.256 -0.277 . . . . 0.0 110.409 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 13.5 tpt85 -54.26 -52.6 60.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.093 0.957 . . . . 0.0 110.898 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -71.78 -37.51 70.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 0.0 OUTLIER -69.7 -39.56 76.85 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.129 -175.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.1 m -69.45 -33.58 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.377 0.271 . . . . 0.0 110.383 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.34 -46.88 87.41 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.26 -43.4 57.11 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.868 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.68 -43.24 48.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.011 0.524 . . . . 0.0 111.382 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.535 ' HB2' HD22 ' A' 2989 ' ' LEU . 27.6 mm-40 -72.13 -57.28 4.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.923 0.489 . . . . 0.0 111.305 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -95.25 -26.74 15.83 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -168.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 73.11 15.17 78.67 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.592 0.558 . . . . 0.0 114.032 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.84 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.571 0.748 . . . . 0.0 109.133 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -93.2 117.35 67.43 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.174 0.59 . . . . 0.0 109.708 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.28 -37.74 59.55 Favored 'Trans proline' 0 CA--C 1.582 2.899 0 C-N-CA 122.379 2.052 . . . . 0.0 114.037 165.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.09 119.32 6.33 Favored 'Trans proline' 0 C--N 1.411 3.866 0 CA-C-N 122.02 1.757 . . . . 0.0 112.447 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 3.6 p -128.31 115.57 18.49 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.321 1.049 . . . . 0.0 109.706 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2996 ' ' ARG . . . . . 0.734 ' HG3' ' HB3' ' A' 3002 ' ' ASN . 20.8 mmt180 -68.41 102.69 1.47 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.909 0.884 . . . . 0.0 110.598 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 71.7 p -80.33 -16.91 53.5 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.804 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -65.59 153.38 90.67 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.144 0.978 . . . . 0.0 111.215 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.02 -31.13 33.59 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.612 2.875 . . . . 0.0 113.28 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 30.0 t -66.27 101.3 0.71 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 110.196 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.1 m -82.58 79.37 9.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.935 0.894 . . . . 0.0 109.058 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 3002 ' ' ASN . . . . . 0.734 ' HB3' ' HG3' ' A' 2996 ' ' ARG . 5.8 t30 -87.95 109.35 19.74 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.262 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 17.6 p . . . . . 0 CA--C 1.551 1.012 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 173.469 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 10.1 t 62.96 17.66 10.25 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.382 1.073 . . . . 0.0 112.185 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 36.6 t -74.02 -4.3 34.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.927 0.891 . . . . 0.0 111.387 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.72 -35.49 70.75 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.979 0.912 . . . . 0.0 111.087 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -114.0 146.41 40.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.589 ' HG2' HD11 ' A' 2964 ' ' LEU . 38.8 tt0 -134.21 85.45 2.19 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.6 125.43 78.39 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.524 1.13 . . . . 0.0 110.897 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.11 -26.26 30.82 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.62 -5.37 52.73 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.365 0.666 . . . . 0.0 111.09 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.65 36.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.446 0.699 . . . . 0.0 111.892 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.2 69.22 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 113.425 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.8 144.56 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.207 0.603 . . . . 0.0 110.648 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 27.8 m -79.5 85.54 5.26 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.785 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.589 HD11 ' HG2' ' A' 2956 ' ' GLU . 27.3 mt -93.77 149.73 37.54 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.505 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.569 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 67.0 Cg_endo -66.85 -178.39 1.27 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 123.296 2.664 . . . . 0.0 114.693 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -70.48 125.76 27.71 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.572 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 64.33 27.29 71.42 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.207 0.942 . . . . 0.0 114.383 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' 2964 ' ' LEU . 6.9 p -89.76 149.84 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.56 132.13 18.59 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.249 1.019 . . . . 0.0 109.296 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.14 -17.2 10.93 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.495 2.797 . . . . 0.0 113.491 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.6 m -53.27 -60.61 3.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 111.671 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.513 ' HB2' HD12 ' A' 2976 ' ' LEU . 55.3 p90 -80.69 -24.96 38.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.307 0.243 . . . . 0.0 111.586 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.68 -35.74 81.65 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.5 -51.25 5.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.681 0.793 . . . . 0.0 111.517 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.18 87.96 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.213 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' 2972 ' ' PHE . 70.7 mt -93.95 160.71 31.83 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.456 0.702 . . . . 0.0 109.452 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.52 178.23 4.0 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.796 2.331 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2978 ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 31.0 m-20 -73.84 -15.49 61.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 112.368 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2979 ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' 2982 ' ' ARG . 7.3 m-20 -62.22 -55.52 27.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.188 0.595 . . . . 0.0 112.106 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.595 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -79.52 -24.1 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 122.129 -0.357 . . . . 0.0 110.499 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.43 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -59.36 -49.02 79.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.947 0.899 . . . . 0.0 109.64 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2982 ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' 2979 ' ' ASP . 17.9 ptt180 -72.85 -34.91 67.08 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.914 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.9 pt-20 -74.7 -42.43 58.39 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.189 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2984 ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' 2988 ' ' GLN . 33.0 m -63.88 -34.52 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 119.108 0.867 . . . . 0.0 110.508 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.75 -62.86 1.56 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.69 0.796 . . . . 0.0 111.005 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -80.2 -47.43 14.67 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.149 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.95 -37.51 81.67 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.357 0.663 . . . . 0.0 112.05 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' 2984 ' ' VAL . 96.3 mt-30 -82.13 -56.56 3.86 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.229 0.468 . . . . 0.0 111.585 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.2 mm? -88.96 -34.36 16.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.104 0.162 . . . . 0.0 111.314 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 93.57 1.09 66.4 Favored Glycine 0 C--N 1.34 0.764 0 O-C-N 123.445 0.466 . . . . 0.0 113.42 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.404 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 121.38 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.303 0.641 . . . . 0.0 109.475 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2992 ' ' ARG . . . . . 0.47 ' HE ' ' HG2' ' A' 2994 ' ' PRO . 13.7 ptm180 -99.54 129.42 29.01 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.722 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.39 -40.42 58.07 Favored 'Trans proline' 0 CA--C 1.572 2.404 0 C-N-CA 122.35 2.033 . . . . 0.0 114.287 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2994 ' ' PRO . . . . . 0.47 ' HG2' ' HE ' ' A' 2992 ' ' ARG . 86.2 Cg_endo -74.27 81.31 2.04 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 121.805 1.67 . . . . 0.0 111.772 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 37.1 p -67.99 93.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.502 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -71.79 94.71 1.42 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.608 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 21.0 p -95.07 101.48 13.23 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -147.8 161.57 34.63 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.133 0.973 . . . . 0.0 109.472 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.76 -35.31 17.37 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.36 2.707 . . . . 0.0 113.088 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 35.8 p -85.74 134.84 33.93 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.058 0.943 . . . . 0.0 110.005 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.0 t -76.68 139.36 40.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.759 0.424 . . . . 0.0 110.147 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.6 t30 -72.92 94.89 1.89 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 123.907 0.883 . . . . 0.0 108.756 -178.463 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 66.3 p -153.42 179.2 9.0 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.251 1.02 . . . . 0.0 109.083 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 66.7 p -103.11 27.41 7.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.443 0.697 . . . . 0.0 110.034 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.24 -35.89 76.48 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 123.986 0.915 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2955 ' ' GLU . . . . . 0.44 ' HA ' ' HB1' ' A' 2974 ' ' ALA . 4.9 pt-20 -124.36 107.0 10.68 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.847 0.832 . . . . 0.0 108.772 162.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.76 131.16 40.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 22.5 t70 -110.96 118.3 48.46 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.226 0.611 . . . . 0.0 110.065 -168.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2958 ' ' PRO . . . . . 0.424 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 42.3 Cg_endo -64.28 -31.41 63.27 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.941 2.427 . . . . 0.0 113.483 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 43.4 tp -78.77 -9.7 59.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.222 0.609 . . . . 0.0 111.339 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.69 -15.41 28.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 88.27 28.91 21.34 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 35.1 pt -87.06 160.46 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 110.973 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 50.9 p -99.13 83.88 2.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.504 0.722 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 83.5 mt -77.64 119.57 77.97 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.426 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 45.1 Cg_endo -67.1 164.92 28.25 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.113 1.876 . . . . 0.0 112.282 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.19 132.62 53.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.445 0.698 . . . . 0.0 111.449 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 71.75 14.52 75.47 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.898 0.749 . . . . 0.0 113.847 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.549 HG21 HD21 ' A' 2989 ' ' LEU . 95.3 t -119.97 111.96 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.099 0.96 . . . . 0.0 109.603 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.04 157.48 33.79 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.813 0.845 . . . . 0.0 109.44 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.424 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 45.4 Cg_endo -82.11 8.02 4.74 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.502 2.135 . . . . 0.0 113.036 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 29.9 p -63.11 -59.37 4.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.339 1.056 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.434 ' HE2' HG21 ' A' 2984 ' ' VAL . 26.6 p90 -75.01 -26.8 59.8 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.3 0.64 . . . . 0.0 110.987 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.72 -29.65 68.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.754 0.422 . . . . 0.0 110.825 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2974 ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' 2955 ' ' GLU . . . -92.1 -43.26 9.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.978 0.911 . . . . 0.0 111.638 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.6 -48.36 55.53 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.391 0.676 . . . . 0.0 111.119 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 51.4 mt -92.31 160.99 33.98 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.239 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2977 ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.9 Cg_endo -61.23 153.05 67.85 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.213 2.609 . . . . 0.0 113.076 -174.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -55.31 -15.52 2.57 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.926 0.89 . . . . 0.0 112.616 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.95 -49.76 65.41 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.717 1.607 . . . . 0.0 111.436 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.95 -32.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -178.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.482 ' N ' HD13 ' A' 2980 ' ' ILE . 23.3 tpt180 -57.6 -52.17 66.52 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.641 1.177 . . . . 0.0 111.119 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -72.08 -42.14 66.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.505 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -71.52 -40.22 70.25 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2984 ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' 2972 ' ' PHE . 18.3 m -73.26 -33.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.25 0.477 . . . . 0.0 110.215 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2985 ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' 2989 ' ' LEU . 34.2 tp -57.22 -48.31 79.12 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.168 0.508 . . . . 0.0 110.701 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -78.8 -48.38 14.91 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.046 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.07 -27.72 57.34 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.05 0.54 . . . . 0.0 112.303 -170.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.55 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.1 mm-40 -91.24 -47.81 7.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.557 0.343 . . . . 0.0 110.856 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -105.26 -45.16 4.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.086 0.154 . . . . 0.0 111.049 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.99 6.07 89.29 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.43 0.456 . . . . 0.0 113.642 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.04 114.97 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -86.43 127.77 59.67 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2993 ' ' PRO . . . . . 0.4 ' N ' ' HD2' ' A' 2994 ' ' PRO . 57.4 Cg_endo -72.97 -23.66 18.28 Favored 'Trans proline' 0 CA--C 1.588 3.18 0 C-N-CA 122.463 2.109 . . . . 0.0 116.275 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2994 ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' 2993 ' ' PRO . 42.7 Cg_endo -62.74 97.04 0.17 Allowed 'Trans proline' 1 C--N 1.418 4.19 0 CA-C-N 123.729 2.368 . . . . 0.0 113.293 177.38 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 47.1 p -90.89 116.71 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 167.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -65.32 96.58 0.24 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 110.789 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 63.1 p -74.9 -48.38 25.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.27 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -81.69 140.67 47.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.847 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -80.73 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.952 2.435 . . . . 0.0 113.751 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 68.0 p 48.98 79.35 0.08 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.714 1.606 . . . . 0.0 111.95 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.5 t -105.67 154.17 20.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.123 0.969 . . . . 0.0 110.906 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.7 t30 -89.89 135.51 33.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.748 0.819 . . . . 0.0 110.008 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 CA--C 1.556 1.21 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.536 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 48.6 p -67.33 100.17 0.79 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 23.3 m -69.58 -17.28 63.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.495 0.718 . . . . 0.0 111.289 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -82.46 78.98 9.03 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -99.54 106.59 18.61 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.076 176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.29 150.2 49.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.306 0.642 . . . . 0.0 109.529 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2957 ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 17.6 t70 -143.21 135.84 13.56 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 122.645 0.378 . . . . 0.0 110.822 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2958 ' ' PRO . . . . . 0.538 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 98.0 Cg_endo -75.05 -23.74 13.43 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.983 2.456 . . . . 0.0 113.49 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.45 28.9 7.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.608 0.763 . . . . 0.0 110.011 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2960 ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -72.66 -13.62 61.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.55 0.74 . . . . 0.0 112.419 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.18 39.29 9.31 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 38.9 pt -124.83 170.83 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.449 1.1 . . . . 0.0 109.974 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.2 m -90.62 100.58 13.4 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.112 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.505 HD22 HG21 ' A' 2968 ' ' VAL . 98.2 mt -72.33 139.9 81.98 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.61 169.96 20.02 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.116 1.877 . . . . 0.0 111.7 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -72.41 139.72 47.96 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 68.33 27.8 73.58 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.774 -0.25 . . . . 0.0 113.128 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.505 HG21 HD22 ' A' 2964 ' ' LEU . 8.0 p -69.52 132.53 33.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.295 0.569 . . . . 0.0 109.933 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2969 ' ' ASP . . . . . 0.493 ' HB3' ' HE1' ' A' 2972 ' ' PHE . 13.4 t70 -144.37 110.37 4.98 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.538 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 72.6 Cg_endo -68.09 -10.11 27.86 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.045 2.497 . . . . 0.0 113.894 -175.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.8 m -62.95 -56.28 18.54 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 122.841 0.456 . . . . 0.0 110.5 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.493 ' HE1' ' HB3' ' A' 2969 ' ' ASP . 50.3 p90 -75.74 -26.61 57.6 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 117.765 0.257 . . . . 0.0 110.972 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.456 HD22 ' HD3' ' A' 2981 ' ' ARG . 95.5 mt -68.79 -26.56 65.27 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.388 0.275 . . . . 0.0 111.312 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.88 -37.53 11.15 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 0.0 111.708 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.24 52.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.36 0.664 . . . . 0.0 111.877 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' 2980 ' ' ILE . 89.8 mt -103.32 152.11 38.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.622 0.769 . . . . 0.0 110.151 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.59 173.58 5.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.978 2.452 . . . . 0.0 113.084 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.0 -19.69 61.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.83 -54.84 13.47 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.61 0.764 . . . . 0.0 112.043 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.456 ' HD3' HD22 ' A' 2973 ' ' LEU . 0.0 OUTLIER -75.21 -32.02 61.07 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.08 -31.55 56.09 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.247 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -39.64 82.16 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 117.836 0.289 . . . . 0.0 110.252 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2984 ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' 2972 ' ' PHE . 33.4 m -72.13 -31.83 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.71 -50.81 72.38 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.036 0.535 . . . . 0.0 111.517 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.52 -39.98 51.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.887 0.475 . . . . 0.0 111.798 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -75.76 -27.16 57.95 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.627 0.371 . . . . 0.0 111.672 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' 2989 ' ' LEU . 29.3 mm-40 -83.98 -56.39 3.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.726 0.239 . . . . 0.0 111.038 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.2 mm? -105.53 -35.61 7.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.79 17.04 72.85 Favored Glycine 0 C--N 1.343 0.957 0 O-C-N 123.176 0.298 . . . . 0.0 113.299 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 130.1 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2992 ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' 2996 ' ' ARG . 15.0 ptp180 -81.25 121.18 80.08 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 123.406 0.441 . . . . 0.0 110.885 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.73 -34.53 91.72 Favored 'Trans proline' 0 CA--C 1.574 2.481 0 C-N-CA 122.674 2.249 . . . . 0.0 114.375 168.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.17 -162.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.404 3.477 0 C-N-CA 122.482 2.122 . . . . 0.0 114.267 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 33.9 m -59.89 109.16 0.88 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.678 0.791 . . . . 0.0 111.044 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2996 ' ' ARG . . . . . 0.577 ' HA ' ' HD2' ' A' 2992 ' ' ARG . 86.9 mtm180 -71.84 95.78 1.57 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.155 0.982 . . . . 0.0 110.47 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 33.3 p -110.18 -6.3 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.204 1.002 . . . . 0.0 111.441 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -106.6 97.13 15.82 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.483 0.713 . . . . 0.0 109.516 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.23 12.17 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.287 2.658 . . . . 0.0 114.885 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 20.5 m 66.35 23.34 10.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.156 1.382 . . . . 0.0 111.518 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 41.4 m -78.21 86.31 4.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.335 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.26 142.54 37.77 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.883 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 CA--C 1.546 0.796 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.23 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 2952 ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' 2954 ' ' GLU . 37.9 t -77.41 170.33 16.75 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.172 0.589 . . . . 0.0 111.272 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 28.7 m -71.61 -4.12 25.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.63 0.772 . . . . 0.0 112.577 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2954 ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 11.2 pt-20 -56.51 -44.41 80.72 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.625 1.17 . . . . 0.0 111.441 173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2955 ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 50.6 mt-10 -113.09 158.36 20.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.79 0.836 . . . . 0.0 110.019 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.77 130.41 48.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2957 ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 26.8 t70 -103.43 134.11 19.93 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.18 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -59.57 -33.45 96.91 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.551 2.167 . . . . 0.0 112.159 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.61 21.91 11.63 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.345 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2960 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -74.73 -10.63 59.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.267 0.627 . . . . 0.0 111.978 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 105.5 29.5 5.03 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 31.9 pt -114.58 163.11 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.154 0.981 . . . . 0.0 111.541 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.0 p -101.48 79.7 1.99 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 111.669 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.86 125.55 58.67 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.91 172.95 4.22 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.169 2.579 . . . . 0.0 113.117 171.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.04 139.28 54.9 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.419 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.73 67.88 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.373 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 26.5 t -89.37 100.0 10.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 117.384 0.592 . . . . 0.0 109.999 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.39 138.37 86.53 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.459 0.703 . . . . 0.0 109.532 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.95 -4.82 15.33 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.488 2.126 . . . . 0.0 111.581 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -60.94 -60.43 3.81 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.934 0.894 . . . . 0.0 110.595 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -73.81 -31.31 63.18 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.074 0.464 . . . . 0.0 110.23 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.696 ' HG ' HH11 ' A' 2981 ' ' ARG . 11.8 tp -69.84 -33.59 72.49 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.818 0.847 . . . . 0.0 111.758 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.77 -35.37 12.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 111.55 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.4 80.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.81 0.444 . . . . 0.0 111.794 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.7 mt -89.25 145.51 34.28 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.95 167.06 5.95 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.039 2.493 . . . . 0.0 113.707 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.38 -27.82 69.35 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.03 -55.41 25.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 112.101 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.62 -24.49 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.629 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.696 HH11 ' HG ' ' A' 2973 ' ' LEU . 0.0 OUTLIER -70.22 -31.98 69.65 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.102 0.41 . . . . 0.0 110.242 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -74.95 -38.86 61.62 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 119.542 -0.266 . . . . 0.0 110.477 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.2 -37.97 84.54 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.955 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2984 ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' 2980 ' ' ILE . 25.0 m -69.51 -33.85 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.114 0.416 . . . . 0.0 110.159 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2985 ' ' LEU . . . . . 0.444 HD12 HD23 ' A' 2989 ' ' LEU . 39.9 tp -61.91 -40.25 94.82 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.355 0.598 . . . . 0.0 110.802 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -79.02 -37.7 38.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.422 0.689 . . . . 0.0 111.584 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -74.78 -38.83 62.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.491 0.717 . . . . 0.0 111.147 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.454 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.6 mt-30 -83.48 -50.82 7.91 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.072 0.549 . . . . 0.0 111.09 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.3 mm? -95.7 -48.17 5.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.561 0.344 . . . . 0.0 110.96 -173.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.91 40.71 74.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 113.745 0.258 . . . . 0.0 113.745 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.82 130.63 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.55 0.74 . . . . 0.0 109.201 -177.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2992 ' ' ARG . . . . . 0.474 ' HE ' ' HG2' ' A' 2994 ' ' PRO . 10.5 ptm85 -96.44 129.06 34.3 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -62.32 -33.54 80.1 Favored 'Trans proline' 0 CA--C 1.579 2.773 0 C-N-CA 121.886 1.724 . . . . 0.0 114.811 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2994 ' ' PRO . . . . . 0.474 ' HG2' ' HE ' ' A' 2992 ' ' ARG . 92.9 Cg_endo -73.16 178.44 6.55 Favored 'Trans proline' 0 C--N 1.398 3.156 0 CA-C-N 122.538 1.942 . . . . 0.0 112.657 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 51.5 p -71.85 152.45 42.62 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.436 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 66.5 mtm-85 -80.88 94.73 6.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 62.8 p -80.86 87.58 5.91 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.613 0.765 . . . . 0.0 109.808 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2998 ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' A' 2999 ' ' PRO . . . -85.91 -63.55 0.23 Allowed Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.023 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2999 ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' 2998 ' ' ALA . 34.3 Cg_endo -93.19 -7.48 2.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.842 1.694 . . . . 0.0 112.163 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 76.3 p -101.58 47.82 0.9 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.697 0.799 . . . . 0.0 110.252 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 11.0 t -139.46 142.95 37.36 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.972 0.509 . . . . 0.0 110.126 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -75.67 123.9 26.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.645 0.778 . . . . 0.0 110.128 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 123.751 0.821 . . . . 0.0 110.725 -177.658 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.5 t 66.84 8.39 5.99 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.416 1.486 . . . . 0.0 112.672 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 43.7 p -89.45 16.65 7.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.976 0.91 . . . . 0.0 111.441 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.91 -41.15 99.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.072 0.949 . . . . 0.0 110.796 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -100.6 170.59 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.248 1.019 . . . . 0.0 111.224 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.467 ' HB2' HD23 ' A' 2973 ' ' LEU . 24.8 mt-10 -92.52 85.39 5.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.454 0.702 . . . . 0.0 109.152 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.2 138.31 19.65 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.14 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -46.99 -44.53 22.78 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 124.133 3.222 . . . . 0.0 114.063 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.25 -10.27 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.248 0.619 . . . . 0.0 111.018 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.55 1.8 15.68 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.33 0.652 . . . . 0.0 111.912 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 77.6 18.99 76.79 Favored Glycine 0 C--N 1.355 1.615 0 C-N-CA 123.313 0.482 . . . . 0.0 113.287 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2962 ' ' ILE . . . . . 0.443 HD13 HD13 ' A' 2964 ' ' LEU . 2.5 pp -76.08 164.21 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.646 0.778 . . . . 0.0 111.876 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 25.0 t -115.97 81.15 1.55 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.478 ' HB3' HG11 ' A' 2968 ' ' VAL . 10.4 mp -112.34 143.24 28.47 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.61 164.63 34.68 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.321 2.681 . . . . 0.0 113.228 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.6 129.05 38.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2967 ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' 2989 ' ' LEU . . . 115.12 25.9 3.69 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' 2964 ' ' LEU . 9.0 p -139.21 153.86 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.74 0.816 . . . . 0.0 109.174 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2969 ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' 2972 ' ' PHE . 3.4 t70 -146.03 124.38 6.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.12 0.968 . . . . 0.0 109.1 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 79.0 Cg_endo -73.58 -0.64 9.59 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.979 2.452 . . . . 0.0 113.971 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.3 m -68.33 -57.09 6.47 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' 2969 ' ' ASP . 22.7 p90 -72.53 -32.23 65.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.587 ' HG ' ' HD3' ' A' 2981 ' ' ARG . 8.6 tp -67.61 -30.88 70.58 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.786 0.834 . . . . 0.0 111.273 -173.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.82 -43.94 7.99 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.727 0.811 . . . . 0.0 111.616 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.73 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.509 0.724 . . . . 0.0 111.878 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 79.5 mt -92.78 150.02 38.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.511 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -58.18 165.69 6.78 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.985 2.457 . . . . 0.0 113.612 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.99 -20.29 66.14 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2979 ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' 2982 ' ' ARG . 16.5 t70 -73.5 -52.54 13.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.634 0.774 . . . . 0.0 112.251 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.0 -24.58 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.133 -0.354 . . . . 0.0 110.553 -178.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.587 ' HD3' ' HG ' ' A' 2973 ' ' LEU . 0.8 OUTLIER -71.52 -35.67 70.79 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2982 ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' 2979 ' ' ASP . 19.3 ptt180 -69.83 -42.76 73.2 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -38.67 84.64 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.944 -174.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 35.3 m -68.32 -40.27 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.482 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2985 ' ' LEU . . . . . 0.458 HD12 HD23 ' A' 2989 ' ' LEU . 57.4 tp -59.67 -45.88 90.73 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.871 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2986 ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' 2991 ' ' ILE . 24.0 mt-30 -74.26 -34.85 63.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.885 0.874 . . . . 0.0 111.999 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.82 -36.76 56.68 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.973 0.509 . . . . 0.0 112.136 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.488 ' HB2' HD22 ' A' 2989 ' ' LEU . 95.2 mt-30 -71.59 -56.98 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.346 0.258 . . . . 0.0 111.233 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.4 mm? -97.45 -22.43 16.58 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.67 -170.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 74.74 40.97 35.83 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' 2986 ' ' GLN . 0.0 OUTLIER -110.62 128.64 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 0.0 108.654 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -116.07 131.1 23.93 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.1 -38.98 63.24 Favored 'Trans proline' 0 CA--C 1.573 2.434 0 C-N-CA 123.281 2.654 . . . . 0.0 115.92 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.31 -179.51 3.66 Favored 'Trans proline' 0 C--N 1.401 3.322 0 CA-C-N 122.255 1.841 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 92.6 m -58.9 103.9 0.2 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.469 0.652 . . . . 0.0 111.602 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.42 96.49 0.89 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.879 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 58.4 p -90.55 2.47 55.76 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.11 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 55.38 70.95 1.38 Allowed Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.833 1.253 . . . . 0.0 110.814 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.89 93.09 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.378 2.718 . . . . 0.0 112.94 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 8.4 t 60.89 29.37 18.97 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.149 1.38 . . . . 0.0 111.644 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.9 t -146.46 158.74 43.94 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.126 0.971 . . . . 0.0 109.602 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -109.89 132.3 54.28 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 123.961 0.904 . . . . 0.0 109.398 179.134 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.555 1.143 0 CA-C-O 121.691 0.758 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 37.7 m -124.13 -165.96 1.43 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.714 1.206 . . . . 0.0 109.911 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 19.2 m -81.97 -2.75 52.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.583 0.753 . . . . 0.0 111.582 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.15 -40.2 95.18 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.996 0.919 . . . . 0.0 111.05 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2955 ' ' GLU . . . . . 0.601 ' HA ' ' HB1' ' A' 2974 ' ' ALA . 1.8 pm0 -82.41 141.12 33.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.643 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' 2974 ' ' ALA . 12.6 pt-20 -107.62 154.2 21.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.884 0.873 . . . . 0.0 109.497 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -146.35 139.98 14.93 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.452 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.68 -33.19 96.34 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.377 2.718 . . . . 0.0 113.688 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.0 -14.89 61.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.119 0.567 . . . . 0.0 110.455 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.99 -21.48 64.88 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.979 0.512 . . . . 0.0 111.68 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 114.3 5.67 20.99 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 123.605 0.621 . . . . 0.0 113.047 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 14.5 pt -92.69 147.68 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.285 0.634 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.8 t -101.58 95.51 6.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.13 0.972 . . . . 0.0 109.99 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.15 136.84 40.41 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.549 ' HG3' HG21 ' A' 2991 ' ' ILE . 52.1 Cg_endo -66.61 141.82 62.02 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.712 2.274 . . . . 0.0 112.02 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.97 122.51 16.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.225 0.61 . . . . 0.0 111.573 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 117.07 -19.87 11.73 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.722 0.639 . . . . 0.0 112.961 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.667 ' HB ' HD21 ' A' 2989 ' ' LEU . 4.7 p -96.57 155.34 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 118.106 0.953 . . . . 0.0 109.071 171.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.82 129.91 22.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.66 -16.26 50.0 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.123 2.548 . . . . 0.0 114.627 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 23.9 m -62.92 -55.39 26.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.737 0.415 . . . . 0.0 111.082 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 20.0 p90 -74.9 -30.71 61.37 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.856 0.36 . . . . 0.0 110.126 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.36 -42.05 96.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.713 0.805 . . . . 0.0 110.737 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2974 ' ' ALA . . . . . 0.62 ' HB2' ' HG2' ' A' 2956 ' ' GLU . . . -93.82 -28.67 15.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.736 0.814 . . . . 0.0 112.535 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -78.38 -43.81 26.59 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.64 0.376 . . . . 0.0 111.425 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 97.2 mt -80.48 157.96 71.95 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.28 1.032 . . . . 0.0 110.749 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.59 -179.47 0.5 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.941 2.427 . . . . 0.0 114.378 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2978 ' ' ASP . . . . . 0.592 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 6.7 p-10 -72.03 -28.64 63.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.751 0.42 . . . . 0.0 111.996 -172.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.19 -55.38 18.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.329 0.652 . . . . 0.0 112.344 -170.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.26 -18.69 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.516 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -74.56 -38.45 62.69 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2978 ' ' ASP . 12.2 ptm180 -75.88 -34.44 60.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 6.8 tp10 -53.06 -52.08 59.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.767 1.227 . . . . 0.0 110.599 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 34.7 m -77.59 -31.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.502 0.321 . . . . 0.0 111.328 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.98 -53.28 18.41 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.421 0.629 . . . . 0.0 111.062 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.34 -44.31 68.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.099 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -77.01 -39.59 49.69 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.25 -55.36 6.13 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.836 0.289 . . . . 0.0 111.418 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.9 mm? -84.98 -29.91 24.66 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.171 0.294 . . . . 0.0 110.645 -172.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 84.19 5.47 87.35 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.726 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.549 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.32 127.74 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.67 0.788 . . . . 0.0 109.086 -177.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -97.04 119.43 63.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.04 -43.23 37.64 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 C-N-CA 122.537 2.158 . . . . 0.0 113.592 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.87 113.82 3.78 Favored 'Trans proline' 0 C--N 1.409 3.712 0 CA-C-N 121.776 1.67 . . . . 0.0 112.152 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 9.8 t -84.37 144.27 28.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.462 0.705 . . . . 0.0 109.68 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -80.14 95.65 6.3 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.724 0.774 . . . . 0.0 110.528 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 39.1 p -116.31 -10.57 11.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.159 0.984 . . . . 0.0 110.625 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -71.66 142.25 85.89 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.565 0.746 . . . . 0.0 109.682 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.83 25.53 0.68 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.919 2.413 . . . . 0.0 112.569 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 13.1 m -79.93 145.32 32.69 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.626 1.17 . . . . 0.0 109.794 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 22.3 m -79.3 82.25 5.47 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 39.2 t30 -105.11 116.09 31.37 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.224 1.009 . . . . 0.0 108.433 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 35.4 p . . . . . 0 CA--C 1.556 1.204 0 C-N-CA 123.183 0.593 . . . . 0.0 110.613 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 50.0 m -68.14 88.4 0.29 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.569 0.747 . . . . 0.0 109.546 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 19.9 m -126.54 -0.35 6.86 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 0.0 110.462 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.32 -22.91 59.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.612 0.765 . . . . 0.0 110.846 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -74.24 94.87 2.54 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.621 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.51 ' HB2' HH22 ' A' 2981 ' ' ARG . 33.5 tt0 -109.32 86.74 2.34 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.94 128.6 26.89 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.27 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2958 ' ' PRO . . . . . 0.465 ' HD3' HD21 ' A' 2964 ' ' LEU . 42.1 Cg_endo -63.27 -30.92 74.12 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.282 1.988 . . . . 0.0 112.287 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2959 ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' 2959 ' ' LEU . 1.0 OUTLIER -86.13 -7.17 58.77 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.331 0.652 . . . . 0.0 110.064 -177.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -65.86 -19.83 66.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.993 -0.442 . . . . 0.0 111.071 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.79 -3.39 28.95 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.523 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.8 pp -88.66 176.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.084 0.554 . . . . 0.0 111.246 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.1 p -120.91 113.48 20.18 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' 2958 ' ' PRO . 2.3 pp -103.42 152.43 38.76 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.689 0.795 . . . . 0.0 109.751 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.24 177.58 8.69 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.807 2.338 . . . . 0.0 113.504 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.68 150.97 42.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.288 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 67.3 21.76 72.38 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.7 0.625 . . . . 0.0 112.915 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 90.6 t -129.38 95.66 2.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.741 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.58 133.95 36.96 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.154 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.37 -14.44 45.02 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.349 2.699 . . . . 0.0 115.015 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 59.0 m -62.45 -56.07 21.69 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.46 0.573 . . . . 0.0 111.404 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 39.2 p90 -72.47 -30.78 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.409 0.623 . . . . 0.0 110.522 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' 2981 ' ' ARG . 17.0 tp -69.81 -33.08 71.86 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.471 -171.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.98 -49.59 5.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.838 . . . . 0.0 111.339 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.45 74.49 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' HD11 ' A' 2980 ' ' ILE . 71.7 mt -83.52 158.78 62.62 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.799 0.84 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.35 178.06 1.0 Allowed 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 123.238 2.625 . . . . 0.0 114.003 -173.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.85 -26.94 65.4 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.48 -54.7 28.39 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.139 0.576 . . . . 0.0 112.072 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -76.48 -32.25 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.637 -178.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.553 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.1 OUTLIER -66.53 -39.88 88.84 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.756 0.312 . . . . 0.0 110.265 -175.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -74.62 -38.38 62.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.159 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.3 pt-20 -73.49 -38.61 65.32 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.259 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 32.6 m -66.41 -34.32 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.326 0.512 . . . . 0.0 110.261 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.23 -52.99 63.29 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.405 0.682 . . . . 0.0 110.136 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.78 -40.01 79.89 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.832 -1.077 . . . . 0.0 112.263 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.14 -41.4 50.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.151 0.581 . . . . 0.0 111.223 -172.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -70.49 -57.06 5.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.8 0.44 . . . . 0.0 111.259 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.15 -34.74 20.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.829 0.452 . . . . 0.0 111.298 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.93 20.82 67.07 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.66 -165.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.68 129.37 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -92.38 126.94 50.7 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.244 0.617 . . . . 0.0 109.672 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.09 -43.67 45.99 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.304 2.003 . . . . 0.0 113.593 168.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.2 95.69 0.44 Allowed 'Trans proline' 0 C--N 1.407 3.655 0 C-N-CA 121.967 1.778 . . . . 0.0 111.773 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 24.7 p -68.55 119.21 12.64 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.91 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -74.28 94.68 2.53 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.889 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 82.3 p -84.92 -43.46 14.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.099 0.959 . . . . 0.0 108.976 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -78.02 155.32 80.1 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.098 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.12 8.33 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.133 2.555 . . . . 0.0 113.721 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 14.8 m -62.81 84.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.471 1.109 . . . . 0.0 110.088 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 23.5 m -90.33 129.15 36.58 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.31 147.21 27.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.233 0.613 . . . . 0.0 109.559 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.117 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.382 0.134 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 66.0 m -66.25 111.85 3.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 0.0 111.106 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 33.5 t -122.75 -15.48 7.44 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.652 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2954 ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 12.2 pt-20 -87.79 -31.79 19.42 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.02 0.528 . . . . 0.0 110.728 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2955 ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 0.6 OUTLIER -142.13 130.03 21.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.846 0.858 . . . . 0.0 109.447 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2956 ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' 2970 ' ' PRO . 11.0 mp0 -108.88 105.49 15.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -105.31 127.36 28.77 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 123.553 0.741 . . . . 0.0 109.608 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.34 -43.79 36.62 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.71 2.94 . . . . 0.0 113.837 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.77 -4.82 55.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.093 0.957 . . . . 0.0 112.017 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.81 -10.82 59.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.902 0.481 . . . . 0.0 111.094 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.15 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 113.593 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -75.81 175.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.339 0.656 . . . . 0.0 111.089 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.9 p -122.46 93.06 3.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.114 0.566 . . . . 0.0 109.913 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 152.89 48.64 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' 2968 ' ' VAL . 33.8 Cg_endo -62.92 152.47 78.93 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.535 2.156 . . . . 0.0 112.35 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.42 145.64 50.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.285 0.634 . . . . 0.0 111.66 -176.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 77.57 18.28 77.85 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.228 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' 2965 ' ' PRO . 38.7 t -120.26 114.75 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.132 0.973 . . . . 0.0 109.44 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -85.64 126.74 65.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 123.556 0.535 . . . . 0.0 109.694 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 58.6 Cg_endo -68.65 -9.36 25.92 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.502 2.801 . . . . 0.0 113.811 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.0 m -58.4 -57.44 12.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.311 0.644 . . . . 0.0 111.251 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -77.14 -31.86 55.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.494 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 15.6 tp -67.08 -31.16 71.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.056 0.942 . . . . 0.0 111.172 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.37 -52.24 4.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.911 0.884 . . . . 0.0 111.373 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.12 76.83 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.837 ' HB3' HD11 ' A' 2980 ' ' ILE . 90.2 mt -81.32 150.57 67.82 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 0.0 110.462 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.3 170.16 8.35 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.44 2.76 . . . . 0.0 113.592 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2978 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 4.5 p-10 -66.84 -18.73 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -169.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.51 -55.64 8.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.029 0.531 . . . . 0.0 111.84 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.837 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -75.14 -29.75 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 119.289 -0.386 . . . . 0.0 110.193 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 23.0 tpt85 -50.97 -49.19 60.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.234 1.013 . . . . 0.0 111.37 173.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.69 -39.4 61.99 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.4 pt-20 -72.25 -42.68 65.36 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.706 -175.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.0 m -65.65 -30.06 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 118.326 0.512 . . . . 0.0 110.197 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.04 -48.8 77.18 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.46 -28.41 41.58 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -77.66 -49.84 13.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.887 0.475 . . . . 0.0 111.089 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.553 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.3 mm-40 -62.85 -56.63 15.67 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.512 0.507 . . . . 0.0 110.791 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -97.32 -37.25 10.12 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 76.87 23.1 70.24 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 123.335 0.397 . . . . 0.0 112.209 -169.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.423 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -80.74 127.42 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.4 121.21 62.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.339 0.656 . . . . 0.0 109.926 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.23 -42.09 37.84 Favored 'Trans proline' 0 CA--C 1.575 2.557 0 C-N-CA 122.298 1.998 . . . . 0.0 113.652 164.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.33 127.2 13.82 Favored 'Trans proline' 0 C--N 1.408 3.709 0 C-N-CA 122.011 1.808 . . . . 0.0 112.3 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 70.8 p -86.72 105.83 17.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.722 0.809 . . . . 0.0 109.276 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -66.16 97.22 0.37 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.109 0.564 . . . . 0.0 109.845 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.2 p -116.0 44.13 2.0 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.486 1.114 . . . . 0.0 108.616 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 60.62 69.7 1.09 Allowed Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 125.039 1.336 . . . . 0.0 110.317 -168.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -63.29 121.31 9.08 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.973 2.448 . . . . 0.0 112.697 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 33.0 p -71.97 -32.6 67.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.942 0.897 . . . . 0.0 110.229 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 12.6 t -71.98 142.99 49.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.646 0.778 . . . . 0.0 110.232 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 19.9 m120 -91.63 102.89 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 123.791 0.837 . . . . 0.0 108.877 -178.353 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 21.5 m -85.1 71.76 10.87 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.194 0.597 . . . . 0.0 109.783 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 22.7 t -117.22 23.36 11.89 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.553 0.741 . . . . 0.0 109.836 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.32 -39.22 82.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.085 0.954 . . . . 0.0 110.33 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.97 100.36 7.17 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.54 86.48 7.09 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 122.096 0.951 . . . . 0.0 109.951 -175.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2957 ' ' ASP . . . . . 0.412 ' O ' HD11 ' A' 2962 ' ' ILE . 30.5 m-20 -71.99 143.38 86.38 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.946 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -78.4 22.61 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.063 2.509 . . . . 0.0 113.483 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2959 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 2959 ' ' LEU . 0.2 OUTLIER -134.8 4.0 3.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.959 0.904 . . . . 0.0 109.137 171.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.2 60.99 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.519 0.728 . . . . 0.0 112.605 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 118.56 -20.58 10.16 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 123.013 0.34 . . . . 0.0 112.442 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2962 ' ' ILE . . . . . 0.665 HD13 HD23 ' A' 2964 ' ' LEU . 2.3 pp -72.83 176.65 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.46 1.104 . . . . 0.0 112.332 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 19.2 m -91.12 76.64 6.1 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 121.135 0.493 . . . . 0.0 111.544 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2964 ' ' LEU . . . . . 0.665 HD23 HD13 ' A' 2962 ' ' ILE . 2.8 mm? -121.88 114.45 31.06 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.74 -171.32 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.636 2.891 . . . . 0.0 113.089 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.87 144.14 30.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.088 0.955 . . . . 0.0 109.795 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.07 20.21 39.93 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.074 0.234 . . . . 0.0 113.128 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 3.3 p -141.44 106.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 124.074 0.949 . . . . 0.0 109.6 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.12 140.92 77.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.053 0.541 . . . . 0.0 110.997 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.35 -10.35 23.93 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.061 2.507 . . . . 0.0 112.434 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 18.4 m -58.64 -59.0 6.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.39 1.076 . . . . 0.0 110.595 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' 2976 ' ' LEU . 34.0 p90 -79.64 -28.33 40.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' 2981 ' ' ARG . 0.5 OUTLIER -65.17 -38.54 90.86 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.842 0.857 . . . . 0.0 110.472 -174.172 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.83 11.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.927 0.491 . . . . 0.0 111.468 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.41 -48.96 59.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.691 ' HB3' HD11 ' A' 2980 ' ' ILE . 93.9 mt -79.42 156.54 75.9 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.929 0.892 . . . . 0.0 110.088 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.09 -178.56 1.77 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.187 2.591 . . . . 0.0 113.593 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2978 ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' 2982 ' ' ARG . 3.6 p30 -72.71 -27.3 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -171.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.81 -52.74 58.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 112.963 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -76.78 -23.08 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' 2973 ' ' LEU . 0.1 OUTLIER -74.56 -36.23 63.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.243 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2982 ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' 2978 ' ' ASP . 5.8 ptm180 -69.81 -40.64 75.8 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 8.5 pt-20 -69.97 -38.36 76.04 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.223 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2984 ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' 2980 ' ' ILE . 33.1 m -69.36 -31.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.87 0.759 . . . . 0.0 110.708 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.13 -50.32 68.69 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.58 0.705 . . . . 0.0 110.967 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -80.27 -45.69 17.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.954 -173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.5 -43.08 81.76 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.06 -56.35 4.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.141 0.276 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.66 -52.63 5.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.251 0.221 . . . . 0.0 111.164 -172.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 106.24 -12.54 44.21 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.786 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.42 125.89 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.368 0.667 . . . . 0.0 109.536 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -93.71 123.1 60.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.051 0.54 . . . . 0.0 110.058 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 -38.89 62.58 Favored 'Trans proline' 0 CA--C 1.582 2.914 0 C-N-CA 122.875 2.383 . . . . 0.0 114.771 170.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 93.39 0.43 Allowed 'Trans proline' 0 C--N 1.409 3.725 0 CA-C-N 122.431 1.904 . . . . 0.0 111.717 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 18.1 p -139.48 132.39 29.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -65.19 92.73 0.12 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.282 1.039 . . . . 0.0 109.888 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 17.2 p -113.93 100.6 8.55 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.623 -1.172 . . . . 0.0 109.325 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 63.57 101.44 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 111.716 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.4 110.04 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.063 1.842 . . . . 0.0 109.587 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 29.9 t -80.41 66.69 6.0 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.125 0.964 . . . . 0.0 111.078 -171.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 61.6 m -145.8 98.45 3.12 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -87.64 97.05 10.66 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.705 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.56 1.356 0 C-N-CA 124.778 1.231 . . . . 0.0 110.959 -179.093 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.342 0.115 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.9 m -96.77 62.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.863 0.84 . . . . 0.0 110.513 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.6 m -85.06 16.33 3.55 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.095 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.11 -42.13 66.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -158.84 108.21 1.95 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.236 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.28 114.79 29.09 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2957 ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 13.6 t70 -62.17 138.54 96.03 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.283 1.033 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2958 ' ' PRO . . . . . 0.516 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 29.5 Cg_endo -60.57 -35.15 91.26 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.234 . . . . 0.0 112.846 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.6 tp -91.05 7.31 41.04 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.663 0.785 . . . . 0.0 111.333 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2960 ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -69.77 -9.98 56.64 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 107.98 4.69 33.59 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 47.0 pt -79.04 168.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.969 0.508 . . . . 0.0 110.453 173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.3 p -127.62 88.03 2.72 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.012 0.525 . . . . 0.0 110.477 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.3 pp -107.66 149.67 39.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.42 156.34 32.59 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.593 2.196 . . . . 0.0 111.911 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.67 121.93 16.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 116.71 -21.93 11.09 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.7 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 93.4 t -88.63 104.11 14.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.402 0.681 . . . . 0.0 109.541 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.34 126.44 92.7 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.009 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2970 ' ' PRO . . . . . 0.516 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 53.7 Cg_endo -65.8 -8.01 18.34 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.879 2.386 . . . . 0.0 112.444 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -59.11 5.37 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.497 1.119 . . . . 0.0 110.737 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2972 ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' 2976 ' ' LEU . 28.8 p90 -80.23 -32.42 38.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.9 0.381 . . . . 0.0 110.387 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 2981 ' ' ARG . 26.6 tp -63.98 -45.08 90.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.465 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.3 -49.75 5.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.969 0.508 . . . . 0.0 111.733 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.9 63.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.7 mt -95.65 160.79 29.58 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.481 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2977 ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 57.8 Cg_endo -66.3 176.73 3.73 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.416 2.077 . . . . 0.0 112.854 -174.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2978 ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 27.2 t70 -70.25 -21.39 62.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.205 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.44 -55.28 16.46 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 123.415 0.686 . . . . 0.0 111.741 -168.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.486 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.04 -31.89 16.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 -177.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.54 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.4 OUTLIER -67.39 -35.84 80.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.741 0.417 . . . . 0.0 110.597 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2982 ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' 2978 ' ' ASP . 8.7 ptm180 -73.76 -46.2 47.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 14.1 pt-20 -69.0 -34.9 76.02 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.455 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 25.0 m -73.08 -34.85 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.04 -43.35 99.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.677 0.751 . . . . 0.0 110.673 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.05 -44.86 45.31 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.776 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -76.68 -33.21 58.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.688 0.395 . . . . 0.0 112.0 -173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.493 ' HB2' HD22 ' A' 2989 ' ' LEU . 96.1 mt-30 -82.47 -52.25 7.05 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.547 0.339 . . . . 0.0 111.235 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' 2991 ' ' ILE . 2.0 mm? -97.43 -39.98 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.635 0.374 . . . . 0.0 110.979 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 90.81 17.88 49.96 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.534 -0.303 . . . . 0.0 112.775 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -108.02 130.23 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -105.59 140.5 21.23 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.48 -42.31 62.67 Favored 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.338 2.025 . . . . 0.0 114.773 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.42 137.56 25.77 Favored 'Trans proline' 0 C--N 1.399 3.222 0 CA-C-N 121.919 1.721 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 36.7 p -69.31 99.47 1.19 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.014 0.926 . . . . 0.0 111.056 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -70.08 124.4 24.0 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.039 0.447 . . . . 0.0 109.854 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 2.8 t -145.18 99.36 3.3 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.62 0.768 . . . . 0.0 109.697 -172.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -72.58 122.77 88.39 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.7 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.25 -24.76 27.77 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.563 2.842 . . . . 0.0 114.802 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 22.9 t -72.75 -31.94 65.3 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.193 0.597 . . . . 0.0 111.61 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 88.8 m -116.94 127.73 54.51 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.246 0.618 . . . . 0.0 110.3 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -64.46 101.37 0.44 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.432 0.634 . . . . 0.0 111.087 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.549 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 109.721 -174.776 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 50.8 m -120.12 82.18 1.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.756 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 14.7 m -116.86 18.19 14.85 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.666 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 70.47 9.61 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.709 1.242 . . . . 0.0 110.463 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.67 105.85 2.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.573 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.63 126.44 42.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.1 126.07 64.09 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.075 0.95 . . . . 0.0 109.763 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.92 -30.57 67.44 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.624 2.216 . . . . 0.0 112.889 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -77.83 -21.23 51.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.432 0.693 . . . . 0.0 110.136 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -58.94 -21.02 57.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.612 0.765 . . . . 0.0 112.679 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.87 -2.63 28.76 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 123.191 0.424 . . . . 0.0 112.767 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.0 172.73 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.354 0.662 . . . . 0.0 110.903 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 28.3 t -112.87 109.77 19.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.481 0.713 . . . . 0.0 109.862 -177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.44 155.6 56.85 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.48 0.712 . . . . 0.0 109.208 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2965 ' ' PRO . . . . . 0.543 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 59.3 Cg_endo -70.29 157.65 58.68 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.314 2.009 . . . . 0.0 112.067 170.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -70.77 141.62 51.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.645 0.778 . . . . 0.0 111.431 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.39 70.24 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.807 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2968 ' ' VAL . . . . . 0.534 HG21 HD21 ' A' 2989 ' ' LEU . 82.6 t -128.54 96.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.62 156.4 41.17 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 124.004 0.922 . . . . 0.0 109.215 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.22 9.31 2.15 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.555 2.17 . . . . 0.0 112.84 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 19.2 m -63.11 -61.41 2.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.214 1.005 . . . . 0.0 111.21 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 23.9 p90 -78.26 -24.27 46.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.679 0.792 . . . . 0.0 111.28 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2973 ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' 2981 ' ' ARG . 68.3 mt -69.43 -37.45 77.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.28 0.632 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.83 -24.89 19.22 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.788 0.835 . . . . 0.0 112.208 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.4 70.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.209 0.604 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2976 ' ' LEU . . . . . 0.462 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 55.9 mt -107.52 164.25 15.19 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.339 1.056 . . . . 0.0 109.346 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2977 ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.1 Cg_endo -60.35 155.29 47.34 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 123.685 2.924 . . . . 0.0 113.078 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.76 -17.33 5.83 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.924 1.29 . . . . 0.0 113.54 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.91 -39.39 90.53 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.143 0.977 . . . . 0.0 111.614 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2980 ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.94 -32.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2981 ' ' ARG . . . . . 0.509 ' N ' HD13 ' A' 2980 ' ' ILE . 10.5 tpt180 -60.04 -55.34 35.12 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.315 1.046 . . . . 0.0 110.422 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -64.38 -43.62 93.91 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.005 0.816 . . . . 0.0 110.961 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2983 ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' 2987 ' ' ASN . 13.5 pt-20 -68.96 -50.34 50.02 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.973 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 19.3 m -67.43 -30.42 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.177 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2985 ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' 2991 ' ' ILE . 18.4 tp -61.61 -55.68 28.05 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.888 0.852 . . . . 0.0 109.868 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2986 ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' 2992 ' ' ARG . 46.7 mt-30 -75.2 -34.7 61.53 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.618 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2987 ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' 2983 ' ' GLU . 2.5 t-20 -75.15 -46.85 31.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.19 0.596 . . . . 0.0 110.24 -172.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2988 ' ' GLN . . . . . 0.435 ' HB2' HD22 ' A' 2989 ' ' LEU . 99.3 mt-30 -72.29 -51.7 19.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.737 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2989 ' ' LEU . . . . . 0.548 ' HB2' HG22 ' A' 2991 ' ' ILE . 1.0 OUTLIER -102.17 -40.04 6.98 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -171.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 102.19 0.03 50.92 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.559 0.537 . . . . 0.0 112.799 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2991 ' ' ILE . . . . . 0.584 HG23 ' HG ' ' A' 2985 ' ' LEU . 0.0 OUTLIER -78.64 121.37 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.206 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2992 ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' 2986 ' ' GLN . 10.2 ptp180 -105.81 145.97 31.94 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.669 0.788 . . . . 0.0 109.705 -176.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 -44.04 30.36 Favored 'Trans proline' 0 CA--C 1.574 2.496 0 C-N-CA 122.683 2.256 . . . . 0.0 114.377 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.06 171.74 15.28 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.296 1.856 . . . . 0.0 112.844 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 60.8 p -79.15 173.72 12.29 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -67.13 97.13 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.184 0.992 . . . . 0.0 110.354 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 19.5 p -118.62 6.75 11.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.546 1.138 . . . . 0.0 111.549 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 53.92 64.1 6.96 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 125.042 1.337 . . . . 0.0 112.565 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.13 152.09 30.91 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 45.4 p -72.75 129.22 37.72 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.095 0.558 . . . . 0.0 109.694 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.8 t -63.51 131.75 49.12 Favored 'General case' 0 CA--C 1.554 1.119 0 O-C-N 123.744 0.652 . . . . 0.0 111.147 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.0 t30 -84.61 134.25 34.39 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.262 0.625 . . . . 0.0 110.662 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 CA--C 1.551 1.004 0 C-N-CA 124.104 0.961 . . . . 0.0 108.932 176.773 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.03 -31.55 83.86 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.307 2.005 . . . . 0.0 113.132 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 -16.57 61.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.118 0.567 . . . . 0.0 109.836 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.97 16.33 0.56 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 65.14 22.45 68.96 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . 0.494 HD11 ' HG3' ' A' 2970 ' ' PRO . 20.4 pt -68.7 141.87 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.605 0.762 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.0 m -83.71 83.29 7.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.469 0.707 . . . . 0.0 111.778 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.448 HD21 HD12 ' A' 2973 ' ' LEU . 11.1 mp -119.28 146.27 40.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.391 1.076 . . . . 0.0 109.674 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.74 162.38 37.64 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.258 2.639 . . . . 0.0 111.845 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.55 141.99 56.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.09 0.556 . . . . 0.0 110.679 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 92.33 -33.23 5.04 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.346 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 13.9 t -84.05 105.98 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.489 0.716 . . . . 0.0 109.515 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.26 135.93 20.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.323 0.649 . . . . 0.0 109.44 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.494 ' HG3' HD11 ' A' 2962 ' ' ILE . 86.7 Cg_endo -74.03 -3.22 13.43 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.137 2.558 . . . . 0.0 115.521 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 73.2 m -62.05 -53.49 54.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.753 0.706 . . . . 0.0 110.916 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 31.6 p90 -71.76 -22.4 61.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.469 HD22 ' HG2' ' A' 2981 ' ' ARG . 55.6 mt -73.57 -37.33 65.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.484 0.313 . . . . 0.0 111.746 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.52 -36.35 12.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.327 0.651 . . . . 0.0 111.391 -174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -76.28 -29.93 57.61 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.145 0.578 . . . . 0.0 111.228 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 68.8 mt -104.26 165.25 13.7 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 32.2 Cg_endo -59.76 168.65 5.3 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.943 2.429 . . . . 0.0 114.519 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.13 -15.46 61.48 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.102 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.46 -53.82 31.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.467 0.707 . . . . 0.0 111.488 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.552 ' HA ' ' HB3' ' A' 2983 ' ' GLU . 0.1 OUTLIER -78.91 -17.7 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 120.653 0.263 . . . . 0.0 110.355 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.469 ' HG2' HD22 ' A' 2973 ' ' LEU . 7.8 tmm_? -63.7 -52.29 61.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.493 1.117 . . . . 0.0 110.645 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.27 -32.96 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.582 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.552 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 8.6 tp10 -51.99 -56.48 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 111.295 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.4 m -68.65 -34.51 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.602 0.361 . . . . 0.0 111.464 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' 2989 ' ' LEU . 25.3 tp -67.3 -54.75 17.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.343 0.592 . . . . 0.0 111.397 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.26 -43.28 74.25 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.442 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.79 -43.01 38.49 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' HD22 ' A' 2989 ' ' LEU . 25.0 mt-30 -76.81 -50.94 12.28 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.713 0.292 . . . . 0.0 111.704 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.7 mm? -93.4 -30.76 14.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.819 0.447 . . . . 0.0 111.086 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 77.52 4.76 85.18 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.23 0.332 . . . . 0.0 113.763 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.54 134.94 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.733 0.813 . . . . 0.0 109.708 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 CA--C 1.548 0.87 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.719 178.426 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 -29.2 80.96 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.902 2.401 . . . . 0.0 112.522 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -19.49 62.71 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.285 0.634 . . . . 0.0 110.254 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.62 -23.14 65.83 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.464 0.706 . . . . 0.0 112.058 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 120.33 -9.97 10.87 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.767 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.9 pp -78.97 165.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 117.054 0.427 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 26.5 p -115.71 96.27 5.53 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.11 0.481 . . . . 0.0 111.915 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 64.6 mt -76.44 139.47 67.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.95 0.5 . . . . 0.0 109.973 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.434 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 20.8 Cg_exo -63.17 167.88 11.84 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.94 2.427 . . . . 0.0 112.785 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.22 132.66 54.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.803 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 85.57 5.19 84.85 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.49 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 37.9 t -111.36 101.04 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.559 0.68 . . . . 0.0 110.387 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.72 151.69 37.74 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.686 0.794 . . . . 0.0 109.352 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 87.0 Cg_endo -72.5 -0.22 8.46 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.559 2.173 . . . . 0.0 112.547 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 16.5 m -65.54 -60.1 3.28 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.903 0.881 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.6 p90 -72.17 -30.04 64.6 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.137 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 10.8 tp -68.23 -30.89 70.06 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.547 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -95.04 -53.37 3.84 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.483 0.713 . . . . 0.0 111.789 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.71 89.0 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.746 0.818 . . . . 0.0 112.113 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.1 mt -80.68 140.5 51.21 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.01 167.01 13.0 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.706 2.271 . . . . 0.0 112.387 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.22 -29.29 63.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.46 -59.2 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.536 0.522 . . . . 0.0 111.715 -171.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.22 -29.71 9.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.732 -175.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -39.35 89.91 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.989 0.423 . . . . 0.0 110.209 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -77.1 -36.81 55.34 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.738 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -36.83 70.23 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.191 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' 2980 ' ' ILE . 26.8 m -65.9 -33.67 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.1 0.409 . . . . 0.0 110.851 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 58.5 tp -59.44 -56.35 23.08 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.177 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -73.8 -25.98 60.39 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.06 -55.05 5.96 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 117.835 0.289 . . . . 0.0 111.032 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -64.54 -42.29 95.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 0.0 112.149 -172.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.1 mm? -101.05 -27.98 12.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.32 0.248 . . . . 0.0 111.498 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 70.2 37.37 71.86 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.25 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.17 122.99 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 . . . . . 0 CA--C 1.551 1.015 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.089 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . 0.513 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 13.4 Cg_endo -55.22 -22.35 32.17 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.154 2.569 . . . . 0.0 114.341 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.48 10.32 9.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 111.721 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -83.63 0.65 45.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.629 0.772 . . . . 0.0 110.273 164.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 97.78 -1.6 59.86 Favored Glycine 0 C--N 1.351 1.388 0 C-N-CA 123.309 0.481 . . . . 0.0 112.708 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 30.9 pt -89.21 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.005 0.522 . . . . 0.0 111.081 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -117.09 102.91 9.72 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.733 0.813 . . . . 0.0 109.66 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.77 120.43 70.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.85 175.32 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.904 3.069 . . . . 0.0 114.064 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -70.29 131.81 44.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.702 0.401 . . . . 0.0 110.457 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.66 -19.93 44.97 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.543 0.527 . . . . 0.0 112.715 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 24.5 t -87.46 90.04 3.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.399 0.68 . . . . 0.0 109.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 56.3 t0 -85.34 118.27 70.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.513 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 56.6 Cg_endo -64.9 -3.6 7.27 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.737 2.291 . . . . 0.0 114.074 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.9 m -60.07 -50.15 74.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.989 0.516 . . . . 0.0 110.932 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 10.7 p90 -75.36 -25.76 57.97 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.526 HD13 HH21 ' A' 2981 ' ' ARG . 87.5 mt -67.17 -37.55 83.93 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.968 0.413 . . . . 0.0 110.599 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -90.02 -38.78 13.37 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.02 0.928 . . . . 0.0 112.223 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.88 63.32 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.09 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' 2980 ' ' ILE . 54.5 mt -93.5 158.59 36.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 123.802 0.841 . . . . 0.0 109.007 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.83 -171.8 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.777 2.318 . . . . 0.0 113.796 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' 2981 ' ' ARG . 29.8 t70 -72.29 -34.89 68.49 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.17 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.34 -54.01 51.88 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.366 1.067 . . . . 0.0 111.285 -165.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.36 -26.31 14.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.371 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.526 HH21 HD13 ' A' 2973 ' ' LEU . 0.0 OUTLIER -68.12 -38.17 81.94 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.449 0.568 . . . . 0.0 110.535 -175.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -41.32 57.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.037 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 9.9 pt-20 -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 118.031 0.378 . . . . 0.0 111.341 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 31.6 m -69.69 -38.94 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 117.929 0.331 . . . . 0.0 110.774 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -49.38 78.07 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.113 0.482 . . . . 0.0 111.57 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.5 -35.81 65.69 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.918 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.39 -31.35 57.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.557 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.9 mm-40 -82.38 -48.23 11.39 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 111.51 -177.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' 2988 ' ' GLN . 0.8 OUTLIER -109.08 -34.88 6.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.346 0.258 . . . . 0.0 111.348 -171.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 86.05 2.04 86.25 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.347 0.404 . . . . 0.0 113.066 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 129.45 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 -176.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 123.399 0.68 . . . . 0.0 109.552 175.929 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.94 -31.47 93.71 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.942 2.428 . . . . 0.0 112.716 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.78 -24.59 44.56 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.491 0.717 . . . . 0.0 110.382 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.2 -21.38 61.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.548 0.739 . . . . 0.0 112.74 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.91 -0.54 64.66 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.271 0.357 . . . . 0.0 113.363 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' 2962 ' ' ILE . 2.5 pp -66.62 167.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.079 0.952 . . . . 0.0 111.164 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -80.25 87.04 5.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.063 0.545 . . . . 0.0 110.904 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 11.1 tp -118.76 124.46 28.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' 2991 ' ' ILE . 96.3 Cg_endo -74.04 -162.04 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.954 2.436 . . . . 0.0 113.735 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -82.44 157.77 23.53 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.765 0.826 . . . . 0.0 110.61 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 62.76 18.22 59.06 Favored Glycine 0 N--CA 1.479 1.511 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.72 146.48 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.138 0.975 . . . . 0.0 108.884 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' 2973 ' ' LEU . 22.0 t70 -132.79 124.32 18.72 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.279 0.632 . . . . 0.0 110.13 -172.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 85.4 Cg_endo -76.21 2.72 6.91 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.675 2.25 . . . . 0.0 114.774 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 8.4 m -72.84 -56.96 4.45 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.881 0.764 . . . . 0.0 109.936 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 27.3 p90 -73.09 -22.33 60.6 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.17 0.188 . . . . 0.0 110.938 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' A' 2970 ' ' PRO . 6.9 mp -63.96 -51.5 64.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.49 0.716 . . . . 0.0 110.703 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -80.12 -26.78 39.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.289 0.636 . . . . 0.0 112.325 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -79.96 -49.3 12.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.676 0.39 . . . . 0.0 110.888 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 40.1 mt -97.73 150.38 36.72 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.113 0.965 . . . . 0.0 109.989 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.76 151.91 60.6 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.148 3.232 . . . . 0.0 113.482 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.21 -21.69 3.63 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 125.199 1.4 . . . . 0.0 113.796 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -51.57 -50.06 60.86 Favored 'General case' 0 C--O 1.248 1.017 0 C-N-CA 124.188 0.995 . . . . 0.0 111.353 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -72.56 -31.62 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.565 -177.035 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.569 ' HB2' ' HG ' ' A' 2973 ' ' LEU . 0.1 OUTLIER -70.06 -43.08 71.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.725 0.81 . . . . 0.0 109.888 -174.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -76.06 -31.34 58.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.219 0.324 . . . . 0.0 110.852 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.21 -40.43 52.25 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.99 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' 2980 ' ' ILE . 27.0 m -66.24 -30.96 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-N 118.34 0.518 . . . . 0.0 110.171 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.15 -51.08 70.58 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 123.774 0.83 . . . . 0.0 110.672 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -75.02 -40.88 60.3 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.631 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -70.1 -53.63 16.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.329 . . . . 0.0 111.0 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.531 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.9 mm-40 -64.07 -54.63 31.11 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.276 0.36 . . . . 0.0 111.891 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -103.99 -35.57 8.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.103 0.252 . . . . 0.0 111.628 -169.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 10.35 85.39 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.354 0.409 . . . . 0.0 113.436 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -72.48 121.96 24.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 . . . . . 0 CA--C 1.547 0.859 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.841 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.36 -24.33 22.92 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.242 2.628 . . . . 0.0 113.175 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 37.1 tp -83.36 -14.0 53.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.008 0.523 . . . . 0.0 110.767 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.34 41.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.402 0.681 . . . . 0.0 112.104 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 92.86 6.78 63.31 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 113.268 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' 2962 ' ' ILE . 2.7 pp -83.09 157.81 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.873 0.469 . . . . 0.0 110.97 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.0 p -88.68 100.4 13.09 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.152 0.581 . . . . 0.0 111.6 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 68.2 mt -100.08 133.73 21.37 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 167.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.79 173.84 13.82 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.205 1.936 . . . . 0.0 111.803 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.11 143.12 50.73 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.386 0.674 . . . . 0.0 111.676 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 81.66 7.02 88.63 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.778 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 62.0 t -105.48 108.66 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.707 0.803 . . . . 0.0 109.609 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.1 141.07 27.57 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.602 0.761 . . . . 0.0 110.647 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' 2973 ' ' LEU . 59.3 Cg_endo -67.23 -10.89 30.2 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.903 2.402 . . . . 0.0 112.687 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.1 m -56.6 -59.22 5.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.565 ' HB2' HD12 ' A' 2976 ' ' LEU . 54.6 p90 -75.57 -24.22 56.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.383 0.273 . . . . 0.0 111.434 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' 2981 ' ' ARG . 81.5 mt -68.5 -35.44 77.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.512 0.325 . . . . 0.0 110.921 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.79 -31.18 14.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.714 0.806 . . . . 0.0 112.134 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.1 24.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.879 0.471 . . . . 0.0 111.732 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' 2972 ' ' PHE . 58.3 mt -108.06 161.23 24.06 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.895 0.878 . . . . 0.0 110.087 -172.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.7 -177.74 1.04 Allowed 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.928 2.418 . . . . 0.0 113.956 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.43 -27.52 62.38 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.012 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' 2982 ' ' ARG . 29.6 t70 -59.19 -54.15 50.19 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.548 0.739 . . . . 0.0 112.524 -170.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -78.91 -28.9 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.65 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.573 ' HB2' HD23 ' A' 2973 ' ' LEU . 0.0 OUTLIER -69.29 -36.81 77.42 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -175.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2979 ' ' ASP . 27.7 ptt180 -74.66 -40.39 61.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.931 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.7 pt-20 -69.65 -43.24 72.99 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.659 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 24.1 m -65.81 -32.81 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.113 0.415 . . . . 0.0 110.466 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 36.0 tp -63.8 -49.56 72.43 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.345 0.658 . . . . 0.0 111.046 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.79 -36.24 50.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.743 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.57 -53.63 11.42 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.718 0.407 . . . . 0.0 110.413 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.424 ' HB2' HD22 ' A' 2989 ' ' LEU . 24.8 mt-30 -66.67 -54.82 19.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.343 0.657 . . . . 0.0 111.401 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.5 mm? -88.23 -48.89 7.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.922 0.489 . . . . 0.0 110.982 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.1 61.95 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.418 -0.657 . . . . 0.0 113.846 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.56 127.01 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.378 0.671 . . . . 0.0 110.473 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.029 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.52 -29.61 88.97 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.897 2.398 . . . . 0.0 113.758 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 32.2 tp -72.89 -16.81 61.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.336 0.655 . . . . 0.0 111.533 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.69 64.5 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.267 0.627 . . . . 0.0 111.525 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 103.84 13.25 28.01 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.442 0.464 . . . . 0.0 112.869 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 23.2 pt -110.18 154.92 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.321 0.648 . . . . 0.0 110.753 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.3 m -105.42 102.05 11.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.55 143.02 96.7 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.194 0.598 . . . . 0.0 109.664 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.601 ' HG2' HG21 ' A' 2968 ' ' VAL . 29.1 Cg_endo -67.48 166.27 24.34 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.443 2.095 . . . . 0.0 112.049 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.17 132.26 53.03 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.48 0.712 . . . . 0.0 111.275 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 76.18 26.17 64.65 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.705 0.628 . . . . 0.0 113.921 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.601 HG21 ' HG2' ' A' 2965 ' ' PRO . 52.2 t -119.01 132.13 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.0 0.52 . . . . 0.0 109.783 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -120.86 134.58 24.34 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.007 0.923 . . . . 0.0 109.176 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.54 -7.6 20.81 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.897 2.398 . . . . 0.0 114.816 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 55.9 m -65.36 -54.97 21.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.334 0.515 . . . . 0.0 110.943 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.9 p90 -71.58 -30.28 65.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.578 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.66 -21.67 61.05 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.986 -174.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -96.94 -47.51 5.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.454 0.702 . . . . 0.0 111.773 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.29 70.43 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.682 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.8 mt -71.73 139.91 83.61 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.784 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 158.16 43.54 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.624 2.216 . . . . 0.0 111.161 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.29 -16.83 61.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.39 -58.17 4.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.306 0.503 . . . . 0.0 112.283 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.682 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.43 -23.08 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.746 -0.596 . . . . 0.0 109.78 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -65.28 -44.89 86.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.613 0.765 . . . . 0.0 110.157 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -70.99 -39.5 72.4 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.377 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.9 pt-20 -70.21 -37.41 75.04 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.855 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.5 m -67.42 -32.11 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 118.255 0.479 . . . . 0.0 110.558 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.67 -45.23 83.67 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 121.48 0.657 . . . . 0.0 109.952 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -73.95 -44.73 53.94 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.386 0.674 . . . . 0.0 112.357 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.3 -39.21 59.81 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.932 0.493 . . . . 0.0 112.008 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.418 ' HB2' HD22 ' A' 2989 ' ' LEU . 24.7 mt-30 -74.51 -48.47 26.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.485 0.314 . . . . 0.0 111.512 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.9 mm? -96.82 -43.52 7.47 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.298 0.239 . . . . 0.0 111.271 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 11.15 84.46 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.819 0.699 . . . . 0.0 113.58 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -74.45 123.93 30.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 . . . . . 0 CA--C 1.547 0.841 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.759 -176.447 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 22.7 Cg_endo -57.11 -34.68 98.18 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.068 2.512 . . . . 0.0 113.536 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -16.33 58.66 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.912 0.485 . . . . 0.0 111.309 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.01 -16.49 61.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.604 0.762 . . . . 0.0 112.503 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 96.58 3.06 59.81 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.797 -0.446 . . . . 0.0 113.606 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.12 156.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 122.913 0.485 . . . . 0.0 110.786 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 54.5 m -94.19 97.46 10.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.99 0.516 . . . . 0.0 111.153 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 81.3 mt -103.14 134.54 19.72 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.397 0.679 . . . . 0.0 109.328 167.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.464 ' HG3' HG21 ' A' 2991 ' ' ILE . 42.2 Cg_endo -64.4 156.72 58.56 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.107 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.15 138.14 43.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.04 0.536 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 110.57 -27.77 10.93 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.962 -0.355 . . . . 0.0 113.461 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.596 ' HB ' HD21 ' A' 2989 ' ' LEU . 7.3 p -91.14 137.78 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 122.894 0.477 . . . . 0.0 110.714 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.4 124.98 59.61 Favored Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 54.4 Cg_endo -65.68 -9.26 22.07 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.828 2.352 . . . . 0.0 113.079 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 40.0 m -54.09 -60.03 3.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.296 1.039 . . . . 0.0 111.456 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 40.6 p90 -79.62 -21.96 44.23 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.325 0.391 . . . . 0.0 111.21 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' 2981 ' ' ARG . 72.8 mt -63.99 -36.02 82.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.22 -35.99 12.84 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.558 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -73.15 -24.44 60.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.581 0.752 . . . . 0.0 112.118 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 58.6 mt -111.26 144.65 30.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.722 0.809 . . . . 0.0 109.603 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.79 172.08 10.06 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.332 2.688 . . . . 0.0 113.553 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 6.3 p-10 -63.12 -17.25 62.13 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -168.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.44 -58.99 4.09 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 121.456 0.646 . . . . 0.0 110.297 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.37 -27.18 8.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.099 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 26.1 tpt85 -51.58 -49.85 61.3 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.664 0.785 . . . . 0.0 111.245 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -72.95 -43.99 61.67 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.036 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.6 pt-20 -66.28 -40.43 90.07 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 117.993 0.361 . . . . 0.0 111.182 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.3 m -68.28 -35.84 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 117.891 0.314 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . 0.426 HD22 ' NH1' ' A' 2981 ' ' ARG . 17.5 tp -65.72 -45.19 83.65 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.409 0.624 . . . . 0.0 110.844 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -73.38 -40.22 64.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.345 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -75.63 -38.62 58.77 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.018 -175.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.541 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.5 mm-40 -75.7 -55.83 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.462 0.305 . . . . 0.0 111.392 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.2 mm? -96.73 -23.47 16.41 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.387 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.21 19.58 71.74 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.585 0.553 . . . . 0.0 113.624 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -84.42 141.38 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 123.687 0.795 . . . . 0.0 109.44 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 . . . . . 0 CA--C 1.559 1.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.242 -179.251 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 22.3 t70 . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . 0.527 ' HA ' HD12 ' A' 2964 ' ' LEU . 56.6 Cg_endo -65.15 -21.41 62.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.103 2.535 . . . . 0.0 113.982 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.05 9.08 30.62 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.234 0.614 . . . . 0.0 110.959 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -67.18 -14.95 63.39 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.16 12.53 76.21 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' 2960 ' ' ALA . 26.5 pt -91.12 162.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.837 0.855 . . . . 0.0 110.577 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 31.9 p -81.04 81.87 7.16 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.21 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' 2958 ' ' PRO . 78.2 mt -106.43 116.26 59.44 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.532 0.733 . . . . 0.0 109.342 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' 2991 ' ' ILE . 72.6 Cg_endo -70.1 168.32 22.33 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.595 2.196 . . . . 0.0 112.461 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' 2989 ' ' LEU . 42.4 tt0 -78.99 129.15 34.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.03 0.532 . . . . 0.0 110.68 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 111.85 0.72 27.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 120.063 -0.298 . . . . 0.0 113.661 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' 2965 ' ' PRO . 11.9 p -110.31 112.71 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 121.677 0.751 . . . . 0.0 109.82 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.97 130.45 36.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 110.187 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.26 28.18 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.304 2.669 . . . . 0.0 115.038 -174.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.6 m -72.05 -47.24 53.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.549 0.613 . . . . 0.0 110.832 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.439 ' HB2' HD12 ' A' 2976 ' ' LEU . 17.4 p90 -73.2 -30.22 63.37 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.319 0.58 . . . . 0.0 110.302 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' 2981 ' ' ARG . 9.8 tp -69.49 -27.05 64.87 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.582 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.65 -54.75 3.38 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.273 1.029 . . . . 0.0 111.443 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.71 80.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.526 0.73 . . . . 0.0 112.168 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.897 ' HB3' HD11 ' A' 2980 ' ' ILE . 86.4 mt -79.58 143.99 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.76 174.54 6.47 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.937 2.425 . . . . 0.0 112.067 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -27.59 68.68 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.93 -57.5 10.55 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 123.974 0.909 . . . . 0.0 112.142 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.66 -28.46 8.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.604 -176.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.3 OUTLIER -68.74 -34.24 75.28 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -176.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -75.33 -40.09 58.71 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 122.542 0.337 . . . . 0.0 110.473 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.7 pt-20 -70.24 -38.42 75.18 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-O 118.952 -0.546 . . . . 0.0 110.987 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 30.8 m -68.99 -34.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.574 0.35 . . . . 0.0 110.638 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.93 -47.6 80.24 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.714 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.89 -32.46 51.87 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.693 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.12 -28.2 54.28 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.801 0.44 . . . . 0.0 111.823 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.453 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.9 mt-30 -78.81 -51.93 9.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.603 0.361 . . . . 0.0 110.871 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.4 mm? -98.43 -49.61 4.6 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.651 0.38 . . . . 0.0 111.914 -171.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 96.36 9.59 56.63 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.431 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.599 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -70.97 125.06 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.843 0.857 . . . . 0.0 109.457 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.549 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 19.1 t0 . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.37 -27.17 71.15 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.066 2.511 . . . . 0.0 112.534 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.38 -19.5 60.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.22 0.608 . . . . 0.0 110.935 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -67.79 -10.98 57.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.094 0.557 . . . . 0.0 111.869 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 74.12 19.88 79.74 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.078 0.37 . . . . 0.0 113.073 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . 0.474 HG13 ' HG ' ' A' 2964 ' ' LEU . 37.6 pt -85.65 167.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.893 0.877 . . . . 0.0 111.114 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.0 p -81.86 79.13 8.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.349 0.66 . . . . 0.0 111.083 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' 2962 ' ' ILE . 76.0 mt -100.02 148.16 34.46 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 123.362 0.665 . . . . 0.0 109.577 173.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 173.4 9.66 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.88 139.65 39.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 69.29 12.77 66.58 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 124.158 0.911 . . . . 0.0 114.965 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 14.4 p -79.43 121.68 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 117.218 0.509 . . . . 0.0 109.865 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.97 120.18 75.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.07 -12.47 19.46 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.03 2.487 . . . . 0.0 113.416 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -69.43 -55.28 10.75 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 122.778 0.431 . . . . 0.0 110.759 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -75.74 -33.19 60.25 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.23 -46.59 88.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.246 1.019 . . . . 0.0 110.88 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -89.45 -35.03 16.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.927 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -72.65 -41.04 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' 2980 ' ' ILE . 87.3 mt -75.0 150.34 85.77 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.486 0.714 . . . . 0.0 109.854 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.39 166.07 6.59 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.982 2.454 . . . . 0.0 113.598 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.14 -23.97 67.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.308 1.043 . . . . 0.0 112.713 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.75 -57.52 10.67 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 124.205 1.002 . . . . 0.0 111.675 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.76 -22.65 8.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 O-C-N 122.256 -0.277 . . . . 0.0 110.409 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 13.5 tpt85 -54.26 -52.6 60.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.093 0.957 . . . . 0.0 110.898 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -71.78 -37.51 70.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 0.0 OUTLIER -69.7 -39.56 76.85 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.129 -175.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.1 m -69.45 -33.58 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.377 0.271 . . . . 0.0 110.383 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.34 -46.88 87.41 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.26 -43.4 57.11 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.868 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.68 -43.24 48.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.011 0.524 . . . . 0.0 111.382 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.535 ' HB2' HD22 ' A' 2989 ' ' LEU . 27.6 mm-40 -72.13 -57.28 4.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.923 0.489 . . . . 0.0 111.305 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -95.25 -26.74 15.83 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -168.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 73.11 15.17 78.67 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.592 0.558 . . . . 0.0 114.032 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.84 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.571 0.748 . . . . 0.0 109.133 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.174 0.59 . . . . 0.0 109.708 -179.578 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t0 . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 119.475 -0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.11 -26.26 30.82 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.62 -5.37 52.73 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.365 0.666 . . . . 0.0 111.09 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.65 36.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.446 0.699 . . . . 0.0 111.892 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.2 69.22 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 113.425 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.8 144.56 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.207 0.603 . . . . 0.0 110.648 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 27.8 m -79.5 85.54 5.26 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.785 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.472 ' HB3' HG11 ' A' 2968 ' ' VAL . 27.3 mt -93.77 149.73 37.54 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.505 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.569 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 67.0 Cg_endo -66.85 -178.39 1.27 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 123.296 2.664 . . . . 0.0 114.693 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -70.48 125.76 27.71 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.572 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 64.33 27.29 71.42 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.207 0.942 . . . . 0.0 114.383 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' 2964 ' ' LEU . 6.9 p -89.76 149.84 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.56 132.13 18.59 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.249 1.019 . . . . 0.0 109.296 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.14 -17.2 10.93 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.495 2.797 . . . . 0.0 113.491 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.6 m -53.27 -60.61 3.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 111.671 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.513 ' HB2' HD12 ' A' 2976 ' ' LEU . 55.3 p90 -80.69 -24.96 38.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.307 0.243 . . . . 0.0 111.586 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.68 -35.74 81.65 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.5 -51.25 5.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.681 0.793 . . . . 0.0 111.517 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.18 87.96 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.213 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' 2972 ' ' PHE . 70.7 mt -93.95 160.71 31.83 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.456 0.702 . . . . 0.0 109.452 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.52 178.23 4.0 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.796 2.331 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 31.0 m-20 -73.84 -15.49 61.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 112.368 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' 2982 ' ' ARG . 7.3 m-20 -62.22 -55.52 27.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.188 0.595 . . . . 0.0 112.106 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.595 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -79.52 -24.1 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 122.129 -0.357 . . . . 0.0 110.499 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.43 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -59.36 -49.02 79.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.947 0.899 . . . . 0.0 109.64 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' 2979 ' ' ASP . 17.9 ptt180 -72.85 -34.91 67.08 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.914 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.9 pt-20 -74.7 -42.43 58.39 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.189 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' 2988 ' ' GLN . 33.0 m -63.88 -34.52 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 119.108 0.867 . . . . 0.0 110.508 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.75 -62.86 1.56 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.69 0.796 . . . . 0.0 111.005 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -80.2 -47.43 14.67 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.149 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.95 -37.51 81.67 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.357 0.663 . . . . 0.0 112.05 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' 2984 ' ' VAL . 27.4 mt-30 -82.13 -56.56 3.86 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.229 0.468 . . . . 0.0 111.585 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.2 mm? -88.96 -34.36 16.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.104 0.162 . . . . 0.0 111.314 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 93.57 1.09 66.4 Favored Glycine 0 C--N 1.34 0.764 0 O-C-N 123.445 0.466 . . . . 0.0 113.42 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.404 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 121.38 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.303 0.641 . . . . 0.0 109.475 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 CA--C 1.549 0.928 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.722 178.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . 0.424 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 42.3 Cg_endo -64.28 -31.41 63.27 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.941 2.427 . . . . 0.0 113.483 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 43.4 tp -78.77 -9.7 59.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.222 0.609 . . . . 0.0 111.339 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.69 -15.41 28.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 88.27 28.91 21.34 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 35.1 pt -87.06 160.46 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 110.973 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 50.9 p -99.13 83.88 2.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.504 0.722 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 83.5 mt -77.64 119.57 77.97 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.426 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 45.1 Cg_endo -67.1 164.92 28.25 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.113 1.876 . . . . 0.0 112.282 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.19 132.62 53.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.445 0.698 . . . . 0.0 111.449 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 71.75 14.52 75.47 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.898 0.749 . . . . 0.0 113.847 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.549 HG21 HD21 ' A' 2989 ' ' LEU . 95.3 t -119.97 111.96 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.099 0.96 . . . . 0.0 109.603 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.04 157.48 33.79 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.813 0.845 . . . . 0.0 109.44 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.424 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 45.4 Cg_endo -82.11 8.02 4.74 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.502 2.135 . . . . 0.0 113.036 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 29.9 p -63.11 -59.37 4.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.339 1.056 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.434 ' HE2' HG21 ' A' 2984 ' ' VAL . 26.6 p90 -75.01 -26.8 59.8 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.3 0.64 . . . . 0.0 110.987 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.72 -29.65 68.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.754 0.422 . . . . 0.0 110.825 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -92.1 -43.26 9.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.978 0.911 . . . . 0.0 111.638 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.6 -48.36 55.53 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.391 0.676 . . . . 0.0 111.119 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 51.4 mt -92.31 160.99 33.98 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.239 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.9 Cg_endo -61.23 153.05 67.85 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.213 2.609 . . . . 0.0 113.076 -174.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -55.31 -15.52 2.57 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.926 0.89 . . . . 0.0 112.616 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.95 -49.76 65.41 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.717 1.607 . . . . 0.0 111.436 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.95 -32.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -178.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.482 ' N ' HD13 ' A' 2980 ' ' ILE . 23.3 tpt180 -57.6 -52.17 66.52 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.641 1.177 . . . . 0.0 111.119 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -72.08 -42.14 66.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.505 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -71.52 -40.22 70.25 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' 2972 ' ' PHE . 18.3 m -73.26 -33.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.25 0.477 . . . . 0.0 110.215 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' 2989 ' ' LEU . 34.2 tp -57.22 -48.31 79.12 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.168 0.508 . . . . 0.0 110.701 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.8 -48.38 14.91 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.046 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.07 -27.72 57.34 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.05 0.54 . . . . 0.0 112.303 -170.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.55 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.1 mm-40 -91.24 -47.81 7.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.557 0.343 . . . . 0.0 110.856 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -105.26 -45.16 4.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.086 0.154 . . . . 0.0 111.049 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.99 6.07 89.29 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.43 0.456 . . . . 0.0 113.642 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.04 114.97 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 . . . . . 0 CA--C 1.55 0.965 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 -173.548 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 17.6 t70 . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . 0.538 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 98.0 Cg_endo -75.05 -23.74 13.43 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.983 2.456 . . . . 0.0 113.49 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.45 28.9 7.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.608 0.763 . . . . 0.0 110.011 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -72.66 -13.62 61.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.55 0.74 . . . . 0.0 112.419 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.18 39.29 9.31 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 38.9 pt -124.83 170.83 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.449 1.1 . . . . 0.0 109.974 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.2 m -90.62 100.58 13.4 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.112 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.505 HD22 HG21 ' A' 2968 ' ' VAL . 98.2 mt -72.33 139.9 81.98 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.61 169.96 20.02 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.116 1.877 . . . . 0.0 111.7 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -72.41 139.72 47.96 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 68.33 27.8 73.58 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.774 -0.25 . . . . 0.0 113.128 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.505 HG21 HD22 ' A' 2964 ' ' LEU . 8.0 p -69.52 132.53 33.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.295 0.569 . . . . 0.0 109.933 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . 0.493 ' HB3' ' HE1' ' A' 2972 ' ' PHE . 13.4 t70 -144.37 110.37 4.98 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.538 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 72.6 Cg_endo -68.09 -10.11 27.86 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.045 2.497 . . . . 0.0 113.894 -175.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.8 m -62.95 -56.28 18.54 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 122.841 0.456 . . . . 0.0 110.5 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.493 ' HE1' ' HB3' ' A' 2969 ' ' ASP . 50.3 p90 -75.74 -26.61 57.6 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 117.765 0.257 . . . . 0.0 110.972 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.456 HD22 ' HD3' ' A' 2981 ' ' ARG . 95.5 mt -68.79 -26.56 65.27 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.388 0.275 . . . . 0.0 111.312 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.88 -37.53 11.15 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 0.0 111.708 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.24 52.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.36 0.664 . . . . 0.0 111.877 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' 2980 ' ' ILE . 89.8 mt -103.32 152.11 38.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.622 0.769 . . . . 0.0 110.151 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.59 173.58 5.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.978 2.452 . . . . 0.0 113.084 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.0 -19.69 61.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.83 -54.84 13.47 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.61 0.764 . . . . 0.0 112.043 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.456 ' HD3' HD22 ' A' 2973 ' ' LEU . 0.0 OUTLIER -75.21 -32.02 61.07 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.08 -31.55 56.09 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.247 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -39.64 82.16 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 117.836 0.289 . . . . 0.0 110.252 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' 2972 ' ' PHE . 33.4 m -72.13 -31.83 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.71 -50.81 72.38 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.036 0.535 . . . . 0.0 111.517 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.52 -39.98 51.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.887 0.475 . . . . 0.0 111.798 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -75.76 -27.16 57.95 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.627 0.371 . . . . 0.0 111.672 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' 2989 ' ' LEU . 29.3 mm-40 -83.98 -56.39 3.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.726 0.239 . . . . 0.0 111.038 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.2 mm? -105.53 -35.61 7.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.79 17.04 72.85 Favored Glycine 0 C--N 1.343 0.957 0 O-C-N 123.176 0.298 . . . . 0.0 113.299 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 130.1 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 CA--C 1.554 1.112 0 O-C-N 123.406 0.441 . . . . 0.0 110.885 -176.187 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 26.8 t70 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -59.57 -33.45 96.91 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.551 2.167 . . . . 0.0 112.159 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.61 21.91 11.63 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.345 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -74.73 -10.63 59.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.267 0.627 . . . . 0.0 111.978 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 105.5 29.5 5.03 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 31.9 pt -114.58 163.11 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.154 0.981 . . . . 0.0 111.541 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.0 p -101.48 79.7 1.99 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 111.669 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.86 125.55 58.67 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.91 172.95 4.22 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.169 2.579 . . . . 0.0 113.117 171.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.04 139.28 54.9 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.419 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.73 67.88 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.373 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 26.5 t -89.37 100.0 10.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 117.384 0.592 . . . . 0.0 109.999 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.39 138.37 86.53 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.459 0.703 . . . . 0.0 109.532 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.95 -4.82 15.33 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.488 2.126 . . . . 0.0 111.581 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -60.94 -60.43 3.81 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.934 0.894 . . . . 0.0 110.595 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -73.81 -31.31 63.18 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.074 0.464 . . . . 0.0 110.23 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.696 ' HG ' HH11 ' A' 2981 ' ' ARG . 11.8 tp -69.84 -33.59 72.49 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.818 0.847 . . . . 0.0 111.758 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.77 -35.37 12.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 111.55 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.4 80.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.81 0.444 . . . . 0.0 111.794 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.7 mt -89.25 145.51 34.28 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.95 167.06 5.95 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.039 2.493 . . . . 0.0 113.707 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.38 -27.82 69.35 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.03 -55.41 25.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 112.101 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.62 -24.49 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.629 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.696 HH11 ' HG ' ' A' 2973 ' ' LEU . 0.0 OUTLIER -70.22 -31.98 69.65 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.102 0.41 . . . . 0.0 110.242 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -74.95 -38.86 61.62 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 119.542 -0.266 . . . . 0.0 110.477 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.2 -37.97 84.54 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.955 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' 2980 ' ' ILE . 25.0 m -69.51 -33.85 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.114 0.416 . . . . 0.0 110.159 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . 0.444 HD12 HD23 ' A' 2989 ' ' LEU . 39.9 tp -61.91 -40.25 94.82 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.355 0.598 . . . . 0.0 110.802 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -79.02 -37.7 38.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.422 0.689 . . . . 0.0 111.584 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -74.78 -38.83 62.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.491 0.717 . . . . 0.0 111.147 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.454 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.6 mt-30 -83.48 -50.82 7.91 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.072 0.549 . . . . 0.0 111.09 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.3 mm? -95.7 -48.17 5.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.561 0.344 . . . . 0.0 110.96 -173.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.91 40.71 74.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 113.745 0.258 . . . . 0.0 113.745 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.82 130.63 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.55 0.74 . . . . 0.0 109.201 -177.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.306 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -46.99 -44.53 22.78 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 124.133 3.222 . . . . 0.0 114.063 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.25 -10.27 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.248 0.619 . . . . 0.0 111.018 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.55 1.8 15.68 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.33 0.652 . . . . 0.0 111.912 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 77.6 18.99 76.79 Favored Glycine 0 C--N 1.355 1.615 0 C-N-CA 123.313 0.482 . . . . 0.0 113.287 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . 0.443 HD13 HD13 ' A' 2964 ' ' LEU . 2.5 pp -76.08 164.21 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.646 0.778 . . . . 0.0 111.876 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 25.0 t -115.97 81.15 1.55 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.478 ' HB3' HG11 ' A' 2968 ' ' VAL . 10.4 mp -112.34 143.24 28.47 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.61 164.63 34.68 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.321 2.681 . . . . 0.0 113.228 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.6 129.05 38.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' 2989 ' ' LEU . . . 115.12 25.9 3.69 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' 2964 ' ' LEU . 9.0 p -139.21 153.86 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.74 0.816 . . . . 0.0 109.174 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' 2972 ' ' PHE . 3.4 t70 -146.03 124.38 6.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.12 0.968 . . . . 0.0 109.1 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 79.0 Cg_endo -73.58 -0.64 9.59 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.979 2.452 . . . . 0.0 113.971 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.3 m -68.33 -57.09 6.47 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' 2969 ' ' ASP . 22.7 p90 -72.53 -32.23 65.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.587 ' HG ' ' HD3' ' A' 2981 ' ' ARG . 8.6 tp -67.61 -30.88 70.58 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.786 0.834 . . . . 0.0 111.273 -173.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.82 -43.94 7.99 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.727 0.811 . . . . 0.0 111.616 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.73 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.509 0.724 . . . . 0.0 111.878 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 79.5 mt -92.78 150.02 38.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.511 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -58.18 165.69 6.78 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.985 2.457 . . . . 0.0 113.612 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.99 -20.29 66.14 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' 2982 ' ' ARG . 16.5 t70 -73.5 -52.54 13.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.634 0.774 . . . . 0.0 112.251 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.0 -24.58 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.133 -0.354 . . . . 0.0 110.553 -178.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.587 ' HD3' ' HG ' ' A' 2973 ' ' LEU . 0.8 OUTLIER -71.52 -35.67 70.79 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' 2979 ' ' ASP . 19.3 ptt180 -69.83 -42.76 73.2 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -38.67 84.64 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.944 -174.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 35.3 m -68.32 -40.27 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.482 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . 0.458 HD12 HD23 ' A' 2989 ' ' LEU . 57.4 tp -59.67 -45.88 90.73 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.871 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' 2991 ' ' ILE . 24.0 mt-30 -74.26 -34.85 63.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.885 0.874 . . . . 0.0 111.999 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.82 -36.76 56.68 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.973 0.509 . . . . 0.0 112.136 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.488 ' HB2' HD22 ' A' 2989 ' ' LEU . 20.0 mt-30 -71.59 -56.98 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.346 0.258 . . . . 0.0 111.233 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.4 mm? -97.45 -22.43 16.58 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.67 -170.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 74.74 40.97 35.83 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' 2986 ' ' GLN . 0.0 OUTLIER -110.62 128.64 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 0.0 108.654 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.882 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.68 -33.19 96.34 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.377 2.718 . . . . 0.0 113.688 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.0 -14.89 61.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.119 0.567 . . . . 0.0 110.455 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.99 -21.48 64.88 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.979 0.512 . . . . 0.0 111.68 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 114.3 5.67 20.99 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 123.605 0.621 . . . . 0.0 113.047 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 14.5 pt -92.69 147.68 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.285 0.634 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.8 t -101.58 95.51 6.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.13 0.972 . . . . 0.0 109.99 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.15 136.84 40.41 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.549 ' HG3' HG21 ' A' 2991 ' ' ILE . 52.1 Cg_endo -66.61 141.82 62.02 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.712 2.274 . . . . 0.0 112.02 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.97 122.51 16.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.225 0.61 . . . . 0.0 111.573 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 117.07 -19.87 11.73 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.722 0.639 . . . . 0.0 112.961 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.667 ' HB ' HD21 ' A' 2989 ' ' LEU . 4.7 p -96.57 155.34 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 118.106 0.953 . . . . 0.0 109.071 171.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.82 129.91 22.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.66 -16.26 50.0 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.123 2.548 . . . . 0.0 114.627 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 23.9 m -62.92 -55.39 26.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.737 0.415 . . . . 0.0 111.082 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 20.0 p90 -74.9 -30.71 61.37 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.856 0.36 . . . . 0.0 110.126 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.36 -42.05 96.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.713 0.805 . . . . 0.0 110.737 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.82 -28.67 15.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.736 0.814 . . . . 0.0 112.535 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -78.38 -43.81 26.59 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.64 0.376 . . . . 0.0 111.425 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 97.2 mt -80.48 157.96 71.95 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.28 1.032 . . . . 0.0 110.749 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.59 -179.47 0.5 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.941 2.427 . . . . 0.0 114.378 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . 0.592 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 6.7 p-10 -72.03 -28.64 63.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.751 0.42 . . . . 0.0 111.996 -172.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.19 -55.38 18.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.329 0.652 . . . . 0.0 112.344 -170.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.26 -18.69 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.516 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -74.56 -38.45 62.69 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2978 ' ' ASP . 12.2 ptm180 -75.88 -34.44 60.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 6.8 tp10 -53.06 -52.08 59.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.767 1.227 . . . . 0.0 110.599 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 34.7 m -77.59 -31.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.502 0.321 . . . . 0.0 111.328 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.98 -53.28 18.41 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.421 0.629 . . . . 0.0 111.062 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -44.31 68.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.099 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -77.01 -39.59 49.69 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.25 -55.36 6.13 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.836 0.289 . . . . 0.0 111.418 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.9 mm? -84.98 -29.91 24.66 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.171 0.294 . . . . 0.0 110.645 -172.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 84.19 5.47 87.35 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.726 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.549 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.32 127.74 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.67 0.788 . . . . 0.0 109.086 -177.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 CA--C 1.553 1.083 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 -178.086 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . 0.465 ' HD3' HD21 ' A' 2964 ' ' LEU . 42.1 Cg_endo -63.27 -30.92 74.12 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.282 1.988 . . . . 0.0 112.287 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' 2959 ' ' LEU . 1.0 OUTLIER -86.13 -7.17 58.77 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.331 0.652 . . . . 0.0 110.064 -177.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -65.86 -19.83 66.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.993 -0.442 . . . . 0.0 111.071 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.79 -3.39 28.95 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.523 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.8 pp -88.66 176.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.084 0.554 . . . . 0.0 111.246 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.1 p -120.91 113.48 20.18 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' 2958 ' ' PRO . 2.3 pp -103.42 152.43 38.76 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.689 0.795 . . . . 0.0 109.751 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.24 177.58 8.69 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.807 2.338 . . . . 0.0 113.504 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.68 150.97 42.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.288 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 67.3 21.76 72.38 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.7 0.625 . . . . 0.0 112.915 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 90.6 t -129.38 95.66 2.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.741 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.58 133.95 36.96 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.154 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.37 -14.44 45.02 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.349 2.699 . . . . 0.0 115.015 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 59.0 m -62.45 -56.07 21.69 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.46 0.573 . . . . 0.0 111.404 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 39.2 p90 -72.47 -30.78 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.409 0.623 . . . . 0.0 110.522 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' 2981 ' ' ARG . 17.0 tp -69.81 -33.08 71.86 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.471 -171.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.98 -49.59 5.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.838 . . . . 0.0 111.339 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.45 74.49 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' HD11 ' A' 2980 ' ' ILE . 71.7 mt -83.52 158.78 62.62 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.799 0.84 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.35 178.06 1.0 Allowed 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 123.238 2.625 . . . . 0.0 114.003 -173.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.85 -26.94 65.4 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.48 -54.7 28.39 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.139 0.576 . . . . 0.0 112.072 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -76.48 -32.25 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.637 -178.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.553 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.1 OUTLIER -66.53 -39.88 88.84 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.756 0.312 . . . . 0.0 110.265 -175.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -74.62 -38.38 62.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.159 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.3 pt-20 -73.49 -38.61 65.32 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.259 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 32.6 m -66.41 -34.32 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.326 0.512 . . . . 0.0 110.261 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.23 -52.99 63.29 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.405 0.682 . . . . 0.0 110.136 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.78 -40.01 79.89 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.832 -1.077 . . . . 0.0 112.263 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.14 -41.4 50.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.151 0.581 . . . . 0.0 111.223 -172.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -70.49 -57.06 5.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.8 0.44 . . . . 0.0 111.259 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.15 -34.74 20.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.829 0.452 . . . . 0.0 111.298 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.93 20.82 67.07 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.66 -165.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.68 129.37 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 123.244 0.617 . . . . 0.0 109.672 -176.41 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 118.914 -0.565 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.34 -43.79 36.62 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.71 2.94 . . . . 0.0 113.837 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.77 -4.82 55.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.093 0.957 . . . . 0.0 112.017 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.81 -10.82 59.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.902 0.481 . . . . 0.0 111.094 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.15 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 113.593 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -75.81 175.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.339 0.656 . . . . 0.0 111.089 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.9 p -122.46 93.06 3.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.114 0.566 . . . . 0.0 109.913 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 152.89 48.64 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' 2968 ' ' VAL . 33.8 Cg_endo -62.92 152.47 78.93 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.535 2.156 . . . . 0.0 112.35 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.42 145.64 50.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.285 0.634 . . . . 0.0 111.66 -176.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 77.57 18.28 77.85 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.228 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' 2965 ' ' PRO . 38.7 t -120.26 114.75 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.132 0.973 . . . . 0.0 109.44 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -85.64 126.74 65.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 123.556 0.535 . . . . 0.0 109.694 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 58.6 Cg_endo -68.65 -9.36 25.92 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.502 2.801 . . . . 0.0 113.811 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.0 m -58.4 -57.44 12.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.311 0.644 . . . . 0.0 111.251 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -77.14 -31.86 55.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.494 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 15.6 tp -67.08 -31.16 71.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.056 0.942 . . . . 0.0 111.172 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.37 -52.24 4.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.911 0.884 . . . . 0.0 111.373 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.12 76.83 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.837 ' HB3' HD11 ' A' 2980 ' ' ILE . 90.2 mt -81.32 150.57 67.82 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 0.0 110.462 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.3 170.16 8.35 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.44 2.76 . . . . 0.0 113.592 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 4.5 p-10 -66.84 -18.73 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -169.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.51 -55.64 8.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.029 0.531 . . . . 0.0 111.84 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.837 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -75.14 -29.75 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 119.289 -0.386 . . . . 0.0 110.193 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 23.0 tpt85 -50.97 -49.19 60.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.234 1.013 . . . . 0.0 111.37 173.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.69 -39.4 61.99 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.4 pt-20 -72.25 -42.68 65.36 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.706 -175.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.0 m -65.65 -30.06 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 118.326 0.512 . . . . 0.0 110.197 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.04 -48.8 77.18 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.46 -28.41 41.58 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -77.66 -49.84 13.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.887 0.475 . . . . 0.0 111.089 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.553 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.3 mm-40 -62.85 -56.63 15.67 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.512 0.507 . . . . 0.0 110.791 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -97.32 -37.25 10.12 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 76.87 23.1 70.24 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 123.335 0.397 . . . . 0.0 112.209 -169.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.423 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -80.74 127.42 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 123.339 0.656 . . . . 0.0 109.926 -177.407 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . 0.412 ' O ' HD11 ' A' 2962 ' ' ILE . 30.5 m-20 . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -78.4 22.61 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.063 2.509 . . . . 0.0 113.483 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 2959 ' ' LEU . 0.2 OUTLIER -134.8 4.0 3.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.959 0.904 . . . . 0.0 109.137 171.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.2 60.99 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.519 0.728 . . . . 0.0 112.605 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 118.56 -20.58 10.16 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 123.013 0.34 . . . . 0.0 112.442 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . 0.665 HD13 HD23 ' A' 2964 ' ' LEU . 2.3 pp -72.83 176.65 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.46 1.104 . . . . 0.0 112.332 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 19.2 m -91.12 76.64 6.1 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 121.135 0.493 . . . . 0.0 111.544 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . 0.665 HD23 HD13 ' A' 2962 ' ' ILE . 2.8 mm? -121.88 114.45 31.06 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.74 -171.32 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.636 2.891 . . . . 0.0 113.089 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.87 144.14 30.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.088 0.955 . . . . 0.0 109.795 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.07 20.21 39.93 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.074 0.234 . . . . 0.0 113.128 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 3.3 p -141.44 106.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 124.074 0.949 . . . . 0.0 109.6 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.12 140.92 77.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.053 0.541 . . . . 0.0 110.997 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.35 -10.35 23.93 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.061 2.507 . . . . 0.0 112.434 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 18.4 m -58.64 -59.0 6.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.39 1.076 . . . . 0.0 110.595 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' 2976 ' ' LEU . 34.0 p90 -79.64 -28.33 40.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' 2981 ' ' ARG . 0.5 OUTLIER -65.17 -38.54 90.86 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.842 0.857 . . . . 0.0 110.472 -174.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.83 11.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.927 0.491 . . . . 0.0 111.468 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.41 -48.96 59.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.691 ' HB3' HD11 ' A' 2980 ' ' ILE . 93.9 mt -79.42 156.54 75.9 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.929 0.892 . . . . 0.0 110.088 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.09 -178.56 1.77 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.187 2.591 . . . . 0.0 113.593 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' 2982 ' ' ARG . 3.6 p30 -72.71 -27.3 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -171.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.81 -52.74 58.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 112.963 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -76.78 -23.08 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' 2973 ' ' LEU . 0.1 OUTLIER -74.56 -36.23 63.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.243 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' 2978 ' ' ASP . 5.8 ptm180 -69.81 -40.64 75.8 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 8.5 pt-20 -69.97 -38.36 76.04 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.223 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' 2980 ' ' ILE . 33.1 m -69.36 -31.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.87 0.759 . . . . 0.0 110.708 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.13 -50.32 68.69 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.58 0.705 . . . . 0.0 110.967 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -80.27 -45.69 17.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.954 -173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.5 -43.08 81.76 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.06 -56.35 4.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.141 0.276 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.66 -52.63 5.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.251 0.221 . . . . 0.0 111.164 -172.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 106.24 -12.54 44.21 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.786 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.42 125.89 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.368 0.667 . . . . 0.0 109.536 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 123.051 0.54 . . . . 0.0 110.058 -178.336 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 13.6 t70 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . 0.516 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 29.5 Cg_endo -60.57 -35.15 91.26 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.234 . . . . 0.0 112.846 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.6 tp -91.05 7.31 41.04 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.663 0.785 . . . . 0.0 111.333 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -69.77 -9.98 56.64 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 107.98 4.69 33.59 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 47.0 pt -79.04 168.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.969 0.508 . . . . 0.0 110.453 173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.3 p -127.62 88.03 2.72 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.012 0.525 . . . . 0.0 110.477 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.3 pp -107.66 149.67 39.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.42 156.34 32.59 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.593 2.196 . . . . 0.0 111.911 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.67 121.93 16.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 116.71 -21.93 11.09 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.7 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 93.4 t -88.63 104.11 14.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.402 0.681 . . . . 0.0 109.541 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.34 126.44 92.7 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.009 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . 0.516 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 53.7 Cg_endo -65.8 -8.01 18.34 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.879 2.386 . . . . 0.0 112.444 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -59.11 5.37 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.497 1.119 . . . . 0.0 110.737 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' 2976 ' ' LEU . 28.8 p90 -80.23 -32.42 38.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.9 0.381 . . . . 0.0 110.387 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 2981 ' ' ARG . 26.6 tp -63.98 -45.08 90.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.465 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.3 -49.75 5.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.969 0.508 . . . . 0.0 111.733 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.9 63.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.7 mt -95.65 160.79 29.58 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.481 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 57.8 Cg_endo -66.3 176.73 3.73 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.416 2.077 . . . . 0.0 112.854 -174.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 27.2 t70 -70.25 -21.39 62.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.205 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.44 -55.28 16.46 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 123.415 0.686 . . . . 0.0 111.741 -168.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.486 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.04 -31.89 16.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 -177.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.54 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.4 OUTLIER -67.39 -35.84 80.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.741 0.417 . . . . 0.0 110.597 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' 2978 ' ' ASP . 8.7 ptm180 -73.76 -46.2 47.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 14.1 pt-20 -69.0 -34.9 76.02 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.455 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 25.0 m -73.08 -34.85 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.04 -43.35 99.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.677 0.751 . . . . 0.0 110.673 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.05 -44.86 45.31 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.776 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' 2987 ' ' ASN . 0.8 OUTLIER -76.68 -33.21 58.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.688 0.395 . . . . 0.0 112.0 -173.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.493 ' HB2' HD22 ' A' 2989 ' ' LEU . 20.8 mt-30 -82.47 -52.25 7.05 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.547 0.339 . . . . 0.0 111.235 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' 2991 ' ' ILE . 2.0 mm? -97.43 -39.98 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.635 0.374 . . . . 0.0 110.979 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 90.81 17.88 49.96 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.534 -0.303 . . . . 0.0 112.775 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -108.02 130.23 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.108 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 118.996 -0.525 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.92 -30.57 67.44 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.624 2.216 . . . . 0.0 112.889 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -77.83 -21.23 51.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.432 0.693 . . . . 0.0 110.136 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -58.94 -21.02 57.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.612 0.765 . . . . 0.0 112.679 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.87 -2.63 28.76 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 123.191 0.424 . . . . 0.0 112.767 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.0 172.73 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.354 0.662 . . . . 0.0 110.903 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2963 ' ' SER . . . . . . . . . . . . . 28.3 t -112.87 109.77 19.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.481 0.713 . . . . 0.0 109.862 -177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.44 155.6 56.85 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.48 0.712 . . . . 0.0 109.208 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2965 ' ' PRO . . . . . 0.543 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 59.3 Cg_endo -70.29 157.65 58.68 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.314 2.009 . . . . 0.0 112.067 170.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -70.77 141.62 51.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.645 0.778 . . . . 0.0 111.431 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.39 70.24 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.807 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2968 ' ' VAL . . . . . 0.534 HG21 HD21 ' A' 2989 ' ' LEU . 82.6 t -128.54 96.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.62 156.4 41.17 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 124.004 0.922 . . . . 0.0 109.215 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.22 9.31 2.15 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.555 2.17 . . . . 0.0 112.84 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2971 ' ' SER . . . . . . . . . . . . . 19.2 m -63.11 -61.41 2.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.214 1.005 . . . . 0.0 111.21 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 23.9 p90 -78.26 -24.27 46.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.679 0.792 . . . . 0.0 111.28 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2973 ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' 2981 ' ' ARG . 68.3 mt -69.43 -37.45 77.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.28 0.632 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.83 -24.89 19.22 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.788 0.835 . . . . 0.0 112.208 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.4 70.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.209 0.604 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2976 ' ' LEU . . . . . 0.462 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 55.9 mt -107.52 164.25 15.19 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.339 1.056 . . . . 0.0 109.346 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2977 ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.1 Cg_endo -60.35 155.29 47.34 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 123.685 2.924 . . . . 0.0 113.078 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.76 -17.33 5.83 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.924 1.29 . . . . 0.0 113.54 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.91 -39.39 90.53 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.143 0.977 . . . . 0.0 111.614 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2980 ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.94 -32.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2981 ' ' ARG . . . . . 0.509 ' N ' HD13 ' A' 2980 ' ' ILE . 10.5 tpt180 -60.04 -55.34 35.12 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.315 1.046 . . . . 0.0 110.422 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -64.38 -43.62 93.91 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.005 0.816 . . . . 0.0 110.961 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2983 ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' 2987 ' ' ASN . 13.5 pt-20 -68.96 -50.34 50.02 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.973 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 19.3 m -67.43 -30.42 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.177 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2985 ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' 2991 ' ' ILE . 18.4 tp -61.61 -55.68 28.05 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.888 0.852 . . . . 0.0 109.868 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2986 ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' 2992 ' ' ARG . 46.7 mt-30 -75.2 -34.7 61.53 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.618 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2987 ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' 2983 ' ' GLU . 2.5 t-20 -75.15 -46.85 31.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.19 0.596 . . . . 0.0 110.24 -172.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2988 ' ' GLN . . . . . 0.435 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.5 mt-30 -72.29 -51.7 19.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.737 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2989 ' ' LEU . . . . . 0.548 ' HB2' HG22 ' A' 2991 ' ' ILE . 1.0 OUTLIER -102.17 -40.04 6.98 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -171.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 102.19 0.03 50.92 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.559 0.537 . . . . 0.0 112.799 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2991 ' ' ILE . . . . . 0.584 HG23 ' HG ' ' A' 2985 ' ' LEU . 0.0 OUTLIER -78.64 121.37 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2992 ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' 2986 ' ' GLN . 10.2 ptp180 . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 123.669 0.788 . . . . 0.0 109.705 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.707 0.289 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 38.6 t -134.01 160.61 37.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.368 0.667 . . . . 0.0 109.897 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 15.4 m -74.73 -19.88 60.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.656 0.782 . . . . 0.0 110.29 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.7 82.28 0.86 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.213 1.005 . . . . 0.0 109.738 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.21 137.41 34.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.557 0.743 . . . . 0.0 109.998 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.42 ' HB2' HG21 ' A' 2962 ' ' ILE . 9.5 pt-20 -86.51 123.52 31.81 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -89.03 138.3 29.2 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.115 0.566 . . . . 0.0 110.22 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.03 -31.55 83.86 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.307 2.005 . . . . 0.0 113.132 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 -16.57 61.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.118 0.567 . . . . 0.0 109.836 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.97 16.33 0.56 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 65.14 22.45 68.96 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.958 0.343 . . . . 0.0 113.958 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . 0.494 HD11 ' HG3' ' A' 2970 ' ' PRO . 20.4 pt -68.7 141.87 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.605 0.762 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.0 m -83.71 83.29 7.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.469 0.707 . . . . 0.0 111.778 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.448 HD21 HD12 ' A' 2973 ' ' LEU . 11.1 mp -119.28 146.27 40.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.391 1.076 . . . . 0.0 109.674 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.74 162.38 37.64 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.258 2.639 . . . . 0.0 111.845 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.55 141.99 56.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.09 0.556 . . . . 0.0 110.679 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 92.33 -33.23 5.04 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.346 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 13.9 t -84.05 105.98 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.489 0.716 . . . . 0.0 109.515 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.26 135.93 20.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.323 0.649 . . . . 0.0 109.44 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.494 ' HG3' HD11 ' A' 2962 ' ' ILE . 86.7 Cg_endo -74.03 -3.22 13.43 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.137 2.558 . . . . 0.0 115.521 -173.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 73.2 m -62.05 -53.49 54.84 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.753 0.706 . . . . 0.0 110.916 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 31.6 p90 -71.76 -22.4 61.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.469 HD22 ' HG2' ' A' 2981 ' ' ARG . 55.6 mt -73.57 -37.33 65.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.484 0.313 . . . . 0.0 111.746 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.52 -36.35 12.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.327 0.651 . . . . 0.0 111.391 -174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -76.28 -29.93 57.61 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.145 0.578 . . . . 0.0 111.228 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 68.8 mt -104.26 165.25 13.7 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 32.2 Cg_endo -59.76 168.65 5.3 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.943 2.429 . . . . 0.0 114.519 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.13 -15.46 61.48 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.102 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.46 -53.82 31.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.467 0.707 . . . . 0.0 111.488 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.552 ' HA ' ' HB3' ' A' 2983 ' ' GLU . 0.1 OUTLIER -78.91 -17.7 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 120.653 0.263 . . . . 0.0 110.355 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.469 ' HG2' HD22 ' A' 2973 ' ' LEU . 7.8 tmm_? -63.7 -52.29 61.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.493 1.117 . . . . 0.0 110.645 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.27 -32.96 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.582 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.552 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 8.6 tp10 -51.99 -56.48 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 111.295 174.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.4 m -68.65 -34.51 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.602 0.361 . . . . 0.0 111.464 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' 2989 ' ' LEU . 25.3 tp -67.3 -54.75 17.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.343 0.592 . . . . 0.0 111.397 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.26 -43.28 74.25 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.442 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.79 -43.01 38.49 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' HD22 ' A' 2989 ' ' LEU . 25.0 mt-30 -76.81 -50.94 12.28 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.713 0.292 . . . . 0.0 111.704 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.7 mm? -93.4 -30.76 14.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.819 0.447 . . . . 0.0 111.086 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 77.52 4.76 85.18 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.23 0.332 . . . . 0.0 113.763 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.54 134.94 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.733 0.813 . . . . 0.0 109.708 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -111.3 115.91 51.68 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.719 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.88 -37.4 92.88 Favored 'Trans proline' 0 CA--C 1.578 2.682 0 C-N-CA 122.931 2.421 . . . . 0.0 114.296 167.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.79 165.84 19.87 Favored 'Trans proline' 0 C--N 1.403 3.444 0 C-N-CA 122.123 1.882 . . . . 0.0 112.634 168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 40.0 p -62.74 121.99 14.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.731 0.812 . . . . 0.0 112.069 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.87 116.93 11.74 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.409 0.623 . . . . 0.0 111.277 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 43.9 p -123.65 1.4 8.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.057 0.943 . . . . 0.0 110.462 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -146.82 114.51 4.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.723 0.809 . . . . 0.0 109.522 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.86 -30.81 39.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.841 2.36 . . . . 0.0 111.863 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 34.7 p -80.39 75.6 7.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.944 0.878 . . . . 0.0 109.629 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.6 t -95.8 171.08 8.87 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.985 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.7 t30 -64.17 103.44 0.62 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.252 0.621 . . . . 0.0 109.359 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -174.844 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.641 0.258 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.8 p -78.41 75.05 4.94 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.645 0.736 . . . . 0.0 109.813 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 25.4 t -134.7 -16.42 2.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 110.389 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -101.53 68.74 1.2 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.09 152.1 36.25 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.817 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' 2964 ' ' LEU . 3.6 mp0 -82.99 89.13 6.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.82 119.87 79.1 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.915 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 -29.2 80.96 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.902 2.401 . . . . 0.0 112.522 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -19.49 62.71 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.285 0.634 . . . . 0.0 110.254 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.62 -23.14 65.83 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.464 0.706 . . . . 0.0 112.058 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 120.33 -9.97 10.87 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.767 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.9 pp -78.97 165.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 117.054 0.427 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 26.5 p -115.71 96.27 5.53 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.11 0.481 . . . . 0.0 111.915 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' 2956 ' ' GLU . 64.6 mt -76.44 139.47 67.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.95 0.5 . . . . 0.0 109.973 170.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.434 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 20.8 Cg_exo -63.17 167.88 11.84 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.94 2.427 . . . . 0.0 112.785 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.22 132.66 54.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.803 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 85.57 5.19 84.85 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.49 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 37.9 t -111.36 101.04 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.559 0.68 . . . . 0.0 110.387 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.72 151.69 37.74 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.686 0.794 . . . . 0.0 109.352 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 87.0 Cg_endo -72.5 -0.22 8.46 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.559 2.173 . . . . 0.0 112.547 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 16.5 m -65.54 -60.1 3.28 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.903 0.881 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.6 p90 -72.17 -30.04 64.6 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.328 0.585 . . . . 0.0 110.137 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 10.8 tp -68.23 -30.89 70.06 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.547 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -95.04 -53.37 3.84 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.483 0.713 . . . . 0.0 111.789 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.71 89.0 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.746 0.818 . . . . 0.0 112.113 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.1 mt -80.68 140.5 51.21 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.01 167.01 13.0 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.706 2.271 . . . . 0.0 112.387 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.22 -29.29 63.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.46 -59.2 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.536 0.522 . . . . 0.0 111.715 -171.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.22 -29.71 9.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.732 -175.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -39.35 89.91 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.989 0.423 . . . . 0.0 110.209 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -77.1 -36.81 55.34 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.738 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -36.83 70.23 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.191 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' 2980 ' ' ILE . 26.8 m -65.9 -33.67 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.1 0.409 . . . . 0.0 110.851 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 58.5 tp -59.44 -56.35 23.08 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.177 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -73.8 -25.98 60.39 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.06 -55.05 5.96 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 117.835 0.289 . . . . 0.0 111.032 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -64.54 -42.29 95.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 0.0 112.149 -172.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.1 mm? -101.05 -27.98 12.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.32 0.248 . . . . 0.0 111.498 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 70.2 37.37 71.86 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.25 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.17 122.99 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -94.44 129.9 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.24 -45.45 31.18 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 121.931 1.754 . . . . 0.0 114.534 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.64 143.44 12.04 Favored 'Trans proline' 0 C--N 1.395 3.021 0 CA-C-N 121.738 1.657 . . . . 0.0 113.801 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 6.6 t -123.64 138.6 54.51 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -71.81 94.83 1.44 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.246 0.546 . . . . 0.0 109.852 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 32.8 p -118.45 114.47 22.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.99 0.916 . . . . 0.0 108.576 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 62.09 83.82 0.2 Allowed Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 124.566 1.147 . . . . 0.0 110.399 -173.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.03 178.4 6.93 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.829 2.353 . . . . 0.0 113.365 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 34.9 t -139.93 146.24 38.94 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.016 0.926 . . . . 0.0 108.895 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.8 t -66.39 145.89 55.19 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.58 0.352 . . . . 0.0 110.369 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -78.61 125.8 29.86 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.535 0.734 . . . . 0.0 109.699 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 CA--C 1.55 0.966 0 C-N-CA 123.442 0.697 . . . . 0.0 109.547 -175.278 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 36.5 m -139.75 -178.36 5.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.483 0.713 . . . . 0.0 109.701 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 23.0 t -127.15 11.04 6.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.296 0.638 . . . . 0.0 109.789 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.54 -1.4 6.18 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.494 0.718 . . . . 0.0 111.682 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.24 143.67 50.34 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.534 0.333 . . . . 0.0 111.24 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -123.55 85.68 2.46 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.837 0.855 . . . . 0.0 109.53 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.63 145.46 78.78 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.214 0.606 . . . . 0.0 110.161 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . 0.513 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 13.4 Cg_endo -55.22 -22.35 32.17 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.154 2.569 . . . . 0.0 114.341 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.48 10.32 9.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 111.721 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -83.63 0.65 45.93 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.629 0.772 . . . . 0.0 110.273 164.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 97.78 -1.6 59.86 Favored Glycine 0 C--N 1.351 1.388 0 C-N-CA 123.309 0.481 . . . . 0.0 112.708 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 30.9 pt -89.21 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.005 0.522 . . . . 0.0 111.081 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -117.09 102.91 9.72 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.733 0.813 . . . . 0.0 109.66 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.77 120.43 70.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.85 175.32 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.904 3.069 . . . . 0.0 114.064 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -70.29 131.81 44.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.702 0.401 . . . . 0.0 110.457 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.66 -19.93 44.97 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.543 0.527 . . . . 0.0 112.715 -175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 24.5 t -87.46 90.04 3.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.399 0.68 . . . . 0.0 109.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 56.3 t0 -85.34 118.27 70.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.513 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 56.6 Cg_endo -64.9 -3.6 7.27 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.737 2.291 . . . . 0.0 114.074 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.9 m -60.07 -50.15 74.85 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.989 0.516 . . . . 0.0 110.932 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 10.7 p90 -75.36 -25.76 57.97 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.526 HD13 HH21 ' A' 2981 ' ' ARG . 87.5 mt -67.17 -37.55 83.93 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.968 0.413 . . . . 0.0 110.599 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -90.02 -38.78 13.37 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.02 0.928 . . . . 0.0 112.223 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.88 63.32 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.09 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' 2980 ' ' ILE . 54.5 mt -93.5 158.59 36.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 123.802 0.841 . . . . 0.0 109.007 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.83 -171.8 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.777 2.318 . . . . 0.0 113.796 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' 2981 ' ' ARG . 29.8 t70 -72.29 -34.89 68.49 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.17 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.34 -54.01 51.88 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.366 1.067 . . . . 0.0 111.285 -165.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.36 -26.31 14.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.371 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.526 HH21 HD13 ' A' 2973 ' ' LEU . 0.0 OUTLIER -68.12 -38.17 81.94 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.449 0.568 . . . . 0.0 110.535 -175.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -41.32 57.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.037 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 9.9 pt-20 -67.74 -37.41 82.14 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 118.031 0.378 . . . . 0.0 111.341 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 31.6 m -69.69 -38.94 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 117.929 0.331 . . . . 0.0 110.774 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -49.38 78.07 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.113 0.482 . . . . 0.0 111.57 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.5 -35.81 65.69 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.918 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.39 -31.35 57.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.557 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.9 mm-40 -82.38 -48.23 11.39 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 111.51 -177.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' 2988 ' ' GLN . 0.8 OUTLIER -109.08 -34.88 6.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.346 0.258 . . . . 0.0 111.348 -171.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 86.05 2.04 86.25 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 123.347 0.404 . . . . 0.0 113.066 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 129.45 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 -176.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' 2996 ' ' ARG . 10.6 ptp85 -116.99 131.6 23.88 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.399 0.68 . . . . 0.0 109.552 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.77 -42.64 51.17 Favored 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 122.757 2.305 . . . . 0.0 115.146 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -177.87 3.7 Favored 'Trans proline' 0 C--N 1.399 3.199 0 CA-C-N 122.111 1.79 . . . . 0.0 113.135 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 17.8 p -61.01 137.21 58.24 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.882 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . 0.551 ' HG3' HH11 ' A' 2992 ' ' ARG . 0.1 OUTLIER -84.39 94.05 8.41 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 71.5 p -97.08 18.43 14.87 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.361 1.064 . . . . 0.0 110.693 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 56.96 74.79 0.63 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.757 1.223 . . . . 0.0 111.042 -171.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -84.45 10.76 3.59 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.946 2.43 . . . . 0.0 112.885 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 24.8 m -73.58 84.29 1.55 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.719 0.808 . . . . 0.0 110.817 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.9 t -88.41 152.07 22.15 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.748 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 13.5 m120 -75.04 111.8 10.63 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.009 0.524 . . . . 0.0 109.818 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.35 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 32.5 t -108.7 148.24 30.75 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.471 0.708 . . . . 0.0 110.245 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 17.2 m -115.8 -23.55 8.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.047 0.939 . . . . 0.0 110.051 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . 0.662 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 12.8 pt-20 -83.3 -36.84 24.14 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.021 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . 0.662 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 43.7 mt-10 -92.99 14.95 16.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.321 0.648 . . . . 0.0 111.785 -174.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -57.52 97.45 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 110.975 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -91.06 129.68 42.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.563 1.145 . . . . 0.0 109.201 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.94 -31.47 93.71 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.942 2.428 . . . . 0.0 112.716 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.78 -24.59 44.56 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.491 0.717 . . . . 0.0 110.382 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.2 -21.38 61.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.548 0.739 . . . . 0.0 112.74 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.91 -0.54 64.66 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.271 0.357 . . . . 0.0 113.363 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' 2962 ' ' ILE . 2.5 pp -66.62 167.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.079 0.952 . . . . 0.0 111.164 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 43.1 m -80.25 87.04 5.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.063 0.545 . . . . 0.0 110.904 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 11.1 tp -118.76 124.46 28.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' 2991 ' ' ILE . 96.3 Cg_endo -74.04 -162.04 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.954 2.436 . . . . 0.0 113.735 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -82.44 157.77 23.53 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.765 0.826 . . . . 0.0 110.61 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 62.76 18.22 59.06 Favored Glycine 0 N--CA 1.479 1.511 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.72 146.48 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.138 0.975 . . . . 0.0 108.884 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' 2973 ' ' LEU . 22.0 t70 -132.79 124.32 18.72 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.279 0.632 . . . . 0.0 110.13 -172.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 85.4 Cg_endo -76.21 2.72 6.91 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.675 2.25 . . . . 0.0 114.774 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 8.4 m -72.84 -56.96 4.45 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.881 0.764 . . . . 0.0 109.936 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 27.3 p90 -73.09 -22.33 60.6 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.17 0.188 . . . . 0.0 110.938 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' A' 2970 ' ' PRO . 6.9 mp -63.96 -51.5 64.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.49 0.716 . . . . 0.0 110.703 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' 2954 ' ' GLU . . . -80.12 -26.78 39.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.289 0.636 . . . . 0.0 112.325 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -79.96 -49.3 12.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.676 0.39 . . . . 0.0 110.888 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . . . . . . . . . 40.1 mt -97.73 150.38 36.72 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.113 0.965 . . . . 0.0 109.989 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.76 151.91 60.6 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.148 3.232 . . . . 0.0 113.482 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -52.21 -21.69 3.63 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 125.199 1.4 . . . . 0.0 113.796 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -51.57 -50.06 60.86 Favored 'General case' 0 C--O 1.248 1.017 0 C-N-CA 124.188 0.995 . . . . 0.0 111.353 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -72.56 -31.62 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.565 -177.035 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.569 ' HB2' ' HG ' ' A' 2973 ' ' LEU . 0.1 OUTLIER -70.06 -43.08 71.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.725 0.81 . . . . 0.0 109.888 -174.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -76.06 -31.34 58.73 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.219 0.324 . . . . 0.0 110.852 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.21 -40.43 52.25 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.99 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' 2980 ' ' ILE . 27.0 m -66.24 -30.96 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-N 118.34 0.518 . . . . 0.0 110.171 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.15 -51.08 70.58 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 123.774 0.83 . . . . 0.0 110.672 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -75.02 -40.88 60.3 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.631 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -70.1 -53.63 16.56 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.329 . . . . 0.0 111.0 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.531 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.9 mm-40 -64.07 -54.63 31.11 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.276 0.36 . . . . 0.0 111.891 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -103.99 -35.57 8.06 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.103 0.252 . . . . 0.0 111.628 -169.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 10.35 85.39 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.354 0.409 . . . . 0.0 113.436 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -72.48 121.96 24.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -106.42 127.97 27.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.87 -43.92 34.09 Favored 'Trans proline' 0 CA--C 1.581 2.825 0 C-N-CA 122.083 1.855 . . . . 0.0 113.554 164.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.64 82.05 2.2 Favored 'Trans proline' 0 C--N 1.409 3.758 0 C-N-CA 121.922 1.748 . . . . 0.0 113.196 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 46.7 p -77.01 122.16 24.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -73.88 95.64 2.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.546 0.738 . . . . 0.0 109.964 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.9 p -88.14 73.1 9.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.117 0.967 . . . . 0.0 110.777 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 55.7 63.29 6.41 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.892 1.277 . . . . 0.0 112.8 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -96.22 -1.36 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.658 2.239 . . . . 0.0 113.115 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 32.3 p -145.26 135.12 23.62 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.626 0.77 . . . . 0.0 110.143 -171.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 90.4 m -72.36 95.02 1.68 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.672 0.608 . . . . 0.0 110.117 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.02 147.73 27.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.241 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 123.302 0.641 . . . . 0.0 109.639 -178.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.5 m -79.04 92.17 4.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.742 0.817 . . . . 0.0 111.253 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 58.9 m -75.97 -4.28 40.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.984 0.914 . . . . 0.0 111.291 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.75 -15.27 62.68 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.458 1.103 . . . . 0.0 112.263 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.7 130.91 19.54 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.249 1.02 . . . . 0.0 108.68 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.404 ' HB3' HD13 ' A' 2973 ' ' LEU . 6.7 tp10 -133.27 102.58 5.61 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -101.85 126.97 32.23 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 123.886 0.874 . . . . 0.0 110.612 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.36 -24.33 22.92 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.242 2.628 . . . . 0.0 113.175 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 37.1 tp -83.36 -14.0 53.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.008 0.523 . . . . 0.0 110.767 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.34 41.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.402 0.681 . . . . 0.0 112.104 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 92.86 6.78 63.31 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 113.268 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' 2962 ' ' ILE . 2.7 pp -83.09 157.81 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.873 0.469 . . . . 0.0 110.97 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.0 p -88.68 100.4 13.09 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.152 0.581 . . . . 0.0 111.6 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 68.2 mt -100.08 133.73 21.37 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 167.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.79 173.84 13.82 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.205 1.936 . . . . 0.0 111.803 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.11 143.12 50.73 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.386 0.674 . . . . 0.0 111.676 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 81.66 7.02 88.63 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.778 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 62.0 t -105.48 108.66 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.707 0.803 . . . . 0.0 109.609 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -90.1 141.07 27.57 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.602 0.761 . . . . 0.0 110.647 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' 2973 ' ' LEU . 59.3 Cg_endo -67.23 -10.89 30.2 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.903 2.402 . . . . 0.0 112.687 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.1 m -56.6 -59.22 5.31 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.565 ' HB2' HD12 ' A' 2976 ' ' LEU . 54.6 p90 -75.57 -24.22 56.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.383 0.273 . . . . 0.0 111.434 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' 2981 ' ' ARG . 81.5 mt -68.5 -35.44 77.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.512 0.325 . . . . 0.0 110.921 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.79 -31.18 14.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.714 0.806 . . . . 0.0 112.134 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -81.37 -40.1 24.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.879 0.471 . . . . 0.0 111.732 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' 2972 ' ' PHE . 58.3 mt -108.06 161.23 24.06 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.895 0.878 . . . . 0.0 110.087 -172.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.7 -177.74 1.04 Allowed 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.928 2.418 . . . . 0.0 113.956 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.43 -27.52 62.38 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.012 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' 2982 ' ' ARG . 29.6 t70 -59.19 -54.15 50.19 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.548 0.739 . . . . 0.0 112.524 -170.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -78.91 -28.9 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.65 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.573 ' HB2' HD23 ' A' 2973 ' ' LEU . 0.0 OUTLIER -69.29 -36.81 77.42 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -175.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2979 ' ' ASP . 27.7 ptt180 -74.66 -40.39 61.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.931 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.7 pt-20 -69.65 -43.24 72.99 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.659 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 24.1 m -65.81 -32.81 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.113 0.415 . . . . 0.0 110.466 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 36.0 tp -63.8 -49.56 72.43 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.345 0.658 . . . . 0.0 111.046 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.79 -36.24 50.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.743 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.57 -53.63 11.42 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.718 0.407 . . . . 0.0 110.413 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.424 ' HB2' HD22 ' A' 2989 ' ' LEU . 24.8 mt-30 -66.67 -54.82 19.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.343 0.657 . . . . 0.0 111.401 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.5 mm? -88.23 -48.89 7.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.922 0.489 . . . . 0.0 110.982 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 97.68 -5.1 61.95 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.418 -0.657 . . . . 0.0 113.846 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.56 127.01 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.378 0.671 . . . . 0.0 110.473 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -107.06 132.34 20.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -59.99 -45.25 25.0 Favored 'Trans proline' 0 CA--C 1.575 2.547 0 C-N-CA 122.22 1.946 . . . . 0.0 113.941 169.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.11 90.11 1.27 Allowed 'Trans proline' 0 C--N 1.405 3.512 0 C-N-CA 121.877 1.718 . . . . 0.0 112.205 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 38.6 p -61.73 122.46 15.4 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.66 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -67.7 97.17 0.6 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.625 0.77 . . . . 0.0 110.304 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 44.0 p -90.47 38.77 0.95 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.64 1.176 . . . . 0.0 110.355 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -96.18 109.14 45.63 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.248 1.019 . . . . 0.0 110.675 -175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.96 175.01 11.93 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.754 2.302 . . . . 0.0 111.79 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 22.1 p -81.46 73.96 8.47 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.47 0.652 . . . . 0.0 110.321 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 4.3 t -130.61 102.48 6.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 0.0 109.627 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -97.12 118.51 33.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.075 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 42.9 p . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.888 0.375 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 40.4 m -95.52 150.76 19.97 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.973 0.909 . . . . 0.0 109.857 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.8 m -135.89 30.95 3.05 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.421 0.688 . . . . 0.0 109.641 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.38 -36.4 83.86 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.614 0.766 . . . . 0.0 111.294 -169.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 128.64 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.577 1.151 . . . . 0.0 109.084 174.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -112.66 97.96 6.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -128.32 138.25 32.61 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.193 -164.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.52 -29.61 88.97 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.897 2.398 . . . . 0.0 113.758 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 32.2 tp -72.89 -16.81 61.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.336 0.655 . . . . 0.0 111.533 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.69 64.5 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.267 0.627 . . . . 0.0 111.525 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 103.84 13.25 28.01 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.442 0.464 . . . . 0.0 112.869 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 23.2 pt -110.18 154.92 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.321 0.648 . . . . 0.0 110.753 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.3 m -105.42 102.05 11.54 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.55 143.02 96.7 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.194 0.598 . . . . 0.0 109.664 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.601 ' HG2' HG21 ' A' 2968 ' ' VAL . 29.1 Cg_endo -67.48 166.27 24.34 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.443 2.095 . . . . 0.0 112.049 177.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.17 132.26 53.03 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.48 0.712 . . . . 0.0 111.275 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 76.18 26.17 64.65 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.705 0.628 . . . . 0.0 113.921 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.601 HG21 ' HG2' ' A' 2965 ' ' PRO . 52.2 t -119.01 132.13 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.0 0.52 . . . . 0.0 109.783 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -120.86 134.58 24.34 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.007 0.923 . . . . 0.0 109.176 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.54 -7.6 20.81 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.897 2.398 . . . . 0.0 114.816 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 55.9 m -65.36 -54.97 21.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.334 0.515 . . . . 0.0 110.943 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 48.9 p90 -71.58 -30.28 65.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.578 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.66 -21.67 61.05 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.986 -174.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -96.94 -47.51 5.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.454 0.702 . . . . 0.0 111.773 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.29 70.43 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.682 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.8 mt -71.73 139.91 83.61 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.784 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 158.16 43.54 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.624 2.216 . . . . 0.0 111.161 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.29 -16.83 61.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.39 -58.17 4.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.306 0.503 . . . . 0.0 112.283 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.682 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.43 -23.08 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.746 -0.596 . . . . 0.0 109.78 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -65.28 -44.89 86.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.613 0.765 . . . . 0.0 110.157 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -70.99 -39.5 72.4 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.377 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.9 pt-20 -70.21 -37.41 75.04 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.855 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.5 m -67.42 -32.11 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 118.255 0.479 . . . . 0.0 110.558 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.67 -45.23 83.67 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-O 121.48 0.657 . . . . 0.0 109.952 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -73.95 -44.73 53.94 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.386 0.674 . . . . 0.0 112.357 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.3 -39.21 59.81 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.932 0.493 . . . . 0.0 112.008 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.418 ' HB2' HD22 ' A' 2989 ' ' LEU . 24.7 mt-30 -74.51 -48.47 26.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.485 0.314 . . . . 0.0 111.512 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.9 mm? -96.82 -43.52 7.47 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.298 0.239 . . . . 0.0 111.271 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 80.5 11.15 84.46 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.819 0.699 . . . . 0.0 113.58 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -74.45 123.93 30.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -106.4 142.88 25.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.759 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.57 -32.7 30.59 Favored 'Trans proline' 0 CA--C 1.581 2.875 0 C-N-CA 122.607 2.205 . . . . 0.0 116.714 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 89.72 0.61 Allowed 'Trans proline' 0 C--N 1.403 3.397 0 CA-C-N 123.362 2.236 . . . . 0.0 113.261 -173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 47.3 p -92.27 94.41 9.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.146 0.978 . . . . 0.0 108.555 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -80.94 96.58 7.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -172.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.4 p -121.76 76.01 1.24 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.982 0.913 . . . . 0.0 109.767 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -159.26 139.61 8.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.31 1.044 . . . . 0.0 109.498 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.18 -12.99 30.82 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 112.305 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 28.9 m -64.76 91.45 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.248 1.019 . . . . 0.0 110.286 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 4.0 t -86.14 91.58 8.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.474 0.71 . . . . 0.0 110.178 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.64 103.22 0.83 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.135 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 123.795 0.838 . . . . 0.0 109.223 -175.823 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.615 0.245 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 31.9 t -106.75 124.66 49.93 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.633 0.773 . . . . 0.0 109.329 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 25.8 m -86.64 -0.86 57.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.39 0.676 . . . . 0.0 111.613 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -90.6 2.67 55.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.251 0.62 . . . . 0.0 111.565 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.02 132.4 19.63 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.233 0.54 . . . . 0.0 111.761 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -104.01 100.9 10.68 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.502 1.121 . . . . 0.0 108.287 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.82 124.81 66.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 123.72 0.808 . . . . 0.0 109.749 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 22.7 Cg_endo -57.11 -34.68 98.18 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.068 2.512 . . . . 0.0 113.536 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 47.0 tp -77.6 -16.33 58.66 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.912 0.485 . . . . 0.0 111.309 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -64.01 -16.49 61.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.604 0.762 . . . . 0.0 112.503 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 96.58 3.06 59.81 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.797 -0.446 . . . . 0.0 113.606 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.12 156.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 122.913 0.485 . . . . 0.0 110.786 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 54.5 m -94.19 97.46 10.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.99 0.516 . . . . 0.0 111.153 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 81.3 mt -103.14 134.54 19.72 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.397 0.679 . . . . 0.0 109.328 167.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.464 ' HG3' HG21 ' A' 2991 ' ' ILE . 42.2 Cg_endo -64.4 156.72 58.56 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.107 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.15 138.14 43.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.04 0.536 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 110.57 -27.77 10.93 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.962 -0.355 . . . . 0.0 113.461 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.596 ' HB ' HD21 ' A' 2989 ' ' LEU . 7.3 p -91.14 137.78 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 122.894 0.477 . . . . 0.0 110.714 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.4 124.98 59.61 Favored Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' 2973 ' ' LEU . 54.4 Cg_endo -65.68 -9.26 22.07 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.828 2.352 . . . . 0.0 113.079 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 40.0 m -54.09 -60.03 3.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.296 1.039 . . . . 0.0 111.456 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 40.6 p90 -79.62 -21.96 44.23 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.325 0.391 . . . . 0.0 111.21 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' 2981 ' ' ARG . 72.8 mt -63.99 -36.02 82.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.22 -35.99 12.84 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.558 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -73.15 -24.44 60.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.581 0.752 . . . . 0.0 112.118 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 58.6 mt -111.26 144.65 30.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.722 0.809 . . . . 0.0 109.603 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.79 172.08 10.06 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.332 2.688 . . . . 0.0 113.553 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 6.3 p-10 -63.12 -17.25 62.13 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -168.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.44 -58.99 4.09 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 121.456 0.646 . . . . 0.0 110.297 -175.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.37 -27.18 8.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.099 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 26.1 tpt85 -51.58 -49.85 61.3 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.664 0.785 . . . . 0.0 111.245 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -72.95 -43.99 61.67 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.036 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.6 pt-20 -66.28 -40.43 90.07 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 117.993 0.361 . . . . 0.0 111.182 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.3 m -68.28 -35.84 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 117.891 0.314 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . 0.426 HD22 ' NH1' ' A' 2981 ' ' ARG . 17.5 tp -65.72 -45.19 83.65 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.409 0.624 . . . . 0.0 110.844 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -73.38 -40.22 64.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.345 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -75.63 -38.62 58.77 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.177 0.591 . . . . 0.0 112.018 -175.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.541 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.5 mm-40 -75.7 -55.83 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.462 0.305 . . . . 0.0 111.392 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.2 mm? -96.73 -23.47 16.41 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.387 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.21 19.58 71.74 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.585 0.553 . . . . 0.0 113.624 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -84.42 141.38 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 123.687 0.795 . . . . 0.0 109.44 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . 0.648 ' HD2' ' HA ' ' A' 2996 ' ' ARG . 20.3 ptp180 -112.67 125.91 29.17 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.242 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -57.96 -36.65 97.97 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.523 2.815 . . . . 0.0 115.122 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -75.59 -169.29 0.64 Allowed 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 122.172 1.811 . . . . 0.0 112.753 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 38.9 p -60.15 136.23 57.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.307 0.643 . . . . 0.0 111.437 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . 0.648 ' HA ' ' HD2' ' A' 2992 ' ' ARG . 15.9 ptp180 -72.17 93.47 1.45 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.572 1.177 . . . . 0.0 110.195 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 39.7 p -81.02 -42.1 21.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.288 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -111.85 98.25 40.92 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 -30.48 92.06 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.298 2.666 . . . . 0.0 113.247 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 18.9 m 61.2 25.97 15.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.644 1.178 . . . . 0.0 112.025 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 50.8 m -89.8 126.91 35.86 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.49 0.716 . . . . 0.0 109.466 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 29.1 p30 -62.85 140.17 58.78 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.536 0.523 . . . . 0.0 110.983 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 124.392 1.077 . . . . 0.0 109.043 -179.319 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -43.21 98.16 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.9 m -123.93 34.88 4.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.102 0.561 . . . . 0.0 110.865 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 62.72 34.61 14.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.021 0.928 . . . . 0.0 110.645 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.93 157.3 26.25 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.498 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.15 116.08 31.33 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 22.3 t70 -83.21 126.94 70.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . 0.527 ' HA ' HD12 ' A' 2964 ' ' LEU . 56.6 Cg_endo -65.15 -21.41 62.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.103 2.535 . . . . 0.0 113.982 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.05 9.08 30.62 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.234 0.614 . . . . 0.0 110.959 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -67.18 -14.95 63.39 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.16 12.53 76.21 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' 2960 ' ' ALA . 26.5 pt -91.12 162.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.837 0.855 . . . . 0.0 110.577 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 31.9 p -81.04 81.87 7.16 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.21 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' 2958 ' ' PRO . 78.2 mt -106.43 116.26 59.44 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.532 0.733 . . . . 0.0 109.342 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' 2991 ' ' ILE . 72.6 Cg_endo -70.1 168.32 22.33 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.595 2.196 . . . . 0.0 112.461 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' 2989 ' ' LEU . 42.4 tt0 -78.99 129.15 34.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.03 0.532 . . . . 0.0 110.68 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 111.85 0.72 27.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 120.063 -0.298 . . . . 0.0 113.661 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' 2965 ' ' PRO . 11.9 p -110.31 112.71 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 121.677 0.751 . . . . 0.0 109.82 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.97 130.45 36.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 110.187 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.26 28.18 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.304 2.669 . . . . 0.0 115.038 -174.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 45.6 m -72.05 -47.24 53.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.549 0.613 . . . . 0.0 110.832 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.439 ' HB2' HD12 ' A' 2976 ' ' LEU . 17.4 p90 -73.2 -30.22 63.37 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.319 0.58 . . . . 0.0 110.302 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' 2981 ' ' ARG . 9.8 tp -69.49 -27.05 64.87 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.582 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.65 -54.75 3.38 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.273 1.029 . . . . 0.0 111.443 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.71 80.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.526 0.73 . . . . 0.0 112.168 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.897 ' HB3' HD11 ' A' 2980 ' ' ILE . 86.4 mt -79.58 143.99 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.76 174.54 6.47 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.937 2.425 . . . . 0.0 112.067 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -27.59 68.68 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.93 -57.5 10.55 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 123.974 0.909 . . . . 0.0 112.142 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.66 -28.46 8.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.604 -176.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.3 OUTLIER -68.74 -34.24 75.28 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -176.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -75.33 -40.09 58.71 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 122.542 0.337 . . . . 0.0 110.473 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.7 pt-20 -70.24 -38.42 75.18 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-O 118.952 -0.546 . . . . 0.0 110.987 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 30.8 m -68.99 -34.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.574 0.35 . . . . 0.0 110.638 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.93 -47.6 80.24 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.714 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.89 -32.46 51.87 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.693 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.12 -28.2 54.28 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.801 0.44 . . . . 0.0 111.823 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.453 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.9 mt-30 -78.81 -51.93 9.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.603 0.361 . . . . 0.0 110.871 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.4 mm? -98.43 -49.61 4.6 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.651 0.38 . . . . 0.0 111.914 -171.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 96.36 9.59 56.63 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.431 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.599 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -70.97 125.06 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.843 0.857 . . . . 0.0 109.457 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -85.28 118.6 71.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.76 -39.47 81.69 Favored 'Trans proline' 0 CA--C 1.582 2.88 0 C-N-CA 122.588 2.192 . . . . 0.0 114.528 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.55 106.75 1.68 Allowed 'Trans proline' 0 C--N 1.412 3.89 0 CA-C-N 121.736 1.656 . . . . 0.0 112.249 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 63.8 p -99.31 139.8 34.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.254 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -120.05 102.94 8.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.537 0.735 . . . . 0.0 109.148 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 50.4 p -88.97 -8.48 54.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.436 0.694 . . . . 0.0 111.187 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -79.74 153.58 75.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.004 0.921 . . . . 0.0 110.022 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.63 15.57 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.083 2.522 . . . . 0.0 113.638 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 15.7 m -77.92 117.8 19.61 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.581 0.752 . . . . 0.0 110.213 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 27.5 m -128.03 137.57 52.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.068 0.947 . . . . 0.0 110.145 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -74.03 87.91 1.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.555 1.137 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.006 176.8 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 93.9 p -85.13 -146.37 0.1 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 123.878 0.871 . . . . 0.0 109.905 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 45.7 m -127.91 13.34 6.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.014 0.925 . . . . 0.0 110.648 174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -83.86 -42.13 16.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.596 0.759 . . . . 0.0 111.811 -171.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.03 95.79 0.5 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.841 0.829 . . . . 0.0 110.661 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.79 85.27 5.57 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 19.1 t0 -96.37 123.05 55.99 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.754 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.37 -27.17 71.15 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.066 2.511 . . . . 0.0 112.534 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.38 -19.5 60.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.22 0.608 . . . . 0.0 110.935 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -67.79 -10.98 57.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.094 0.557 . . . . 0.0 111.869 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 74.12 19.88 79.74 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.078 0.37 . . . . 0.0 113.073 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . 0.474 HG13 ' HG ' ' A' 2964 ' ' LEU . 37.6 pt -85.65 167.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.893 0.877 . . . . 0.0 111.114 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.0 p -81.86 79.13 8.48 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.349 0.66 . . . . 0.0 111.083 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' 2962 ' ' ILE . 76.0 mt -100.02 148.16 34.46 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 123.362 0.665 . . . . 0.0 109.577 173.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 173.4 9.66 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.88 139.65 39.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 69.29 12.77 66.58 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 124.158 0.911 . . . . 0.0 114.965 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 14.4 p -79.43 121.68 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 117.218 0.509 . . . . 0.0 109.865 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.97 120.18 75.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.07 -12.47 19.46 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.03 2.487 . . . . 0.0 113.416 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -69.43 -55.28 10.75 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 122.778 0.431 . . . . 0.0 110.759 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -75.74 -33.19 60.25 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.23 -46.59 88.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.246 1.019 . . . . 0.0 110.88 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -89.45 -35.03 16.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.927 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -72.65 -41.04 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' 2980 ' ' ILE . 87.3 mt -75.0 150.34 85.77 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.486 0.714 . . . . 0.0 109.854 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.39 166.07 6.59 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.982 2.454 . . . . 0.0 113.598 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.14 -23.97 67.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.308 1.043 . . . . 0.0 112.713 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.75 -57.52 10.67 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 124.205 1.002 . . . . 0.0 111.675 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.76 -22.65 8.92 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.96 0 O-C-N 122.256 -0.277 . . . . 0.0 110.409 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . . . . . . . . . 13.5 tpt85 -54.26 -52.6 60.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.093 0.957 . . . . 0.0 110.898 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -71.78 -37.51 70.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 0.0 OUTLIER -69.7 -39.56 76.85 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.129 -175.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 33.1 m -69.45 -33.58 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.377 0.271 . . . . 0.0 110.383 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.34 -46.88 87.41 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.26 -43.4 57.11 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.868 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.68 -43.24 48.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.011 0.524 . . . . 0.0 111.382 -173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.535 ' HB2' HD22 ' A' 2989 ' ' LEU . 27.6 mm-40 -72.13 -57.28 4.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.923 0.489 . . . . 0.0 111.305 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -95.25 -26.74 15.83 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -168.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 73.11 15.17 78.67 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.592 0.558 . . . . 0.0 114.032 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.84 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.571 0.748 . . . . 0.0 109.133 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -93.2 117.35 67.43 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.174 0.59 . . . . 0.0 109.708 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.28 -37.74 59.55 Favored 'Trans proline' 0 CA--C 1.582 2.899 0 C-N-CA 122.379 2.052 . . . . 0.0 114.037 165.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.09 119.32 6.33 Favored 'Trans proline' 0 C--N 1.411 3.866 0 CA-C-N 122.02 1.757 . . . . 0.0 112.447 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 3.6 p -128.31 115.57 18.49 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.321 1.049 . . . . 0.0 109.706 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . 0.734 ' HG3' ' HB3' ' A' 3002 ' ' ASN . 20.8 mmt180 -68.41 102.69 1.47 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.909 0.884 . . . . 0.0 110.598 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 71.7 p -80.33 -16.91 53.5 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.804 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -65.59 153.38 90.67 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.144 0.978 . . . . 0.0 111.215 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.02 -31.13 33.59 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.612 2.875 . . . . 0.0 113.28 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 30.0 t -66.27 101.3 0.71 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 110.196 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.1 m -82.58 79.37 9.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.935 0.894 . . . . 0.0 109.058 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . 0.734 ' HB3' ' HG3' ' A' 2996 ' ' ARG . 5.8 t30 -87.95 109.35 19.74 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.262 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 17.6 p . . . . . 0 CA--C 1.551 1.012 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 173.469 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 10.1 t 62.96 17.66 10.25 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.382 1.073 . . . . 0.0 112.185 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 36.6 t -74.02 -4.3 34.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.927 0.891 . . . . 0.0 111.387 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.72 -35.49 70.75 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.979 0.912 . . . . 0.0 111.087 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -114.0 146.41 40.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.589 ' HG2' HD11 ' A' 2964 ' ' LEU . 38.8 tt0 -134.21 85.45 2.19 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.6 125.43 78.39 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.524 1.13 . . . . 0.0 110.897 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.11 -26.26 30.82 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.62 -5.37 52.73 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.365 0.666 . . . . 0.0 111.09 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.65 36.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.446 0.699 . . . . 0.0 111.892 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 94.99 -6.2 69.22 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 120.054 -0.303 . . . . 0.0 113.425 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.8 144.56 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.207 0.603 . . . . 0.0 110.648 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 27.8 m -79.5 85.54 5.26 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.785 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.589 HD11 ' HG2' ' A' 2956 ' ' GLU . 27.3 mt -93.77 149.73 37.54 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.505 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.569 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 67.0 Cg_endo -66.85 -178.39 1.27 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 123.296 2.664 . . . . 0.0 114.693 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -70.48 125.76 27.71 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.572 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 64.33 27.29 71.42 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.207 0.942 . . . . 0.0 114.383 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' 2964 ' ' LEU . 6.9 p -89.76 149.84 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.56 132.13 18.59 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.249 1.019 . . . . 0.0 109.296 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.14 -17.2 10.93 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.495 2.797 . . . . 0.0 113.491 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.6 m -53.27 -60.61 3.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 111.671 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.513 ' HB2' HD12 ' A' 2976 ' ' LEU . 55.3 p90 -80.69 -24.96 38.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.307 0.243 . . . . 0.0 111.586 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.68 -35.74 81.65 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.5 -51.25 5.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.681 0.793 . . . . 0.0 111.517 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.18 87.96 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.213 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' 2972 ' ' PHE . 70.7 mt -93.95 160.71 31.83 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.456 0.702 . . . . 0.0 109.452 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.52 178.23 4.0 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.796 2.331 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 31.0 m-20 -73.84 -15.49 61.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 112.368 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' 2982 ' ' ARG . 7.3 m-20 -62.22 -55.52 27.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.188 0.595 . . . . 0.0 112.106 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.595 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -79.52 -24.1 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 122.129 -0.357 . . . . 0.0 110.499 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.43 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -59.36 -49.02 79.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.947 0.899 . . . . 0.0 109.64 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' 2979 ' ' ASP . 17.9 ptt180 -72.85 -34.91 67.08 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.914 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.9 pt-20 -74.7 -42.43 58.39 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.189 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' 2988 ' ' GLN . 33.0 m -63.88 -34.52 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 119.108 0.867 . . . . 0.0 110.508 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.75 -62.86 1.56 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.69 0.796 . . . . 0.0 111.005 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -80.2 -47.43 14.67 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.149 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.95 -37.51 81.67 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.357 0.663 . . . . 0.0 112.05 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' 2984 ' ' VAL . 27.4 mt-30 -82.13 -56.56 3.86 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.229 0.468 . . . . 0.0 111.585 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' 2965 ' ' PRO . 2.2 mm? -88.96 -34.36 16.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.104 0.162 . . . . 0.0 111.314 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 93.57 1.09 66.4 Favored Glycine 0 C--N 1.34 0.764 0 O-C-N 123.445 0.466 . . . . 0.0 113.42 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.404 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -73.53 121.38 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.303 0.641 . . . . 0.0 109.475 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . 0.47 ' HE ' ' HG2' ' A' 2994 ' ' PRO . 13.7 ptm180 -99.54 129.42 29.01 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.722 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.39 -40.42 58.07 Favored 'Trans proline' 0 CA--C 1.572 2.404 0 C-N-CA 122.35 2.033 . . . . 0.0 114.287 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . 0.47 ' HG2' ' HE ' ' A' 2992 ' ' ARG . 86.2 Cg_endo -74.27 81.31 2.04 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 121.805 1.67 . . . . 0.0 111.772 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 37.1 p -67.99 93.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.502 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -71.79 94.71 1.42 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.608 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 21.0 p -95.07 101.48 13.23 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -147.8 161.57 34.63 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.133 0.973 . . . . 0.0 109.472 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.76 -35.31 17.37 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.36 2.707 . . . . 0.0 113.088 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 35.8 p -85.74 134.84 33.93 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.058 0.943 . . . . 0.0 110.005 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.0 t -76.68 139.36 40.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.759 0.424 . . . . 0.0 110.147 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.6 t30 -72.92 94.89 1.89 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 123.907 0.883 . . . . 0.0 108.756 -178.463 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 66.3 p -153.42 179.2 9.0 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.251 1.02 . . . . 0.0 109.083 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 66.7 p -103.11 27.41 7.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.443 0.697 . . . . 0.0 110.034 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.24 -35.89 76.48 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 123.986 0.915 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . 0.44 ' HA ' ' HB1' ' A' 2974 ' ' ALA . 4.9 pt-20 -124.36 107.0 10.68 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.847 0.832 . . . . 0.0 108.772 162.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.76 131.16 40.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 22.5 t70 -110.96 118.3 48.46 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.226 0.611 . . . . 0.0 110.065 -168.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . 0.424 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 42.3 Cg_endo -64.28 -31.41 63.27 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.941 2.427 . . . . 0.0 113.483 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 43.4 tp -78.77 -9.7 59.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.222 0.609 . . . . 0.0 111.339 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -60.69 -15.41 28.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 88.27 28.91 21.34 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 35.1 pt -87.06 160.46 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 110.973 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 50.9 p -99.13 83.88 2.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.504 0.722 . . . . 0.0 110.07 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 83.5 mt -77.64 119.57 77.97 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.426 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 45.1 Cg_endo -67.1 164.92 28.25 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.113 1.876 . . . . 0.0 112.282 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.19 132.62 53.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.445 0.698 . . . . 0.0 111.449 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 71.75 14.52 75.47 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.898 0.749 . . . . 0.0 113.847 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.549 HG21 HD21 ' A' 2989 ' ' LEU . 95.3 t -119.97 111.96 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.099 0.96 . . . . 0.0 109.603 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.04 157.48 33.79 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.813 0.845 . . . . 0.0 109.44 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.424 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 45.4 Cg_endo -82.11 8.02 4.74 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.502 2.135 . . . . 0.0 113.036 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 29.9 p -63.11 -59.37 4.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.339 1.056 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.434 ' HE2' HG21 ' A' 2984 ' ' VAL . 26.6 p90 -75.01 -26.8 59.8 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.3 0.64 . . . . 0.0 110.987 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.72 -29.65 68.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.754 0.422 . . . . 0.0 110.825 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' 2955 ' ' GLU . . . -92.1 -43.26 9.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.978 0.911 . . . . 0.0 111.638 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.6 -48.36 55.53 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.391 0.676 . . . . 0.0 111.119 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 51.4 mt -92.31 160.99 33.98 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.239 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.9 Cg_endo -61.23 153.05 67.85 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.213 2.609 . . . . 0.0 113.076 -174.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -55.31 -15.52 2.57 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.926 0.89 . . . . 0.0 112.616 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.95 -49.76 65.41 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.717 1.607 . . . . 0.0 111.436 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.95 -32.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -178.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.482 ' N ' HD13 ' A' 2980 ' ' ILE . 23.3 tpt180 -57.6 -52.17 66.52 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.641 1.177 . . . . 0.0 111.119 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -72.08 -42.14 66.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.505 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 13.2 pt-20 -71.52 -40.22 70.25 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' 2972 ' ' PHE . 18.3 m -73.26 -33.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.25 0.477 . . . . 0.0 110.215 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' 2989 ' ' LEU . 34.2 tp -57.22 -48.31 79.12 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.168 0.508 . . . . 0.0 110.701 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.8 -48.38 14.91 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.046 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.07 -27.72 57.34 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.05 0.54 . . . . 0.0 112.303 -170.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.55 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.1 mm-40 -91.24 -47.81 7.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.557 0.343 . . . . 0.0 110.856 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.1 mm? -105.26 -45.16 4.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.086 0.154 . . . . 0.0 111.049 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.99 6.07 89.29 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.43 0.456 . . . . 0.0 113.642 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.04 114.97 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -86.43 127.77 59.67 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . 0.4 ' N ' ' HD2' ' A' 2994 ' ' PRO . 57.4 Cg_endo -72.97 -23.66 18.28 Favored 'Trans proline' 0 CA--C 1.588 3.18 0 C-N-CA 122.463 2.109 . . . . 0.0 116.275 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' 2993 ' ' PRO . 42.7 Cg_endo -62.74 97.04 0.17 Allowed 'Trans proline' 1 C--N 1.418 4.19 0 CA-C-N 123.729 2.368 . . . . 0.0 113.293 177.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 47.1 p -90.89 116.71 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 167.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -65.32 96.58 0.24 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 110.789 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 63.1 p -74.9 -48.38 25.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.27 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -81.69 140.67 47.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.847 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -80.73 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.952 2.435 . . . . 0.0 113.751 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 68.0 p 48.98 79.35 0.08 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.714 1.606 . . . . 0.0 111.95 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.5 t -105.67 154.17 20.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.123 0.969 . . . . 0.0 110.906 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.7 t30 -89.89 135.51 33.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.748 0.819 . . . . 0.0 110.008 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 CA--C 1.556 1.21 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.536 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 48.6 p -67.33 100.17 0.79 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 23.3 m -69.58 -17.28 63.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.495 0.718 . . . . 0.0 111.289 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -82.46 78.98 9.03 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -99.54 106.59 18.61 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.076 176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.29 150.2 49.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.306 0.642 . . . . 0.0 109.529 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 17.6 t70 -143.21 135.84 13.56 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 122.645 0.378 . . . . 0.0 110.822 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . 0.538 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 98.0 Cg_endo -75.05 -23.74 13.43 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.983 2.456 . . . . 0.0 113.49 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.45 28.9 7.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.608 0.763 . . . . 0.0 110.011 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -72.66 -13.62 61.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.55 0.74 . . . . 0.0 112.419 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 84.18 39.29 9.31 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 38.9 pt -124.83 170.83 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.449 1.1 . . . . 0.0 109.974 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 44.2 m -90.62 100.58 13.4 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.112 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.505 HD22 HG21 ' A' 2968 ' ' VAL . 98.2 mt -72.33 139.9 81.98 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.61 169.96 20.02 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.116 1.877 . . . . 0.0 111.7 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -72.41 139.72 47.96 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 68.33 27.8 73.58 Favored Glycine 0 C--N 1.346 1.11 0 C-N-CA 121.774 -0.25 . . . . 0.0 113.128 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.505 HG21 HD22 ' A' 2964 ' ' LEU . 8.0 p -69.52 132.53 33.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.295 0.569 . . . . 0.0 109.933 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . 0.493 ' HB3' ' HE1' ' A' 2972 ' ' PHE . 13.4 t70 -144.37 110.37 4.98 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.538 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 72.6 Cg_endo -68.09 -10.11 27.86 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.045 2.497 . . . . 0.0 113.894 -175.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.8 m -62.95 -56.28 18.54 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 122.841 0.456 . . . . 0.0 110.5 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.493 ' HE1' ' HB3' ' A' 2969 ' ' ASP . 50.3 p90 -75.74 -26.61 57.6 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 117.765 0.257 . . . . 0.0 110.972 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.456 HD22 ' HD3' ' A' 2981 ' ' ARG . 95.5 mt -68.79 -26.56 65.27 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.388 0.275 . . . . 0.0 111.312 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.88 -37.53 11.15 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 0.0 111.708 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.24 52.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.36 0.664 . . . . 0.0 111.877 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' 2980 ' ' ILE . 89.8 mt -103.32 152.11 38.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.622 0.769 . . . . 0.0 110.151 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.59 173.58 5.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.978 2.452 . . . . 0.0 113.084 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.0 -19.69 61.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.83 -54.84 13.47 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.61 0.764 . . . . 0.0 112.043 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.456 ' HD3' HD22 ' A' 2973 ' ' LEU . 0.0 OUTLIER -75.21 -32.02 61.07 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.08 -31.55 56.09 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.247 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -39.64 82.16 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 117.836 0.289 . . . . 0.0 110.252 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' 2972 ' ' PHE . 33.4 m -72.13 -31.83 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.71 -50.81 72.38 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.036 0.535 . . . . 0.0 111.517 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.52 -39.98 51.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.887 0.475 . . . . 0.0 111.798 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -75.76 -27.16 57.95 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.627 0.371 . . . . 0.0 111.672 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' 2989 ' ' LEU . 29.3 mm-40 -83.98 -56.39 3.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.726 0.239 . . . . 0.0 111.038 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.2 mm? -105.53 -35.61 7.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.79 17.04 72.85 Favored Glycine 0 C--N 1.343 0.957 0 O-C-N 123.176 0.298 . . . . 0.0 113.299 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 130.1 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' 2996 ' ' ARG . 15.0 ptp180 -81.25 121.18 80.08 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 123.406 0.441 . . . . 0.0 110.885 -176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.73 -34.53 91.72 Favored 'Trans proline' 0 CA--C 1.574 2.481 0 C-N-CA 122.674 2.249 . . . . 0.0 114.375 168.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.17 -162.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.404 3.477 0 C-N-CA 122.482 2.122 . . . . 0.0 114.267 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 33.9 m -59.89 109.16 0.88 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.678 0.791 . . . . 0.0 111.044 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . 0.577 ' HA ' ' HD2' ' A' 2992 ' ' ARG . 86.9 mtm180 -71.84 95.78 1.57 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.155 0.982 . . . . 0.0 110.47 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 33.3 p -110.18 -6.3 15.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.204 1.002 . . . . 0.0 111.441 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -106.6 97.13 15.82 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.483 0.713 . . . . 0.0 109.516 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.23 12.17 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.287 2.658 . . . . 0.0 114.885 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 20.5 m 66.35 23.34 10.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.156 1.382 . . . . 0.0 111.518 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 41.4 m -78.21 86.31 4.33 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.335 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.26 142.54 37.77 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.883 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 CA--C 1.546 0.796 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.23 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' 2954 ' ' GLU . 37.9 t -77.41 170.33 16.75 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.172 0.589 . . . . 0.0 111.272 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 28.7 m -71.61 -4.12 25.33 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.63 0.772 . . . . 0.0 112.577 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 11.2 pt-20 -56.51 -44.41 80.72 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.625 1.17 . . . . 0.0 111.441 173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 50.6 mt-10 -113.09 158.36 20.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.79 0.836 . . . . 0.0 110.019 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.77 130.41 48.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 26.8 t70 -103.43 134.11 19.93 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.18 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -59.57 -33.45 96.91 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.551 2.167 . . . . 0.0 112.159 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.61 21.91 11.63 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.345 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -74.73 -10.63 59.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.267 0.627 . . . . 0.0 111.978 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 105.5 29.5 5.03 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 31.9 pt -114.58 163.11 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.154 0.981 . . . . 0.0 111.541 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.0 p -101.48 79.7 1.99 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 111.669 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.86 125.55 58.67 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.91 172.95 4.22 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.169 2.579 . . . . 0.0 113.117 171.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -69.04 139.28 54.9 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.419 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.73 67.88 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.373 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 26.5 t -89.37 100.0 10.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 117.384 0.592 . . . . 0.0 109.999 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.39 138.37 86.53 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.459 0.703 . . . . 0.0 109.532 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.95 -4.82 15.33 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.488 2.126 . . . . 0.0 111.581 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 14.5 m -60.94 -60.43 3.81 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.934 0.894 . . . . 0.0 110.595 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -73.81 -31.31 63.18 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.074 0.464 . . . . 0.0 110.23 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.696 ' HG ' HH11 ' A' 2981 ' ' ARG . 11.8 tp -69.84 -33.59 72.49 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.818 0.847 . . . . 0.0 111.758 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.77 -35.37 12.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 111.55 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.4 80.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.81 0.444 . . . . 0.0 111.794 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' 2980 ' ' ILE . 69.7 mt -89.25 145.51 34.28 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.95 167.06 5.95 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.039 2.493 . . . . 0.0 113.707 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.38 -27.82 69.35 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.03 -55.41 25.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 112.101 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.62 -24.49 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.629 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.696 HH11 ' HG ' ' A' 2973 ' ' LEU . 0.0 OUTLIER -70.22 -31.98 69.65 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.102 0.41 . . . . 0.0 110.242 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -74.95 -38.86 61.62 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 119.542 -0.266 . . . . 0.0 110.477 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.2 -37.97 84.54 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.955 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' 2980 ' ' ILE . 25.0 m -69.51 -33.85 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.114 0.416 . . . . 0.0 110.159 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . 0.444 HD12 HD23 ' A' 2989 ' ' LEU . 39.9 tp -61.91 -40.25 94.82 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.355 0.598 . . . . 0.0 110.802 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -79.02 -37.7 38.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.422 0.689 . . . . 0.0 111.584 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -74.78 -38.83 62.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.491 0.717 . . . . 0.0 111.147 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.454 ' HB2' HD22 ' A' 2989 ' ' LEU . 28.6 mt-30 -83.48 -50.82 7.91 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.072 0.549 . . . . 0.0 111.09 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' 2988 ' ' GLN . 2.3 mm? -95.7 -48.17 5.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.561 0.344 . . . . 0.0 110.96 -173.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 69.91 40.71 74.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 113.745 0.258 . . . . 0.0 113.745 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.82 130.63 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.55 0.74 . . . . 0.0 109.201 -177.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . 0.474 ' HE ' ' HG2' ' A' 2994 ' ' PRO . 10.5 ptm85 -96.44 129.06 34.3 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -62.32 -33.54 80.1 Favored 'Trans proline' 0 CA--C 1.579 2.773 0 C-N-CA 121.886 1.724 . . . . 0.0 114.811 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . 0.474 ' HG2' ' HE ' ' A' 2992 ' ' ARG . 92.9 Cg_endo -73.16 178.44 6.55 Favored 'Trans proline' 0 C--N 1.398 3.156 0 CA-C-N 122.538 1.942 . . . . 0.0 112.657 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 51.5 p -71.85 152.45 42.62 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.436 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 66.5 mtm-85 -80.88 94.73 6.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 62.8 p -80.86 87.58 5.91 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.613 0.765 . . . . 0.0 109.808 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' A' 2999 ' ' PRO . . . -85.91 -63.55 0.23 Allowed Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.023 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' 2998 ' ' ALA . 34.3 Cg_endo -93.19 -7.48 2.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.842 1.694 . . . . 0.0 112.163 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 76.3 p -101.58 47.82 0.9 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.697 0.799 . . . . 0.0 110.252 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 11.0 t -139.46 142.95 37.36 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.972 0.509 . . . . 0.0 110.126 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -75.67 123.9 26.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.645 0.778 . . . . 0.0 110.128 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 123.751 0.821 . . . . 0.0 110.725 -177.658 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.5 t 66.84 8.39 5.99 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.416 1.486 . . . . 0.0 112.672 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 43.7 p -89.45 16.65 7.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.976 0.91 . . . . 0.0 111.441 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.91 -41.15 99.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.072 0.949 . . . . 0.0 110.796 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -100.6 170.59 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.248 1.019 . . . . 0.0 111.224 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.467 ' HB2' HD23 ' A' 2973 ' ' LEU . 24.8 mt-10 -92.52 85.39 5.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.454 0.702 . . . . 0.0 109.152 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.2 138.31 19.65 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.14 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -46.99 -44.53 22.78 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 124.133 3.222 . . . . 0.0 114.063 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.25 -10.27 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.248 0.619 . . . . 0.0 111.018 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.55 1.8 15.68 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.33 0.652 . . . . 0.0 111.912 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 77.6 18.99 76.79 Favored Glycine 0 C--N 1.355 1.615 0 C-N-CA 123.313 0.482 . . . . 0.0 113.287 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . 0.443 HD13 HD13 ' A' 2964 ' ' LEU . 2.5 pp -76.08 164.21 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.646 0.778 . . . . 0.0 111.876 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 25.0 t -115.97 81.15 1.55 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.478 ' HB3' HG11 ' A' 2968 ' ' VAL . 10.4 mp -112.34 143.24 28.47 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.071 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.61 164.63 34.68 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.321 2.681 . . . . 0.0 113.228 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.6 129.05 38.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' 2989 ' ' LEU . . . 115.12 25.9 3.69 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' 2964 ' ' LEU . 9.0 p -139.21 153.86 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.74 0.816 . . . . 0.0 109.174 176.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' 2972 ' ' PHE . 3.4 t70 -146.03 124.38 6.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.12 0.968 . . . . 0.0 109.1 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 79.0 Cg_endo -73.58 -0.64 9.59 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.979 2.452 . . . . 0.0 113.971 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 13.3 m -68.33 -57.09 6.47 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' 2969 ' ' ASP . 22.7 p90 -72.53 -32.23 65.94 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.58 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.587 ' HG ' ' HD3' ' A' 2981 ' ' ARG . 8.6 tp -67.61 -30.88 70.58 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.786 0.834 . . . . 0.0 111.273 -173.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.82 -43.94 7.99 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.727 0.811 . . . . 0.0 111.616 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.73 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.509 0.724 . . . . 0.0 111.878 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' 2980 ' ' ILE . 79.5 mt -92.78 150.02 38.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.511 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -58.18 165.69 6.78 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.985 2.457 . . . . 0.0 113.612 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.99 -20.29 66.14 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' 2982 ' ' ARG . 16.5 t70 -73.5 -52.54 13.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.634 0.774 . . . . 0.0 112.251 -172.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -82.0 -24.58 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.133 -0.354 . . . . 0.0 110.553 -178.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.587 ' HD3' ' HG ' ' A' 2973 ' ' LEU . 0.8 OUTLIER -71.52 -35.67 70.79 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' 2979 ' ' ASP . 19.3 ptt180 -69.83 -42.76 73.2 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -38.67 84.64 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.944 -174.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 35.3 m -68.32 -40.27 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.482 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . 0.458 HD12 HD23 ' A' 2989 ' ' LEU . 57.4 tp -59.67 -45.88 90.73 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.871 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' 2991 ' ' ILE . 24.0 mt-30 -74.26 -34.85 63.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.885 0.874 . . . . 0.0 111.999 -176.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.82 -36.76 56.68 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.973 0.509 . . . . 0.0 112.136 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.488 ' HB2' HD22 ' A' 2989 ' ' LEU . 20.0 mt-30 -71.59 -56.98 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.346 0.258 . . . . 0.0 111.233 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.4 mm? -97.45 -22.43 16.58 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.67 -170.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 74.74 40.97 35.83 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' 2986 ' ' GLN . 0.0 OUTLIER -110.62 128.64 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 0.0 108.654 -177.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -116.07 131.1 23.93 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.1 -38.98 63.24 Favored 'Trans proline' 0 CA--C 1.573 2.434 0 C-N-CA 123.281 2.654 . . . . 0.0 115.92 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.31 -179.51 3.66 Favored 'Trans proline' 0 C--N 1.401 3.322 0 CA-C-N 122.255 1.841 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 92.6 m -58.9 103.9 0.2 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.469 0.652 . . . . 0.0 111.602 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.42 96.49 0.89 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.879 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 58.4 p -90.55 2.47 55.76 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.11 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 55.38 70.95 1.38 Allowed Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.833 1.253 . . . . 0.0 110.814 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.89 93.09 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.378 2.718 . . . . 0.0 112.94 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 8.4 t 60.89 29.37 18.97 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.149 1.38 . . . . 0.0 111.644 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 9.9 t -146.46 158.74 43.94 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.126 0.971 . . . . 0.0 109.602 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -109.89 132.3 54.28 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 123.961 0.904 . . . . 0.0 109.398 179.134 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.555 1.143 0 CA-C-O 121.691 0.758 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 37.7 m -124.13 -165.96 1.43 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.714 1.206 . . . . 0.0 109.911 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 19.2 m -81.97 -2.75 52.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.583 0.753 . . . . 0.0 111.582 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.15 -40.2 95.18 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.996 0.919 . . . . 0.0 111.05 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . 0.601 ' HA ' ' HB1' ' A' 2974 ' ' ALA . 1.8 pm0 -82.41 141.12 33.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.643 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' 2974 ' ' ALA . 12.6 pt-20 -107.62 154.2 21.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.884 0.873 . . . . 0.0 109.497 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -146.35 139.98 14.93 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.452 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -57.68 -33.19 96.34 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.377 2.718 . . . . 0.0 113.688 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.0 -14.89 61.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.119 0.567 . . . . 0.0 110.455 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -61.99 -21.48 64.88 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.979 0.512 . . . . 0.0 111.68 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 114.3 5.67 20.99 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 123.605 0.621 . . . . 0.0 113.047 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 14.5 pt -92.69 147.68 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.285 0.634 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 47.8 t -101.58 95.51 6.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.13 0.972 . . . . 0.0 109.99 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.15 136.84 40.41 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.549 ' HG3' HG21 ' A' 2991 ' ' ILE . 52.1 Cg_endo -66.61 141.82 62.02 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.712 2.274 . . . . 0.0 112.02 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.97 122.51 16.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.225 0.61 . . . . 0.0 111.573 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 117.07 -19.87 11.73 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.722 0.639 . . . . 0.0 112.961 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.667 ' HB ' HD21 ' A' 2989 ' ' LEU . 4.7 p -96.57 155.34 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 118.106 0.953 . . . . 0.0 109.071 171.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -130.82 129.91 22.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.66 -16.26 50.0 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.123 2.548 . . . . 0.0 114.627 -171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 23.9 m -62.92 -55.39 26.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.737 0.415 . . . . 0.0 111.082 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 20.0 p90 -74.9 -30.71 61.37 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.856 0.36 . . . . 0.0 110.126 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . . . . . . . . . 15.3 tp -64.36 -42.05 96.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.713 0.805 . . . . 0.0 110.737 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . 0.62 ' HB2' ' HG2' ' A' 2956 ' ' GLU . . . -93.82 -28.67 15.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.736 0.814 . . . . 0.0 112.535 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -78.38 -43.81 26.59 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.64 0.376 . . . . 0.0 111.425 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' 2980 ' ' ILE . 97.2 mt -80.48 157.96 71.95 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.28 1.032 . . . . 0.0 110.749 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.59 -179.47 0.5 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.941 2.427 . . . . 0.0 114.378 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . 0.592 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 6.7 p-10 -72.03 -28.64 63.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.751 0.42 . . . . 0.0 111.996 -172.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.19 -55.38 18.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.329 0.652 . . . . 0.0 112.344 -170.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -79.26 -18.69 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.516 -177.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' 2978 ' ' ASP . 0.0 OUTLIER -74.56 -38.45 62.69 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -177.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' 2978 ' ' ASP . 12.2 ptm180 -75.88 -34.44 60.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' 2980 ' ' ILE . 6.8 tp10 -53.06 -52.08 59.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.767 1.227 . . . . 0.0 110.599 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 34.7 m -77.59 -31.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.502 0.321 . . . . 0.0 111.328 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.98 -53.28 18.41 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.421 0.629 . . . . 0.0 111.062 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -44.31 68.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.099 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -77.01 -39.59 49.69 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.25 -55.36 6.13 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.836 0.289 . . . . 0.0 111.418 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' 2968 ' ' VAL . 1.9 mm? -84.98 -29.91 24.66 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.171 0.294 . . . . 0.0 110.645 -172.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 84.19 5.47 87.35 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.726 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.549 HG21 ' HG3' ' A' 2965 ' ' PRO . 0.0 OUTLIER -72.32 127.74 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.67 0.788 . . . . 0.0 109.086 -177.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -97.04 119.43 63.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.04 -43.23 37.64 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 C-N-CA 122.537 2.158 . . . . 0.0 113.592 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.87 113.82 3.78 Favored 'Trans proline' 0 C--N 1.409 3.712 0 CA-C-N 121.776 1.67 . . . . 0.0 112.152 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 9.8 t -84.37 144.27 28.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.462 0.705 . . . . 0.0 109.68 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -80.14 95.65 6.3 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.724 0.774 . . . . 0.0 110.528 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 39.1 p -116.31 -10.57 11.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.159 0.984 . . . . 0.0 110.625 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -71.66 142.25 85.89 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.565 0.746 . . . . 0.0 109.682 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.83 25.53 0.68 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.919 2.413 . . . . 0.0 112.569 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 13.1 m -79.93 145.32 32.69 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.626 1.17 . . . . 0.0 109.794 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 22.3 m -79.3 82.25 5.47 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 39.2 t30 -105.11 116.09 31.37 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.224 1.009 . . . . 0.0 108.433 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 35.4 p . . . . . 0 CA--C 1.556 1.204 0 C-N-CA 123.183 0.593 . . . . 0.0 110.613 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 50.0 m -68.14 88.4 0.29 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.569 0.747 . . . . 0.0 109.546 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 19.9 m -126.54 -0.35 6.86 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 0.0 110.462 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.32 -22.91 59.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.612 0.765 . . . . 0.0 110.846 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -74.24 94.87 2.54 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.621 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.51 ' HB2' HH22 ' A' 2981 ' ' ARG . 33.5 tt0 -109.32 86.74 2.34 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.94 128.6 26.89 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.27 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . 0.465 ' HD3' HD21 ' A' 2964 ' ' LEU . 42.1 Cg_endo -63.27 -30.92 74.12 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.282 1.988 . . . . 0.0 112.287 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' 2959 ' ' LEU . 1.0 OUTLIER -86.13 -7.17 58.77 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.331 0.652 . . . . 0.0 110.064 -177.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -65.86 -19.83 66.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.993 -0.442 . . . . 0.0 111.071 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.79 -3.39 28.95 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.523 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.8 pp -88.66 176.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.084 0.554 . . . . 0.0 111.246 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 46.1 p -120.91 113.48 20.18 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.465 HD21 ' HD3' ' A' 2958 ' ' PRO . 2.3 pp -103.42 152.43 38.76 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.689 0.795 . . . . 0.0 109.751 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.24 177.58 8.69 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.807 2.338 . . . . 0.0 113.504 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.68 150.97 42.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.288 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 67.3 21.76 72.38 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.7 0.625 . . . . 0.0 112.915 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 90.6 t -129.38 95.66 2.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.741 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.58 133.95 36.96 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.154 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.37 -14.44 45.02 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.349 2.699 . . . . 0.0 115.015 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 59.0 m -62.45 -56.07 21.69 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.46 0.573 . . . . 0.0 111.404 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 39.2 p90 -72.47 -30.78 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.409 0.623 . . . . 0.0 110.522 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' 2981 ' ' ARG . 17.0 tp -69.81 -33.08 71.86 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.471 -171.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.98 -49.59 5.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.838 . . . . 0.0 111.339 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.45 74.49 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.44 ' HB3' HD11 ' A' 2980 ' ' ILE . 71.7 mt -83.52 158.78 62.62 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.799 0.84 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.35 178.06 1.0 Allowed 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 123.238 2.625 . . . . 0.0 114.003 -173.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.85 -26.94 65.4 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.48 -54.7 28.39 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.139 0.576 . . . . 0.0 112.072 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -76.48 -32.25 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.637 -178.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.553 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.1 OUTLIER -66.53 -39.88 88.84 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.756 0.312 . . . . 0.0 110.265 -175.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -74.62 -38.38 62.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.159 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 10.3 pt-20 -73.49 -38.61 65.32 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.259 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 32.6 m -66.41 -34.32 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.326 0.512 . . . . 0.0 110.261 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.23 -52.99 63.29 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.405 0.682 . . . . 0.0 110.136 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -68.78 -40.01 79.89 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.832 -1.077 . . . . 0.0 112.263 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.14 -41.4 50.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.151 0.581 . . . . 0.0 111.223 -172.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -70.49 -57.06 5.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.8 0.44 . . . . 0.0 111.259 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.15 -34.74 20.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.829 0.452 . . . . 0.0 111.298 -171.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 79.93 20.82 67.07 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.66 -165.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.68 129.37 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -92.38 126.94 50.7 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.244 0.617 . . . . 0.0 109.672 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.09 -43.67 45.99 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.304 2.003 . . . . 0.0 113.593 168.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.2 95.69 0.44 Allowed 'Trans proline' 0 C--N 1.407 3.655 0 C-N-CA 121.967 1.778 . . . . 0.0 111.773 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 24.7 p -68.55 119.21 12.64 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.91 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -74.28 94.68 2.53 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.889 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 82.3 p -84.92 -43.46 14.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.099 0.959 . . . . 0.0 108.976 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -78.02 155.32 80.1 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.098 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.12 8.33 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.133 2.555 . . . . 0.0 113.721 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 14.8 m -62.81 84.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.471 1.109 . . . . 0.0 110.088 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 23.5 m -90.33 129.15 36.58 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.31 147.21 27.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.233 0.613 . . . . 0.0 109.559 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.117 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.382 0.134 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 66.0 m -66.25 111.85 3.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 0.0 111.106 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 33.5 t -122.75 -15.48 7.44 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.652 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' 2955 ' ' GLU . 12.2 pt-20 -87.79 -31.79 19.42 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.02 0.528 . . . . 0.0 110.728 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' 2954 ' ' GLU . 0.6 OUTLIER -142.13 130.03 21.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.846 0.858 . . . . 0.0 109.447 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' 2970 ' ' PRO . 11.0 mp0 -108.88 105.49 15.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -105.31 127.36 28.77 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 123.553 0.741 . . . . 0.0 109.608 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.34 -43.79 36.62 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.71 2.94 . . . . 0.0 113.837 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.77 -4.82 55.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.093 0.957 . . . . 0.0 112.017 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -76.81 -10.82 59.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.902 0.481 . . . . 0.0 111.094 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.15 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 113.593 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.6 pp -75.81 175.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.339 0.656 . . . . 0.0 111.089 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 22.9 p -122.46 93.06 3.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.114 0.566 . . . . 0.0 109.913 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 152.89 48.64 Favored Pre-proline 0 N--CA 1.481 1.077 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' 2968 ' ' VAL . 33.8 Cg_endo -62.92 152.47 78.93 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.535 2.156 . . . . 0.0 112.35 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.42 145.64 50.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.285 0.634 . . . . 0.0 111.66 -176.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 77.57 18.28 77.85 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.228 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' 2965 ' ' PRO . 38.7 t -120.26 114.75 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.132 0.973 . . . . 0.0 109.44 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -85.64 126.74 65.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 123.556 0.535 . . . . 0.0 109.694 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' 2973 ' ' LEU . 58.6 Cg_endo -68.65 -9.36 25.92 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.502 2.801 . . . . 0.0 113.811 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.0 m -58.4 -57.44 12.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.311 0.644 . . . . 0.0 111.251 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -77.14 -31.86 55.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.494 ' HB3' ' HA ' ' A' 2970 ' ' PRO . 15.6 tp -67.08 -31.16 71.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.056 0.942 . . . . 0.0 111.172 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.37 -52.24 4.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.911 0.884 . . . . 0.0 111.373 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.12 76.83 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.837 ' HB3' HD11 ' A' 2980 ' ' ILE . 90.2 mt -81.32 150.57 67.82 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 0.0 110.462 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.3 170.16 8.35 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.44 2.76 . . . . 0.0 113.592 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' 2981 ' ' ARG . 4.5 p-10 -66.84 -18.73 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -169.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.51 -55.64 8.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.029 0.531 . . . . 0.0 111.84 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.837 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -75.14 -29.75 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 119.289 -0.386 . . . . 0.0 110.193 175.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' A' 2978 ' ' ASP . 23.0 tpt85 -50.97 -49.19 60.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.234 1.013 . . . . 0.0 111.37 173.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.69 -39.4 61.99 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 11.4 pt-20 -72.25 -42.68 65.36 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.706 -175.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 21.0 m -65.65 -30.06 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 118.326 0.512 . . . . 0.0 110.197 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.04 -48.8 77.18 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.46 -28.41 41.58 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -77.66 -49.84 13.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.887 0.475 . . . . 0.0 111.089 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.553 ' HB2' HD22 ' A' 2989 ' ' LEU . 26.3 mm-40 -62.85 -56.63 15.67 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.512 0.507 . . . . 0.0 110.791 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' 2988 ' ' GLN . 1.6 mm? -97.32 -37.25 10.12 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 76.87 23.1 70.24 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 123.335 0.397 . . . . 0.0 112.209 -169.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.423 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -80.74 127.42 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.4 121.21 62.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.339 0.656 . . . . 0.0 109.926 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.23 -42.09 37.84 Favored 'Trans proline' 0 CA--C 1.575 2.557 0 C-N-CA 122.298 1.998 . . . . 0.0 113.652 164.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.33 127.2 13.82 Favored 'Trans proline' 0 C--N 1.408 3.709 0 C-N-CA 122.011 1.808 . . . . 0.0 112.3 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 70.8 p -86.72 105.83 17.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.722 0.809 . . . . 0.0 109.276 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -66.16 97.22 0.37 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.109 0.564 . . . . 0.0 109.845 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 40.2 p -116.0 44.13 2.0 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.486 1.114 . . . . 0.0 108.616 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 60.62 69.7 1.09 Allowed Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 125.039 1.336 . . . . 0.0 110.317 -168.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -63.29 121.31 9.08 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.973 2.448 . . . . 0.0 112.697 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 33.0 p -71.97 -32.6 67.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.942 0.897 . . . . 0.0 110.229 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 12.6 t -71.98 142.99 49.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.646 0.778 . . . . 0.0 110.232 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 19.9 m120 -91.63 102.89 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 123.791 0.837 . . . . 0.0 108.877 -178.353 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 21.5 m -85.1 71.76 10.87 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.194 0.597 . . . . 0.0 109.783 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 22.7 t -117.22 23.36 11.89 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.553 0.741 . . . . 0.0 109.836 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.32 -39.22 82.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.085 0.954 . . . . 0.0 110.33 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.97 100.36 7.17 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.54 86.48 7.09 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 122.096 0.951 . . . . 0.0 109.951 -175.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . 0.412 ' O ' HD11 ' A' 2962 ' ' ILE . 30.5 m-20 -71.99 143.38 86.38 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.946 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -78.4 22.61 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.063 2.509 . . . . 0.0 113.483 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 2959 ' ' LEU . 0.2 OUTLIER -134.8 4.0 3.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.959 0.904 . . . . 0.0 109.137 171.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.2 60.99 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.519 0.728 . . . . 0.0 112.605 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 118.56 -20.58 10.16 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 123.013 0.34 . . . . 0.0 112.442 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . 0.665 HD13 HD23 ' A' 2964 ' ' LEU . 2.3 pp -72.83 176.65 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.46 1.104 . . . . 0.0 112.332 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 19.2 m -91.12 76.64 6.1 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 121.135 0.493 . . . . 0.0 111.544 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . 0.665 HD23 HD13 ' A' 2962 ' ' ILE . 2.8 mm? -121.88 114.45 31.06 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.74 -171.32 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.636 2.891 . . . . 0.0 113.089 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.87 144.14 30.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.088 0.955 . . . . 0.0 109.795 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 91.07 20.21 39.93 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.074 0.234 . . . . 0.0 113.128 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 3.3 p -141.44 106.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 124.074 0.949 . . . . 0.0 109.6 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.12 140.92 77.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.053 0.541 . . . . 0.0 110.997 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.35 -10.35 23.93 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.061 2.507 . . . . 0.0 112.434 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 18.4 m -58.64 -59.0 6.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.39 1.076 . . . . 0.0 110.595 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' 2976 ' ' LEU . 34.0 p90 -79.64 -28.33 40.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.749 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' 2981 ' ' ARG . 0.5 OUTLIER -65.17 -38.54 90.86 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.842 0.857 . . . . 0.0 110.472 -174.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.83 11.44 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.927 0.491 . . . . 0.0 111.468 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -69.41 -48.96 59.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.691 ' HB3' HD11 ' A' 2980 ' ' ILE . 93.9 mt -79.42 156.54 75.9 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.929 0.892 . . . . 0.0 110.088 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.09 -178.56 1.77 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.187 2.591 . . . . 0.0 113.593 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' 2982 ' ' ARG . 3.6 p30 -72.71 -27.3 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -171.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.81 -52.74 58.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.637 0.775 . . . . 0.0 112.963 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' 2976 ' ' LEU . 0.2 OUTLIER -76.78 -23.08 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' 2973 ' ' LEU . 0.1 OUTLIER -74.56 -36.23 63.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.243 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' 2978 ' ' ASP . 5.8 ptm180 -69.81 -40.64 75.8 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 8.5 pt-20 -69.97 -38.36 76.04 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.223 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' 2980 ' ' ILE . 33.1 m -69.36 -31.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.87 0.759 . . . . 0.0 110.708 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.13 -50.32 68.69 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.58 0.705 . . . . 0.0 110.967 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -80.27 -45.69 17.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.954 -173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.5 -43.08 81.76 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.06 -56.35 4.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.141 0.276 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.66 -52.63 5.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.251 0.221 . . . . 0.0 111.164 -172.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 106.24 -12.54 44.21 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.786 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.42 125.89 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.368 0.667 . . . . 0.0 109.536 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -93.71 123.1 60.84 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.051 0.54 . . . . 0.0 110.058 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 -38.89 62.58 Favored 'Trans proline' 0 CA--C 1.582 2.914 0 C-N-CA 122.875 2.383 . . . . 0.0 114.771 170.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 93.39 0.43 Allowed 'Trans proline' 0 C--N 1.409 3.725 0 CA-C-N 122.431 1.904 . . . . 0.0 111.717 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 18.1 p -139.48 132.39 29.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.045 1.338 . . . . 0.0 107.841 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -65.19 92.73 0.12 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.282 1.039 . . . . 0.0 109.888 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 17.2 p -113.93 100.6 8.55 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.623 -1.172 . . . . 0.0 109.325 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 63.57 101.44 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 111.716 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.4 110.04 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.063 1.842 . . . . 0.0 109.587 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 29.9 t -80.41 66.69 6.0 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.125 0.964 . . . . 0.0 111.078 -171.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 61.6 m -145.8 98.45 3.12 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -87.64 97.05 10.66 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.705 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.56 1.356 0 C-N-CA 124.778 1.231 . . . . 0.0 110.959 -179.093 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.342 0.115 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 25.9 m -96.77 62.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.863 0.84 . . . . 0.0 110.513 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 50.6 m -85.06 16.33 3.55 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.095 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.11 -42.13 66.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -158.84 108.21 1.95 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.236 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.28 114.79 29.09 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' 2960 ' ' ALA . 13.6 t70 -62.17 138.54 96.03 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.283 1.033 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . 0.516 ' HD3' ' HG3' ' A' 2970 ' ' PRO . 29.5 Cg_endo -60.57 -35.15 91.26 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.234 . . . . 0.0 112.846 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 28.6 tp -91.05 7.31 41.04 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.663 0.785 . . . . 0.0 111.333 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' 2957 ' ' ASP . . . -69.77 -9.98 56.64 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 107.98 4.69 33.59 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 47.0 pt -79.04 168.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.969 0.508 . . . . 0.0 110.453 173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 35.3 p -127.62 88.03 2.72 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.012 0.525 . . . . 0.0 110.477 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 4.3 pp -107.66 149.67 39.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.42 156.34 32.59 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.593 2.196 . . . . 0.0 111.911 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.67 121.93 16.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 116.71 -21.93 11.09 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.7 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . . . . . . . . . 93.4 t -88.63 104.11 14.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.402 0.681 . . . . 0.0 109.541 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.34 126.44 92.7 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.009 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . 0.516 ' HG3' ' HD3' ' A' 2958 ' ' PRO . 53.7 Cg_endo -65.8 -8.01 18.34 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.879 2.386 . . . . 0.0 112.444 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -59.11 5.37 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.497 1.119 . . . . 0.0 110.737 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' 2976 ' ' LEU . 28.8 p90 -80.23 -32.42 38.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.9 0.381 . . . . 0.0 110.387 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' 2981 ' ' ARG . 26.6 tp -63.98 -45.08 90.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.465 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -94.3 -49.75 5.57 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.969 0.508 . . . . 0.0 111.733 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.9 63.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' 2980 ' ' ILE . 82.7 mt -95.65 160.79 29.58 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.481 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 57.8 Cg_endo -66.3 176.73 3.73 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.416 2.077 . . . . 0.0 112.854 -174.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' 2981 ' ' ARG . 27.2 t70 -70.25 -21.39 62.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.205 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.44 -55.28 16.46 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 123.415 0.686 . . . . 0.0 111.741 -168.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.486 ' HA ' ' HG2' ' A' 2983 ' ' GLU . 0.2 OUTLIER -78.04 -31.89 16.98 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 -177.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.54 ' HB2' HD12 ' A' 2973 ' ' LEU . 0.4 OUTLIER -67.39 -35.84 80.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.741 0.417 . . . . 0.0 110.597 -175.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' 2978 ' ' ASP . 8.7 ptm180 -73.76 -46.2 47.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' 2980 ' ' ILE . 14.1 pt-20 -69.0 -34.9 76.02 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.455 -174.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 25.0 m -73.08 -34.85 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.04 -43.35 99.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.677 0.751 . . . . 0.0 110.673 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.05 -44.86 45.31 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.776 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' 2987 ' ' ASN . 0.8 OUTLIER -76.68 -33.21 58.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.688 0.395 . . . . 0.0 112.0 -173.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.493 ' HB2' HD22 ' A' 2989 ' ' LEU . 20.8 mt-30 -82.47 -52.25 7.05 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.547 0.339 . . . . 0.0 111.235 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' 2991 ' ' ILE . 2.0 mm? -97.43 -39.98 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.635 0.374 . . . . 0.0 110.979 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 90.81 17.88 49.96 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.534 -0.303 . . . . 0.0 112.775 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' 2989 ' ' LEU . 0.0 OUTLIER -108.02 130.23 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -105.59 140.5 21.23 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.48 -42.31 62.67 Favored 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.338 2.025 . . . . 0.0 114.773 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.42 137.56 25.77 Favored 'Trans proline' 0 C--N 1.399 3.222 0 CA-C-N 121.919 1.721 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 36.7 p -69.31 99.47 1.19 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.014 0.926 . . . . 0.0 111.056 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -70.08 124.4 24.0 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.039 0.447 . . . . 0.0 109.854 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 2.8 t -145.18 99.36 3.3 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.62 0.768 . . . . 0.0 109.697 -172.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . -72.58 122.77 88.39 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.7 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.25 -24.76 27.77 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.563 2.842 . . . . 0.0 114.802 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 22.9 t -72.75 -31.94 65.3 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.193 0.597 . . . . 0.0 111.61 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 88.8 m -116.94 127.73 54.51 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.246 0.618 . . . . 0.0 110.3 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -64.46 101.37 0.44 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.432 0.634 . . . . 0.0 111.087 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.549 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 109.721 -174.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 2951 ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 2952 ' ' SER . . . . . . . . . . . . . 50.8 m -120.12 82.18 1.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.756 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2953 ' ' SER . . . . . . . . . . . . . 14.7 m -116.86 18.19 14.85 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.666 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2954 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 70.47 9.61 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.709 1.242 . . . . 0.0 110.463 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2955 ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.67 105.85 2.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.573 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2956 ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.63 126.44 42.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2957 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.1 126.07 64.09 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.075 0.95 . . . . 0.0 109.763 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2958 ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.92 -30.57 67.44 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.624 2.216 . . . . 0.0 112.889 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2959 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -77.83 -21.23 51.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.432 0.693 . . . . 0.0 110.136 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2960 ' ' ALA . . . . . . . . . . . . . . . -58.94 -21.02 57.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.612 0.765 . . . . 0.0 112.679 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2961 ' ' GLY . . . . . . . . . . . . . . . 110.87 -2.63 28.76 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 123.191 0.424 . . . . 0.0 112.767 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2962 ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.0 172.73 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.354 0.662 . . . . 0.0 110.903 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2963 ' ' SER . . . . . . . . . . . . . 28.3 t -112.87 109.77 19.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.481 0.713 . . . . 0.0 109.862 -177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2964 ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.44 155.6 56.85 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.48 0.712 . . . . 0.0 109.208 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2965 ' ' PRO . . . . . 0.543 ' HB2' ' HG ' ' A' 2989 ' ' LEU . 59.3 Cg_endo -70.29 157.65 58.68 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.314 2.009 . . . . 0.0 112.067 170.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2966 ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -70.77 141.62 51.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.645 0.778 . . . . 0.0 111.431 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2967 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.39 70.24 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.807 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2968 ' ' VAL . . . . . 0.534 HG21 HD21 ' A' 2989 ' ' LEU . 82.6 t -128.54 96.93 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2969 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.62 156.4 41.17 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 124.004 0.922 . . . . 0.0 109.215 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2970 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.22 9.31 2.15 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.555 2.17 . . . . 0.0 112.84 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2971 ' ' SER . . . . . . . . . . . . . 19.2 m -63.11 -61.41 2.4 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.214 1.005 . . . . 0.0 111.21 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2972 ' ' PHE . . . . . . . . . . . . . 23.9 p90 -78.26 -24.27 46.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.679 0.792 . . . . 0.0 111.28 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2973 ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' 2981 ' ' ARG . 68.3 mt -69.43 -37.45 77.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.28 0.632 . . . . 0.0 110.808 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2974 ' ' ALA . . . . . . . . . . . . . . . -91.83 -24.89 19.22 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.788 0.835 . . . . 0.0 112.208 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2975 ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.4 70.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.209 0.604 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2976 ' ' LEU . . . . . 0.462 ' HB3' ' HD2' ' A' 2977 ' ' PRO . 55.9 mt -107.52 164.25 15.19 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.339 1.056 . . . . 0.0 109.346 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2977 ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' 2976 ' ' LEU . 44.1 Cg_endo -60.35 155.29 47.34 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 123.685 2.924 . . . . 0.0 113.078 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2978 ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.76 -17.33 5.83 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.924 1.29 . . . . 0.0 113.54 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2979 ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.91 -39.39 90.53 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.143 0.977 . . . . 0.0 111.614 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2980 ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' 2981 ' ' ARG . 0.1 OUTLIER -69.94 -32.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2981 ' ' ARG . . . . . 0.509 ' N ' HD13 ' A' 2980 ' ' ILE . 10.5 tpt180 -60.04 -55.34 35.12 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.315 1.046 . . . . 0.0 110.422 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2982 ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -64.38 -43.62 93.91 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.005 0.816 . . . . 0.0 110.961 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2983 ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' 2987 ' ' ASN . 13.5 pt-20 -68.96 -50.34 50.02 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.973 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2984 ' ' VAL . . . . . . . . . . . . . 19.3 m -67.43 -30.42 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.177 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2985 ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' 2991 ' ' ILE . 18.4 tp -61.61 -55.68 28.05 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.888 0.852 . . . . 0.0 109.868 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2986 ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' 2992 ' ' ARG . 46.7 mt-30 -75.2 -34.7 61.53 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.618 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2987 ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' 2983 ' ' GLU . 2.5 t-20 -75.15 -46.85 31.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.19 0.596 . . . . 0.0 110.24 -172.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2988 ' ' GLN . . . . . 0.435 ' HB2' HD22 ' A' 2989 ' ' LEU . 23.5 mt-30 -72.29 -51.7 19.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.737 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2989 ' ' LEU . . . . . 0.548 ' HB2' HG22 ' A' 2991 ' ' ILE . 1.0 OUTLIER -102.17 -40.04 6.98 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -171.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2990 ' ' GLY . . . . . . . . . . . . . . . 102.19 0.03 50.92 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.559 0.537 . . . . 0.0 112.799 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2991 ' ' ILE . . . . . 0.584 HG23 ' HG ' ' A' 2985 ' ' LEU . 0.0 OUTLIER -78.64 121.37 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2992 ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' 2986 ' ' GLN . 10.2 ptp180 -105.81 145.97 31.94 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.669 0.788 . . . . 0.0 109.705 -176.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2993 ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 -44.04 30.36 Favored 'Trans proline' 0 CA--C 1.574 2.496 0 C-N-CA 122.683 2.256 . . . . 0.0 114.377 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2994 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.06 171.74 15.28 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.296 1.856 . . . . 0.0 112.844 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2995 ' ' THR . . . . . . . . . . . . . 60.8 p -79.15 173.72 12.29 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2996 ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -67.13 97.13 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.184 0.992 . . . . 0.0 110.354 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2997 ' ' THR . . . . . . . . . . . . . 19.5 p -118.62 6.75 11.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.546 1.138 . . . . 0.0 111.549 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2998 ' ' ALA . . . . . . . . . . . . . . . 53.92 64.1 6.96 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 125.042 1.337 . . . . 0.0 112.565 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2999 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.13 152.09 30.91 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 3000 ' ' SER . . . . . . . . . . . . . 45.4 p -72.75 129.22 37.72 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.095 0.558 . . . . 0.0 109.694 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 3001 ' ' THR . . . . . . . . . . . . . 14.8 t -63.51 131.75 49.12 Favored 'General case' 0 CA--C 1.554 1.119 0 O-C-N 123.744 0.652 . . . . 0.0 111.147 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 3002 ' ' ASN . . . . . . . . . . . . . 7.0 t30 -84.61 134.25 34.39 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.262 0.625 . . . . 0.0 110.662 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 3003 ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 CA--C 1.551 1.004 0 C-N-CA 124.104 0.961 . . . . 0.0 108.932 176.773 . . . . . . . . 0 0 . 1 stop_ save_